[
  {
    "id": 1,
    "source": "guideline_c3debd",
    "text": "APA CLINICAL PRACTICE GUIDELINE for the Treatment of Depression Across Three Age Cohorts GUIDELINE DEVELOPMENT PANEL FOR THE TREATMENT OF DEPRESSIVE DISORDERS APPROVED BY APA COUNCIL OF REPRESENTATIVES FEBRUARY 2019 APA   Guideline for the Treatment of Depression I Copyright   2019 by the American Psychological Association. This material may be reproduced and distributed without permission provided that acknowledgment is given to the American Psychological Association. This material may not be reprinted, translated, or distributed electronically without prior permission in writing from the publisher. For permission, contact APA, Rights and Permissions, 750 First Street, NE, Washington, DC 20002-4242. This document was approved by the APA Council of Representatives over the course of its"
  },
  {
    "id": 2,
    "source": "guideline_c3debd",
    "text": "For permission, contact APA, Rights and Permissions, 750 First Street, NE, Washington, DC 20002-4242. This document was approved by the APA Council of Representatives over the course of its February 2019 meeting and is set to expire in approximately 2024. It is available online at  Please refer to p. 59 of this guideline for a statement on conflicts of interest as well as p. 61 for acknowledgments. Correspondence concerning this guideline should be addressed to Practice Directorate, American Psychological Association, 750 First Street, NE, Washington, DC 20002-4242. E-mail: cpg apa.org Suggested Citation American Psychological Association. (2019). Clinical practice guideline for the treatment of depression across three age cohorts. Retrieved from  II APA   Guideline for the Treatment of"
  },
  {
    "id": 3,
    "source": "guideline_c3debd",
    "text": "Citation American Psychological Association. (2019). Clinical practice guideline for the treatment of depression across three age cohorts. Retrieved from  II APA   Guideline for the Treatment of Depression APA CLINICAL PRACTICE GUIDELINE for the Treatment of Depression Across Three Age Cohorts Guideline Development Panel APA Staff John R. McQuaid (chair) Vanessa Y. Jones Lynn F. Bufka Department of Veteran s Affairs Washington, District of Columbia Practice Transformation and Quality San Francisco, California Practice Directorate Michael  Misha  Kessler Elizabeth H. Lin (vice-chair) New York, New York Raquel W. Halfond University of Washington School of Medicine Practice Transformation and Quality Laura H. Mufson Practice Directorate Jacques P. Barber Department of Psychiatry Gordon F."
  },
  {
    "id": 4,
    "source": "guideline_c3debd",
    "text": "New York Raquel W. Halfond University of Washington School of Medicine Practice Transformation and Quality Laura H. Mufson Practice Directorate Jacques P. Barber Department of Psychiatry Gordon F. Derner School of Psychology Columbia University College of Physicians and Howard S. Kurtzman Adelphi University Surgeons Science Directorate Alfiee M. Breland-Noble Arthur M. Nezu AAKOMA Project Department of Psychology Arlington, Virginia Drexel University Pim Cuijpers Charles F. Reynolds, III Faculty of Behavioural and Movement Sciences Department of Psychiatry Vrijie Universiteit Amsterdam, Netherlands University of Pittsburgh School of Medicine Leslie S. Greenberg Forrest Scogin, Jr. Department of Psychology Department of Psychology York University, Toronto, Ontario, Canada University of"
  },
  {
    "id": 5,
    "source": "guideline_c3debd",
    "text": "University of Pittsburgh School of Medicine Leslie S. Greenberg Forrest Scogin, Jr. Department of Psychology Department of Psychology York University, Toronto, Ontario, Canada University of Alabama literature about treatments as well as limitations in the specific literature ABSTRACT reviewed by the panel due to methodological constraints, as discussed The American Psychological Association developed this clinical practice later in the guideline document. Clinicians are encouraged to provide guideline to provide recommendations for the treatment of depressive informed consent to patients. disorders (including major depression, subsyndromal depression, and per- sistent depressive disorder). It addresses three developmental cohorts: children and adolescents; general adults; and older adults"
  },
  {
    "id": 6,
    "source": "guideline_c3debd",
    "text": "(including major depression, subsyndromal depression, and per- sistent depressive disorder). It addresses three developmental cohorts: children and adolescents; general adults; and older adults (ages 60 and INDIVIDUALIZING TREATMENT over). Ten systematic reviews and meta-analyses, along with other litera- Clinicians strive to individualize treatments. So how might one follow ture and observations from practitioners and patients, served as the basis evidence-based clinical practice guidelines, yet honor the individuality for the guideline. The guideline development panel consisted of health of patients? A comprehensive assessment can help identify factors that professionals from psychology, psychiatry, and primary care as well as might require modifications to a treatment recommended by"
  },
  {
    "id": 7,
    "source": "guideline_c3debd",
    "text": "of patients? A comprehensive assessment can help identify factors that professionals from psychology, psychiatry, and primary care as well as might require modifications to a treatment recommended by clinical community members who self-identified as having had depression. The practice guidelines. These include patient factors such as race; ethnicity; panel examined the efficacy of psychological treatments and of comple- socioeconomic status; culture and or heritage; or other features of their mentary and alternative medicine treatments. It also examined compara- identities, values, or preferences. In addition, the patient s comorbidities, tive effectiveness among psychological treatments (by themselves and in social support, and ability to obtain childcare when needed, as well as the"
  },
  {
    "id": 8,
    "source": "guideline_c3debd",
    "text": "In addition, the patient s comorbidities, tive effectiveness among psychological treatments (by themselves and in social support, and ability to obtain childcare when needed, as well as the combination with pharmacotherapy) and comparative effectiveness of clinician s accessibility, location, hours of operation, available appoint- psychological treatments in relation to pharmacotherapy and to comple- ments, proximity to public transportation, and other resources that can mentary and alternative treatments. The panel made no treatment recom- affect treatment, must be considered. Further, provider and setting fac- mendations specific to children but did make recommendations for tors like constraints tied to duration of treatment, provider availability, or treatment of depression in"
  },
  {
    "id": 9,
    "source": "guideline_c3debd",
    "text": "provider and setting fac- mendations specific to children but did make recommendations for tors like constraints tied to duration of treatment, provider availability, or treatment of depression in adolescents, adults, and older adults. These other factors will impact the application of a treatment recommended by recommendations are detailed in the guideline. a clinical practice guideline. Combining an individual assessment with the research summarized in the clinical practice guideline can help develop Keywords: Depression; clinical practice guideline; best practices a conceptualization of the change processes that underpin the effective treatment to guide individualization decisions. This can promote  flex- ibility within fidelity  (Kendall, Gosch, Furr,   Sood, 2008) to facilitate"
  },
  {
    "id": 10,
    "source": "guideline_c3debd",
    "text": "of the change processes that underpin the effective treatment to guide individualization decisions. This can promote  flex- ibility within fidelity  (Kendall, Gosch, Furr,   Sood, 2008) to facilitate INTENDED USE OF GUIDELINE the use of research-supported change processes to achieve the patient s goals while individualizing the specific strategies. Especially when a rec- This guideline is intended to be aspirational and is not intended to create a ommended treatment is modified, providing full informed consent about requirement for practice. It is not intended to limit scope of practice in possible treatments is necessary. It is also important across models to licensing laws for psychologists or for other independently licensed profes- set individualized treatment goals collaboratively"
  },
  {
    "id": 11,
    "source": "guideline_c3debd",
    "text": "possible treatments is necessary. It is also important across models to licensing laws for psychologists or for other independently licensed profes- set individualized treatment goals collaboratively with the patient and sionals, nor limit coverage for reimbursement by third party payers. Nor is clearly monitor progress on those goals. All these steps can help provid- the guideline intended to be used within a legal or judicial context to imply ers use the guidelines in a way that respects the enormous variability in that psychologists or other independently licensed professionals are patients  needs and backgrounds. For more information about individu- required to comply with any of its recommendations. alizing treatments, see p. 43 of this guideline. The term guideline refers to"
  },
  {
    "id": 12,
    "source": "guideline_c3debd",
    "text": "patients  needs and backgrounds. For more information about individu- required to comply with any of its recommendations. alizing treatments, see p. 43 of this guideline. The term guideline refers to statements that suggest or recommend specific professional behavior, endeavor, or conduct for psychologists and may be useful for other clinicians. Guidelines differ from standards in that standards are mandatory and may be accompanied by an enforce- ment mechanism. Thus, guidelines are aspirational in intent. They are intended to facilitate the continued systematic development of the pro- fession and to help assure a high level of professional practice by psy- chologists. Guidelines are not intended to be mandatory or exhaustive and may not be applicable to every professional and clinical"
  },
  {
    "id": 13,
    "source": "guideline_c3debd",
    "text": "and to help assure a high level of professional practice by psy- chologists. Guidelines are not intended to be mandatory or exhaustive and may not be applicable to every professional and clinical situation. They are not definitive, and they are not intended to take precedence over the judgment of psychologists. Please refer to the APA s (2015a) Professional Practice Guidelines: Guidance for Developers and Users for a discussion of the several types of guidelines produced by APA. Clinical practice guidelines are an important tool for determining intervention options but are not the only resource. Clinicians are encouraged to consider the report from the APA Presidential Task Force on Evidence-Based Practice (APA, 2006), Evidence-Based Practice in Psychology, which emphasizes the"
  },
  {
    "id": 14,
    "source": "guideline_c3debd",
    "text": "resource. Clinicians are encouraged to consider the report from the APA Presidential Task Force on Evidence-Based Practice (APA, 2006), Evidence-Based Practice in Psychology, which emphasizes the integration of best available research; patient characteristics, culture, and preferenc- es; and clinical expertise for making treatment decisions. In reviewing the recommendation statements, the panel reminds the reader that a lack of evidence about a treatment does not imply that that treatment is not efficacious. Rather, there are several gaps in the TABLE OF CONTENTS Abstract II Considerations for Treatment Implementation 41 Intended Use of Guideline II Importance of Informed Consent 41 Table of Contents 1 Improving Access While Supporting Patient Culture, Values, and Preferences 42 Executive"
  },
  {
    "id": 15,
    "source": "guideline_c3debd",
    "text": "Treatment Implementation 41 Intended Use of Guideline II Importance of Informed Consent 41 Table of Contents 1 Improving Access While Supporting Patient Culture, Values, and Preferences 42 Executive Summary 3 Table 1: Recommendations for the Child Population from the APA Table 6: Patients  Values and Preferences 42 Guideline Development Panel for the Treatment of Depression 7 Adapting Treatment to Fit the Individual 43 Table 2: Recommendations for the Adolescent Population from the APA Considering Patients  Diverse Backgrounds, Identities, and Guideline Development Panel for the Treatment of Depression 8 Comorbidities 44 Table 3: Recommendations for the General Adult Population from the Generalizability of Treatments to Different Settings and Providers 44 APA Guideline Development Panel"
  },
  {
    "id": 16,
    "source": "guideline_c3debd",
    "text": "Depression 8 Comorbidities 44 Table 3: Recommendations for the General Adult Population from the Generalizability of Treatments to Different Settings and Providers 44 APA Guideline Development Panel for the Treatment of Depression 10 Monitoring Engagement with Treatment 44 Table 4: Recommendations for the Older Adult Population from the APA Contributions from Shared and Specific Factors Guideline Development Panel for the Treatment of Depression 13 to Treatment Outcome 45 Clinical Practice Guideline for the Treatment of Depression Enhancing Therapeutic Alliance and Other Across Three Age Cohorts 18 Principles Processes of Change 46 Scope of the Problem 19 Change Principles 47 Children and Adolescents 20 Change Mechanisms 47 General Adult Population 22 Change Events 47 Older Adult"
  },
  {
    "id": 17,
    "source": "guideline_c3debd",
    "text": "Age Cohorts 18 Principles Processes of Change 46 Scope of the Problem 19 Change Principles 47 Children and Adolescents 20 Change Mechanisms 47 General Adult Population 22 Change Events 47 Older Adult Population 23 How the APA Clinical Practice Guideline Compares to Other The Need for a Clinical Practice Guideline and Decisions Clinical Practice Guidelines for Treatment of Depression 48 about Scope and Goals of the Clinical Practice Guideline 25 Challenges in Developing the Guideline The APA Clinical Practice Guideline for the Treatment of the Problem 25 and Recommendations for Future Efforts 51 Guideline Purpose and Scope: What the Guideline Does Considerations Regarding Guideline Scope 51 and Does Not Address 26 Implications of Alignment with the Institute of Medicine Standards 52"
  },
  {
    "id": 18,
    "source": "guideline_c3debd",
    "text": "51 Guideline Purpose and Scope: What the Guideline Does Considerations Regarding Guideline Scope 51 and Does Not Address 26 Implications of Alignment with the Institute of Medicine Standards 52 Process and Method 28 Limitations of Existing Treatment Research Literature 53 Vetting and Appointment of Members to the Depression Guideline Need for a Clearer Taxonomy of Psychotherapies 55 Development Panel 28 Need for Rigorous Comparisons of Treatments Conflicts of Interest 29 and Treatment Modality 56 Scoping 29 Improving Methodology and Reporting in Treatment Studies 56 Comprehensive Search of the Professional Literature 29 Testing Moderators and Mediators of Treatment Outcome 56 Table 5: Summary of Systematic Reviews and Meta-Analyses Funding Needs 57 Used for Each Age Group 31 Conclusion 58"
  },
  {
    "id": 19,
    "source": "guideline_c3debd",
    "text": "Professional Literature 29 Testing Moderators and Mediators of Treatment Outcome 56 Table 5: Summary of Systematic Reviews and Meta-Analyses Funding Needs 57 Used for Each Age Group 31 Conclusion 58 Strengths and Limitations of the Systematic Reviews and Meta- Conflicts of Interest 59 Analyses 32 Author Disclosures 59 Characterizing the Study Samples Included in the Reviews 32 Developer 61 Defining Efficacy and Comparative Effectiveness 33 Funding Source Sponsor 61 Evaluating the Evidence 34 Acknowledgments 61 External Review Process 36 References 62 Discussion of Clinical Recommendations 37 Children and Adolescents 37 General Adult Population 38 Older Adults 39 APA   Guideline for the Treatment of Depression 1 2 APA   Guideline for the Treatment of Depression EXECUTIVE SUMMARY Scope This"
  },
  {
    "id": 20,
    "source": "guideline_c3debd",
    "text": "and Adolescents 37 General Adult Population 38 Older Adults 39 APA   Guideline for the Treatment of Depression 1 2 APA   Guideline for the Treatment of Depression EXECUTIVE SUMMARY Scope This guideline is intended to provide recommendations for the treatment of depressive disor- ders (including major depression, subsyndromal depression, and persistent depressive disor- der1) based on systematic reviews of the evidence. It addresses three developmental cohorts: children and adolescents, general adults, and older adults (ages 60 and over2). Ten systematic reviews and meta-analyses (Cipriani et al., 2016; Cuijpers, Driessen, et al., 2012a; Cuijpers, Karyotaki, Pot, Park,   Reynolds, 2014a; Cuijpers, Koole, van Dijke, Roca,   Reynolds, 2014b; Cuijpers, Donker, Weissman, Ravitz,   Cristea,"
  },
  {
    "id": 21,
    "source": "guideline_c3debd",
    "text": "et al., 2016; Cuijpers, Driessen, et al., 2012a; Cuijpers, Karyotaki, Pot, Park,   Reynolds, 2014a; Cuijpers, Koole, van Dijke, Roca,   Reynolds, 2014b; Cuijpers, Donker, Weissman, Ravitz,   Cristea, 2016; Driessen et al., 2015; ECRI Institute, 2015; Gartlehner et al., 2015; Wilkinson   Izmeth, 2012; Zhou et al., 2015) served as the basis for this guideline. This guideline addresses the efficacy of psychological and complementary and alternative medicine treatments, the comparative effectiveness of psychotherapy in combination with pharmacotherapy as well as compared to pharmacotherapy and comple- mentary and alternative treatments.3 For child and adolescent populations only, the guideline also examines the efficacy of medications, but because other existing guidelines adequately address"
  },
  {
    "id": 22,
    "source": "guideline_c3debd",
    "text": "mentary and alternative treatments.3 For child and adolescent populations only, the guideline also examines the efficacy of medications, but because other existing guidelines adequately address this for adults, the panel chose not to review this body of evidence. The guideline then addresses harms and burdens of treatment and patient4 values and preferences. The reviews on which this guideline is based did not specifically address screening for depression, assess- ment of associated comorbid conditions (e.g., suicidality, medical problems), monitoring response to treatment, locus of care, prevention of depression, dose, timing or duration of treatments for depression, costs of treatment, long-term benefits of treatment, mechanisms of change, bipolar disorder, or efficacy of treatments for"
  },
  {
    "id": 23,
    "source": "guideline_c3debd",
    "text": "of depression, dose, timing or duration of treatments for depression, costs of treatment, long-term benefits of treatment, mechanisms of change, bipolar disorder, or efficacy of treatments for disorders other than depression. 1 Note that psychotic depression is not covered by this guideline. The panel recognizes this as an important sub- set of depression. However, the scope of the guideline is currently extensive, and the incorporation of psy- chotic depression would have required additional reviews focusing on antipsychotic medications. 2 Although the panel defined older adults as ages 60 and over, at least one study included in the older adult reviews included individuals as young as 50. This resulted in some overlap between the general adult and older adult populations that the panel"
  },
  {
    "id": 24,
    "source": "guideline_c3debd",
    "text": "over, at least one study included in the older adult reviews included individuals as young as 50. This resulted in some overlap between the general adult and older adult populations that the panel was not able to separate out due to the way the data was analyzed. However, a majority of studies defined older adults as ages 60 and up and individual studies that defined older adults as 50 and up will be noted. This overlap may be considered by clinicians when making recommendations for indi- vidual patients that fall within this age range. 3 The panel initially intended to include somatic treatments, but due to limitations in the available reviews the current guideline does not address these areas. 4 To be consistent with discussions of evidence-based practice in other areas of health care,"
  },
  {
    "id": 25,
    "source": "guideline_c3debd",
    "text": "but due to limitations in the available reviews the current guideline does not address these areas. 4 To be consistent with discussions of evidence-based practice in other areas of health care, we use the term patient to refer to the child, adolescent, adult, older adult, couple, family, group, organization, community, or other populations receiving psychological services. However, we recognize that in many situations there are important and valid reasons for using such terms as client, consumer or person in place of patient to describe the recipients of services. APA   Guideline for the Treatment of Depression 3 These topics are important to patient care and discussed as appro- (recurrent brief depression) or experience a depressive episode for priate, but the guideline does not contain"
  },
  {
    "id": 26,
    "source": "guideline_c3debd",
    "text": "of Depression 3 These topics are important to patient care and discussed as appro- (recurrent brief depression) or experience a depressive episode for priate, but the guideline does not contain specific recommendations 4 13 days (short-duration depressive episode), the DSM-5 presents in these domains. The Process and Methods section details the this as Other Specified Depressive Disorder (American Psychiatric panel s decision-making throughout guideline development. It is Association, 2013).5 important to note that the phrase  insufficient evidence  indicates The current guideline is designed to complement the existing that there were not enough data to provide for definitive recommen- knowledge base in several ways. It covers a broad range of the pop- dations. However, this lack of data"
  },
  {
    "id": 27,
    "source": "guideline_c3debd",
    "text": "to complement the existing that there were not enough data to provide for definitive recommen- knowledge base in several ways. It covers a broad range of the pop- dations. However, this lack of data can be due to the situation where ulation (children through older adults) and includes psychothera- (a) no relevant studies existed within the time frame of this review, peutic interventions. Earlier guidelines have either been completed (b) a very small number of relevant studies existed, or (c) multiple 5 or more years prior, provided limited guidance on psychothera- relevant studies existed but only provided equivocal findings. In addi- pies, or focused on recommendations for a specific population. The tion, the lack of relevant studies can exist even if multiple studies did current"
  },
  {
    "id": 28,
    "source": "guideline_c3debd",
    "text": "but only provided equivocal findings. In addi- pies, or focused on recommendations for a specific population. The tion, the lack of relevant studies can exist even if multiple studies did current guideline follows the Institute of Medicine (IOM, 2011a; compare certain interventions but did not provide robust findings, as IOM, 2011b)6 standards to the extent possible for rigorous guide- well as no studies were conducted that included comparisons line development. This guideline is also intended for a broad inter- between various interventions. national audience, not only for individuals in the United States. Background Process and Method Major depression is the second leading cause of disability as of 2013 Undertaking the creation of a guideline requires several key decisions. both"
  },
  {
    "id": 29,
    "source": "guideline_c3debd",
    "text": "in the United States. Background Process and Method Major depression is the second leading cause of disability as of 2013 Undertaking the creation of a guideline requires several key decisions. both worldwide (Vos et al., 2015) as well as in the United States (U.S. APA s Advisory Steering Committee issued a call for nominations Burden of Disease Collaborators, 2013). Major depressive disorder is (including self-nominations) for individuals to serve as panel members characterized by a depressed mood (or irritability in children) or loss from a variety of backgrounds (patient, psychology, psychiatry, general of pleasure or interest for at least 2 weeks (American Psychiatric medicine) with content knowledge or methodological expertise. Association, 2013). It is also accompanied by at least"
  },
  {
    "id": 30,
    "source": "guideline_c3debd",
    "text": "general of pleasure or interest for at least 2 weeks (American Psychiatric medicine) with content knowledge or methodological expertise. Association, 2013). It is also accompanied by at least three (for a total Conflicts of interest (financial and nonfinancial) were considered and of at least five) of the following symptoms present most days: weight managed both during panel member selection and throughout the loss or change in appetite, insomnia or hypersomnia, psychomotor guideline development process. Research Triangle International  retardation or agitation, fatigue or loss of energy, excessive inappro- University of North Carolina (RTI-UNC) Evidence-Based Practice priate guilt or feelings of worthlessness, indecisiveness or diminished Center and American Psychological Association"
  },
  {
    "id": 31,
    "source": "guideline_c3debd",
    "text": "excessive inappro- University of North Carolina (RTI-UNC) Evidence-Based Practice priate guilt or feelings of worthlessness, indecisiveness or diminished Center and American Psychological Association (APA) staff used the ability to concentrate or think, and recurrent thoughts of death or Population, Interventions, Comparators, Outcomes, Timing, and suicidal ideation or suicide plan or attempt (American Psychiatric Settings (PICOTS) framework (a systematic approach to conducting a Association, 2013). Another depressive disorder, persistent depres- comprehensive literature review of a clinical subject matter) to guide sive disorder (formerly called dysthymia) in the Diagnostic and the panel during its initial question-formulation stage. Statistical Manual of Mental Disorders (5th ed.;"
  },
  {
    "id": 32,
    "source": "guideline_c3debd",
    "text": "subject matter) to guide sive disorder (formerly called dysthymia) in the Diagnostic and the panel during its initial question-formulation stage. Statistical Manual of Mental Disorders (5th ed.; DSM-5; American In selecting which outcomes were most critical for deciding on Psychiatric Association, 2013), is characterized by a depressed mood the level or strength of a recommendation, the panel decided that most of the time for at least 2 years, along with at least two of the response to treatment (reduction in depressive symptoms) and seri- following symptoms: feeling hopeless, insomnia or hypersomnia, ous associated harms adverse events were critical. The panel fur- overeating or poor appetite, fatigue or low energy, low self-esteem, ther decided that the following additional outcomes"
  },
  {
    "id": 33,
    "source": "guideline_c3debd",
    "text": "hypersomnia, ous associated harms adverse events were critical. The panel fur- overeating or poor appetite, fatigue or low energy, low self-esteem, ther decided that the following additional outcomes were important: and indecisiveness or poor concentration (American Psychiatric remission (no longer having symptoms), quality of life, functional Association, 2013). In children and adolescents, the mood can be capacity, patient satisfaction, relapse, recurrence, and suicidality. irritable, and the duration of persistent depressive disorder is at least The guideline was developed in a series of phases, based on 1 year. Moreover, there cannot be a gap in these symptoms for more the three developmental cohorts. Briefly, with the support of the than 2 months, a hypomanic or manic episode during"
  },
  {
    "id": 34,
    "source": "guideline_c3debd",
    "text": "based on 1 year. Moreover, there cannot be a gap in these symptoms for more the three developmental cohorts. Briefly, with the support of the than 2 months, a hypomanic or manic episode during this time period, RTI-UNC Evidence-Based Practice Center scientists, the older adult nor criteria met for cyclothymic disorder, and symptoms are not literature was reviewed based on the results of an umbrella review better explained by another disorder, cause significant impairment in they conducted to determine existing systematic reviews in the lit- functioning or distress, and are not due to a different medical condi- erature. RTI-UNC Evidence-Based Practice Center scientists devel- tion or a substance use disorder (American Psychiatric Association, oped evidence profiles for the panel compiling"
  },
  {
    "id": 35,
    "source": "guideline_c3debd",
    "text": "medical condi- erature. RTI-UNC Evidence-Based Practice Center scientists devel- tion or a substance use disorder (American Psychiatric Association, oped evidence profiles for the panel compiling data from reviews 2013). For patients that do not meet full criteria for the aforemen- by Wilkinson and Izmeth (2012) and Cuijpers, Karyotaki, Pot, et al. tioned depressive disorders (depressive episode with insufficient (2014a). For the general adult section, the panel used data from an symptoms) but either experience recurrent episodes of depressed existing systematic review by RTI-UNC Evidence-Based Practice mood and at least four other symptoms of depression for 2 13 days Center scientists (Gartlehner et al., 2015). The panel supplemented 5 However, the systematic reviews and studies that are"
  },
  {
    "id": 36,
    "source": "guideline_c3debd",
    "text": "Practice mood and at least four other symptoms of depression for 2 13 days Center scientists (Gartlehner et al., 2015). The panel supplemented 5 However, the systematic reviews and studies that are discussed in this guideline use the broader definitions  subclinical  or  subsyndromal  depression (i.e., Cuijpers, Koole, van Dijke et al., 2014). 6 Of note, as of March 2016, the division of the National Academies of Sciences, Engineering, and Medicine (the National Academies) formerly known as Institute of Medicine (IOM) was renamed the National Academy of Medicine (NAM). Despite the recent name change, the guideline will use IOM when referring to the IOM stan- dards for guideline development and systematic reviews. 4 APA   Guideline for the Treatment of Depression this to fill in gaps of"
  },
  {
    "id": 37,
    "source": "guideline_c3debd",
    "text": "change, the guideline will use IOM when referring to the IOM stan- dards for guideline development and systematic reviews. 4 APA   Guideline for the Treatment of Depression this to fill in gaps of information with data from several others populations (i.e., reviews focused exclusively on individuals with reviews that met quality criteria based on either an AMSTAR (A comorbid medical disorders), and settings (i.e., inpatient, collab- Measurement Tool to Assess Systematic Reviews; an instrument orative care) were not included in the reviews. Another challenge used to evaluate systematic reviews and meta-analyses for quality; was balancing adherence to the IOM (2011a) standards for rigor- Shea et al., 2007) review (Cuijpers, Driessen, et al., 2012a; Cuijpers, ous guideline development while"
  },
  {
    "id": 38,
    "source": "guideline_c3debd",
    "text": "and meta-analyses for quality; was balancing adherence to the IOM (2011a) standards for rigor- Shea et al., 2007) review (Cuijpers, Driessen, et al., 2012a; Cuijpers, ous guideline development while also including adequate coverage Koole, et al., 2014b; Cuijpers et al., 2016; Driessen et al., 2015) or of the research literature. We discuss these limitations in full on having followed IOM systematic review standards (ECRI Institute, p. 53 of the guideline. Further, the panel noted a wide range of 2015). Specifically, this AMSTAR instrument consists of a checklist research concerns, including that many of the studies included in assessing 11 items and was used by scientists who were not panel reviews were of low quality. In particular, the panel noted the need members to evaluate systematic"
  },
  {
    "id": 39,
    "source": "guideline_c3debd",
    "text": "many of the studies included in assessing 11 items and was used by scientists who were not panel reviews were of low quality. In particular, the panel noted the need members to evaluate systematic reviews for quality. For the child to expand the research literature to specifically include underrep- and adolescent literature, the panel used two systematic reviews  resented and underserved populations, including people of diverse meta-analyses that met quality criteria based on an AMSTAR racial ethnic and cultural heritage backgrounds, gender and sex- review: Cipriani et al. (2016) and Zhou et al. (2015). Based on the ual minority populations, and socioeconomically diverse groups. results of the umbrella review as well as follow-up AMSTAR quali- In addition to the multifocal call for"
  },
  {
    "id": 40,
    "source": "guideline_c3debd",
    "text": "et al. (2015). Based on the ual minority populations, and socioeconomically diverse groups. results of the umbrella review as well as follow-up AMSTAR quali- In addition to the multifocal call for inclusivity in research design ty reviews, it was determined that existing systematic reviews and and funding to better address the needs of diverse populations, meta-analyses were of sufficient breadth and quality such that it including those that experience lower SES, we encourage clini- was not necessary to commission a de novo review. The panel uti- cians to refer to APA s (2017b) Multicultural Guidelines: An Ecological lized systematic reviews meta-analyses that were current within Approach to Context, Identity, and Intersectionality to assist in imple- the past 5 years at the time the"
  },
  {
    "id": 41,
    "source": "guideline_c3debd",
    "text": "Guidelines: An Ecological lized systematic reviews meta-analyses that were current within Approach to Context, Identity, and Intersectionality to assist in imple- the past 5 years at the time the panel made its recommendation mentation of recommendations. The labeling of psychotherapies decisions that met IOM (2011b) development and AMSTAR quality is a challenge as well, given the large variability in how a system- standards. While this is consistent with rigorous guideline develop- atic review team clusters particular forms of psychotherapies (i.e., ment, the panel noted this approach can be limiting in that studies  cognitive-behavioral approaches  includes a number of specific exploring the efficacy of psychotherapy are not conducted equally treatments such as problem-solving therapy"
  },
  {
    "id": 42,
    "source": "guideline_c3debd",
    "text": "limiting in that studies  cognitive-behavioral approaches  includes a number of specific exploring the efficacy of psychotherapy are not conducted equally treatments such as problem-solving therapy and dialectical behav- across modalities and are not regularly updated every 5 years due, ior therapy; see Table 2 in Appendix G for details). in part, to psychotherapy research receiving support from govern- Additional limitations the panel noted across cohorts include ment funds (rather than private companies). Altogether, system- that much research is highly dependent on federal research funding, atic reviews and meta-analyses conducted more than 5 years ago particularly psychotherapy research. Also, there are differences in were not explicitly examined by the panel. the amount of research"
  },
  {
    "id": 43,
    "source": "guideline_c3debd",
    "text": "atic reviews and meta-analyses conducted more than 5 years ago particularly psychotherapy research. Also, there are differences in were not explicitly examined by the panel. the amount of research evidence available for different therapeutic The panel considered four factors as it drafted recommenda- approaches (e.g., there is more evidence available for cognitive-be- tions based on IOM standards: (1) overall strength of the evidence, havioral therapy than for psychodynamic therapy and hardly any (2) balance of benefits versus harms burdens, (3) patient values for humanistic therapies). Each of these factors limits the broad and preferences, and (4) applicability. Based on the combination applicability of research findings. Further, while much research of these factors, the panel made a"
  },
  {
    "id": 44,
    "source": "guideline_c3debd",
    "text": "of these factors limits the broad and preferences, and (4) applicability. Based on the combination applicability of research findings. Further, while much research of these factors, the panel made a recommendation or condition- focused on symptomatic change, more research is needed on al recommendation for or against each particular treatment or additional important outcomes such as patient-centered outcomes made a statement that there was insufficient evidence to be able (i.e., quality of life and interpersonal relationships, social engage- to make a recommendation for or against. The panel used a tool ment, occupational functioning). Research is also needed on the called a decision table (created by APA staff) to document its deci- moderators of treatment and outcomes, matching of"
  },
  {
    "id": 45,
    "source": "guideline_c3debd",
    "text": "used a tool ment, occupational functioning). Research is also needed on the called a decision table (created by APA staff) to document its deci- moderators of treatment and outcomes, matching of patients with sion-making process for each recommendation for older adults. treatments, and innovative approaches to dissemination (e.g., col- Copies of the decision tables are available in Appendix C of the laborative care and integrated care). Finally, the panel agreed that supplemental materials. The panel later streamlined the decision the body of the depression treatment research literature needs far table to a  grid  to document decision-making, which can also be more attention on patient populations that have comorbid condi- found in the supplemental materials (linked separately). tions;"
  },
  {
    "id": 46,
    "source": "guideline_c3debd",
    "text": "far table to a  grid  to document decision-making, which can also be more attention on patient populations that have comorbid condi- found in the supplemental materials (linked separately). tions; long-term outcomes of psychotherapy; treatment for racial- ly, ethnically, or socioeconomically diverse populations as well as marginalized communities and gender diverse populations; as well Discussion as a personalized medicine approach to treatment. Throughout the panel s discussions, it was emphasized that patient values and preferences should be taken into consideration through Recommendations shared decision-making with the clinician. Clinicians using this guideline are encouraged to consider challenges faced by patients In reviewing the recommendations from the panel, it is important for"
  },
  {
    "id": 47,
    "source": "guideline_c3debd",
    "text": "shared decision-making with the clinician. Clinicians using this guideline are encouraged to consider challenges faced by patients In reviewing the recommendations from the panel, it is important for such as barriers to treatment (i.e., structural and perceptual). the reader to be familiar with the definition of several terms as follows: While the panel followed a rigorous methodological process for guideline development, the panel identified challenges and Treatment as usual. Refers to the care that is customarily provided limitations to consider for future efforts. The panel tried to be in a particular situation. The panel notes the challenge of a consistent as broad as possible and used the PICOTS outline, but the scope definition of treatment as usual, given that the exact definition"
  },
  {
    "id": 48,
    "source": "guideline_c3debd",
    "text": "a particular situation. The panel notes the challenge of a consistent as broad as possible and used the PICOTS outline, but the scope definition of treatment as usual, given that the exact definition can could not be all-encompassing and thus excluded many important vary by study. APA   Guideline for the Treatment of Depression 5 No treatment. No active treatment was provided (i.e., waitlist). Efficacy. The impact of an intervention compared to an inactive control. Comparative effectiveness. Compares at least two different active treatments to each other to assess for the benefits of one (or combi- nation) versus the other (or combination). The tables below list the recommendations from the APA guideline development panel for treating depression in children and adolescents, the general"
  },
  {
    "id": 49,
    "source": "guideline_c3debd",
    "text": "combi- nation) versus the other (or combination). The tables below list the recommendations from the APA guideline development panel for treating depression in children and adolescents, the general adult population, and older adults. Note that the recommendations pertaining to efficacy do not imply that these treatments are superior to other active treatments. Further note that the recommendations made by the panel are based on the literature that was included in the guideline (i.e., that met inclu- sion criteria) and not all the literature on depression treatment. Whenever possible, the tables list which treatments work best for which patients and under what conditions (i.e., treatment for a particular diagnosis for an older adult population with a particular condition). But when not"
  },
  {
    "id": 50,
    "source": "guideline_c3debd",
    "text": "list which treatments work best for which patients and under what conditions (i.e., treatment for a particular diagnosis for an older adult population with a particular condition). But when not noted, this information was not available. Please see Appendix I for details about the interventions (i.e., dos- ing, timing) and Appendix J for a list of interventions that were part of the search but for which there was not enough high-quality evi- dence to make a determination. The ultimate decision about treat- ment should be based on shared decision-making with the patient and, in the case of youth patients, the parents guardians or family members actively involved in their care. The panel used the following as guidance for its decision making: 1. The panel recommended treatments that were"
  },
  {
    "id": 51,
    "source": "guideline_c3debd",
    "text": "patients, the parents guardians or family members actively involved in their care. The panel used the following as guidance for its decision making: 1. The panel recommended treatments that were consistent- ly superior to nonactive control conditions or for which there was evidence of equivalency or superiority to other treatments. 2. The panel conditionally recommended treatments that were consistently superior to nonactive control conditions but there were either: a. Other active treatments that were superior to the treatment being conditionally recommended. b. Insufficient evidence that the treatment was equivalent to other effective treatments. c. Greater harms burdens than with other treatments. 3. The panel did not recommend treatments or recom- mended against treatments if there"
  },
  {
    "id": 52,
    "source": "guideline_c3debd",
    "text": "the treatment was equivalent to other effective treatments. c. Greater harms burdens than with other treatments. 3. The panel did not recommend treatments or recom- mended against treatments if there was insufficient evidence of efficacy or if the harms were considered to outweigh any benefits. 6 APA   Guideline for the Treatment of Depression The panel s recommendations are as follows7: TABLE 1 Recommendations for the Child Population from the APA Guideline Development Panel for the Treatment of Depression8 Recommendation Strength of Recommendation Justification Initial Treatment For initial treatment of child patients with depressive disorders9 there Insufficient evidence for Based on the literature reviewed was insufficient evidence to make a recommendation regarding any of a"
  },
  {
    "id": 53,
    "source": "guideline_c3debd",
    "text": "initial treatment of child patients with depressive disorders9 there Insufficient evidence for Based on the literature reviewed was insufficient evidence to make a recommendation regarding any of a recommendation that met the AMSTAR requirements, the following psychotherapies interventions10: there was insufficient evidence to ei- ther recommend or not recommend   Behavioral therapy use of the listed psychotherapies    Cognitive therapy interventions in children with depres-   Cognitive-behavioral therapy sive disorders.   Family therapy   Play therapy Based on the literature reviewed   Problem-solving therapy that met the AMSTAR requirements   Psychodynamic therapy there was insufficient evidence to ei-   Supportive therapy ther recommend or not recommend pharmacotherapy for child"
  },
  {
    "id": 54,
    "source": "guideline_c3debd",
    "text": "Problem-solving therapy that met the AMSTAR requirements   Psychodynamic therapy there was insufficient evidence to ei-   Supportive therapy ther recommend or not recommend pharmacotherapy for child patients There was insufficient evidence to make a recommendation regarding with depressive disorders. The panel pharmacotherapy for child patients with depressive disorders. noted safety concerns with using pharmacotherapy with children and recommends shared decision-mak- ing regarding medication options with a child psychiatrist in addition to the clinician, patient, and their parents guardians or family mem- bers actively involved in their care. 7 Please refer to the section on scoping (p. 29) for the list of topics that the guideline does and does not address. For the list of descriptions"
  },
  {
    "id": 55,
    "source": "guideline_c3debd",
    "text": "or family mem- bers actively involved in their care. 7 Please refer to the section on scoping (p. 29) for the list of topics that the guideline does and does not address. For the list of descriptions of treatments derived from research included in the reviews, please refer to Appendix A of the supplement. 8 For further details about the evidence underlying each guideline statement please refer to the child adolescent grid accompanying the supplemental materials. In this grid, the information on effect sizes incorporated from Figure 3 on p. 216 of Zou et al. s (2015) review is presented first across the top row followed by information for the Cipriani et al. (2016). Each column in the grid reflects a particular treatment or treatment comparison from the reviews while each row reflects a"
  },
  {
    "id": 56,
    "source": "guideline_c3debd",
    "text": "across the top row followed by information for the Cipriani et al. (2016). Each column in the grid reflects a particular treatment or treatment comparison from the reviews while each row reflects a particular outcome (i.e., reduction in depressive symptoms). The effect size along with relevant information (i.e., confidence interval) is presented at the intersection of rows and columns. This is followed by information on the panel s ratings of the benefits, harms, balance of benefits vs. harms, patient values and preferences, applicability, and overall recommenda- tion statement for each intervention or comparison of treatments. 9 Types included: minor depression, major depression, persistent depressive disorder (formerly called  dysthymia ), intermittent depression, or having depression"
  },
  {
    "id": 57,
    "source": "guideline_c3debd",
    "text": "or comparison of treatments. 9 Types included: minor depression, major depression, persistent depressive disorder (formerly called  dysthymia ), intermittent depression, or having depression symptoms at or above a prespecified level based on a validated measure of depression severity. The Zhou et al. (2015) review excluded patients with psychotic depression. 10 Throughout the table, interventions are listed alphabetically. APA   Guideline for the Treatment of Depression 7 TABLE 2 Recommendations for the Adolescent Population from the APA Guideline Development Panel for the Treatment of Depression11 Recommendation Strength of Recommendation Justification Initial Treatment For initial treatment of adolescent patients with depressive disorders12 Recommendation for use Based on the literature"
  },
  {
    "id": 58,
    "source": "guideline_c3debd",
    "text": "Recommendation Strength of Recommendation Justification Initial Treatment For initial treatment of adolescent patients with depressive disorders12 Recommendation for use Based on the literature reviewed the panel recommends that clinicians offer one of the following psycho- that met the AMSTAR requirements, therapies interventions13: cognitive-behavioral therapy and   Cognitive-behavioral therapy interpersonal psychotherapy adapt-   Interpersonal psychotherapy adapted for adolescents (IPT-A) ed for adolescents (IPT-A) were the only psychotherapy interventions The panel recommends fluoxetine as a first-line medication compared with evidence of efficacy. to other medications for adolescent patients with major depressive disorder, specifically when considering medication options. There was"
  },
  {
    "id": 59,
    "source": "guideline_c3debd",
    "text": "as a first-line medication compared with evidence of efficacy. to other medications for adolescent patients with major depressive disorder, specifically when considering medication options. There was insufficient evidence to recommend either treatment (psy- chotherapy or fluoxetine) over the other for major depressive disorder. Additional psychotherapy recommendations for initial treatment If neither recommended psychotherapy is available or neither is accept- Insufficient evidence for Based on the literature reviewed able to the patient and their parent guardian, the panel suggests con- a recommendation that met the AMSTAR requirements, sidering an alternative model. However, at this time, while the following for all interventions except for cog- interventions have been evaluated in"
  },
  {
    "id": 60,
    "source": "guideline_c3debd",
    "text": "a recommendation that met the AMSTAR requirements, sidering an alternative model. However, at this time, while the following for all interventions except for cog- interventions have been evaluated in adolescents, there is insufficient nitive-behavioral therapy and inter- evidence to recommend for or against clinicians offering any one of the personal psychotherapy adapted for following psychotherapies interventions over the others: adolescents (IPT-A), evidence was   Behavioral therapy not strong enough to determine that   Cognitive therapy any one therapy was superior to an-   Family therapy other. Decision should be based on   Problem-solving therapy shared decision-making with youth   Psychodynamic therapy patients, their parents guardians, or   Supportive therapy family members"
  },
  {
    "id": 61,
    "source": "guideline_c3debd",
    "text": "other. Decision should be based on   Problem-solving therapy shared decision-making with youth   Psychodynamic therapy patients, their parents guardians, or   Supportive therapy family members actively involved in their care. 11 For further details about the evidence underlying each guideline statement please refer to the child adolescent grid accompanying the supplemental materials. In this grid, the information on effect sizes incorporated from Figure 3 on p. 216 of Zou et al s (2015) review is presented first across the top row followed by information for the Cipriani et al (2016). Each column in the grid reflects a particular treatment or treatment comparison from the reviews while each row reflects a particular outcome (i.e., reduction in depressive symptoms). The effect size along"
  },
  {
    "id": 62,
    "source": "guideline_c3debd",
    "text": "in the grid reflects a particular treatment or treatment comparison from the reviews while each row reflects a particular outcome (i.e., reduction in depressive symptoms). The effect size along with relevant information (i.e., confidence interval) is presented at the intersection of rows and columns. This is followed by information on the panel s ratings of the benefits, harms, balance of benefits vs. harms, patient values and preferences, applicability, and overall recommendation state- ment for each intervention or comparison of treatments. 12 Types included: minor depression, major depression, persistent depressive disorder (formerly called  dysthymia ), intermittent depression, or having depression symptoms at or above a prespecified level based on a validated measure of depression"
  },
  {
    "id": 63,
    "source": "guideline_c3debd",
    "text": "persistent depressive disorder (formerly called  dysthymia ), intermittent depression, or having depression symptoms at or above a prespecified level based on a validated measure of depression severity. The Zhou et al. (2015) review excluded patients with psychotic depression 13 Throughout the table, interventions are listed alphabetically. 8 APA   Guideline for the Treatment of Depression Additional pharmacotherapy guidance for initial treatment Information is lacking regarding other medication options for adoles- Conditional recommendation Recommendation is due to safety cents. Thus, if fluoxetine is not a treatment option or is not acceptable, for use concerns such as increased suicide the panel recommends shared decision-making regarding medication risk for adolescents when using"
  },
  {
    "id": 64,
    "source": "guideline_c3debd",
    "text": "fluoxetine is not a treatment option or is not acceptable, for use concerns such as increased suicide the panel recommends shared decision-making regarding medication risk for adolescents when using other options with a child psychiatrist in addition to the clinician, patient, medications. and their parents guardians or family members actively involved in their care. In general, the panel recommends against using the following medica- Recommend against use Based on the literature reviewed tions for adolescent patients with major depressive disorder. However, that met the AMSTAR requirements when other options are not available, effective, and or acceptable to the the panel recommends against the patient, the panel recommends shared decision-making between the medications as noted due to"
  },
  {
    "id": 65,
    "source": "guideline_c3debd",
    "text": "when other options are not available, effective, and or acceptable to the the panel recommends against the patient, the panel recommends shared decision-making between the medications as noted due to safety patient and clinician. concerns with using these medica-   Clomipramine tions on adolescents.   Imipramine Further, the panel recommends only   Mirtazapine choosing between the medications   Paroxetine as noted when other options have   Venlafaxine been exhausted or are unavailable. If these medications are being considered, the panel recommends: This is due to safety concerns with using these medications on children.   paroxetine over clomipramine when both are being considered.   paroxetine over imipramine when both are being considered.   There was no information available for other"
  },
  {
    "id": 66,
    "source": "guideline_c3debd",
    "text": "medications on children.   paroxetine over clomipramine when both are being considered.   paroxetine over imipramine when both are being considered.   There was no information available for other comparisons between the listed medications. APA   Guideline for the Treatment of Depression 9 TABLE 3 Recommendations for the General Adult Population from the APA Guideline Development Panel for the Treatment of Depression14 Recommendation15 Strength of Recommendation Justification Initial Treatment Psychotherapy and Pharmacotherapy Recommendation for use Based on the literature reviewed that For initial treatment of adult patients with depression,16 the panel rec- met the IOM or AMSTAR require- ommends the following in the context of sharing decision-making with ments, comparative effectiveness"
  },
  {
    "id": 67,
    "source": "guideline_c3debd",
    "text": "treatment of adult patients with depression,16 the panel rec- met the IOM or AMSTAR require- ommends the following in the context of sharing decision-making with ments, comparative effectiveness the patient when considering options: research finds either similar effects between treatments or insufficient 1. That clinicians offer either psychotherapy or second-generation evidence to determine that one treat- antidepressant.17 ment can be offered over another.   When selecting between treatments, the panel recommends considering the following options:   Second-generation antidepressants   The panel found that effectiveness studies demonstrated similar effects across psychotherapy. Thus, the panel is not able to recommend specific monotherapies for initial treatment. General models that"
  },
  {
    "id": 68,
    "source": "guideline_c3debd",
    "text": "panel found that effectiveness studies demonstrated similar effects across psychotherapy. Thus, the panel is not able to recommend specific monotherapies for initial treatment. General models that appear to have comparable effects include:   Behavioral therapy   Cognitive, cognitive-behavioral, and mindfulness-based cognitive-therapy   Interpersonal psychotherapy   Psychodynamic therapies   Supportive therapy 2. If considering combined treatment, the panel recommends cog- nitive-behavioral therapy or interpersonal psychotherapy plus a second-generation antidepressant. For adult patients with depression who are also experiencing relation- Conditional recommendation Based on the literature reviewed that ship distress, if a recommended treatment is not acceptable or available, for use met"
  },
  {
    "id": 69,
    "source": "guideline_c3debd",
    "text": "depression who are also experiencing relation- Conditional recommendation Based on the literature reviewed that ship distress, if a recommended treatment is not acceptable or available, for use met the IOM or AMSTAR require- the panel suggests that clinicians offer problem-focused couples  ments, if a recommended treatment therapy. is not available or acceptable, the panel suggests the listed interven- When selecting between treatments the panel suggests considering the tions, which demonstrated efficacy following options: when compared with no treatment   Suggest behavioral therapy rather than antidepressant medication (i.e., waitlist) or control. alone.   If considering combined treatment, the panel suggests cognitive therapy plus antidepressant medication to improve likelihood of full"
  },
  {
    "id": 70,
    "source": "guideline_c3debd",
    "text": "antidepressant medication (i.e., waitlist) or control. alone.   If considering combined treatment, the panel suggests cognitive therapy plus antidepressant medication to improve likelihood of full recovery in treatment. 14 The recommendations made by the panel are based on the literature that was included in the guideline (i.e., that met inclusion criteria), and not on all the literature on depression treatment. 15 For further details about the evidence underlying each guideline statement please refer to the general adult grid accompanying the supplemental materials. In this grid, the information for the Gartlehner et al. (2015) is present first across the top row followed by the additional reviews, Cuijpers et al. (2014), Driessen et al. (2015), Cuijpers et al. (2012), VA DoD evidence"
  },
  {
    "id": 71,
    "source": "guideline_c3debd",
    "text": "for the Gartlehner et al. (2015) is present first across the top row followed by the additional reviews, Cuijpers et al. (2014), Driessen et al. (2015), Cuijpers et al. (2012), VA DoD evidence synthesis report (ECRI Institute, 2015), and Cuijpers et al. (2016). Each column in the grid reflects a particular treatment or treatment compari- son from the reviews while each row reflects a particular outcome (i.e., reduction in depressive symptoms). The effect size along with relevant information (i.e., confidence interval) is presented at the intersection of rows and columns. This is followed by information on the panel s ratings of the benefits, harms, balance of benefits vs. harms, patient values and preferences, applicability, and overall recommendation statement for each intervention or"
  },
  {
    "id": 72,
    "source": "guideline_c3debd",
    "text": "information on the panel s ratings of the benefits, harms, balance of benefits vs. harms, patient values and preferences, applicability, and overall recommendation statement for each intervention or comparison of treatments. 16 The depression recommendations refer to the full range of depression diagnoses identified by the panel for inclusion unless a recommendation specifies otherwise. Note that recommendations do not pertain to psychotic depression. 17 Throughout the recommendations, both the terms  antidepressant medication  and  second-generation antidepressant  are used. Note that  second-generation antide- pressants  refers specifically to selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) while the term  antidepressant medication"
  },
  {
    "id": 73,
    "source": "guideline_c3debd",
    "text": "antide- pressants  refers specifically to selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) while the term  antidepressant medication  could include second-generation antidepressants as well as other antidepressants. 10 APA   Guideline for the Treatment of Depression For adult patients with depression, there is insufficient evidence to Insufficient evidence for Based on the literature reviewed that recommend for or against clinicians offering: a recommendation met the IOM or AMSTAR require-   CBASP (cognitive behavioral analysis system of psychotherapy) ments the evidence was insufficient   Brief problem-solving therapy (10 or fewer sessions) vs. treatment to be able to recommend for or as usual. against the listed interventions or"
  },
  {
    "id": 74,
    "source": "guideline_c3debd",
    "text": "of psychotherapy) ments the evidence was insufficient   Brief problem-solving therapy (10 or fewer sessions) vs. treatment to be able to recommend for or as usual. against the listed interventions or treatment comparisons. Decision should be based on shared decision-making with the patient. Complementary and Alternative Treatments18 Based on the literature reviewed For adults with depression for whom psychotherapy or pharmacothera- Conditional recommendation that met the IOM or AMSTAR py is either ineffective or unacceptable the panel suggests the following for use requirements, evidence indicates options: no difference in effects between St.   Exercise Monotherapy19 John s Wort and second-generation   St. John s Wort Monotherapy20 antidepressants and indicates some small to medium"
  },
  {
    "id": 75,
    "source": "guideline_c3debd",
    "text": "indicates options: no difference in effects between St.   Exercise Monotherapy19 John s Wort and second-generation   St. John s Wort Monotherapy20 antidepressants and indicates some small to medium benefits of the If neither is acceptable or available, the panel suggests consideration of Conditional recommendation other suggested complementary and   Bright light therapy21 for use alternative treatments.   Yoga22 Evidence is insufficient to recom-   If considering adjunctive treatments, the panel suggests adding mend the last list of complementary acupuncture to antidepressant medication.23 and alternative treatments as noted. There is insufficient evidence to recommend Insufficient evidence for   Tai Chi a recommendation   Acupuncture Monotherapy   Combination of second-generation"
  },
  {
    "id": 76,
    "source": "guideline_c3debd",
    "text": "and alternative treatments as noted. There is insufficient evidence to recommend Insufficient evidence for   Tai Chi a recommendation   Acupuncture Monotherapy   Combination of second-generation antidepressant and acupuncture   Omega-3 Fatty Acids Monotherapy   Combination of second-generation antidepressant and Omega-3 Fatty Acids   S-Adenosyl Methionine Monotherapy   Combination of second-generation antidepressant and exercise For adult patients with subclinical depression, the panel suggests that Conditional recommendation When subclinical depression is the clinicians offer psychotherapy24 (psychotherapy in general including for use focus of treatment, based on the both cognitive-behavioral therapy and noncognitive-behavioral therapy literature reviewed that met the IOM psychotherapies"
  },
  {
    "id": 77,
    "source": "guideline_c3debd",
    "text": "(psychotherapy in general including for use focus of treatment, based on the both cognitive-behavioral therapy and noncognitive-behavioral therapy literature reviewed that met the IOM psychotherapies [e.g., interpersonal counseling, problem-solving thera- or AMSTAR requirements, the panel py, life review therapy]). suggests the listed interventions, which demonstrated efficacy when compared with control. 18 The panel urges caution when using over-the-counter agents to prevent unintended drug-drug interactions particularly given variable manufacturing practices. 19 Patients in these trials had moderate to severe depression, according to the HAM-D Scale (Babyak et al., 2000; Blumenthal et al., 1999, 2007; Hoffman et al., 2008). The panel gave a conditional recommendation because it had only"
  },
  {
    "id": 78,
    "source": "guideline_c3debd",
    "text": "moderate to severe depression, according to the HAM-D Scale (Babyak et al., 2000; Blumenthal et al., 1999, 2007; Hoffman et al., 2008). The panel gave a conditional recommendation because it had only efficacy data and not comparative effectiveness data. 20 The trials included patients with moderate to severe depression. 21 Included patients aged 60 years and older with a diagnosis of MDD. 22 Based on a trial with female patients between 18 to 40 years of age. 23 Trials included patients with a diagnosis of MDD or poststroke depression and were between 33 to 60 years of age. 24 Recommendation also includes separate examination of non-cognitive behavioral therapy approaches. Psychotherapy in general also found to reduce future episodes of major depressive disorder. APA   Guideline for the"
  },
  {
    "id": 79,
    "source": "guideline_c3debd",
    "text": "also includes separate examination of non-cognitive behavioral therapy approaches. Psychotherapy in general also found to reduce future episodes of major depressive disorder. APA   Guideline for the Treatment of Depression 11 PARTIAL or NONRESPONDERS to INITIAL ANTIDEPRESSANT TREATMENT For adult patients with depression who have either not responded or Recommendation for use Based on the literature reviewed only partially responded to initial antidepressant medication treatment that met the IOM or AMSTAR the panel recommends the following options: requirements, the panel equally recommends the listed interventions, 1. Switch from antidepressant medication alone to cognitive therapy there is evidence demonstrating no alone or, difference in effect. 2. Switch from antidepressant medication"
  },
  {
    "id": 80,
    "source": "guideline_c3debd",
    "text": "listed interventions, 1. Switch from antidepressant medication alone to cognitive therapy there is evidence demonstrating no alone or, difference in effect. 2. Switch from antidepressant medication alone to another antidepres- sant medication For adult patients with depression who have either not responded or Conditional recommendation Based on the literature reviewed that only partially responded to initial antidepressant medication treatment for use met the IOM or AMSTAR require- the panel suggests that clinicians offer one of the following psychother- ments, the panel suggests adding one apies interventions and select between treatments as follows: of the psychotherapies listed or aug- menting with another antidepressant 1. Add psychotherapy (interpersonal psychotherapy,"
  },
  {
    "id": 81,
    "source": "guideline_c3debd",
    "text": "adding one apies interventions and select between treatments as follows: of the psychotherapies listed or aug- menting with another antidepressant 1. Add psychotherapy (interpersonal psychotherapy, cognitive-behav- medication the treatment of adult ioral therapy, or psychodynamic psychotherapy)25 to the antidepres- patients who have not responded sant medication treatment or only partially responded to initial 2. Augment with another antidepressant medication antidepressant medication treatment. However, the panel does not suggest adding CBASP (cognitive-behavioral analysis system of psychotherapy) or brief supportive therapy to antide- pressant medication treatment. For adult patients with major depressive disorder who have either not Insufficient evidence for Based on the literature"
  },
  {
    "id": 82,
    "source": "guideline_c3debd",
    "text": "or brief supportive therapy to antide- pressant medication treatment. For adult patients with major depressive disorder who have either not Insufficient evidence for Based on the literature reviewed responded or only partially responded to initial adequate second-gener- a recommendation that met the IOM or AMSTAR ation antidepressant treatment attempt there is insufficient evidence to requirements the evidence was determine differences in treatment effect for the following: insufficient to be able to recommend   Switching to another second-generation antidepressant26 for or against adding guided cogni-   Switching to a nonpharmacologic (i.e., cognitive therapy) monother- tive-behavioral therapy self-help to apy antidepressant medication treatment   Augmenting with guided"
  },
  {
    "id": 83,
    "source": "guideline_c3debd",
    "text": "adding guided cogni-   Switching to a nonpharmacologic (i.e., cognitive therapy) monother- tive-behavioral therapy self-help to apy antidepressant medication treatment   Augmenting with guided cognitive-behavioral therapy self-help or switching or augmenting among other second-generation antide- pressants or nonpharmacologic (i.e., cognitive therapy) modalities. RELAPSE PREVENTION For adult patients with depression who have achieved remission the Conditional recommendation Based on the literature reviewed that panel suggests clinicians offer psychotherapy (cognitive-behavioral for use met the IOM or AMSTAR require- therapy, mindfulness-based cognitive therapy, or interpersonal psycho- ments, the panel suggests psycho- therapy) rather than antidepressant medication or treatment as usual to"
  },
  {
    "id": 84,
    "source": "guideline_c3debd",
    "text": "IOM or AMSTAR require- therapy, mindfulness-based cognitive therapy, or interpersonal psycho- ments, the panel suggests psycho- therapy) rather than antidepressant medication or treatment as usual to therapy in general (cognitive- be- prevent relapse. havioral therapy, mindfulness-based There is insufficient evidence to recommend one form of the three cognitive therapy, or interpersonal psychotherapies listed. psychotherapy), which demonstrat- ed comparative effectiveness when compared with treatment as usual and antidepressant medication to prevent relapse. However, there was insufficient evidence to be able to recommend a specific form of psy- chotherapy to prevent relapse. 25 The general group of psychotherapies included in the review (ECRI Institute, 2015) were interpersonal"
  },
  {
    "id": 85,
    "source": "guideline_c3debd",
    "text": "evidence to be able to recommend a specific form of psy- chotherapy to prevent relapse. 25 The general group of psychotherapies included in the review (ECRI Institute, 2015) were interpersonal psychotherapy, cognitive-behavioral therapy, and CBASP (cognitive behavioral analysis system of psychotherapy). However, based on additional information, CBASP is not recommended due to the increased burden with limited evidence of additional benefit. 26 Switches included various medications such as bupropion, sertraline, venlafaxine, etc. Please see Table E22, pages E35 E37 of Gartlehner et al. (2015) for specific switch details. 12 APA   Guideline for the Treatment of Depression TABLE 4 Recommendations for the Older Adult Population from the APA Guideline Development Panel for the Treatment of"
  },
  {
    "id": 86,
    "source": "guideline_c3debd",
    "text": "for specific switch details. 12 APA   Guideline for the Treatment of Depression TABLE 4 Recommendations for the Older Adult Population from the APA Guideline Development Panel for the Treatment of Depression Recommendation Strength of Recommendation Justification INITIAL TREATMENT Major Depressive Disorder For initial treatment of older27 adult patients with depression, the panel Recommendation for use Based on the literature reviewed that recommends the following in the context of shared decision-making met the IOM or AMSTAR require- with the patient: ments, cognitive-behavioral therapy (group) and life review (group) 1. Either group life review treatment or Group Cognitive Behavioral based interventions were the only Therapy (either alone or added to usual care) over no treatment"
  },
  {
    "id": 87,
    "source": "guideline_c3debd",
    "text": "(group) and life review (group) 1. Either group life review treatment or Group Cognitive Behavioral based interventions were the only Therapy (either alone or added to usual care) over no treatment interventions with adequate efficacy 2. Combined pharmacotherapy and IPT over IPT alone. Of note, while evidence. However, comparative the study upon which this is based used nortriptyline, the panel rec- effectiveness research either finds ommends a second-generation antidepressant due to the reduced sufficient evidence to recommend risk of side effects. between some treatment compari- sons or finds similar effects between treatments. While nortriptyline was used in the past due to its efficacy and safety, practices have changed significantly, and nortriptyline is now viewed as a second- or"
  },
  {
    "id": 88,
    "source": "guideline_c3debd",
    "text": "similar effects between treatments. While nortriptyline was used in the past due to its efficacy and safety, practices have changed significantly, and nortriptyline is now viewed as a second- or third-line pharmacothera- py strategy for major depression. It is generally reserved for patients who have not done well with a selective serotonin reuptake inhibitor or a serotonin-norepinephrine reuptake inhibitor, which are generally consid- ered to be safer for older adults than nortriptyline. There is some efficacy data from systematic reviews me- ta-analyses showing efficacy of second-generation antidepressants over placebo. [Refer to Decision Tables 14, 18, 28 in Appendix C of the supplement.]28 27 While the panel defined older adults as ages 60 and over, there was at least one study"
  },
  {
    "id": 89,
    "source": "guideline_c3debd",
    "text": "antidepressants over placebo. [Refer to Decision Tables 14, 18, 28 in Appendix C of the supplement.]28 27 While the panel defined older adults as ages 60 and over, there was at least one study included in the older adult reviews that included some individuals as young as 50. However, the majority were ages 60 and over. 28 Decision tables were used in developing the recommendations. These tables begin in Appendix C of the supplement. APA   Guideline for the Treatment of Depression 13 For older adult patients with depression, if a recommended treatment is Conditional recommendation Based on the literature reviewed that not acceptable or available, the panel suggests that clinicians offer one for use met the IOM or AMSTAR require- of the following psychotherapies interventions29: ments, if a"
  },
  {
    "id": 90,
    "source": "guideline_c3debd",
    "text": "literature reviewed that not acceptable or available, the panel suggests that clinicians offer one for use met the IOM or AMSTAR require- of the following psychotherapies interventions29: ments, if a recommended treatment   Cognitive-behavioral therapy (individual) (either standalone or in is not available or acceptable, the combination with usual care), which was found to be superior to: panel suggests the use of interven-   no treatment tions that demonstrated efficacy   a nonspecific talk therapy control when compared with no treatment   usual care (i.e., waitlist) or treatment as usual.   desipramine Further, comparative effectiveness   Combination cognitive-behavioral therapy and nonspecific thera- research finds evidence to suggest peutic techniques (individual) with"
  },
  {
    "id": 91,
    "source": "guideline_c3debd",
    "text": "as usual.   desipramine Further, comparative effectiveness   Combination cognitive-behavioral therapy and nonspecific thera- research finds evidence to suggest peutic techniques (individual) with pharmacotherapy, which was certain treatments or combinations superior to pharmacotherapy alone. Of note, while a specific study of treatments over others. While upon which this is based used desipramine, the panel recommends nortriptyline and other tricyclic a second-generation antidepressant due to the reduced risk of side antidepressants were used in the effects. past due to its efficacy and safety, practices have changed significantly,   Interpersonal psychotherapy and pharmacotherapy, which was and nortriptyline is now viewed as a conditionally superior for preventing recurrence to either:"
  },
  {
    "id": 92,
    "source": "guideline_c3debd",
    "text": "practices have changed significantly,   Interpersonal psychotherapy and pharmacotherapy, which was and nortriptyline is now viewed as a conditionally superior for preventing recurrence to either: second- or third-line pharmacothera-   Supportive care py strategy for major depression. It is   IPT and supportive care generally reserved for patients who   Of note, while the study on which this is based used nortriptyline, have not done well with a selective the panel recommends a second-generation antidepressant due serotonin reuptake inhibitor or a to the reduced risk of side effects serotonin-norepinephrine reuptake   Problem-solving therapy (group), which was superior to reminis- inhibitor, which are generally consid- cence therapy (group) ered to be safer for older adults than"
  },
  {
    "id": 93,
    "source": "guideline_c3debd",
    "text": "reuptake   Problem-solving therapy (group), which was superior to reminis- inhibitor, which are generally consid- cence therapy (group) ered to be safer for older adults than   Interpersonal psychotherapy (individual), which was superior to nortriptyline. There is some efficacy supportive care data from systematic reviews me- ta-analyses showing efficacy of second-generation antidepressants over placebo. [Refer to Decision Tables 6, 8, 10, 11, 15, 16, 23, 35, 36 in Appendix C of the supplement.] For older adult patients with depression, there is insufficient evidence to Insufficient evidence for Based on the literature reviewed that recommend for or against clinicians offering a recommendation met the IOM or AMSTAR require-   Problem-solving therapy (in-person) vs. attention control"
  },
  {
    "id": 94,
    "source": "guideline_c3debd",
    "text": "for Based on the literature reviewed that recommend for or against clinicians offering a recommendation met the IOM or AMSTAR require-   Problem-solving therapy (in-person) vs. attention control (phone ments there is insufficient evidence call) for major depressive disorder available to determine differences in   Problem-solving therapy (video call) vs. attention control (phone treatment effect for the listed treat- call) for major depressive disorder ment comparisons for older adult patients with depression. Thus, the panel makes no recommendations of one treatment over the other for the treatments in each pair comparison. Decision should be based on shared decision-making with the patient. [Refer to Decision Tables 33, 34 in Appendix C of the supplement.] 29 Throughout the table,"
  },
  {
    "id": 95,
    "source": "guideline_c3debd",
    "text": "treatments in each pair comparison. Decision should be based on shared decision-making with the patient. [Refer to Decision Tables 33, 34 in Appendix C of the supplement.] 29 Throughout the table, interventions are listed alphabetically. 14 APA   Guideline for the Treatment of Depression INITIAL TREATMENT Subthreshold minor depression The panel suggests considering one of the following options for sub- Conditional recommendation Based on the literature reviewed that threshold or minor depression for use met the IOM or AMSTAR require-   Cognitive-behavioral therapy (internet) for subthreshold depression ments for subthreshold depression,   Cognitive-behavioral therapy (individual) and usual care for minor there was no efficacy data sufficient depressive disorder to recommend treatment."
  },
  {
    "id": 96,
    "source": "guideline_c3debd",
    "text": "depression ments for subthreshold depression,   Cognitive-behavioral therapy (individual) and usual care for minor there was no efficacy data sufficient depressive disorder to recommend treatment. Thus, the   Cognitive-behavioral therapy (group) and usual care for treating panel makes the listed suggestions. minor depressive disorder While paroxetine was used in the   Combination cognitive- behavioral therapy and treatment as usual past, currently many geriatric psy- rather than combination of talking control30 (individual) and usual chiatrists would prefer another SSRI care for older adults with minor or major depressive disorder (like escitalopram or sertraline) to   Life review course (group) rather than an educational video for older paroxetine due to the anticholinergic adults with"
  },
  {
    "id": 97,
    "source": "guideline_c3debd",
    "text": "with minor or major depressive disorder (like escitalopram or sertraline) to   Life review course (group) rather than an educational video for older paroxetine due to the anticholinergic adults with subclinical depression side effects of paroxetine. [Refer to   Problem-solving therapy (individual) Decision Tables 3, 13, 24, 24B, 29,   paroxetine 30, 31, 39, 42 in Appendix C of the supplement.]   Of note, while the study on which this is based used paroxetine, some argue that paroxetine is contraindicated in older adults due to its anticholinergic side effects and many geriatric psychiatrists would prefer another SSRI (i.e., escitalopram or sertraline). The panel encourages shared decision-making with patients of bene- fits versus harms of treatment. The panel had insufficient evidence to"
  },
  {
    "id": 98,
    "source": "guideline_c3debd",
    "text": "would prefer another SSRI (i.e., escitalopram or sertraline). The panel encourages shared decision-making with patients of bene- fits versus harms of treatment. The panel had insufficient evidence to recommend the following treat- Insufficient evidence for Based on the literature reviewed that ments: a recommendation met the IOM or AMSTAR require-   Behavioral bibliotherapy (self-guided) vs. treatment as usual for ments there is insufficient evidence subthreshold depression. available to determine differences   Life review therapy (individual) vs. treatment as usual for subclinical in treatment effect for the listed depression. treatment comparisons for older adult patients with subthreshold or minor depression. Thus, the panel makes no recommendations of one treatment over the other for"
  },
  {
    "id": 99,
    "source": "guideline_c3debd",
    "text": "effect for the listed depression. treatment comparisons for older adult patients with subthreshold or minor depression. Thus, the panel makes no recommendations of one treatment over the other for the treatments in each pair comparison. Decision should be based on shared decision-making with the patient. [Refer to Decision Tables 38, 46 in Appendix C of the supplement.] MDD or minor depression   cognitive impairment dementia The panel suggests considering one of the following options for MDD or Conditional recommendation Based on the literature reviewed that minor depression in the context of cognitive impairment or dementia: for use met the IOM or AMSTAR require-   Problem-solving therapy (individual) for older adult patients with ments for MDD or minor depression major depressive"
  },
  {
    "id": 100,
    "source": "guideline_c3debd",
    "text": "of cognitive impairment or dementia: for use met the IOM or AMSTAR require-   Problem-solving therapy (individual) for older adult patients with ments for MDD or minor depression major depressive disorder and executive dysfunction31 plus cognitive impairment dementia,   Problem-solving behavioral therapy (individual) or pleasant events there was no efficacy data sufficient behavioral therapy (individual) for minor or major depressive disor- to recommend treatment. Thus, the der in older adults with dementia panel makes the listed suggestions. [Refer to Decision Tables 2, 26 in Appendix C of the supplement.] 30 Participants in this condition received attention and warm interactions from therapists during discussion of neutral topics. 31 Disruption to cognitive processes generally housed in"
  },
  {
    "id": 101,
    "source": "guideline_c3debd",
    "text": "supplement.] 30 Participants in this condition received attention and warm interactions from therapists during discussion of neutral topics. 31 Disruption to cognitive processes generally housed in the frontal lobes of the brain. APA   Guideline for the Treatment of Depression 15 The panel had insufficient evidence to recommend the combination of Insufficient evidence for Based on the literature reviewed that behavioral activation therapy (individual) and treatment as usual over a recommendation met the IOM or AMSTAR require- treatment as usual for depressive symptoms in older adults with mild to ments there is insufficient evidence moderate cognitive impairment. available to determine differences in treatment effect for the listed treat- ment comparisons for older adult pa- tients with"
  },
  {
    "id": 102,
    "source": "guideline_c3debd",
    "text": "to ments there is insufficient evidence moderate cognitive impairment. available to determine differences in treatment effect for the listed treat- ment comparisons for older adult pa- tients with MDD or minor depression plus cognitive impairment dementia. Thus, the panel makes no recom- mendations of one treatment over the other for the treatments in each pair comparison. Decision should be based on shared decision-making with the patient. [Refer to Deci- sion Table 27 in Appendix C of the supplement.] Persistent depressive disorder The panel suggests considering one of the following options for MDD or Conditional recommendation Based on the literature reviewed that minor depression in the context of cognitive impairment or dementia: for use met the IOM or AMSTAR require-"
  },
  {
    "id": 103,
    "source": "guideline_c3debd",
    "text": "options for MDD or Conditional recommendation Based on the literature reviewed that minor depression in the context of cognitive impairment or dementia: for use met the IOM or AMSTAR require-   Problem-solving therapy (individual) or paroxetine for persistent ments for persistent depressive depressive disorder disorder in older adults, there was no efficacy data sufficient to recom- Of note, while the study on which this is based used paroxetine, some mend treatment. Thus, the panel argue that paroxetine is contraindicated in older adults due to its anti- makes the listed suggestions. Of cholinergic side effects, and many geriatric psychiatrists would prefer note, while some evidence supported another SSRI (i.e., escitalopram or sertraline). problem-solving therapy, it was not"
  },
  {
    "id": 104,
    "source": "guideline_c3debd",
    "text": "Of cholinergic side effects, and many geriatric psychiatrists would prefer note, while some evidence supported another SSRI (i.e., escitalopram or sertraline). problem-solving therapy, it was not significantly superior to attentional control conditions using either phone or video contact. While paroxetine was used in the past, currently many geriatric psychiatrists would prefer another SSRI (like escitalopram or sertraline) to paroxetine due to the anticholinergic side effects of parox- etine. [Refer to Decision Table 12 in Appendix C of the supplement.] MDD with medical or other complications The panel suggests considering the following options for patients with Conditional recommendation Based on the literature reviewed that both depression and the indicated complicating factors: for"
  },
  {
    "id": 105,
    "source": "guideline_c3debd",
    "text": "The panel suggests considering the following options for patients with Conditional recommendation Based on the literature reviewed that both depression and the indicated complicating factors: for use met the IOM or AMSTAR require-   Combination of cognitive- behavioral therapy (individual) and usual ments for MDD with medical or care for minor or major depressive disorder with type II diabetes other complications, there was no ef- mellitus or chronic obstructive pulmonary disease ficacy data sufficient to recommend   Multicomponent intervention (individual) for treating symptoms of treatment. Thus, the panel makes the depression in temporarily homebound African American adults listed suggestions. [Refer to Decision   Coping improvement (group) rather than psychotherapy32 on Tables 25, 37,"
  },
  {
    "id": 106,
    "source": "guideline_c3debd",
    "text": "Thus, the panel makes the depression in temporarily homebound African American adults listed suggestions. [Refer to Decision   Coping improvement (group) rather than psychotherapy32 on Tables 25, 37, 51 in Appendix C of the request (individual) for older adults with mild to severe depressive supplement.] symptoms and HIV 32 Participants in this condition were able to access typical psychosocial services from the community (e.g., 12-step programs, support groups for AIDS, individual therapy). They also were given three brief phone calls to assess for any clinical concerns that may have arisen. 16 APA   Guideline for the Treatment of Depression PREVENTION OF RECURRENCE-MDD For older adult patients with a history of depression, the panel recom- Recommendation for use Based on the literature"
  },
  {
    "id": 107,
    "source": "guideline_c3debd",
    "text": "16 APA   Guideline for the Treatment of Depression PREVENTION OF RECURRENCE-MDD For older adult patients with a history of depression, the panel recom- Recommendation for use Based on the literature reviewed that mends clinicians offer any of the following options: met the IOM or AMSTAR require- ments, comparative effectiveness Either: research demonstrated sufficient   Combination interpersonal psychotherapy and pharmacotherapy evidence for the panel to recommend   Combination supportive care and pharmacotherapy some combinations of treatments Of note, while the study on which this is based used nortriptyline, the over others due to differences in panel recommends a second-generation antidepressant due to the treatment effect for prevention of reduced risk of side effects. recurrence."
  },
  {
    "id": 108,
    "source": "guideline_c3debd",
    "text": "used nortriptyline, the over others due to differences in panel recommends a second-generation antidepressant due to the treatment effect for prevention of reduced risk of side effects. recurrence. The panel suggests considering the following option if the prior options Conditional recommendation Other treatment combinations of are not acceptable or available: for use treatments were equally recom-   Interpersonal psychotherapy (individual) alone mended by the panel based on comparative effectiveness re- search evidence demonstrating no difference in effect for prevention of recurrence. While nortriptyline was used in the past due to its efficacy and safety, practices have changed significantly, and nortriptyline is now viewed as a second- or third-line pharmacothera- py strategy for"
  },
  {
    "id": 109,
    "source": "guideline_c3debd",
    "text": "nortriptyline was used in the past due to its efficacy and safety, practices have changed significantly, and nortriptyline is now viewed as a second- or third-line pharmacothera- py strategy for major depression. It is generally reserved for patients who have not done well with a selective serotonin reuptake inhibitor or a serotonin-norepinephrine reuptake inhibitor, which are generally consid- ered to be safer for older adults than nortriptyline. There is some efficacy data from systematic reviews me- ta-analyses showing efficacy of second-generation antidepressants over placebo. [Refer to Decision Tables 19, 20, 20 (pg. A-378), 21, 22 in Appendix C of the supplement.] For older adult patients with a history of depression there is insufficient Insufficient evidence for Based on the"
  },
  {
    "id": 110,
    "source": "guideline_c3debd",
    "text": "to Decision Tables 19, 20, 20 (pg. A-378), 21, 22 in Appendix C of the supplement.] For older adult patients with a history of depression there is insufficient Insufficient evidence for Based on the literature reviewed that evidence to recommend between clinicians offering cognitive-behavior- a recommendation met the IOM or AMSTAR require- al therapy (group) plus pharmacotherapy and pharmacotherapy alone ments, there is insufficient evidence. for preventing recurrence. Thus, the panel makes no recommendations available to determine differences of one treatment over the other. in treatment effect. Thus, the panel makes no recommendations of one treatment over the other. Decision should be based on shared deci- sion-making with the patient. [Refer to Decision Table 17 in Appendix C of the"
  },
  {
    "id": 111,
    "source": "guideline_c3debd",
    "text": "Thus, the panel makes no recommendations of one treatment over the other. Decision should be based on shared deci- sion-making with the patient. [Refer to Decision Table 17 in Appendix C of the supplement.] APA   Guideline for the Treatment of Depression 17 FULL GUIDELINE Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts 18 APA   Guideline for the Treatment of Depression Scope of the Problem Definition of the problem. Depressive disorders (e.g., major depressive disorder, persistent depressive disorder) are some of the most prevalent, impairing, and costly disorders of any kind. The Global Burden of Disease Study reported that major depression was the third lead- ing cause of worldwide disability in 1990 and had risen to the second leading cause by 2013"
  },
  {
    "id": 112,
    "source": "guideline_c3debd",
    "text": "of any kind. The Global Burden of Disease Study reported that major depression was the third lead- ing cause of worldwide disability in 1990 and had risen to the second leading cause by 2013 both worldwide (Vos et al., 2015) and in the United States (U.S. Burden of Disease Collaborators, 2013). Major depression leads to lost work productivity and increased morbidity and mortal- ity due to direct effects associated with increased risk of suicide, reduced functional behaviors, and interpersonal functioning. It also leads to added consequences due to indirect effects on health through the exacerbation of other major causes of morbidity and mortality (Cuijpers, Vogelzangs, Twisk, Kleiboer,   Penninx, 2014c; Elderon   Whooley, 2013; Katon, 2003; Liu et al., 2017) and increasing prevalence of"
  },
  {
    "id": 113,
    "source": "guideline_c3debd",
    "text": "of other major causes of morbidity and mortality (Cuijpers, Vogelzangs, Twisk, Kleiboer,   Penninx, 2014c; Elderon   Whooley, 2013; Katon, 2003; Liu et al., 2017) and increasing prevalence of diabetes especially among youth and middle-aged adults in the United States and worldwide (Lin et al., 2009). Major depressive disorder is characterized by a depressed mood (or irritability in children) and or loss of pleasure or interest for at least 2 weeks (American Psychiatric Association, 2013). It is accompanied by at least three (for a total of at least five) of the following symptoms present most days: weight loss and or change in appetite, insomnia or hypersomnia, psychomotor retardation or agitation, fatigue or loss of energy, excessive  inappropriate guilt or feelings of worthlessness,"
  },
  {
    "id": 114,
    "source": "guideline_c3debd",
    "text": "days: weight loss and or change in appetite, insomnia or hypersomnia, psychomotor retardation or agitation, fatigue or loss of energy, excessive  inappropriate guilt or feelings of worthlessness, indecisiveness or diminished ability to concentrate or think, and recurrent thoughts of death or suicidal ideation or suicide plan or attempt (American Psychiatric Association, 2013). Another depressive disorder, per- sistent depressive disorder, is characterized by a depressed mood most of the time for at least 2 years, along with at least two of the following symptoms: feeling hopeless, insom- nia or hypersomnia, overeating or poor appetite, fatigue or low energy, low self-esteem, and indecisiveness or poor concentration (American Psychiatric Association, 2013). In children and adolescents, the"
  },
  {
    "id": 115,
    "source": "guideline_c3debd",
    "text": "hypersomnia, overeating or poor appetite, fatigue or low energy, low self-esteem, and indecisiveness or poor concentration (American Psychiatric Association, 2013). In children and adolescents, the duration is at least one year, and the mood can be irritable. Moreover, there cannot be a gap in these symptoms for more than 2 months, a hypomanic or manic episode during this time period, nor criteria met for cyclothymic disorder. Further, symptoms are not better explained by another disorder, cause significant impairment in functioning or distress, and are not due to a different medical condition or a substance (American Psychiatric Association, 2013). The level of population disability associated with depressive disorders (major depres- sive disorder, persistent depressive disorder,"
  },
  {
    "id": 116,
    "source": "guideline_c3debd",
    "text": "or a substance (American Psychiatric Association, 2013). The level of population disability associated with depressive disorders (major depres- sive disorder, persistent depressive disorder, subsyndromal depression, and other mani- festations) is a function of the severity and chronic or recurrent nature of the symptoms, and the high frequency of the disorder. Unlike other chronic illnesses, first onset of major depressive disorder often occurs in late teens or early adulthood. In the United States, approximately 6.7  to 7.6  of adults report an episode of major depression in a 12-month period, with women having approximately 1.7 times the risk as men (Substance Abuse and Mental Health Service Administration, 2015; Kessler, McGonagle, Swartz, Blazer,   Nelson, 1993). In marginalized"
  },
  {
    "id": 117,
    "source": "guideline_c3debd",
    "text": "period, with women having approximately 1.7 times the risk as men (Substance Abuse and Mental Health Service Administration, 2015; Kessler, McGonagle, Swartz, Blazer,   Nelson, 1993). In marginalized populations and those of lower SES, rates are likely to be significantly higher (Weinberger et al., 2017). Lifetime prevalence is estimated at 17.9 . Major depres- sion is frequently comorbid with other mental health disorders, particularly anxiety disor- ders and substance use disorders. The extensive burden on individuals, families, health care systems, and society makes it imperative to develop and implement effective tools and strategies to assess and treat major depressive disorder and other depressive disorders. APA   Guideline for the Treatment of Depression 19 Children and Adolescents"
  },
  {
    "id": 118,
    "source": "guideline_c3debd",
    "text": "and implement effective tools and strategies to assess and treat major depressive disorder and other depressive disorders. APA   Guideline for the Treatment of Depression 19 Children and Adolescents receive outpatient treatment for depression each year (Avenevoli et al., 2015). In particular, racially and ethnically diverse youth con- sistently demonstrate the greatest unmet need for mental health Prevalence among children and adolescents. Depression is one of treatment (Alegr a, Vallas,   Pumariega, 2010; Caldwell, Assari,   the most common psychiatric disorders in adolescents (Costello, Breland-Noble, 2016). Children and youth living in rural, remote, Erkanli,   Angold, 2006). There are reports of a 11.7  lifetime prev- and other underserved locations are least likely to receive needed"
  },
  {
    "id": 119,
    "source": "guideline_c3debd",
    "text": "2016). Children and youth living in rural, remote, Erkanli,   Angold, 2006). There are reports of a 11.7  lifetime prev- and other underserved locations are least likely to receive needed alence rate for major depressive disorder or dysthymic disorder in mental health treatment (Blackstock, Chae, Mauk,   McDonald, adolescents based on data from the National Comorbidity Study  2018). Depressed children and adolescents are much less likely Adolescent Supplement (Merikangas et al., 2010). Moreover, there to receive mental health treatment than adults (Olfson, Gameroff, was a 2.6  increase between 2005 to 2014 in adolescents experi- Marcus,   Waslick, 2003). Most youth who do use mental health encing a major depressive episode (Mojtabai, Olfson,   Han, 2016). services receive them in the"
  },
  {
    "id": 120,
    "source": "guideline_c3debd",
    "text": "2005 to 2014 in adolescents experi- Marcus,   Waslick, 2003). Most youth who do use mental health encing a major depressive episode (Mojtabai, Olfson,   Han, 2016). services receive them in the school setting (Slade, 2003). Of Rates among same-aged youth of low SES, or who are members of those who reported receiving treatment for major depressive dis- marginalized populations, are believed to be significantly higher order in any setting (60.4 ) in the National Comorbidity Study  (Hasin, Goodwin, Stinson,   Grant, 2005). Adolescence is a unique Adolescent Supplement, only 33.9  stated that they received period given the dramatic increase in risk for depression during this treatment specific to their depressive disorder or in a mental period. The impairments associated with adolescent"
  },
  {
    "id": 121,
    "source": "guideline_c3debd",
    "text": "they received period given the dramatic increase in risk for depression during this treatment specific to their depressive disorder or in a mental period. The impairments associated with adolescent depression also health service setting (Avenevoli et al., 2015). Accordingly, it is have been found to persist into adulthood and reflect the significant important to identify effective treatment strategies for childhood morbidity and lifelong impairment associated with the disorder and adolescent depression to decrease current functional impair- (Glied   Pine, 2002; Lewinsohn et al., 1994; Lewinsohn, Rohde, Klein, ments and potentially disrupt the negative developmental trajecto-   Seeley, 1999). The National Comorbidity Study Adolescent ries that can continue into adulthood. Supplement found"
  },
  {
    "id": 122,
    "source": "guideline_c3debd",
    "text": "Rohde, Klein, ments and potentially disrupt the negative developmental trajecto-   Seeley, 1999). The National Comorbidity Study Adolescent ries that can continue into adulthood. Supplement found that rates of depression markedly increased among youth ages 13 through 18 years (Avenevoli, Swendsen, He, Characteristics of depression in children and adolescents. With Burstein,   Merikangas. 2015) and that prevalence of major depres- the introduction of the DSM-5, what were formerly known as  Mood sive disorder (MDD) is two times higher in older than younger ado- Disorders  are now referred to as  Depressive Disorders  and include lescents as well as higher in female than male adolescents (Avenevoli Disruptive Mood Dysregulation Disorder, Major Depressive et al., 2015). Furthermore,"
  },
  {
    "id": 123,
    "source": "guideline_c3debd",
    "text": "to as  Depressive Disorders  and include lescents as well as higher in female than male adolescents (Avenevoli Disruptive Mood Dysregulation Disorder, Major Depressive et al., 2015). Furthermore, adolescents with anxiety disorders, atten- Disorder Single and Recurrent Episodes, Persistent Depressive tion-deficit hyperactivity disorder, substance use disorders, and Disorder, Premenstrual Dysphoric Disorder, Substance Medication- behavior disorders (i.e., oppositional defiant disorder, conduct disor- Induced Depressive Disorder, Depressive Disorder Due to Another der) have significant rates of comorbid MDD and higher risks of Medical Condition, Other Specified Depressive Disorder, and developing MDD, particularly severe MDD (Avenevoli et al., 2015). Unspecified Depressive Disorder (American"
  },
  {
    "id": 124,
    "source": "guideline_c3debd",
    "text": "MDD and higher risks of Medical Condition, Other Specified Depressive Disorder, and developing MDD, particularly severe MDD (Avenevoli et al., 2015). Unspecified Depressive Disorder (American Psychiatric Association, In contrast, prevalence rates for depression are lower in chil- 2013). As indicated earlier, Major Depressive Disorder Single and dren and preadolescents ranging from 0.4  to 2.5  of preadoles- Recurrent Episodes and Persistent Depressive Disorder are the dis- cent children (Birmaher   Rozel, 2003). These rates are for those orders with the highest prevalence in adolescents. children meeting full diagnostic criteria for major depressive dis- Depressive disorders are generally characterized by a clus- order. Therefore, rates likely underestimate the impact of depres- ter of"
  },
  {
    "id": 125,
    "source": "guideline_c3debd",
    "text": "meeting full diagnostic criteria for major depressive dis- Depressive disorders are generally characterized by a clus- order. Therefore, rates likely underestimate the impact of depres- ter of symptoms including sadness or low mood, crying, loss of sion on youth, as preadolescent children who present with clini- interest in once-enjoyed activities, decreased energy, and sleep- cally significant symptoms and impaired functioning, but not full ing and eating changes. While these symptoms can be present clinical diagnosis are not always considered. These data may also in youth and adults, in adolescence, depression may manifest in not include significant representation of children of color or other slightly diverse ways. For example, over 60  of depressed teens minorities less likely to"
  },
  {
    "id": 126,
    "source": "guideline_c3debd",
    "text": "adolescence, depression may manifest in not include significant representation of children of color or other slightly diverse ways. For example, over 60  of depressed teens minorities less likely to receive evaluation and treatment. These reported severe impairment in functioning related to school work, children with subsyndromal depression are at risk for developing family, chores, and social roles (Avenevoli et al., 2015). Recent depression diagnoses later in childhood and adolescence. Early research has shown that typical presentations of youth depressive longitudinal studies of children with depression suggested that illness may include fatigue, irritability, and anger with behavioral early onset depression in children was associated with a more pro- correlates including poor school"
  },
  {
    "id": 127,
    "source": "guideline_c3debd",
    "text": "with depression suggested that illness may include fatigue, irritability, and anger with behavioral early onset depression in children was associated with a more pro- correlates including poor school performance, negative acting tracted course of illness and was a marker for more severe psychi- out, and poor interpersonal and peer relationships (Jaycox et al., atric outcomes in adolescence and adulthood (Kovacs et al., 1984; 2009). Typically, individual behavior changes must occur for at Kovacs, Feinberg, Crouse-Novak, Paulauskas,   Finkelstein, 1984). least 2 weeks and must represent a notable change in functioning Specifically, it was also associated with adult depression based in from earlier levels considered normal for that individual to be con- part on family psychiatric history"
  },
  {
    "id": 128,
    "source": "guideline_c3debd",
    "text": "change in functioning Specifically, it was also associated with adult depression based in from earlier levels considered normal for that individual to be con- part on family psychiatric history (Wickramaratne, Greenwald, sidered impaired. Although episodes of major depressive disorder   Weissman, 2000). The Oregon Adolescent Depression Study are less frequent in children than adolescents, the length of the findings suggested that childhood depression doubled the risk of episode was significantly longer in duration in children than ado- experiencing depression in adolescence, and adolescent depres- lescents (median of 16 weeks versus 8 weeks, respectively; Rohde sion strongly predicted depression in early adulthood (Lewinsohn, et al., 2013). Regardless of the length of the episode,"
  },
  {
    "id": 129,
    "source": "guideline_c3debd",
    "text": "depres- lescents (median of 16 weeks versus 8 weeks, respectively; Rohde sion strongly predicted depression in early adulthood (Lewinsohn, et al., 2013). Regardless of the length of the episode, clinicians are Rohde, Seeley, Klein,   Gotlib, 2000; Rohde, Lewinsohn, Klein, encouraged to intervene as opposed to watchful waiting to allevi- Seeley,   Gau, 2013). ate suffering, particularly given the sensitive developmental peri- Despite the prevalence of symptoms, less than 1  of com- ods and tasks of childhood and adolescence. munity-dwelling children and adolescents in the United States 20 APA   Guideline for the Treatment of Depression The DSM-5 diagnostic criteria for characteristics of depres- clinicians researchers, fears of exploitation, and lack of knowledge sive disorders note some"
  },
  {
    "id": 130,
    "source": "guideline_c3debd",
    "text": "Guideline for the Treatment of Depression The DSM-5 diagnostic criteria for characteristics of depres- clinicians researchers, fears of exploitation, and lack of knowledge sive disorders note some exceptions for children or adolescents, about the process of medical research and clinical care as the ratio- such as an exception specific to children for major depressive nale for people of color not participating in clinical research treat- disorder that failure to gain expected weight rather than just sig- ment (Connell, Shaw, Holmes,   Foster, 2001; Corbie-Smith, Thomas, nificant weight loss or gain should be considered during diagnosis Williams,   Moody-Ayers, 1999; Murray, 1998). As it relates to (American Psychiatric Association, 2013). Regarding the mani- youth, the literature"
  },
  {
    "id": 131,
    "source": "guideline_c3debd",
    "text": "loss or gain should be considered during diagnosis Williams,   Moody-Ayers, 1999; Murray, 1998). As it relates to (American Psychiatric Association, 2013). Regarding the mani- youth, the literature indicates that African American parents specif- festations of major depressive disorder in youth, the American ically are fearful of the negative consequences typically prescribed Academy of Child and Adolescent Psychiatry (2013) indicated for emotionally or behaviorally disturbed children, as well as misla- that children and adolescents with depression exhibit symptoms beling of their children with disruptive behavior problems instead of including social isolation, extreme sensitivity to rejection or failure, depressive illness (McMiller   Weisz, 1996; Pastore, Juszczak, Fisher, and increased"
  },
  {
    "id": 132,
    "source": "guideline_c3debd",
    "text": "disruptive behavior problems instead of including social isolation, extreme sensitivity to rejection or failure, depressive illness (McMiller   Weisz, 1996; Pastore, Juszczak, Fisher, and increased irritability. While these symptoms can also occur in   Friedman, 1998; Wu et al., 2001). These concerns are also relevant adults, these are symptoms that may be of great import for recog- for other groups of people of color. nizing depression in youth, particularly because there are import- Research has suggested heterogeneity in the development ant developmental differences in verbal expression and emotional and expression of depressive symptoms, as evidenced by diverse maturity between youth and adults. Overall, much of the literature trajectories for different racial ethnic groups (Costello,"
  },
  {
    "id": 133,
    "source": "guideline_c3debd",
    "text": "emotional and expression of depressive symptoms, as evidenced by diverse maturity between youth and adults. Overall, much of the literature trajectories for different racial ethnic groups (Costello, Swendsen, does not treat children and adolescents as separate developmen- Rose,   Dierker, 2008). Some studies reported higher rates of tal cohorts, thereby limiting our understanding of unique symptom depression among non-White youth than White youth (Moon   presentations among children and adolescents, respectively. This Rao, 2010; van Voorhees et al., 2008), while others show a greater is a concern because distinct differences in development may have percentage of White youth with depressive symptoms than African implications for treatment (e.g., the appropriateness of some cog- American"
  },
  {
    "id": 134,
    "source": "guideline_c3debd",
    "text": "because distinct differences in development may have percentage of White youth with depressive symptoms than African implications for treatment (e.g., the appropriateness of some cog- American youth (Saluja et al., 2004). Additionally, data from sever- nitive strategies or forms of play therapy). al large studies suggested that, after controlling for socioeconom- ic status, there are no differences in the prevalence of depressive Sex differences in children and adolescents. Rates of depression symptoms or affective disorders among Black, Hispanic Latino, differ among the sexes across the age span of childhood to adoles- Asian, and White youth (Doi, Roberts, Takeuchi,   Suzuki, 2001; cence. Prior to puberty, rates for depressive disorders are equivalent Garrison, Addy, Jackson, McKeown,"
  },
  {
    "id": 135,
    "source": "guideline_c3debd",
    "text": "span of childhood to adoles- Asian, and White youth (Doi, Roberts, Takeuchi,   Suzuki, 2001; cence. Prior to puberty, rates for depressive disorders are equivalent Garrison, Addy, Jackson, McKeown,   Waller, 1992; Rushton, between the sexes. After puberty, this shifts to a 2:1 ratio of females Forcier,   Schectman, 2002). Other studies indicated that Latino to males, which continues throughout adulthood (Hatcher-Kay   and Native American youth have the highest rates of depression King, 2003). The emergence of the sex difference in adolescence is among youth of color (Centers for Disease Control [CDC], 2012; consistent across samples from different countries and irrespective Kann et al., 2014; Saluja et al., 2004). Given the profound impact of the measure used to assess depressive"
  },
  {
    "id": 136,
    "source": "guideline_c3debd",
    "text": "Control [CDC], 2012; consistent across samples from different countries and irrespective Kann et al., 2014; Saluja et al., 2004). Given the profound impact of the measure used to assess depressive symptomatology (Wade, of SES on the developmental trajectory and the strong association Cairney,   Pevalin, 2002). Studies are consistent in finding that the between poor mental health outcomes and the sequelae of poverty increase in rates for females begins to emerge around the age of 13 (Matthew   Brodersen, 2018), further research that better depicts (Nolen-Hoeksema   Girgus, 1994; Thapar, Collishaw, Pine,   Thapar, rates and presentation of depression among marginalized popula- 2012). The reasons for the post-pubertal onset of rate differences tions is necessary. among the sexes are not"
  },
  {
    "id": 137,
    "source": "guideline_c3debd",
    "text": "Pine,   Thapar, rates and presentation of depression among marginalized popula- 2012). The reasons for the post-pubertal onset of rate differences tions is necessary. among the sexes are not fully understood, but factors thought to play While treatment of depression in children and adolescents an influence include the hormonal and social changes that occur with cognitive treatments is promising, little research exists about during puberty (Hatcher-Kay   King, 2003; Nolen-Hoeksema, 2001; the treatment of depressive illnesses in exclusive samples of youth Thapar et al., 2012). of color. Specifically, only a small handful of studies on exclusive samples of youth of color were identified through APA staff review Child adolescent depression and race ethnicity. Researchers have of studies"
  },
  {
    "id": 138,
    "source": "guideline_c3debd",
    "text": "only a small handful of studies on exclusive samples of youth of color were identified through APA staff review Child adolescent depression and race ethnicity. Researchers have of studies included in the underlying reviews. For example, a ran- posited many explanations for the disengagement of African domized controlled trial examined the use of interpersonal psy- Americans and other people of color in clinical treatment, mostly chotherapy (IPT) for the treatment of depression in Latino youth focusing on access to care barriers (Alegr a et al., 2002; Snowden   (Mufson et al., 2004). In this study, IPT was found to be superi- Yamada, 2005). For example, many African Americans view psychi- or to treatment as usual33 for a sample of under resourced Latino atric illness as a proscribed"
  },
  {
    "id": 139,
    "source": "guideline_c3debd",
    "text": "this study, IPT was found to be superi- Yamada, 2005). For example, many African Americans view psychi- or to treatment as usual33 for a sample of under resourced Latino atric illness as a proscribed subject unattributable to genetic and youth regarding symptom reduction and behavioral functioning dysfunctional familial precursors, favoring instead attributes toward compared with youth receiving treatment as usual. Two addition- lack of resoluteness, spirituality, and stress (Cauce et al., 2002; al studies examined the use of both cognitive-behavioral therapy Kendrick, Anderson,   Moore, 2007; Schnittker, Freese,   Powell, and interpersonal psychotherapy for the treatment of Latino youth 2000). Further, there are barriers to care related to other people of (Rossell    Bernal, 1999;"
  },
  {
    "id": 140,
    "source": "guideline_c3debd",
    "text": "2007; Schnittker, Freese,   Powell, and interpersonal psychotherapy for the treatment of Latino youth 2000). Further, there are barriers to care related to other people of (Rossell    Bernal, 1999; Rossell , Bernal,   Rivera-Medina, 2012). color focused on lack of multilingual, multicultural providers; differ- These findings are promising, but considerably more research on ing conceptualizations of mental illness; and stigma. Other literature youth of color from varied socioeconomic backgrounds is needed has suggested reasons including lack of nonracially diverse profes- to support these findings and to expand the knowledge base regard- sionals in leadership roles, questioning of motives of nondiverse ing the treatment of depression in racially diverse youth. Finally, 33 Treatment as"
  },
  {
    "id": 141,
    "source": "guideline_c3debd",
    "text": "findings and to expand the knowledge base regard- sionals in leadership roles, questioning of motives of nondiverse ing the treatment of depression in racially diverse youth. Finally, 33 Treatment as usual refers to the treatment that a patient would ordinarily receive. The panel noted the challenge of a consistent definition for treatment as usual given that the definition varies by study. APA   Guideline for the Treatment of Depression 21 given greater underutilization of clinical depression care by youth (Curry   Hersch, 2016), sleep problems and attention-deficit hyper- of color, more research is needed to examine the impacts of engag- activity disorder (Becker, Langberg,   Evans, 2015). ing this population in depression treatment. Currently, a growing There are also some reported sex"
  },
  {
    "id": 142,
    "source": "guideline_c3debd",
    "text": "is needed to examine the impacts of engag- activity disorder (Becker, Langberg,   Evans, 2015). ing this population in depression treatment. Currently, a growing There are also some reported sex differences in patterns of body of research exists in treatment engagement (Breland-Noble concurrent comorbidity, with some studies showing depression   AAKOMA Project Adult Advisory Board, 2012; Breland-Noble, comorbid with conduct disorder in girls but not boys, and depres- Bell, Burriss,   AAKOMA Project Adult Advisory Board, 2011), with sion comorbid with substance use disorders in boys but not girls promising findings. However, considerably more research is need- (Costello, Mustillo, Erkanli, Keeler,   Angold, 2003). However, ed to replicate current findings and establish the effectiveness of"
  },
  {
    "id": 143,
    "source": "guideline_c3debd",
    "text": "promising findings. However, considerably more research is need- (Costello, Mustillo, Erkanli, Keeler,   Angold, 2003). However, ed to replicate current findings and establish the effectiveness of recent research points to fewer sex differences and greater depres- engagement methods (Lindsey et al., 2014). And, research with sive illness severity associated with likelihood of co-morbidity youth of color must be based on an understanding of multicultural equally between boys and girls (i.e., more severe major depres- concerns as well as practical barriers that limit access to care. sive disorder is associated with presence of conduct and anxiety problems than less severe major depressive disorder in both sexes; Child adolescent depression and suicide. While adolescents who Avenevoli et"
  },
  {
    "id": 144,
    "source": "guideline_c3debd",
    "text": "is associated with presence of conduct and anxiety problems than less severe major depressive disorder in both sexes; Child adolescent depression and suicide. While adolescents who Avenevoli et al., 2015). As shown earlier, depression was often experience an episode of depression have a 30-fold increased risk of studied as a secondary co-occurring disorder to other behavior deaths by suicide (Brent, 1993; Brent et al., 1988), the suicide rates and mental health problems (i.e., conduct disorder and opposi- for children and adolescents have generally stabilized or declined tional defiant disorder) in youth of color. However, it is unlikely that over the past 20 years (McLoughlin, Gould,   Malone, 2015). high representation of this research area shows greater likelihood According to Shain"
  },
  {
    "id": 145,
    "source": "guideline_c3debd",
    "text": "in youth of color. However, it is unlikely that over the past 20 years (McLoughlin, Gould,   Malone, 2015). high representation of this research area shows greater likelihood According to Shain and colleagues  (2016) analysis, the suicide rate of externalizing behavior problems in depressed youth of color. in teens decreased by 28  from 1990 to 2013. Therefore, future research is needed with large samples of youth of Even though there is stability in rates of suicide among youth, color to determine actual correlation between disruptive behavior suicide is the third leading cause of death for youth between the problems and the presence of major depressive disorder in racially ages of 10 and 24 (CDC, 2017) as well as for Hispanic males ages 15 diverse youth. to 34 (Suicide Prevention"
  },
  {
    "id": 146,
    "source": "guideline_c3debd",
    "text": "for youth between the problems and the presence of major depressive disorder in racially ages of 10 and 24 (CDC, 2017) as well as for Hispanic males ages 15 diverse youth. to 34 (Suicide Prevention Resource Center, 2013) and Black youth Finally, physical health conditions, such as smoking, obesi- ages 15 to 24 (Al-Mateen   Rogers, 2018). Depressive disorders ty, and drug use (Conway, Swendsen, Husky, He,   Merikangas, are linked with increased risk for suicidal ideation, suicide attempts, 2016; Merikangas, Mendola, Pastor, Reuben,   Cleary, 2012) are and completed suicides (Hatcher-Kay   King, 2003). The preva- also associated with depression that differs across racial groups. lence of seriously attempting suicide was higher among gay, les- Overall, the current body of research has"
  },
  {
    "id": 147,
    "source": "guideline_c3debd",
    "text": "King, 2003). The preva- also associated with depression that differs across racial groups. lence of seriously attempting suicide was higher among gay, les- Overall, the current body of research has suggested that youth bian, and bisexual youth than their heterosexual counterparts across race and sex experience depression in consort with other (42.8  and 14.8 , respectively; Frieden, Jaffe, Cono, Richards, mental illnesses and that clinical interventions for depression may   Iademarco, 2016). Depression is a major risk factor for suicide need to account for the presence of symptoms reflecting multiple with more than half of adolescent suicide victims reported to have mental illnesses in children and teens. a depressive disorder at time of death (Thapar et al., 2012). Rates of suicide"
  },
  {
    "id": 148,
    "source": "guideline_c3debd",
    "text": "multiple with more than half of adolescent suicide victims reported to have mental illnesses in children and teens. a depressive disorder at time of death (Thapar et al., 2012). Rates of suicide among Native American youth are the highest across all populations and are at epidemic levels (Herne, Bertholomew,   General Adult Population Weahkee, 2014). According to the National Comorbidity Study  Adolescent Supplement, nearly 30  of adolescents with major Prevalence among adults. Major depression is one of the most com- depressive disorder reported some form of suicidality in the past mon mood disorders among young and middle-aged adults. year, with 10.8  reporting a suicide attempt (Avenevoli et al., According to a 2014 report by the Substance Abuse and Mental 2015). Thus, providing"
  },
  {
    "id": 149,
    "source": "guideline_c3debd",
    "text": "mood disorders among young and middle-aged adults. year, with 10.8  reporting a suicide attempt (Avenevoli et al., According to a 2014 report by the Substance Abuse and Mental 2015). Thus, providing effective treatment for depression in youth Health Services Administration (SAMHSA), an estimated 15.7 mil- and reduction of access to lethal means might have a significant lion adults in the United States aged 18 and older had at least one impact on preventing suicidal behavior and attempts in this age major depressive episode during the past year. This represented group. 6.7  of all U.S. adults (SAMHSA, 2015). In addition, 4.3  of adults (10.2 million individuals) reported Child adolescent depression and co-morbidity. A large proportion of experiencing a major depressive episode with  severe"
  },
  {
    "id": 150,
    "source": "guideline_c3debd",
    "text": "2015). In addition, 4.3  of adults (10.2 million individuals) reported Child adolescent depression and co-morbidity. A large proportion of experiencing a major depressive episode with  severe impairment  children and adolescents with depression also meet criteria for comor- (SAMHSA, 2015). Severe impairment occurred if their depression bid psychiatric disorders, with the most common disorders including resulted in severe problems in their ability  to manage at home, anxiety and behavioral (conduct and oppositional defiant) disorders manage well at work, have relationships with others, or have a (Avenevoli et al., 2015). Research has indicated that youth with pri- social life  (SAMHSA, 2015, p. 30). Among the U.S. adult popu- mary depression, compared with youth with primary anxiety, are"
  },
  {
    "id": 151,
    "source": "guideline_c3debd",
    "text": "a (Avenevoli et al., 2015). Research has indicated that youth with pri- social life  (SAMHSA, 2015, p. 30). Among the U.S. adult popu- mary depression, compared with youth with primary anxiety, are more lation, the highest percentage of individuals with a previous-year likely to have other comorbidities (such as anxiety). For example, major depressive episode occurred for young adults aged 18 to 25 research over the past 10 years suggests that almost half of community (9.3 ). This was followed by adults aged 26 to 49 (7.2 ) and then youth with primary depression also meet criteria for anxiety disorders by individuals older than 50 (5.2 ). Regarding the experience of while just under 20  of community youth with primary anxiety also a major depressive episode leading to severe impairment,"
  },
  {
    "id": 152,
    "source": "guideline_c3debd",
    "text": "disorders by individuals older than 50 (5.2 ). Regarding the experience of while just under 20  of community youth with primary anxiety also a major depressive episode leading to severe impairment, the age meet criteria for a depressive disorder (Garber   Weersing, 2010). group with the highest percentage of adults involved those aged 18 Aside from anxiety, other common psychiatric comorbidities present to 25 (6.0 ), followed by people aged 26 to 49 (4.6 ) and per- in youth with primary depression include substance use and abuse sons older than 50 (3.5 ; SAMHSA, 2015). 22 APA   Guideline for the Treatment of Depression Not only is depression pervasive, it also carries the heaviest depression prevalence rates. One study found that prevalence rates burden of disability among psychological"
  },
  {
    "id": 153,
    "source": "guideline_c3debd",
    "text": "the Treatment of Depression Not only is depression pervasive, it also carries the heaviest depression prevalence rates. One study found that prevalence rates burden of disability among psychological disorders. Specifically, of depression among U.S. born Chinese Americans was much high- major depression accounts for 3.7  of all U.S. disability-adjusted er (21.5 ) than that of non-U.S. born Chinese Americans (7.7 ; life years and 8.3  of all U.S. years lived with disability (National Jackson et al., 2011). Further, the prevalence rates of depression Institute of Mental Health, 2015). Worldwide, it is estimated that among Asian Americans were higher than among Asians in Asia on average 1 in 20 people experienced a depressive episode in the (Yang   WonPat-Borja, 2007). An added concern in"
  },
  {
    "id": 154,
    "source": "guideline_c3debd",
    "text": "it is estimated that among Asian Americans were higher than among Asians in Asia on average 1 in 20 people experienced a depressive episode in the (Yang   WonPat-Borja, 2007). An added concern in estimating dif- previous year, affecting 350 million people (Marcus et al., 2012). ferences in prevalence rates is that socioeconomic status and pov- erty are not only independent predictors of depression, they are Characteristics of depression in the general adult population: Sex also strongly associated with race ethnicity and depression (Riolo, differences in adults. Across the world, women are approximately Nguyen, Greden,   King, 2005). Notably, in many places around twice as likely to experience depression as men (Albert, 2015). For the world, people of color (compared with Whites) are"
  },
  {
    "id": 155,
    "source": "guideline_c3debd",
    "text": "approximately Nguyen, Greden,   King, 2005). Notably, in many places around twice as likely to experience depression as men (Albert, 2015). For the world, people of color (compared with Whites) are overrep- example, women have a lifetime prevalence for major depression of resented in groups with less access to socioeconomic resources. approximately 21 , compared with 12  among men (Kessler et al., Research that fully explores rates of depression among multicultur- 1993). This sex difference appears early during adolescence. al and diverse populations inclusive of SES, gender identity, sexual Explanations for this difference include a variety of developmental, orientation, cultural heritage, and geography is needed. biological, cultural, and social causes (Albert, 2015). Regardless of the"
  },
  {
    "id": 156,
    "source": "guideline_c3debd",
    "text": "Explanations for this difference include a variety of developmental, orientation, cultural heritage, and geography is needed. biological, cultural, and social causes (Albert, 2015). Regardless of the reasons, the World Health Organization Adult depression and suicide. It is estimated that approximately two (WHO) estimated that the burden of depression is approximately thirds of those in the United States who die by suicide suffer from 50  higher for women than men (WHO, 2008). Moreover, it is the depression at the time of the suicide act (CDC, 2012). Moreover, the leading cause of functional impairment for women regardless of likelihood for a lifetime suicide attempt has been estimated to be the socioeconomic status of a given country. Of related concern is approximately five times"
  },
  {
    "id": 157,
    "source": "guideline_c3debd",
    "text": "impairment for women regardless of likelihood for a lifetime suicide attempt has been estimated to be the socioeconomic status of a given country. Of related concern is approximately five times greater for individuals with major depres- the notion that maternal depression, especially in developing coun- sive disorder or persistent depressive disorder compared with an tries, may be a risk factor for impoverished growth in young chil- individual without a diagnosis (Nock, Hwang, Sampson,   Kessler, dren (Rahman, Patel, Maselko,   Kirkwood, 2008), underscoring 2010). Such statistics strongly underscore the need for adequate the cross-generational impact of depression. assessment of the presence and degree of suicidality when working There are also sex differences in the presentation of adult"
  },
  {
    "id": 158,
    "source": "guideline_c3debd",
    "text": "the need for adequate the cross-generational impact of depression. assessment of the presence and degree of suicidality when working There are also sex differences in the presentation of adult with depressed adults, the reduction of access to lethal means, and depression. For example, according to the National Institute of the need for effective depression treatment to reduce suicide. Mental Health (NIMH), women tend to have symptoms of sadness, worthlessness, and guilt, whereas men are more likely to report Adult depression and comorbidity. Depressive symptoms and disor- experiencing tiredness, irritability, sleep problems, and loss of ders are commonly associated with a wide range of other psychiatric interest in previously pleasurable activities (NIMH, 2015). and medical disorders and"
  },
  {
    "id": 159,
    "source": "guideline_c3debd",
    "text": "irritability, sleep problems, and loss of ders are commonly associated with a wide range of other psychiatric interest in previously pleasurable activities (NIMH, 2015). and medical disorders and diseases. These include anxiety, posttrau- matic stress disorder, substance use, personality disorders, heart dis- Adult depression and race ethnicity. Different depression prevalence ease, cancer, multiple sclerosis, pain, dementia, and diabetes (e.g., rates as a function of race and ethnicity have been identified. This Katon et al., 2010; Richards   O Hara, 2014; Simon et al., 2005). Such relationship, however, can be somewhat complex. For example, while comorbidity can have significant impact on people s health outcome large-scale studies tend to find that Blacks (e.g., African Americans,"
  },
  {
    "id": 160,
    "source": "guideline_c3debd",
    "text": "however, can be somewhat complex. For example, while comorbidity can have significant impact on people s health outcome large-scale studies tend to find that Blacks (e.g., African Americans, beyond the disease itself. For example, depression among patients Caribbean Blacks) have lower lifetime rates of major depressive dis- with diabetes is associated with higher risk of significant complications order compared with non-Hispanic Whites, the chronicity and bur- such as amputation, blindness, and dementia (Katon et al., 2010; den of depression appears the opposite for these groups. Specifically, Simon et al., 2005). Moreover, depression itself has been found to one study found that while lifetime major depressive disorder preva- predict comorbid medical diseases such as diabetes (Katon et"
  },
  {
    "id": 161,
    "source": "guideline_c3debd",
    "text": "Simon et al., 2005). Moreover, depression itself has been found to one study found that while lifetime major depressive disorder preva- predict comorbid medical diseases such as diabetes (Katon et al., lence estimates were the highest for Whites, the chronicity of major 2010). Research has shown that among people without cardiovascular depressive disorder for the Caribbean Black and African American disease but depression at baseline, there is an approximately 200  samples was substantially higher than for Whites (Williams et al., increase in relative risk (or probability) of developing heart disease 2007). Moreover, both Black groups, in comparison to Whites, were compared with nondepressed persons (Wulson   Singal, 2003). less likely to receive any form of psychotherapy or"
  },
  {
    "id": 162,
    "source": "guideline_c3debd",
    "text": "heart disease 2007). Moreover, both Black groups, in comparison to Whites, were compared with nondepressed persons (Wulson   Singal, 2003). less likely to receive any form of psychotherapy or pharmacotherapy Additionally, depression is commonly reported in patients with HIV  for depression and were more likely to rate their major depressive AIDS (Rabkin, 2008). The literature on the assessment and treatment disorder as more severe and disabling. of diseases comorbid with depression is large and growing. One concern involved in estimating difference in prevalence rates as a function of race and ethnicity is to avoid  lumping  var- ious subgroups together. For example, 27  of a group of over Older Adult Population 16,000 individuals of Hispanic Latino origin reported elevated levels of"
  },
  {
    "id": 163,
    "source": "guideline_c3debd",
    "text": "and ethnicity is to avoid  lumping  var- ious subgroups together. For example, 27  of a group of over Older Adult Population 16,000 individuals of Hispanic Latino origin reported elevated levels of depressive symptoms, but rates varied between 22.3  Prevalence of depression in older adults. The prevalence rate of among individuals of Mexican background to 38  among those of depression in the overall older adult population is estimated to be Puerto Rican background (Wassertheil-Smoller et al., 2014). Also, 2.6  (Haigh, Bogucki, Sigmon,   Blazer, 2016; Kessler et al., 2003). despite similarities in ethnic background heritage, an individu- The estimate point prevalence of major depression among older al s location of birth may play a role in influencing differences in patients ranges between"
  },
  {
    "id": 164,
    "source": "guideline_c3debd",
    "text": "in ethnic background heritage, an individu- The estimate point prevalence of major depression among older al s location of birth may play a role in influencing differences in patients ranges between 5  10  in primary care settings and is APA   Guideline for the Treatment of Depression 23 higher still (10  42 ) among older patients in inpatient settings, research is needed to understand other groups of people of color including long-term care (Blazer, 2003; Djernes, 2006; Schulberg, and people of color across socioeconomic strata. Katon, Simon,   Rush, 1998). Epidemiological studies of late-life depression show that the prevalence of depression and of clinically Older adult depression and suicide. Another and particularly import- significant depressive symptoms increases with greater"
  },
  {
    "id": 165,
    "source": "guideline_c3debd",
    "text": "depression show that the prevalence of depression and of clinically Older adult depression and suicide. Another and particularly import- significant depressive symptoms increases with greater medical ant aspect of depression in older adults is the risk for suicide, partic- burden comorbidity and disability. Subthreshold depression is 2 3 ularly in older White males who typically use handguns to end their times more common than major depression in older adults, and lives (Bruce et al., 2004). Increasing the accessibility and utilization 8  10  of those with subthreshold symptoms develop major of care for depression in older adults as well as all age populations depression each year (Meeks, Vahia, Lavretsky, Kulkarni,   Jeste, and reducing access to highly lethal means (e.g., firearms) are"
  },
  {
    "id": 166,
    "source": "guideline_c3debd",
    "text": "of care for depression in older adults as well as all age populations depression each year (Meeks, Vahia, Lavretsky, Kulkarni,   Jeste, and reducing access to highly lethal means (e.g., firearms) are key 2011). Cognitive decline, age-associated neurobiological changes, strategies for reducing proximal risk factors for suicide. stressful events, and sleep disturbance are also risk factors for late- life depression (Fiske, Wetherell,   Gatz, 2010; S zeri-Varma, 2012). Older adult depression and comorbidity. Although core symptoms It is also important to consider cohort differences in the prevalence, are the same as in the general adult population (e.g., low mood and presentation, and treatment of depression among older adults. For anhedonia), depression in older adults typically co-occurs"
  },
  {
    "id": 167,
    "source": "guideline_c3debd",
    "text": "are the same as in the general adult population (e.g., low mood and presentation, and treatment of depression among older adults. For anhedonia), depression in older adults typically co-occurs with often example, the issues of a typical young old person in their 60s may chronic medical disorders, amplifying disability (Lin et al., 2003). For be quite different than that of an older old person in their 90s. example, Lin and colleagues (2003) found that enhancing care for depression was related to lower levels of pain as well as higher qual- Characteristics of depression in older adults. The clinical presenta- ity of life and functional status among a diverse sample of older tion of depression in older adults is also distinctive and, to an import- adults with comorbid depression and"
  },
  {
    "id": 168,
    "source": "guideline_c3debd",
    "text": "The clinical presenta- ity of life and functional status among a diverse sample of older tion of depression in older adults is also distinctive and, to an import- adults with comorbid depression and arthritis. Further, depression in ant extent, differs from early periods in the life cycle by following a older adults either coexists with or foreshadows the development of relapsing and recurrent course. Depression in older adults is often cognitive impairment and dementia (Butters et al., 2004; Diniz, treatment resistant, that is, patients may improve partially but do not Butters, Albert, Dew,   Reynolds, 2013). For example, in a meta-anal- remit symptomatically nor regain full functional status (Ng   ysis, Diniz and colleagues (2013) found a link between depression in Schweitzer, 2002)."
  },
  {
    "id": 169,
    "source": "guideline_c3debd",
    "text": "Reynolds, 2013). For example, in a meta-anal- remit symptomatically nor regain full functional status (Ng   ysis, Diniz and colleagues (2013) found a link between depression in Schweitzer, 2002). Partial response, as marked by the presence of older adults and risk of dementia, including both Alzheimer s disease residual symptoms, is associated both with continuing disability, and vascular dementia. This risk was particularly high for vascular caregiver burden, and elevated risk for early relapse and recurrence. dementia compared with Alzheimer s disease. These signature The literature on treatment resistance in older adults is still rather comorbidities of late-life depression complicate its management and sparse, but recent leads in the pharmacotherapy of treatment-resis- need to be"
  },
  {
    "id": 170,
    "source": "guideline_c3debd",
    "text": "treatment resistance in older adults is still rather comorbidities of late-life depression complicate its management and sparse, but recent leads in the pharmacotherapy of treatment-resis- need to be addressed in treatment planning. tant depression are promising (Lenze et al., 2015). Subsyndromal depression in old age is an important oppor- Treatment issues in older adults. Many older adults prefer psycho- tunity for early interventions to preempt the development of full- social treatments to pharmacotherapy for depression (Hanson   blown clinical depression. Learning-based interventions and those Scogin, 2008; Raue, Schulberg, Heo, Klimstra,   Bruce, 2009). that are behaviorally activating (e.g., behavioral activation, cogni- Multiple factors influence these preferences including"
  },
  {
    "id": 171,
    "source": "guideline_c3debd",
    "text": "and those Scogin, 2008; Raue, Schulberg, Heo, Klimstra,   Bruce, 2009). that are behaviorally activating (e.g., behavioral activation, cogni- Multiple factors influence these preferences including insurance tive-behavioral therapy, problem-solving therapy) are a promising coverage, availability of specific treatments, transportation, and method of depression prevention (with a focus on mildly symp- reduced patient mobility and make input from patients and families tomatic people; Reynolds et al., 2014). These interventions are important. In depression treatments, older adults with depression, as also amenable for outreach to, and effective in, low-income older well as their family caregivers, define treatment goals in terms of African Americans (Reynolds et al., 2014). well-being and"
  },
  {
    "id": 172,
    "source": "guideline_c3debd",
    "text": "as also amenable for outreach to, and effective in, low-income older well as their family caregivers, define treatment goals in terms of African Americans (Reynolds et al., 2014). well-being and return of functional status and engagement in key social and familial roles (Lebowitz et al., 1997). It is often difficult, Older adult depression and race ethnicity. The growth in the nation s however, to provide psychosocial treatment, given the paucity of older population is characterized also by increasing racial and ethnic specialty-trained providers to treat depression in older adults, espe- diversity and the need for preventive and treatment interventions cially in primary care settings. Primary care settings remain the that are culturally appropriate. Models employing lay health counsel-"
  },
  {
    "id": 173,
    "source": "guideline_c3debd",
    "text": "and the need for preventive and treatment interventions cially in primary care settings. Primary care settings remain the that are culturally appropriate. Models employing lay health counsel- principal locus where treatment of late-life depression takes place. ors of similar ethnic and racial backgrounds to the patient increas- At any one point in time, it is estimated that 6  10  of older patients ingly seem to be a rational and cost-effective use of resources to in primary care settings qualify for a diagnosis of current major reach diverse racial and ethnic groups in underserved and disadvan- depressive episode and another 10  20  have subsyndromal taged older adults (Patel et al., 2010). symptoms that are disabling and that pose risk for conversion to Treatment accessibility and use"
  },
  {
    "id": 174,
    "source": "guideline_c3debd",
    "text": "depressive episode and another 10  20  have subsyndromal taged older adults (Patel et al., 2010). symptoms that are disabling and that pose risk for conversion to Treatment accessibility and use can vary among older adults of major depression. To some extent the locus of care reflects patient differing ethnic backgrounds. Such disparities in treatment accessi- and family preferences, as well as stigma against mental health spe- bility and or use have been attributed to financial hardship, unique cialty referral. The challenge here is to identify models of evi- presentations of depressive symptoms, culturally based mistrust of dence-based depression care management that are transferrable to providers, negative attitudes about seeking mental health care (e.g., and practical within primary"
  },
  {
    "id": 175,
    "source": "guideline_c3debd",
    "text": "culturally based mistrust of dence-based depression care management that are transferrable to providers, negative attitudes about seeking mental health care (e.g., and practical within primary care settings (e.g., Improving Mood- feelings of shame guilt), anticipated or previously experienced rac- Promoting Access to Collaborative Treatment [IMPACT] interven- ism or discrimination in treatment settings, language barriers, and tion; Un tzer et al., 2002); and Prevention of Suicide in Primary Care the limited accessibility of ethnically diverse mental health profes- Elderly: Collaborative Trial [PROSPECT]; Bruce et al., 2004). There sionals (Conner et al., 2010; Un tzer et al., 2003). However, more is considerable progress in the development and implementation of 24 APA   Guideline for the"
  },
  {
    "id": 176,
    "source": "guideline_c3debd",
    "text": "[PROSPECT]; Bruce et al., 2004). There sionals (Conner et al., 2010; Un tzer et al., 2003). However, more is considerable progress in the development and implementation of 24 APA   Guideline for the Treatment of Depression collaborative care models for both treatment and prevention. In low The APA Clinical Practice Guideline for the resource countries, such as India, progress is also evident in the Treatment of the Problem development of models that use lay health counsellors for the imple- mentation of depression treatment and prevention programs (e.g., In considering how the current guideline development could comple- the MANAS trial in Goa; Patel et al., 2010). Many frail, homebound ment the existing knowledge base, the guideline development panel older adults who have symptoms of"
  },
  {
    "id": 177,
    "source": "guideline_c3debd",
    "text": "development could comple- the MANAS trial in Goa; Patel et al., 2010). Many frail, homebound ment the existing knowledge base, the guideline development panel older adults who have symptoms of depression and cognitive impair- had several overarching goals. The panel intended to develop a ment have difficulties in obtaining appropriate care. Programs for guideline that would be applicable to a broad range of the population, reaching out to this particularly vulnerable population have been including adolescents through older adult populations. Of note, in developed, together with pathways to implementation of appropri- reviewing the literature, the panel found that it was unable to sepa- ate treatment (Scogin, Moss, Harris,   Presnell, 2014; Sirey, Hannon, rate child research from"
  },
  {
    "id": 178,
    "source": "guideline_c3debd",
    "text": "to implementation of appropri- reviewing the literature, the panel found that it was unable to sepa- ate treatment (Scogin, Moss, Harris,   Presnell, 2014; Sirey, Hannon, rate child research from adolescent research consistently and, there- D Angelo,   Knies, 2012). Family and psychoeducational interven- fore, expanded the domain reviewed to include children. In addition, tions may be particularly useful in reaching diverse older adults. As the panel identified the need to include psychotherapeutic interven- such, a public health and clinical priority in optimizing care for older tions. In considering prior guidelines, they either provided limited adults is identifying psychosocial treatments that are effective across guidance on psychotherapies or had been completed 5 years or more"
  },
  {
    "id": 179,
    "source": "guideline_c3debd",
    "text": "In considering prior guidelines, they either provided limited adults is identifying psychosocial treatments that are effective across guidance on psychotherapies or had been completed 5 years or more diverse racial, ethnic, and socioeconomic groups; can be carried out prior and there was a need for an updated review of the literature in general medical settings (such as problem-solving therapy; (following IOM [2011b] standards). One exception is the Department Un tzer et al., 2002); and are sensitive to culturally specific experi- of Veterans Affairs Department of Defense guideline focused on ences and beliefs of diverse racial, ethnic, and socioeconomic groups. veteran and military populations, which was completed while this guideline was in development and whose underlying systematic"
  },
  {
    "id": 180,
    "source": "guideline_c3debd",
    "text": "on ences and beliefs of diverse racial, ethnic, and socioeconomic groups. veteran and military populations, which was completed while this guideline was in development and whose underlying systematic review has been drawn on to support this current effort. The Need for a Clinical Practice Guideline and Decisions about Scope and Goals of the Clinical What the current guideline provides beyond existing ones. This Practice Guideline clinical practice guideline differs in substantive ways from others that are currently available. This guideline is predicated on the three Available treatment guidelines for the problem. Given the evidence dimensions mentioned in the American Psychological Association that depression is a disorder whose cost and burden justify extensive Presidential Task Force"
  },
  {
    "id": 181,
    "source": "guideline_c3debd",
    "text": "for the problem. Given the evidence dimensions mentioned in the American Psychological Association that depression is a disorder whose cost and burden justify extensive Presidential Task Force on Evidence-Based Practice (2006): (1) efforts at intervention, providers need access to information that will grounding in the best available science; (2) practitioner expertise in help guide intervention. While there is now a substantial body of application decisions; and (3) patient expertise regarding their pref- research literature examining a broad range of approaches to assess- erences, culture, and values. These three areas were consistent with ment and treatment (including psychotherapeutic, pharmacologic, earlier work by the Institute of Medicine (IOM) and are areas that and other"
  },
  {
    "id": 182,
    "source": "guideline_c3debd",
    "text": "and values. These three areas were consistent with ment and treatment (including psychotherapeutic, pharmacologic, earlier work by the Institute of Medicine (IOM) and are areas that and other interventional approaches), studies have indicated that of are universally accepted in medicine. In addition, the steering com- those who receive treatment, between 30  (Teh et al., 2010) and mittee and panel made every effort to fully apply the standards set 59  (Kessler et al., 2003) do not receive a minimally adequate dose forth by the Institute of Medicine of the National Academies of of treatment (as defined by Kessler et al., 2003 on p. 3098). Some Sciences, Engineering, and Medicine for developing independent, subpopulations are at even higher risk for failure to receive adequate reliable, and"
  },
  {
    "id": 183,
    "source": "guideline_c3debd",
    "text": "defined by Kessler et al., 2003 on p. 3098). Some Sciences, Engineering, and Medicine for developing independent, subpopulations are at even higher risk for failure to receive adequate reliable, and high-quality clinical practice guidelines (IOM, 2011a; treatment (i.e., African Americans and individuals who begin their IOM, 2011b).34 This document goes beyond previous treatment of depression treatment with an inpatient hospitalization for depres- depression guidelines and literature in the following important ways: sion; Teh et al., 2010). These findings strongly demonstrate the need (a) involvement of consumer (patient) stakeholders as panel mem- for providers, consumers, and health care systems to have access to bers in addition to professionals from multiple disciplines involved in"
  },
  {
    "id": 184,
    "source": "guideline_c3debd",
    "text": "of consumer (patient) stakeholders as panel mem- for providers, consumers, and health care systems to have access to bers in addition to professionals from multiple disciplines involved in guidelines that provide information about effective treatment options the delivery of the treatment of depression; (b) use of procedures for as well as a focused application of dissemination and implementa- identifying and managing real and potential conflicts of interest tion science. (COIs) throughout the guideline development process that required Fortunately, there have been several guideline develop- all panel members to routinely disclose all conflicts of interest; (c) ment efforts addressing major depression, including the National identification of patient values and preferences through review"
  },
  {
    "id": 185,
    "source": "guideline_c3debd",
    "text": "all panel members to routinely disclose all conflicts of interest; (c) ment efforts addressing major depression, including the National identification of patient values and preferences through review of Institute for Health and Care Excellence (NICE) guideline in the published research literature and input from consumer members of United Kingdom (NICE, 2009), the Department of Veterans the panel; (d) identification of harms and burdens of treatments Affairs Department of Defense (2016) guideline, and the American through review of published research literature and input of consum- Psychiatric Association (2010). How the current guideline comple- ers and clinician members of the panel in evaluating those harms and ments these prior efforts is discussed on p. 72. burdens; (e) the use of"
  },
  {
    "id": 186,
    "source": "guideline_c3debd",
    "text": "Association (2010). How the current guideline comple- ers and clinician members of the panel in evaluating those harms and ments these prior efforts is discussed on p. 72. burdens; (e) the use of decision-table (for older adults) and grid (for general adults and children adolescents) templates to systematically guide panel members in the development of recommendations that 34 Of note, as of March 2016, the division of the National Academies of Sciences, Engineering, and Medicine (the National Academies) formerly known as Institute of Medicine (IOM) was renamed the National Academy of Medicine (NAM). Despite the recent name change, the guideline will use IOM when referring to the IOM stan- dards for guideline development and systematic reviews. APA   Guideline for the Treatment of"
  },
  {
    "id": 187,
    "source": "guideline_c3debd",
    "text": "Medicine (NAM). Despite the recent name change, the guideline will use IOM when referring to the IOM stan- dards for guideline development and systematic reviews. APA   Guideline for the Treatment of Depression 25 take into account the strength of the research evidence for benefits and in some reviews, treatments were grouped that were arguably not part harms, the relative balance of treatment benefit versus treatment of the shared family of interventions, reducing panel confidence in harm, the values and preferences of patients, and applicability. consistency across treatment comparisons and judgments about spe- For the general adult population, the panel used an indepen- cific contributions of distinct psychotherapies. Thus, the panel was not dent, newly released, systematic review of"
  },
  {
    "id": 188,
    "source": "guideline_c3debd",
    "text": "judgments about spe- For the general adult population, the panel used an indepen- cific contributions of distinct psychotherapies. Thus, the panel was not dent, newly released, systematic review of the depression treat- able to realize this goal but makes recommendations for future ment literature that provided clearly specified inclusion and exclu- research that explicitly addresses the shared components of effective sion criteria, a standard method for grading risk of bias of individual psychotherapy, the necessity of appropriately defining treatments, studies and strength of evidence for bodies of evidence. The sys- and newer models of the treatment of depression. Further discussion tematic review was supplemented by a review of existing reviews of this topic is provided in the"
  },
  {
    "id": 189,
    "source": "guideline_c3debd",
    "text": "for bodies of evidence. The sys- and newer models of the treatment of depression. Further discussion tematic review was supplemented by a review of existing reviews of this topic is provided in the Discussion section. as well as meta-analyses to provide more comprehensive coverage of the literature. The panel used existing meta-analyses of the child Guideline recommendations for underserved populations. Similarly, and adolescent literature that were identified by panel members, a fifth goal was to provide appropriate guideline recommendations and all existing meta-analyses and reviews were evaluated using for underserved populations. However, it was immediately apparent the same AMSTAR (a measurement tool to assess systematic that randomized controlled trials (RCTs) included in the"
  },
  {
    "id": 190,
    "source": "guideline_c3debd",
    "text": "evaluated using for underserved populations. However, it was immediately apparent the same AMSTAR (a measurement tool to assess systematic that randomized controlled trials (RCTs) included in the reviews had reviews; Shea et al., 2007) quality criteria. limited information available to inform recommendations for such populations. While the panel made extensive efforts to draw guid- Institute of Medicine (IOM) standards as the basis for this clinical ance from the literature available, the limitations of that literature practice guideline. Another goal of the panel was to take a method- made clear to the panel the need for a vigorous call for increased ologically rigorous approach to guideline development, following the dedication to RCTs specifically studying diverse samples. Of note,"
  },
  {
    "id": 191,
    "source": "guideline_c3debd",
    "text": "clear to the panel the need for a vigorous call for increased ologically rigorous approach to guideline development, following the dedication to RCTs specifically studying diverse samples. Of note, current IOM recommendations (IOM, 2011a). This, however, led to the limitations of the literature highlighted the need for funding agen- one of the more significant challenges in the guideline development cies and investigators to explicitly address differences, in particular, process. The systematic reviews conducted by the evidence-based culture, ethnicity, sex, sexual minority, gender identity, disability, practice centers met IOM criteria but excluded bodies of literature nationality of origin, generation status, race, socioeconomic status, because of inadequate quality, yet such exclusions"
  },
  {
    "id": 192,
    "source": "guideline_c3debd",
    "text": "practice centers met IOM criteria but excluded bodies of literature nationality of origin, generation status, race, socioeconomic status, because of inadequate quality, yet such exclusions meant some of and others, as well as the intersection of these variables, which can the panel s key questions were not addressed. Rather than not further influence treatment. These are areas that could contribute to address those questions, the panel chose to modify its criteria for the experience and treatment of depression but for which the panel systematic reviews and include manuscripts that had used a single did not have an adequate literature to address. rather than dual review process to evaluate articles for inclusion in Finally, arising from these last two goals, the panel was deter- the review"
  },
  {
    "id": 193,
    "source": "guideline_c3debd",
    "text": "did not have an adequate literature to address. rather than dual review process to evaluate articles for inclusion in Finally, arising from these last two goals, the panel was deter- the review (i.e., one reviewer vs. two for article inclusion) but other- mined to develop a series of recommendations for future research wise met all IOM requirements. The consequence is a less method- to address the gaps and limitations in the literature that were ologically rigorous systematic review because there is an increased observed. The panel s goal is that this guideline serves as a current risk of bias in the choice of journal articles (Edwards et al., 2002; IOM, and functional tool to guide providers, health care systems, and 2011b). However, key questions could not have been answered oth-"
  },
  {
    "id": 194,
    "source": "guideline_c3debd",
    "text": "of bias in the choice of journal articles (Edwards et al., 2002; IOM, and functional tool to guide providers, health care systems, and 2011b). However, key questions could not have been answered oth- consumers in decision-making regarding treatment and provides erwise. The single reviewer in each of the three meta-analyses utiliz- investigators guidance on key clinical research questions that are ing single review was panel member and lead author of these necessary to address so that all can meaningfully improve the abil- published meta-analyses, Dr. Pim Cuijpers. To reduce potential COI, ity to treat this pervasive and debilitating disorder. as noted each of these reviews was independently analyzed with AMSTAR prior to use by the panel. The panel is therefore able to address these"
  },
  {
    "id": 195,
    "source": "guideline_c3debd",
    "text": "ity to treat this pervasive and debilitating disorder. as noted each of these reviews was independently analyzed with AMSTAR prior to use by the panel. The panel is therefore able to address these questions but does so with proper precautions about Guideline Purpose and Scope: What the the literature on which the recommendations are based. Guideline Does and Does Not Address Shared versus unique contributions of different psychotherapy The purpose of this guideline is to provide recommendations on the models. A fourth goal was to attempt to address the issue of shared treatment of depression in three developmental cohorts: children and versus unique contributions of different psychotherapy models. Most adolescents; general population of adults; and older adults. This guide- of the"
  },
  {
    "id": 196,
    "source": "guideline_c3debd",
    "text": "in three developmental cohorts: children and versus unique contributions of different psychotherapy models. Most adolescents; general population of adults; and older adults. This guide- of the psychotherapy treatment literature examines specifically line is based on several systematic reviews and meta-analyses of the defined models. However, there is a growing body of literature suggest- evidence on treatment of depression, two of which were sponsored by ing that shared aspects (common factors [e.g., hope, expectancy, the Agency for Health Care Research and Quality (AHRQ)35 and con- therapeutic alliance]) of interventions (Norcross, 2011) relative to ducted by the Research Triangle Institute University of North Carolina model-specific components are germane to optimal treatment out-"
  },
  {
    "id": 197,
    "source": "guideline_c3debd",
    "text": "alliance]) of interventions (Norcross, 2011) relative to ducted by the Research Triangle Institute University of North Carolina model-specific components are germane to optimal treatment out- (RTI-UNC) Evidence-Based Practice Center (Gartlehner et al., 2015) comes (regardless of the therapeutic orientation implemented). An and the ECRI Institute (2015). The other reviews were independently analysis of treatments for major depression found evidence consistent conducted by teams of researchers (Cipriani et al., 2016; Cuijpers, with this (Cuijpers, Driessen, Hollon et al., 2012a). In addition, the Driessen, et al., 2012a; Cuijpers, Karyotaki, Pot, et al., 2014a; Cuijpers, definitions of treatments in articles and reviews varied greatly. Further, 35 The AHRQ (an agency that works within the"
  },
  {
    "id": 198,
    "source": "guideline_c3debd",
    "text": "the Driessen, et al., 2012a; Cuijpers, Karyotaki, Pot, et al., 2014a; Cuijpers, definitions of treatments in articles and reviews varied greatly. Further, 35 The AHRQ (an agency that works within the U.S. Department of Health and Human Services) strives to improve health care by enhancing access to the relevant evidence bases in collaboration with partners. 26 APA   Guideline for the Treatment of Depression Koole, et al., 2014b; Cuijpers et al., 2016, Driessen et al., 2015; Wilkinson   Efficacy of treatments for disorders other than depression.   Izmeth, 2012; Zhou et al., 2015).   Bipolar disorder. This guideline attempted to address the following four key questions36: The panel had originally proposed to include somatic treat- 1. For individuals in each of the three age cohorts with"
  },
  {
    "id": 199,
    "source": "guideline_c3debd",
    "text": "disorder. This guideline attempted to address the following four key questions36: The panel had originally proposed to include somatic treat- 1. For individuals in each of the three age cohorts with major ments in the review, but the nature of the search criteria did not depressive disorder, persistent depressive disorder,37 or adequately capture the literature, and the panel was unable to subsyndromal depression,38 what is the efficacy and risk of make recommendations about those interventions. The panel uti- harms of psychotherapy or complementary and alternative lized systematic reviews  meta-analyses that were current (within medicine treatments?39 the past 5 years) at the time the panel made its recommendation 2. For individuals in each of the three age cohorts with major decisions"
  },
  {
    "id": 200,
    "source": "guideline_c3debd",
    "text": "meta-analyses that were current (within medicine treatments?39 the past 5 years) at the time the panel made its recommendation 2. For individuals in each of the three age cohorts with major decisions that met IOM (2011b) development and AMSTAR quality depressive disorder, persistent depressive disorder, or sub- standards (Shea et al., 2007).43 syndromal depression, what is the effectiveness and risk of harms of psychotherapy or complementary and alternative medicine treatments in comparison either with one another or with pharmacotherapy? 3. For individuals in each of the three age cohorts with major depressive disorder, persistent depressive disorder, or sub- syndromal depression, what is the effectiveness and risk of harms of combinations of pharmacotherapy, psycho- therapy, or"
  },
  {
    "id": 201,
    "source": "guideline_c3debd",
    "text": "with major depressive disorder, persistent depressive disorder, or sub- syndromal depression, what is the effectiveness and risk of harms of combinations of pharmacotherapy, psycho- therapy, or complementary and alternative medicine treat- ments compared with inactive or active single or combined treatments? 4. Are the benefits and risks of these treatment options moder- ated by subgroup characteristics, including suicidal ideation, treatment-resistant depression, co-occurring anxiety disor- ders, or co-occurring personality disorders?40 The reviews underlying this guideline did not explicitly search for or include the following items:   Screening for depression, assessment of associated or comorbid conditions (e.g., suicidality,41 medical prob- lems), monitoring response to treatment, or"
  },
  {
    "id": 202,
    "source": "guideline_c3debd",
    "text": "search for or include the following items:   Screening for depression, assessment of associated or comorbid conditions (e.g., suicidality,41 medical prob- lems), monitoring response to treatment, or follow-up after treatment.   Prevention of depression.   Dose (differential beyond current recommended), timing, or duration of treatments for depression.   Costs of treatments.   Model or locus of care.   The long-term benefits of treatment for maintenance of recovery and prevention of relapse.42   Mechanisms of change. 36 The exact wording of the key questions evolved from the original commissioned review in order to best capture the full scope of the work of the panel. The original key questions can be found in the RTI-UNC Evidence-Based Practice Center Team paper (2014). 37 Formerly"
  },
  {
    "id": 203,
    "source": "guideline_c3debd",
    "text": "review in order to best capture the full scope of the work of the panel. The original key questions can be found in the RTI-UNC Evidence-Based Practice Center Team paper (2014). 37 Formerly  dysthymia,  changed to be consistent with DSM-5 though some studies were conducted prior to the release of the DSM-5. 38 Also known as  Other Specified Depressive Disorder  (DSM-5, APA, 2013). 39 Note that while the panel initially decided not to look at efficacy of medication treatments alone, rather to only examine medications in combination with or in comparison to (comparative effectiveness) psychotherapy, it later decided to examine efficacy of medication treatment alone (using medication only studies) for children adolescents due to potential safety concerns about medications in this population."
  },
  {
    "id": 204,
    "source": "guideline_c3debd",
    "text": "it later decided to examine efficacy of medication treatment alone (using medication only studies) for children adolescents due to potential safety concerns about medications in this population. 40 Note that while the panel was also interested in differential effectiveness based on race ethnicity, the included reviews did not have sufficient information to inform such recommendations. 41 In particular, there is need for expanded guidance on the assessment and management of suicidal behavior. While beyond the scope of this guideline, recent evidence of increasing rates of suicide across a number of cohorts indicates this is a high-priority domain. 42 There were not enough studies in the reviews to address this independently. The panel stresses the importance of this area of practice and"
  },
  {
    "id": 205,
    "source": "guideline_c3debd",
    "text": "of cohorts indicates this is a high-priority domain. 42 There were not enough studies in the reviews to address this independently. The panel stresses the importance of this area of practice and the need for more research to contribute to systematic reviews of long-term depression treatment. 43 By the time of finalization of the current guideline document several of the underlying reviews will have crossed the 5-year mark for being considered a current review. However, it should be noted that the panel completed its decision-making about the recommendations during the 5-year window in which each review was considered current. APA   Guideline for the Treatment of Depression 27 PROCESS AND METHOD Vetting and Appointment of Members to the Depression Guideline Development Panel The Advisory"
  },
  {
    "id": 206,
    "source": "guideline_c3debd",
    "text": "each review was considered current. APA   Guideline for the Treatment of Depression 27 PROCESS AND METHOD Vetting and Appointment of Members to the Depression Guideline Development Panel The Advisory Steering Committee (ASC) put out a call for the nomination (including self-nom- ination) of both researchers and clinicians across various professional disciplines (psychology, social work, psychiatry, general medicine) who had content expertise in the topic area of depression treatment as well as in biostatistics or methodology. The ASC sought those with knowledge of depression across age groups, gender identity, populations (veterans, ethnic minorities), and treatment settings to seat a diverse panel with a variety of perspectives on depression and its treatment that could discuss the"
  },
  {
    "id": 207,
    "source": "guideline_c3debd",
    "text": "gender identity, populations (veterans, ethnic minorities), and treatment settings to seat a diverse panel with a variety of perspectives on depression and its treatment that could discuss the research data and its applicability to those seeking treatment. Additionally, the ASC sought community members who self-identified as having had depression (currently or in the past) or were a close family member of someone with depression and who were active in the leadership of groups that looked to enhance public awareness and access to services. In constituting the panel, there was an effort to incorporate members who represented a broad range of experiences and expertise in the treatment of depression, including vari- ation in terms of psychotherapy models, populations (e.g., adolescent, adult,"
  },
  {
    "id": 208,
    "source": "guideline_c3debd",
    "text": "members who represented a broad range of experiences and expertise in the treatment of depression, including vari- ation in terms of psychotherapy models, populations (e.g., adolescent, adult, older adult, underserved populations), settings (academic, community, primary care), roles (clinician providers, researchers, health care administrator, health care consumer), and discipline (psychology, psychiatry, family medicine). While it would not be possible in a panel of this size to represent all constituencies and interests in a truly equitable fashion, the mandate to the panel was to include as broad a perspective as possible when reviewing the literature. 28 APA   Guideline for the Treatment of Depression Conflicts of Interest Scoping As noted above, before final appointment to the"
  },
  {
    "id": 209,
    "source": "guideline_c3debd",
    "text": "as broad a perspective as possible when reviewing the literature. 28 APA   Guideline for the Treatment of Depression Conflicts of Interest Scoping As noted above, before final appointment to the guideline develop- At its first in-person meeting, the panel began discussion of topic ment panel, nominees gave information about possible conflicts of scoping and continued to discuss scope over several subsequent interest (COIs), a significant issue in the IOM standards and current conference calls. The panel followed a PICOTS (Population, best practices in guideline development. COIs are defined as: Intervention, Comparator, Outcomes, Timing, and Setting) approach to scoping. Using this approach, each PICOTS element served to a divergence between an individual s private interests and frame"
  },
  {
    "id": 210,
    "source": "guideline_c3debd",
    "text": "as: Intervention, Comparator, Outcomes, Timing, and Setting) approach to scoping. Using this approach, each PICOTS element served to a divergence between an individual s private interests and frame decision-making about scope. The panel also used the Delphi his or her professional obligations such that an indepen- method to complete an outcomes prioritization survey. On this sur- dent observer might reasonably question whether the vey panel members rated outcomes from 1  not important  to 9 individual s professional actions or decisions are motivated  critical  for deciding about what treatment to recommend. Based on by personal gain, such as financial, academic advancement, the results of this survey, the panel found  response to treatment  clinical revenue streams, or community"
  },
  {
    "id": 211,
    "source": "guideline_c3debd",
    "text": "treatment to recommend. Based on by personal gain, such as financial, academic advancement, the results of this survey, the panel found  response to treatment  clinical revenue streams, or community standing. (Institute (reduction in depressive symptoms) and  serious adverse events  as of Medicine [IOM], 2011a, p. 78; the definition is drawn its two most critical outcomes. Scoping decisions about which pop- from Sch nemann et al., 2009, p. 565) ulations, interventions, comparators, outcomes, timing, and settings The IOM report additionally discusses intellectual COIs rele- to include as well as the key questions are noted in the Scoping sec- vant to clinical practice guidelines, defined as  academic activities tion at the beginning of this document. that create the potential for an"
  },
  {
    "id": 212,
    "source": "guideline_c3debd",
    "text": "well as the key questions are noted in the Scoping sec- vant to clinical practice guidelines, defined as  academic activities tion at the beginning of this document. that create the potential for an attachment to a specific point of view that could unduly affect an individual s judgment about a spe- cific recommendation  (IOM, 2011a, p. 78; the definition is drawn from Guyatt et al., 2010, p. 739). Comprehensive Search of the Candidates to the guideline development panel each com- Professional Literature pleted an APA Conflicts of Interest disclosure form. Emphasis was placed on disclosing all potential conflicts for the APA staff and ASC members to review and decide on. While intellectual affilia- SYSTEMATIC REVIEWS AND META-ANALYSES tions were expected, no panel members were to be"
  },
  {
    "id": 213,
    "source": "guideline_c3debd",
    "text": "all potential conflicts for the APA staff and ASC members to review and decide on. While intellectual affilia- SYSTEMATIC REVIEWS AND META-ANALYSES tions were expected, no panel members were to be singularly iden- A systematic review involves a methodical and organized search for tified with particular interventions, nor were they to have significant studies and evidence of efficacy and effectiveness of the treatment known financial conflicts that would compromise their ability (or under consideration (IOM, 2011b). A meta-analysis is the use of quan- appearance thereof) to weigh evidence fairly. The ASC understood, titative statistical methods in a systematic review to integrate the however, that some  adversarial collaboration  (Mellers, Hertwig, results of included studies. Briefly, a"
  },
  {
    "id": 214,
    "source": "guideline_c3debd",
    "text": "The ASC understood, titative statistical methods in a systematic review to integrate the however, that some  adversarial collaboration  (Mellers, Hertwig, results of included studies. Briefly, a systematic review or meta-anal-   Kahneman, 2001) or standing for different points of view was ysis involves searching a variety of scientific databases using selec- expected and encouraged as part of the process. On successful tive search terms to find relevant studies. The individual studies completion of the reviews, the ASC made the final membership identified by the panel are then assessed to decide whether they recommendations to the APA Board of Directors for confirmation. meet inclusion criteria as well as assessed for the risk of bias using Once the panel was formed, all members completed"
  },
  {
    "id": 215,
    "source": "guideline_c3debd",
    "text": "whether they recommendations to the APA Board of Directors for confirmation. meet inclusion criteria as well as assessed for the risk of bias using Once the panel was formed, all members completed an educa- predefined criteria. Results are then compiled and analyzed. tional module on conflicts of interest that underscored the impor- Institute of Medicine (IOM) guidelines require the use of tance of identifying and managing any that had either been identi- one or more systematic reviews for guideline development. APA, fied or that might come to light. At request, members verbalized initially, commissioned an  umbrella review  of relevant system- any actual or potential conflicts in their face-to-face meetings, so atic reviews and meta-analyses by the RTI-UNC Evidence-Based all members of"
  },
  {
    "id": 216,
    "source": "guideline_c3debd",
    "text": "commissioned an  umbrella review  of relevant system- any actual or potential conflicts in their face-to-face meetings, so atic reviews and meta-analyses by the RTI-UNC Evidence-Based all members of the guideline development panel would be familiar Practice Center, which helped to identify already existing bases of with the diversity of perspectives and range of possible influences evidence and areas that might be missing. For the current guide- and biases. Conflicts of interest forms were updated annually, and line, the panel used a systematic review of the literature focused panel members and staff were asked to give more prompt updates on comparisons of mainly second-generation antidepressant med- if there were any changes in their disclosures that could be relevant ication and"
  },
  {
    "id": 217,
    "source": "guideline_c3debd",
    "text": "and staff were asked to give more prompt updates on comparisons of mainly second-generation antidepressant med- if there were any changes in their disclosures that could be relevant ication and psychotherapy with focus on primary treatment goals to the development of an unbiased guideline. (e.g., achieving response and remission) rather than those of longer Multiple strategies were used to identify and manage COI. term treatment (e.g., preventing relapse and recurrence), although Panel members (and ASC members and associated staff) all com- the panel recognizes the latter is essential for individual well-being. pleted a disclosure form on an annual basis that was reviewed by However, due to gaps in the types of treatment comparisons and the panel and ASC chairs. Panel members were"
  },
  {
    "id": 218,
    "source": "guideline_c3debd",
    "text": "for individual well-being. pleted a disclosure form on an annual basis that was reviewed by However, due to gaps in the types of treatment comparisons and the panel and ASC chairs. Panel members were expected to dis- approaches included in the first review, more reviews were identi- close potential COI at all face-to-face meetings and on phone calls fied and used to address the limitations of the initial review. Gaps whenever new COI emerged. This was structured in the agendas found by the panel included an examination of supportive psycho- for the meetings. Several strategies were used to manage COI and therapy, psychodynamic psychotherapy, subclinical depression, typically these involved some combination of recusing from the and efficacy of psychological treatments. The panel followed"
  },
  {
    "id": 219,
    "source": "guideline_c3debd",
    "text": "COI and therapy, psychodynamic psychotherapy, subclinical depression, typically these involved some combination of recusing from the and efficacy of psychological treatments. The panel followed best discussion of a particular topic, recusing from voting on certain practices of using reviews current within the past 5 years, and an issues, or a combination of the two. The APA conflicts of interest independent search was not conducted outside of these reviews for policy and disclosure form is in Appendix E. APA   Guideline for the Treatment of Depression 29 additional studies that may not have met inclusion criteria for the older having received a first diagnosis of major depression, currently reviews. The panel used 10 systematic reviews or meta-analyses, receiving treatment for depression,"
  },
  {
    "id": 220,
    "source": "guideline_c3debd",
    "text": "inclusion criteria for the older having received a first diagnosis of major depression, currently reviews. The panel used 10 systematic reviews or meta-analyses, receiving treatment for depression, and adults with chronic depres- each either independently conducted via IOM standards or evalu- sion in a VA DoD setting (ECRI Institute, 2015). For more informa- ated using AMSTAR quality standards and went ahead to draft rec- tion on the inclusion exclusion criteria used for this review, please ommendations in three phases based on population age: first older refer to the VA DoD s section Methods of Systematic Review: Study adults, next the general adult population, and finally adolescents Selection Criteria (p. 5). and children. Systematic reviews and meta-analyses used were as The panel"
  },
  {
    "id": 221,
    "source": "guideline_c3debd",
    "text": "of Systematic Review: Study adults, next the general adult population, and finally adolescents Selection Criteria (p. 5). and children. Systematic reviews and meta-analyses used were as The panel then used four additional AMSTAR evaluated follows (see Table 5 on p. 34 for a summary) and refer to Appendix meta-analyses to supplement the reviews. The first focused on H for results of the AMSTAR evaluation of these reviews. By the nondirective supportive psychotherapy (Cuijpers, Driessen, et time of finalization of the current guideline document, several of al., 2012a), and the second focused on subclinical depression the underlying reviews will have crossed the 5-year mark for being (Cuijpers, Koole, et al., 2014b). Cuijpers, Driessen, and colleagues considered a current review according to"
  },
  {
    "id": 222,
    "source": "guideline_c3debd",
    "text": "subclinical depression the underlying reviews will have crossed the 5-year mark for being (Cuijpers, Koole, et al., 2014b). Cuijpers, Driessen, and colleagues considered a current review according to best practices. However, (2012a) defined depression as adults who received a diagnosis of it should be noted that the panel completed its decision-making major depressive disorder from either a diagnostic interview or a about the recommendations during the 5-year window in which validated self-report measure. For the inclusion exclusion crite- each review was considered current. ria of selecting the studies for this review, please refer to Cuijpers, Reynolds, et al. s (2012b) section 2.1 Identification and selection of Children and adolescents. The panel used two meta-analyses after studies"
  },
  {
    "id": 223,
    "source": "guideline_c3debd",
    "text": "the studies for this review, please refer to Cuijpers, Reynolds, et al. s (2012b) section 2.1 Identification and selection of Children and adolescents. The panel used two meta-analyses after studies (pp. 281 282). The authors of the second review defined determining they were of sufficient quality. One meta-analysis depression as either having scores above the threshold on a vali- focused on psychotherapies for depression in children and adoles- dated questionnaire or meeting the standardized diagnostic crite- cents (Zhou et al., 2015). In this review, the study authors defined ria for minor depression (Cuijpers, Koole, et al., 2014b). To review depression in youth ages 6 to 18 years having either received a diag- the authors  inclusion exclusion criteria for selecting studies in this"
  },
  {
    "id": 224,
    "source": "guideline_c3debd",
    "text": "depression (Cuijpers, Koole, et al., 2014b). To review depression in youth ages 6 to 18 years having either received a diag- the authors  inclusion exclusion criteria for selecting studies in this nosis of depression (minor, intermittent, or major) or dysthymia or review, please refer to Cuijpers, Koole, et al. s (2014b) Method sec- had an elevated score on the depression rating scale. The other tion (pp. 268 269). The third review focused on short-term psy- meta-analysis focused on antidepressants for major depressive dis- chodynamic psychotherapy (Driessen et al., 2015), and the fourth order in children and adolescents (Cipriani et al., 2016). Cipriani and focused on interpersonal psychotherapy (Cuijpers et al., 2016). colleagues defined depression in youth ages 9 to 18 years having The"
  },
  {
    "id": 225,
    "source": "guideline_c3debd",
    "text": "in children and adolescents (Cipriani et al., 2016). Cipriani and focused on interpersonal psychotherapy (Cuijpers et al., 2016). colleagues defined depression in youth ages 9 to 18 years having The authors of the third review defined depression in adults ages 18 received a diagnosis of major depressive disorder according to the and older that either met the diagnostic criteria for a mood disorder, DSM-III-TR, DSM-IV, or DSM-IV-TR. For more information on the specifically major depressive disorder, or had elevated scores on inclusion exclusion criteria implemented in these reviews, please a validated instrument (Driessen et al., 2015). For the inclusion  refer to sections in Zhou et al. s (2015) Study selection (pp. 208 209) exclusion criteria utilized in this review, please refer to"
  },
  {
    "id": 226,
    "source": "guideline_c3debd",
    "text": "a validated instrument (Driessen et al., 2015). For the inclusion  refer to sections in Zhou et al. s (2015) Study selection (pp. 208 209) exclusion criteria utilized in this review, please refer to Driessen et and Cipriani et al. s (2016) Methods: Search strategy and selection cri- al. s (2015) section 2.3 Selection of studies (p. 3). The authors of the teria (p. 2). For the list of keywords used in searches for articles final review defined depression as elevated scores on a validated for these reviews, please refer to sections in Cipriani et al. s (2016) instrument pre- and posttreatment (Cuijpers et al., 2016). For more Appendix 2: Search strategy and results (pp. 4 5) and Zhou et al. s information on the inclusion exclusion criteria utilized, please (2015) Study protocol and search"
  },
  {
    "id": 227,
    "source": "guideline_c3debd",
    "text": "(Cuijpers et al., 2016). For more Appendix 2: Search strategy and results (pp. 4 5) and Zhou et al. s information on the inclusion exclusion criteria utilized, please (2015) Study protocol and search strategy (p. 208). refer to Cuijpers et al. s (2016) section Method: Identification and Selection of Studies (p. 681). To view the list of keywords used in General adult population. The panel used data from several reviews searches for articles in the four reviews, please refer to the follow- and meta-analyses that met quality criteria. The panel used two ing references  sections: systematic reviews conducted by Evidence-Based Practice Centers,   Section 2.1: Identification and selection of studies (Cuijpers, which follow quality standards for conducting systematic reviews set Driessen, et"
  },
  {
    "id": 228,
    "source": "guideline_c3debd",
    "text": "conducted by Evidence-Based Practice Centers,   Section 2.1: Identification and selection of studies (Cuijpers, which follow quality standards for conducting systematic reviews set Driessen, et al., 2012a, p. 281). forth by the former Institute of Medicine (2011b) report. The first of   Table 1: Searches in bibliographical databases: Searchstrings and these focused on comparisons of pharmacological treatments with hits (Cuijpers et al., 2008). nonpharmacological treatments (Gartlehner et al., 2015) while the   Identification and selection of studies (Cuijpers et al., 2016, p. second covered a broad range of treatment comparisons (ECRI 681). Institute, 2015). The Veteran s Administration Department of   Section 2.2: Search strategy (Driessen et al., 2015). Defense (VA DoD) utilized the"
  },
  {
    "id": 229,
    "source": "guideline_c3debd",
    "text": "a broad range of treatment comparisons (ECRI 681). Institute, 2015). The Veteran s Administration Department of   Section 2.2: Search strategy (Driessen et al., 2015). Defense (VA DoD) utilized the latter in their creation of a clinical   Appendix A: Literature search methods (ECRI Institute, 2015, practice guideline, and the review was used by this panel with per- pp. 492 517) mission. This systematic review for the VA DoD included as data   Appendix A: Search strategy (pp. A1 A20) and Appendix B: previously published systematic reviews as well as clinical studies. Cochrane depression, anxiety, and neurosis (CCDAN) topic list: Gartlehner and colleagues (2015) defined depression in adults ages Intervention-psychological therapies (pp. B1 B3) (Gartlehner 18 and older who received diagnoses"
  },
  {
    "id": 230,
    "source": "guideline_c3debd",
    "text": "and neurosis (CCDAN) topic list: Gartlehner and colleagues (2015) defined depression in adults ages Intervention-psychological therapies (pp. B1 B3) (Gartlehner 18 and older who received diagnoses of major depressive disorder et al., 2015). from a standardized diagnostic manual or from elevated scores on validated instruments. For more information on the inclusion exclu- Older adults. The panel used two reviews identified via the umbrella sion criteria used in this review, please refer to Gartlehner et al. s review. One review (Cuijpers, Karyotaki, Pot, et al., 2014a) served as (2015) Table A. Inclusion exclusion criteria (pp. ES-3 to ES-5). The VA  the basis for developing evidence profiles on active interventions. DoD guideline developers defined depression in adults age 18 or The other"
  },
  {
    "id": 231,
    "source": "guideline_c3debd",
    "text": "Inclusion exclusion criteria (pp. ES-3 to ES-5). The VA  the basis for developing evidence profiles on active interventions. DoD guideline developers defined depression in adults age 18 or The other review (Wilkinson   Izmeth, 2012) served as the basis for 30 APA   Guideline for the Treatment of Depression developing evidence profiles on maintenance treatments. Authors of Cuijper et al. s (2008) Table 1: Searches in bibliographical databases: the first review defined depression in older adults ages 50 and older Searchstrings and hits and Wilkinson and Izmeth s (2012) Search who either met the diagnostic criteria for depression at assessment methods for identification of studies (pp. 5 6). or had ratings beyond the threshold in a validated self-report mea- Generally, the identified reviews"
  },
  {
    "id": 232,
    "source": "guideline_c3debd",
    "text": "diagnostic criteria for depression at assessment methods for identification of studies (pp. 5 6). or had ratings beyond the threshold in a validated self-report mea- Generally, the identified reviews and meta-analyses covered sure (Cuijpers, Karyotaki, Pot, et al., 2014a). For more information on cognitive-behavior therapy, interpersonal psychotherapy, prob- the inclusion exclusion criteria utilized in this review, please refer to lem-solving therapy, and psychodynamic treatment of depression. Cuijpers Karyotaki, Pot, et al. s (2014a) section 2.1 Identification and No acceptable meta-analyses or reviews included humanistic ther- selection of studies (p. 2). Wilkinson and Izmeth (2012) defined apies or emotion-focused therapy. Also, while the panel wished to depression in older adults aged"
  },
  {
    "id": 233,
    "source": "guideline_c3debd",
    "text": "or reviews included humanistic ther- selection of studies (p. 2). Wilkinson and Izmeth (2012) defined apies or emotion-focused therapy. Also, while the panel wished to depression in older adults aged 60 and older who met diagnostic review different treatment modalities, including self-help, Internet, criteria for a depressive disorder (in remission) or have experienced and group compared with individual, appropriate studies were a depressive episode. Please refer to Wilkinson and Izmeth s (2012) not included in the identified reviews to be able to examine this Methods: Criteria for considering studies for this review section for more question. The panel did not evaluate evidence reviews of long-term information on their inclusion exclusion criteria. For the list of key- intervention to"
  },
  {
    "id": 234,
    "source": "guideline_c3debd",
    "text": "studies for this review section for more question. The panel did not evaluate evidence reviews of long-term information on their inclusion exclusion criteria. For the list of key- intervention to target relapse and recurrence and evidence reviews words used in searches for articles for these reviews, please refer to of prevention intervention, consistent with its scoping decision. TABLE 5 Summary of Systematic Reviews and Meta-Analyses Used for Each Age Group Age Group Systematic Reviews and Meta-Analyses Used Children and Adolescents    Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis  (Zhou et al., 2015)    Comparative efficacy and tolerability of antidepressants for major depressive"
  },
  {
    "id": 235,
    "source": "guideline_c3debd",
    "text": "for depression in children and adolescents: A systematic review and network meta-analysis  (Zhou et al., 2015)    Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: A network meta-analysis  (Cipriani et al., 2016) General Adult Population    Nonpharmacological versus pharmacological treatments for adult patients with major depressive disorder  (Gartlehner et al., 2015)    Management of major depressive disorder, Evidence synthesis report, Clinical practice guideline  (ECRI Institute, 2015)    The efficacy of non-directive supportive psychotherapy for adult depression: A meta-analysis  (Cuijpers, Driessen, et al., 2012a)    Psychotherapy for subclinical depression: Meta-analysis  (Cuijpers, Koole, et al., 2014b)    The"
  },
  {
    "id": 236,
    "source": "guideline_c3debd",
    "text": "supportive psychotherapy for adult depression: A meta-analysis  (Cuijpers, Driessen, et al., 2012a)    Psychotherapy for subclinical depression: Meta-analysis  (Cuijpers, Koole, et al., 2014b)    The efficacy of short-term psychodynamic psychotherapy for depression: A meta-analysis update  (Driessen et al., 2015)    Interpersonal Psychotherapy for Mental Health Problems: A Comprehensive Meta-Analysis  (Cuijpers et al., 2016) Older Adults    Managing depression in older age: Psychological interventions  (Cuijpers Karyotaki, Pot, et al., 2014a)    Continuation and maintenance treatments for depression in older people  (Wilkinson   Izmeth, 2012) APA   Guideline for the Treatment of Depression 31 Strengths and Limitations of the Systematic a list of studies that were included and excluded."
  },
  {
    "id": 237,
    "source": "guideline_c3debd",
    "text": "in older people  (Wilkinson   Izmeth, 2012) APA   Guideline for the Treatment of Depression 31 Strengths and Limitations of the Systematic a list of studies that were included and excluded. Beyond these, limitations varied based on the particular review and included such Reviews and Meta-Analyses things as not duplicating the selection of studies and extraction of data, not having study design a priori, and not stating conflicts of There are a number of strengths as well as some limitations of the interest (see Appendix H for details of AMSTAR ratings by review). systematic reviews and meta-analyses underlying the panel s recom- In summary, each review used by the panel has strengths as mendations. The two systematic reviews conducted by evi- well as limitations. Importantly, a review is"
  },
  {
    "id": 238,
    "source": "guideline_c3debd",
    "text": "underlying the panel s recom- In summary, each review used by the panel has strengths as mendations. The two systematic reviews conducted by evi- well as limitations. Importantly, a review is not a final statement dence-based practice centers (ECRI Institute, 2015; Gartlehner et al., and has its own limits, but it allows the field to obtain a better han- 2015) (two of five used for the general adult population) had import- dle on what information is lacking and what needs to be done in ant strengths as well as limitations. First, they were conducted in the future (e.g., more funding, better quality research, more focus accordance with the IOM s (2011b) systematic review standards by on diverse populations, etc.). Information from these reviews was designated Agency for Healthcare Research"
  },
  {
    "id": 239,
    "source": "guideline_c3debd",
    "text": "research, more focus accordance with the IOM s (2011b) systematic review standards by on diverse populations, etc.). Information from these reviews was designated Agency for Healthcare Research and Quality (AHRQ) considered together with information on strength of the evidence evidence-based practice centers. Further, both reviews are transpar- base, balance of the benefits vs. harms burdens of a treatment, ent in including background data as well as strength of evidence and patient values and preferences, and applicability to form the pan- risk of bias information. However, some limitations of these reviews el s recommendations. In light of these limitations, it needs to be included that there were some areas not covered (as noted above) recognized that any recommendations made are based"
  },
  {
    "id": 240,
    "source": "guideline_c3debd",
    "text": "these reviews el s recommendations. In light of these limitations, it needs to be included that there were some areas not covered (as noted above) recognized that any recommendations made are based on evi- on which the panel would have liked information and the focus of dence derived by a method with some drawbacks for psychothera- both was only on major depressive disorder, thus the panel had to py research. Psychotherapy research differs in nature from medical look elsewhere for information on additional diagnoses. research both in the number of variables effecting outcomes and The reviews for older adults (Cuijpers Karyotaki, Pot, et al., the amount of research that met IOM standards. Results should 2014a; Wilkinson   Izmeth, 2012) were examined by RTI-UNC therefore be read as best"
  },
  {
    "id": 241,
    "source": "guideline_c3debd",
    "text": "for older adults (Cuijpers Karyotaki, Pot, et al., the amount of research that met IOM standards. Results should 2014a; Wilkinson   Izmeth, 2012) were examined by RTI-UNC therefore be read as best evidence according to method used and Evidence Based Practice Center scientists who then extracted viewed as a guideline not a prescription for treatment funding and data from these reviews into evidence profiles for the panel to use. decision-making. Strengths of the Wilkinson and Izmeth (2012) review include that it focused on a population that is understudied and focused on longer term continuation and maintenance treatment as opposed to the Characterizing the Study Samples Included in shorter term acute focus of most older adult reviews (Wilkinson   Izmeth, 2012). The authors of the review"
  },
  {
    "id": 242,
    "source": "guideline_c3debd",
    "text": "and maintenance treatment as opposed to the Characterizing the Study Samples Included in shorter term acute focus of most older adult reviews (Wilkinson   Izmeth, 2012). The authors of the review noted that there was a the Reviews significant amount of clinical heterogeneity between trials. Further, it is possible that there was selection bias (i.e., given challenges Decisions regarding assessment and inclusion exclusion of studies. of recruiting older adults, it is possible that those recruited do not Decisions on the assessment and inclusion exclusion of studies varied fully represent older adults in the general population) as well as based on the particular systematic review meta-analysis. Please refer possible funding bias (the authors were not able to analyze data on to the"
  },
  {
    "id": 243,
    "source": "guideline_c3debd",
    "text": "older adults in the general population) as well as based on the particular systematic review meta-analysis. Please refer possible funding bias (the authors were not able to analyze data on to the systematic reviews meta-analyses for specific details. However, this possibility as data were not collected) in the included studies broadly, the reviews included only randomized controlled trial (RCT) (Wilkinson   Izmeth, 2012). However, the authors concluded that studies (Driessen et al. s, 2015 review was an exception to this because altogether the studies had low risk of bias (Wilkinson   Izmeth, it included non-RCT data in addition to RCT data; however, the APA 2012). Strengths of the Cuijpers, Karyotaki, Pot, et al. (2014a) panel used only the RCT data to examine efficacy of interventions)"
  },
  {
    "id": 244,
    "source": "guideline_c3debd",
    "text": "it included non-RCT data in addition to RCT data; however, the APA 2012). Strengths of the Cuijpers, Karyotaki, Pot, et al. (2014a) panel used only the RCT data to examine efficacy of interventions) as review include that it focuses on an understudied population and those studies met the quality criteria for questions regarding efficacy. provides an update of the literature in an area that is quickly chang- Some reviews excluded certain diagnoses such as psychotic depres- ing. Some limitations of this review are that many included studies sion and required that the included studies be published in particular that were not of ideal quality, and few included studies used control languages. Several reviews included studies that had patients with groups that were placebos (most used treatment"
  },
  {
    "id": 245,
    "source": "guideline_c3debd",
    "text": "in particular that were not of ideal quality, and few included studies used control languages. Several reviews included studies that had patients with groups that were placebos (most used treatment as usual or wait- comorbidities such as other psychiatric disorders. Please refer to the ing list comparisons; Cuijpers, Karyotaki, Pot, et al., 2014a). section on comorbidities for further detail. Among the reviews that were not provided or assessed by an evidence-based practice center (Cipriani et al., 2016; Cuijpers, Diversity of samples included in reviews. The reviews used to Driessen, et al., 2012a; Cuijpers, Koole, et al., 2014b; Cuijpers et al., explore the effectiveness of treatments for depression in children and 2016; Driessen et al., 2015; and Zhou et al., 2015) (two for the child"
  },
  {
    "id": 246,
    "source": "guideline_c3debd",
    "text": "2012a; Cuijpers, Koole, et al., 2014b; Cuijpers et al., explore the effectiveness of treatments for depression in children and 2016; Driessen et al., 2015; and Zhou et al., 2015) (two for the child  adolescents are comprised of 51 studies examining psychotherapies adolescent population, the remainder for the general adult popula- (Zhou et al., 2015) and 27 studies examining antidepressants tion) there were a number of strengths as well as some limitations. (Cipriani et al., 2016). These studies included ages ranging from 6 to Based on an AMSTAR review, strengths of all these reviews were 18 years of age and, out of the studies with available data, 75 studies that they included a comprehensive literature search; provided for children and adolescents had approximately 50  female. Also,"
  },
  {
    "id": 247,
    "source": "guideline_c3debd",
    "text": "18 years of age and, out of the studies with available data, 75 studies that they included a comprehensive literature search; provided for children and adolescents had approximately 50  female. Also, characteristics of the included studies; an assessment of quality studies included international samples with approximately 85  of was conducted, documented, and used in conclusions; and finally, samples from United States. The non-U.S.-based samples included the methods used to combine findings were appropriate. Further Mexico, Finland, France, Germany, Russia, Slovakia, Estonia, Ukraine, strengths are that five of the six did not base inclusion on publica- South Africa, Belgium, Italy, United Kingdom, Spain, The Netherlands, tion status and also assessed for likelihood of publication bias."
  },
  {
    "id": 248,
    "source": "guideline_c3debd",
    "text": "are that five of the six did not base inclusion on publica- South Africa, Belgium, Italy, United Kingdom, Spain, The Netherlands, tion status and also assessed for likelihood of publication bias. A Canada, South Africa, United Arab Emirates, Argentina, Japan, China, limitation of all but one of these reviews is that they did not provide Costa Rica, India, Uganda, Turkey, Norway, New Zealand, Australia, 32 APA   Guideline for the Treatment of Depression and Greece. Overall, of the studies with available data, 63 studies for with comorbid psychiatric disorders, they excluded studies that children and adolescents had a range of 10  to 100  of non-White recruited  participants with treatment-resistant depression, with participants. Regarding study exclusions in each of the respective"
  },
  {
    "id": 249,
    "source": "guideline_c3debd",
    "text": "children and adolescents had a range of 10  to 100  of non-White recruited  participants with treatment-resistant depression, with participants. Regarding study exclusions in each of the respective treatment duration of less than 4 weeks, or with an overall sample child adolescent reviews, the Zhou et al. (2015) excluded clinical size of fewer than ten patients  (p. 2). trials where children and adolescents had a diagnosis of treat- ment-resistant depression or psychotic depression in order to elimi- General adult population. Four out of the six reviews of depression in nate extraneous noise in their results. the general adult population did not exclude comorbid psychiatric The reviews used for general adult population included 482 and medical disorders (Cuijpers, Driessen, et al., 2012a;"
  },
  {
    "id": 250,
    "source": "guideline_c3debd",
    "text": "their results. the general adult population did not exclude comorbid psychiatric The reviews used for general adult population included 482 and medical disorders (Cuijpers, Driessen, et al., 2012a; Cuijpers, studies exploring psychotherapies and medication in this popula- Koole, et al., 2014b; ECRI Institute, 2015; Gartlehner et al., 2015).46 tion (Cuijpers, Driessen, et al., 2012a; Cuijpers, Koole, et al., 2014b; Reviewers from the ECRI Institute (2015) included the following Driessen et al., 2015; ECRI Institute, 2015; Gartlehner et al., 2015) comorbid psychiatric and medical disorders in one of their key ques- and 84 studies for medication. These studies included individ- tions: cardiovascular disease, dementia, arrythmias, seizure disor- uals between 18 to greater than 65 years of age"
  },
  {
    "id": 251,
    "source": "guideline_c3debd",
    "text": "of their key ques- and 84 studies for medication. These studies included individ- tions: cardiovascular disease, dementia, arrythmias, seizure disor- uals between 18 to greater than 65 years of age and are 70.7  ders, lower back pain, Alzheimer s, and stroke. Regarding the review female. Also, studies included international samples with approx- of short-term psychodynamic psychotherapy (Driessen et al., 2015), imately 38  of samples from United States. The non-U.S.-based the reviewers did not consider comorbid somatic disorders. While samples include Canada, Iran, Switzerland, Italy, United Kingdom, Gartlehner and colleagues (2015) searched for studies that had Germany, The Netherlands, Australia, Sweden, Finland, Denmark, comorbidity as an inclusion criterion, they noted the paucity of"
  },
  {
    "id": 252,
    "source": "guideline_c3debd",
    "text": "Kingdom, Gartlehner and colleagues (2015) searched for studies that had Germany, The Netherlands, Australia, Sweden, Finland, Denmark, comorbidity as an inclusion criterion, they noted the paucity of Chile, Mexico, Spain, Brazil, China, and Romania. The review that high-quality studies that included patients with comorbid psychiatric assessed efficacy of short-term psychodynamic psychotherapy for and medical disorders in most of the studies. depression included 35 RCTs (Driessen et al., 2015). Overall, in the studies with available data, general adult population had approxi- Older adult population. The reviews for depression in older adults did mately 50  of non-White participants. not exclude comorbidity. However, Cuijpers, Karyotaki, Pot, and col- Finally, the combined reviews for older"
  },
  {
    "id": 253,
    "source": "guideline_c3debd",
    "text": "The reviews for depression in older adults did mately 50  of non-White participants. not exclude comorbidity. However, Cuijpers, Karyotaki, Pot, and col- Finally, the combined reviews for older adults included 53 leagues (2014a) as well as Wilkinson and Izmeth (2012)47 were studies for psychotherapies and medication (Cuijpers, Karyotaki, unable to find studies that included older adults with depression as Pot, et al., 2014a; Wilkinson   Izmeth, 2012). The samples within well as comorbid medical and psychiatric disorders in clinical trials. the reviews included adults ages 50 and older with approximately Both reviews emphasized the need for future research to include 83  females across all studies. Reviews had limited internation- comorbid disorders in assessing treatment efficacy for"
  },
  {
    "id": 254,
    "source": "guideline_c3debd",
    "text": "approximately Both reviews emphasized the need for future research to include 83  females across all studies. Reviews had limited internation- comorbid disorders in assessing treatment efficacy for depression in al representation compared with the other age groups with sam- older adults. ples from the following countries: Singapore, The Netherlands, Germany, Switzerland, Spain, Canada, Australia, United Kingdom, United States, Denmark, and various European countries. Of the Defining Efficacy and Comparative studies in the reviews with reported data, the sample included only Effectiveness a range of 6.7  to 100  of non-White participants.44 In this guideline, the term efficacy refers to the impact of a treatment Comorbidity of samples included in the reviews: Children and ado- compared"
  },
  {
    "id": 255,
    "source": "guideline_c3debd",
    "text": "range of 6.7  to 100  of non-White participants.44 In this guideline, the term efficacy refers to the impact of a treatment Comorbidity of samples included in the reviews: Children and ado- compared with an inactive control (i.e., waitlist). The term compara- lescents. The reviews for depression in children and adolescents did tive effectiveness refers to the benefit of one active treatment com- not exclude comorbid psychiatric disorders. However, there were a pared with another. few limitations noted in these reviews. Regarding the review that assessed the efficacy of interpersonal psychotherapy adapted for Types of comparison (control) groups used by studies. The type of adolescents (IPT-A) versus cognitive-behavioral therapy in the treat- comparison (control) group used by studies"
  },
  {
    "id": 256,
    "source": "guideline_c3debd",
    "text": "adapted for Types of comparison (control) groups used by studies. The type of adolescents (IPT-A) versus cognitive-behavioral therapy in the treat- comparison (control) group used by studies varied across the sys- ment of child adolescent depression, Zhou and colleagues (2015) tematic reviews meta-analyses. Please refer directly to the reviews found that the studies that recruited patients with comorbid psychi- for specific details. Broadly, however, control groups used by studies atric disorders had lower effect sizes.45 The authors emphasized the included both active and nonactive controls. An example of an often- need for more research on the efficacy of IPT-A and cognitive-behav- used active control was treatment as usual (whose exact definition ioral therapy in patients with comorbid"
  },
  {
    "id": 257,
    "source": "guideline_c3debd",
    "text": "An example of an often- need for more research on the efficacy of IPT-A and cognitive-behav- used active control was treatment as usual (whose exact definition ioral therapy in patients with comorbid psychiatric disorders due to varies by study). Examples of nonactive controls included such things the small samples sizes that may have contributed to this finding as waitlist and no treatment. (Zhou et al., 2015). While Cipriani and colleagues (2016) included pharmacological studies that recruited children and adolescents 44 Please see Appendix K of the supplement which summarizes the demographics from each of the 10 reviews. 45 To view the forest plot presentation of the effect sizes for both child adolescent reviews, the interested reader is referred to Appendix 11, pp. 36-40 of Cipriani"
  },
  {
    "id": 258,
    "source": "guideline_c3debd",
    "text": "from each of the 10 reviews. 45 To view the forest plot presentation of the effect sizes for both child adolescent reviews, the interested reader is referred to Appendix 11, pp. 36-40 of Cipriani et al. (2016) and p. 218 of Zhou et al. (2015). 46 To view the forest plot presentation of the effect sizes for the adult reviews, please refer to p. 287 of Cuijpers, Driessen, et al. (2012a), pp. 271-272 of Cuijpers, Koole, et al. (2014b), pp. 7-11 of Driessen et al. (2015), and pp. ES-7-ES-8, 26-27, 33-35, 53-54, 77-84, 89-91, 94, and 97 of Gartlehner et al. (2015). 47 To view the forest plot presentation of the two older adult reviews, please refer to p. 165 of Cuijpers, Karyotaki, Pot, et al. (2014a) and p. 14, pp. 16-17, and pp. 19-20 of Wilkinson   Izmeth (2012). APA   Guideline for the"
  },
  {
    "id": 259,
    "source": "guideline_c3debd",
    "text": "of the two older adult reviews, please refer to p. 165 of Cuijpers, Karyotaki, Pot, et al. (2014a) and p. 14, pp. 16-17, and pp. 19-20 of Wilkinson   Izmeth (2012). APA   Guideline for the Treatment of Depression 33 Evaluating the Evidence the panel might want to reference for discussions on applicability. As the panel discussed each decision table or grid, APA staff tran- scribed the panel s decisions into each decision table or grid. The development of evidence profiles. Evidence profiles (summaries As the panel progressed with its work, they decided that the of data in available studies) were created by the RTI-UNC Evidence- creation and review of evidence in decision tables resulted in redun- Based Practice Center team from data reported in the systematic dancy as the same information"
  },
  {
    "id": 260,
    "source": "guideline_c3debd",
    "text": "created by the RTI-UNC Evidence- creation and review of evidence in decision tables resulted in redun- Based Practice Center team from data reported in the systematic dancy as the same information concerning possible harms and bur- reviews on the efficacy of psychological treatments and the compar- dens or patient values and preferences was considered repeatedly ative effectiveness of psychological treatments to pharmacological for different bodies of outcome evidence. To facilitate decision treatments in head-to-head trials for older adults. The evidence making yet maintain consistency and transparency, a revised  grid  profiles were summaries of data included in the systematic reviews process was created that included distinct columns for separate and include, for each outcome, the"
  },
  {
    "id": 261,
    "source": "guideline_c3debd",
    "text": "transparency, a revised  grid  profiles were summaries of data included in the systematic reviews process was created that included distinct columns for separate and include, for each outcome, the number of studies, absolute effect questions and outcomes and individual decision-making regarding sizes, confidence intervals (when available), and strength of evidence efficacy but allowed consideration of the same data for harms and ratings. For adults, evidence profiles were provided in the report burdens across those columns. This greatly increased the efficiency  Nonpharmacological Versus Pharmacological Treatments for Adult of the evidence review while keeping consistency and transparency. Patients With Major Depressive Disorder,  (Gartlehner et al., 2015). Although some have questioned"
  },
  {
    "id": 262,
    "source": "guideline_c3debd",
    "text": "Treatments for Adult of the evidence review while keeping consistency and transparency. Patients With Major Depressive Disorder,  (Gartlehner et al., 2015). Although some have questioned the applicability of some The panel worked with data directly from the report for the remainder randomized trials due to potential differences between sample of the systematic reviews and meta-analyses. Thus, the panel had characteristics or treatment settings and the  real world  appli- evidence profiles for some but not all of the data. Evidence profiles cation (Shean, 2016), the panel decided to not supplement the (in the format provided by the Grading of Recommendations randomized trials included in the reviews with observational (i.e., Assessment, Development and Evaluation (GRADE) Consortium"
  },
  {
    "id": 263,
    "source": "guideline_c3debd",
    "text": "supplement the (in the format provided by the Grading of Recommendations randomized trials included in the reviews with observational (i.e., Assessment, Development and Evaluation (GRADE) Consortium nonrandomized and less methodologically rigorous) or other treat- Working Group in particular) typically have information beyond ment studies, due to the potential for confounding bias in observa- effect size, such as information about the quality of included aggre- tional studies (Fewell, Smith,   Sterne, 2007; Rothman, Greenland, gated studies for a particular outcome, which is not always the case   Lash, 2008). This decision is consistent with the position of all for data taken directly from other systematic reviews or meta-anal- major organizations that evaluate research and conduct"
  },
  {
    "id": 264,
    "source": "guideline_c3debd",
    "text": "the case   Lash, 2008). This decision is consistent with the position of all for data taken directly from other systematic reviews or meta-anal- major organizations that evaluate research and conduct system- yses. So, in some cases the panel had additional quality information atic reviews, including GRADE, Cochrane, The National Institute for particular outcomes included in the evidence profiles but did not for Health and Care Excellence (NICE), The Agency for Healthcare have that data for all interventions and outcomes. Research and Quality (AHRQ) Evidence-Based Practice Centers (Guyatt et al., 2011; NICE, 2012; Reeves, Deeks, Higgins,   Wells on The development and use of decision tables and the grid. Decision behalf of the Cochrane Non-Randomised Studies Methods Group, tables and grids"
  },
  {
    "id": 265,
    "source": "guideline_c3debd",
    "text": "2011; NICE, 2012; Reeves, Deeks, Higgins,   Wells on The development and use of decision tables and the grid. Decision behalf of the Cochrane Non-Randomised Studies Methods Group, tables and grids are documents developed and then used by panel 2011; Viswanathan et al., 2012). members to summarize and evaluate the evidence generated in the Panel members made two significant exceptions to this deci- systematic review or meta-analyses, along with any supplemental sion when it became clear that data were lacking in randomized information. Panel ratings and judgments were documented on the trials findings on two outcomes: (1) harms and burdens of psycho- decision tables and grids to aid in the formulation of recommenda- logical treatments and (2) patient values and preferences regard- tions"
  },
  {
    "id": 266,
    "source": "guideline_c3debd",
    "text": "findings on two outcomes: (1) harms and burdens of psycho- decision tables and grids to aid in the formulation of recommenda- logical treatments and (2) patient values and preferences regard- tions (Treweek et al., 2013). These tables allow panel members to ing particular treatments. In response, the panel decided there document decisions, compare consistency across decisions, and give was a need to gather and review more information on these topics. transparency to reviewers and users of the guideline document. The Concerning harms, panel members decided to review those obser- four main domains of decision-making are documented as follows: vational studies that gave attention to the assessment of harms that (1) strength of evidence; (2) treatment outcomes and the balance of were"
  },
  {
    "id": 267,
    "source": "guideline_c3debd",
    "text": "domains of decision-making are documented as follows: vational studies that gave attention to the assessment of harms that (1) strength of evidence; (2) treatment outcomes and the balance of were identified in the reviews. It also authorized APA staff assigned benefits vs. harms and burdens of interventions; (3) patient values to the guideline development panel to compile information on pos- and preferences; and (4) applicability of the evidence to various sible harms and burdens of interventions as well as patient values treatment populations. and preferences from an additional search of the literature. Details Strength of evidence was rated as either insufficient very of the search process methodology for both of these supplemental low, low, moderate, or high based on the combined"
  },
  {
    "id": 268,
    "source": "guideline_c3debd",
    "text": "the literature. Details Strength of evidence was rated as either insufficient very of the search process methodology for both of these supplemental low, low, moderate, or high based on the combined results of anal- sources of information are described below. The findings of these yses of risk of bias, inconsistency, indirectness, and imprecision. additional reviews along with input from clinicians and consumers Only for interventions that had at least low strength of evidence on the panel were used to make the treatment recommendations for one of the outcomes were decision tables or grids completed. more comprehensive with regard to the risk of harm or adverse The panel generated evidence that met the criteria for the com- events associated with various interventions for depression"
  },
  {
    "id": 269,
    "source": "guideline_c3debd",
    "text": "completed. more comprehensive with regard to the risk of harm or adverse The panel generated evidence that met the criteria for the com- events associated with various interventions for depression (deter- pletion of 38 decision tables and three grids on which to base the mined to be a critical outcome) and patient values and preferences. APA Depression Guideline. While APA staff prepared the decision Each panel member received an explicit opportunity to raise tables and grids for the panel based on information extracted from any questions or concerns about the process of completing each the reviews and studies, the panel made all the decisions regarding decision table or the grid. The panel as a group reviewed each the evidence and recommendations. Specifically, APA staff insert- decision"
  },
  {
    "id": 270,
    "source": "guideline_c3debd",
    "text": "and studies, the panel made all the decisions regarding decision table or the grid. The panel as a group reviewed each the evidence and recommendations. Specifically, APA staff insert- decision table and grid to identify any questions or concerns that ed information from the reviews and studies on quality ratings, out- users of the guideline (including patients, clinicians, scientists, comes examined and associated effect sizes, harms and burdens of and administrators) might raise. After completing all the decision interventions (as described in more detail below), study results on tables and grids, the panel globally reviewed all tables and grids to patient values and preferences, and study participant descriptions 34 APA   Guideline for the Treatment of Depression assess any"
  },
  {
    "id": 271,
    "source": "guideline_c3debd",
    "text": "tables and grids, the panel globally reviewed all tables and grids to patient values and preferences, and study participant descriptions 34 APA   Guideline for the Treatment of Depression assess any inconsistency and assure consistency in decision-mak- decided on by the panel, these needed more precise specification ing across tables. For purposes of consistency across all clinical and definition. Ultimately, panel members considered events such practice guidelines, the Advisory Steering Committee established as the need for hospitalization secondary to suicidality as a seri- voting procedures that can be found in Appendix F. ous adverse event and then identified additional harms such as medication side effects. Harms were differentiated from burdens Completion of decision tables and"
  },
  {
    "id": 272,
    "source": "guideline_c3debd",
    "text": "that can be found in Appendix F. ous adverse event and then identified additional harms such as medication side effects. Harms were differentiated from burdens Completion of decision tables and grid. The four domains below that were identified as disruptions associated with treatment (i.e., formed the basis on which each treatment recommendation and its time spent, homework need to practice, cost, convenience) rath- strength were decided. For each recommendation, text description er than as injury. As discussed earlier, the review of the treatment and a justification for the recommendation were included on the literature did not generate sufficient data on harms and burdens decision table and grid (see Appendix C as well as additional appen- of interventions because, unfortunately, this"
  },
  {
    "id": 273,
    "source": "guideline_c3debd",
    "text": "included on the literature did not generate sufficient data on harms and burdens decision table and grid (see Appendix C as well as additional appen- of interventions because, unfortunately, this information is not dices links). routinely reported in studies of psychosocial interventions and Rating of aggregate global strength of evidence. For each of the not reported in detail in many studies of psychopharmacologi- decision tables and grids, aggregate global strength of evidence was cal interventions. In light of this deficit, the APA Task Force to based on the strength of evidence from the review for the two criti- Revise the Journal Article Reporting Standards (JARS) for quanti- cal outcomes, namely, response to treatment (reduction in depres- tative research included in the new"
  },
  {
    "id": 274,
    "source": "guideline_c3debd",
    "text": "the review for the two criti- Revise the Journal Article Reporting Standards (JARS) for quanti- cal outcomes, namely, response to treatment (reduction in depres- tative research included in the new standards the suggestion that sive symptoms) and serious adverse events. The panel adopted the randomized controlled trial researchers report data regarding GRADE (Grading of Recommendations, Assessment, Development harms and burdens including indicating  none  if there were none and Evaluation) consortium standard that the aggregate strength of (Appelbaum et al., 2018). evidence could be no higher than the lowest individual strength of In response to this deficit, the panel requested that APA evidence for each of the critical outcomes (Guyatt et al., 2013). For staff examine each article in"
  },
  {
    "id": 275,
    "source": "guideline_c3debd",
    "text": "than the lowest individual strength of In response to this deficit, the panel requested that APA evidence for each of the critical outcomes (Guyatt et al., 2013). For staff examine each article in the reviews to extract data regarding example, if one critical outcome had  high  strength of evidence harms and burdens, such as dropout attrition, symptom wors- but the other critical outcome had  low  strength of evidence, the ening, homework, etc. For the older adult review, the same data global quality of evidence for that particular decision table or col- extraction was also conducted on those studies identified but umn in the grid would be low, because that is the lowest strength excluded from the systematic review because of high risk of bias of evidence for an individual critical"
  },
  {
    "id": 276,
    "source": "guideline_c3debd",
    "text": "those studies identified but umn in the grid would be low, because that is the lowest strength excluded from the systematic review because of high risk of bias of evidence for an individual critical outcome. The strength of evi- to expand the available pool of information. In addition, a focused dence for serious harms, one of the panel s critical outcomes, was literature search of the PsycINFO  database was conducted for insufficient very low, for all interventions for which decision tables older adults. Some of the search terms used included:  depression,  and grid columns were completed. This explains why the global  treatment,  and  older adults.  Recognizing time constraints and strength of evidence was insufficient very low for all interventions, expecting only limited incremental"
  },
  {
    "id": 277,
    "source": "guideline_c3debd",
    "text": "This explains why the global  treatment,  and  older adults.  Recognizing time constraints and strength of evidence was insufficient very low for all interventions, expecting only limited incremental additional evidence, the adult despite low, moderate, or high strength of evidence for the critical and child adolescent data on harms and burdens was derived from outcome of response to treatment. only an examination of the articles included within the reviews and Assessing magnitude of benefits. One of the key components of not additional searches or examination of any excluded articles. It the decision-making process for the guideline developmental panel was from these studies that the panel had additional information on was assessment of the balance between benefits and harms. This"
  },
  {
    "id": 278,
    "source": "guideline_c3debd",
    "text": "It the decision-making process for the guideline developmental panel was from these studies that the panel had additional information on was assessment of the balance between benefits and harms. This possible harms or burdens associated with the interventions under required the quantification of both benefits and harms. consideration. Further, as described in more detail below, physician Quantification of benefits was based on data from the quan- members of the panel provided information on potential harms  titative meta-analyses for each of the important and critical out- burdens of medications. Moreover, panel members consulted with comes that the panel had selected at the start of the guideline a prominent expert in child psychiatry regarding the panel s rec- development panel process"
  },
  {
    "id": 279,
    "source": "guideline_c3debd",
    "text": "Moreover, panel members consulted with comes that the panel had selected at the start of the guideline a prominent expert in child psychiatry regarding the panel s rec- development panel process for those interventions that had at ommendations pertaining to medication in children adolescents to least low quality of evidence for the critical outcome, response to review and assess for any potential concerns. treatment. For each of the outcomes on the decision tables, mag- The panel also addressed the issue of attrition as a possible nitude of benefits and harms burdens was rated on a five-point harm. Because attrition in a randomized trial can signify different scale: (1) large modest48 benefit; (2) small benefit; (3) no effect; things (e.g., stopping because treatment is not acceptable or"
  },
  {
    "id": 280,
    "source": "guideline_c3debd",
    "text": "harm. Because attrition in a randomized trial can signify different scale: (1) large modest48 benefit; (2) small benefit; (3) no effect; things (e.g., stopping because treatment is not acceptable or tol- (4) small harm; and (5) modest49 large harm.50 On the grids, the erable versus discontinuing due to early symptom relief) the panel panel rated the magnitude of benefits as large, modest,51 or small did not consider it to be a harm unless information regarding the benefit of Treatment 1 relative to Treatment 2 and the reverse or reasons for attrition were specified or unless there were differen- No difference in effect or Unable to rate. The same was done for tial attrition rates across treatment groups (Zandberg, Rosenfield, harms burdens. Alpert, McLean,   Foa, 2016). Assessing"
  },
  {
    "id": 281,
    "source": "guideline_c3debd",
    "text": "differen- No difference in effect or Unable to rate. The same was done for tial attrition rates across treatment groups (Zandberg, Rosenfield, harms burdens. Alpert, McLean,   Foa, 2016). Assessing magnitude of harm burdens. Because  serious Finally, in order to supplement the limited information on adverse events  was one of the two critical outcomes of treatment harms and burdens gleaned from published research, clinicians 48 However, the panel later decided that it preferred the term  moderate  instead of  modest.  49 Same as footnote  48. 50 The following served as an approximate rule of thumb: a small effect size is 0.20, medium is 0.50 and large is 0.90. 51 Same as footnote  48. APA   Guideline for the Treatment of Depression 35 on the panel reported their experiences in delivering,"
  },
  {
    "id": 282,
    "source": "guideline_c3debd",
    "text": "a small effect size is 0.20, medium is 0.50 and large is 0.90. 51 Same as footnote  48. APA   Guideline for the Treatment of Depression 35 on the panel reported their experiences in delivering, supervising, decide that there was insufficient evidence to make a recommen- or training in particular interventions and the concerns noted by dation about a particular treatment. Panel members were able to colleagues. Consumer members reported on both their own and reach consensus regarding the strength of recommendation given peer experiences with various interventions. In general, many of to each treatment in most cases via discussion but, for several, a the identified harms and burdens pertaining to psychosocial inter- vote was required. Please refer to Appendix F in the supplemen- ventions"
  },
  {
    "id": 283,
    "source": "guideline_c3debd",
    "text": "treatment in most cases via discussion but, for several, a the identified harms and burdens pertaining to psychosocial inter- vote was required. Please refer to Appendix F in the supplemen- ventions were more general and common to most psychosocial tal appendices for voting procedures established by the Advisory treatments, for example, the potential for short-term exacerba- Steering Committee (ASC). tion of symptoms (harm) or the time necessary for multiple psy- chotherapy sessions (burden). Further, clinicians and consumer members reported various side effects as potential harms of med- EXTERNAL REVIEW PROCESS ication treatment. Though it was important to obtain all available sources of information on patient values and preferences, due to the inclusion of both anecdotal (i.e.,"
  },
  {
    "id": 284,
    "source": "guideline_c3debd",
    "text": "med- EXTERNAL REVIEW PROCESS ication treatment. Though it was important to obtain all available sources of information on patient values and preferences, due to the inclusion of both anecdotal (i.e., clinician and consumer report) A draft document was submitted to the APA Advisory Steering and peer-reviewed article information, the strength of evidence on Committee for Development of Clinical Practice Guidelines for feed- these topics was rated as insufficient very low. back and modified based on that feedback. This draft document was Once possible harms and burdens were identified, panel posted on the APA website and public feedback was solicited for 60 members then compared these with the benefits of the interven- days. That draft document was revised based on that feedback. tions. On"
  },
  {
    "id": 285,
    "source": "guideline_c3debd",
    "text": "on the APA website and public feedback was solicited for 60 members then compared these with the benefits of the interven- days. That draft document was revised based on that feedback. tions. On the decision table for each intervention, the panel rated Detailed responses to public comments will be made available on the whether the benefits  clearly outweigh  or  slightly outweigh  the APA website. harms and burdens or the reverse. On the grids the panel rated The final document will be reviewed within 5 years follow- whether the balance of benefits to harms burdens strongly or ing adoption as policy. A decision to sunset, update, or revise the slightly favors Treatment 1 over Treatment 2 or the reverse, the bal- guideline will be made at that time. ance of benefits to harms burdens was"
  },
  {
    "id": 286,
    "source": "guideline_c3debd",
    "text": "as policy. A decision to sunset, update, or revise the slightly favors Treatment 1 over Treatment 2 or the reverse, the bal- guideline will be made at that time. ance of benefits to harms burdens was the same, or it was unable to determine the balance of benefits to harms burdens between Treatment 1 and Treatment 2. Assessing patient values and preferences. In addition to assess- ing the benefits and the harms burdens associated with specific interventions, the panel attempted to ascertain patient values and preferences. As described above, in order to ascertain this infor- mation, the panel relied on a search of the literature as well as cli- nicians and consumers on the panel who voiced their perspectives about preferences for different interventions as well as the value that patients"
  },
  {
    "id": 287,
    "source": "guideline_c3debd",
    "text": "relied on a search of the literature as well as cli- nicians and consumers on the panel who voiced their perspectives about preferences for different interventions as well as the value that patients might place on different outcomes or harms burdens associated with particular treatments. The strength of evidence (SOE) for all this information was very low because it included observational studies and  expert  (i.e., panel member) opinion. Applicability of evidence. The final determinant that panel members considered, before making recommendations, was the applicability (generalizability) of the evidence to various popula- tions and settings. To organize information on applicability, panel members applied the PICOTS framework (referring to Populations, Interventions, Comparators, Outcomes,"
  },
  {
    "id": 288,
    "source": "guideline_c3debd",
    "text": "evidence to various popula- tions and settings. To organize information on applicability, panel members applied the PICOTS framework (referring to Populations, Interventions, Comparators, Outcomes, Time and Settings; Samson   Schoelles, 2012) to review specific information from the studies to determine if there were any concerns pertinent to applicability pertaining to population, interventions, comparators, outcomes, timing, or settings to be noted in each decision table or on the grid. Decision-making regarding treatment recommendations. On the basis of the ratings of these four factors (strength of evidence, bal- ance of benefits versus harms burdens, patient values and prefer- ences, and applicability), the panel then made a decision regarding its recommendation for a particular"
  },
  {
    "id": 289,
    "source": "guideline_c3debd",
    "text": "(strength of evidence, bal- ance of benefits versus harms burdens, patient values and prefer- ences, and applicability), the panel then made a decision regarding its recommendation for a particular treatment or comparison of treatments. The options ranged from a strong ( the panel recom- mends ) or conditional ( the panel suggests ) recommendation either in support of or against a particular treatment based on the combination of these factors. The panel could also choose to 36 APA   Guideline for the Treatment of Depression DISCUSSION OF CLINICAL RECOMMENDATIONS Children and Adolescents The treatment of depression in children and adolescents is recognized as an issue of public health significance given the detrimental impacts of depression on development and inter- personal interactions,"
  },
  {
    "id": 290,
    "source": "guideline_c3debd",
    "text": "of depression in children and adolescents is recognized as an issue of public health significance given the detrimental impacts of depression on development and inter- personal interactions, as well as functioning at school and work, impairments that continue to have deleterious effects into adulthood (Avenevoli et al., 2015; Glied   Pine, 2002; Lewinsohn et al., 1994; Lewinsohn et al., 1999; Merikangas et al., 2010). The panel originally drafted recommendation statements for the combined populations of children and adoles- cents given that the underlying reviews on children and adolescents combined the age groups together and it was not possible to review the data separately. However, on further consider- ation the panel decided to separate the recommendations for children and"
  },
  {
    "id": 291,
    "source": "guideline_c3debd",
    "text": "combined the age groups together and it was not possible to review the data separately. However, on further consider- ation the panel decided to separate the recommendations for children and adolescents, not only for reasons of development but also due to underlying methodological reasons in the included reviews. Specifically, the child and adolescent reviews (Cipriani et al., 2016; Zhou et al., 2015) both included only a relatively small pool of studies that focused on children only as opposed to a combined or adolescent population and the Zhou et al. (2015) review specif- ically noted less robust findings for children specific to CBT and IPT. Thus, the panel retained the recommendation statements for adolescents only and then separately noted that evi- dence was insufficient to be able"
  },
  {
    "id": 292,
    "source": "guideline_c3debd",
    "text": "robust findings for children specific to CBT and IPT. Thus, the panel retained the recommendation statements for adolescents only and then separately noted that evi- dence was insufficient to be able to make specific recommendations for type of psychotherapy or pharmacotherapy for children. The generalizability of the evidence reviewed and presented here has some important limitations, which must be noted at the outset. Very few of the studies included in the reviews included a wide range of racially diverse youth and focused instead primarily on socioeconomically diverse White youth and lower socioeconomic status youth of color (when they were included). This reflects both that relatively few studies met the inclusion criteria (thereby potentially excluding studies that included more"
  },
  {
    "id": 293,
    "source": "guideline_c3debd",
    "text": "socioeconomic status youth of color (when they were included). This reflects both that relatively few studies met the inclusion criteria (thereby potentially excluding studies that included more diverse samples) and the limited diversity in treatment samples in the published literature in general. Therefore, these recommendations must be viewed as limited in applicability to a diverse community of mental health consumers. APA   Guideline for the Treatment of Depression 37 With this caveat, the panel s comprehensive review leads to including the other Food and Drug Administration (FDA) approved the recommendation for the use of psychotherapy to treat adoles- antidepressant for youth, escitalopram (Lexapro). In this regard, we cent depression. The best evidence is for interpersonal"
  },
  {
    "id": 294,
    "source": "guideline_c3debd",
    "text": "approved the recommendation for the use of psychotherapy to treat adoles- antidepressant for youth, escitalopram (Lexapro). In this regard, we cent depression. The best evidence is for interpersonal psychother- note that although the FDA approved the medication escitalopram, in apy (adapted for adolescents) and cognitive-behavioral therapy the panel s review of the evidence, we were unable to recommend for (CBT), enabling a recommendation for both of these psychosocial or against this medication. Finally, although Nefazodone (Serzone) interventions versus no treatment or waitlist, and versus treatment was included in our review, the panel has elected not to provide rec- as usual or psychological placebo conditions. The evidence base ommendation on the use of this medication as an"
  },
  {
    "id": 295,
    "source": "guideline_c3debd",
    "text": "versus treatment was included in our review, the panel has elected not to provide rec- as usual or psychological placebo conditions. The evidence base ommendation on the use of this medication as an antidepressant given for behavioral therapy, cognitive therapy, family therapy, play ther- its lack of clinical relevance for current practice (i.e., expert psychiatrist apy, problem-solving therapy, and psychodynamic and supportive indication that this medication is almost never used for child or ado- psychotherapy is insufficient for recommendation of any of these lescent care due to significant side effects). Thus, the panel concludes treatments versus no treatment or waitlist, and versus treatment that the strongest evidence for a pharmacologic treatment for adoles- as usual or"
  },
  {
    "id": 296,
    "source": "guideline_c3debd",
    "text": "significant side effects). Thus, the panel concludes treatments versus no treatment or waitlist, and versus treatment that the strongest evidence for a pharmacologic treatment for adoles- as usual or psychological placebo conditions. When the aforemen- cent depression is for fluoxetine (Prozac). If fluoxetine is not a treat- tioned treatments (CBT, interpersonal psychotherapy [adapted for ment option or is not acceptable, the panel recommends shared adolescents], behavioral therapy, cognitive therapy, family therapy, decision-making regarding medication options with a child psychia- play therapy, problem-solving therapy, psychodynamic and sup- trist in addition to the clinician, patient, and their parents guardians or portive psychotherapy) were compared with each other, there was family"
  },
  {
    "id": 297,
    "source": "guideline_c3debd",
    "text": "problem-solving therapy, psychodynamic and sup- trist in addition to the clinician, patient, and their parents guardians or portive psychotherapy) were compared with each other, there was family members actively involved in their care. However, more research insufficient evidence for the panel to recommend for or against cli- is needed comparing the efficacy of active medications with diverse nicians offering any of the psychotherapies over any of the other populations and in combination with psychotherapy. psychotherapies listed. CBT and IPT are two psychotherapies which have multiple RCTs demonstrating their efficacy in decreas- ing depression symptoms in adolescents. The comparison condi- General Adult Population tions in these studies include waitlist control group and supportive"
  },
  {
    "id": 298,
    "source": "guideline_c3debd",
    "text": "demonstrating their efficacy in decreas- ing depression symptoms in adolescents. The comparison condi- General Adult Population tions in these studies include waitlist control group and supportive psychotherapy treatment as usual; however, they do not include The panel found that various types of interventions are available for the behavior therapy, play therapy, problem-solving therapy, psycho- treatment of depression in the general adult population. For the initial dynamic psychotherapy, or manualized supportive psychotherapy. treatment of adult patients with depression, the panel recommends that Thus, there is insufficient information regarding their comparative clinicians offer either psychotherapy or second-generation antidepres- effectiveness to a greater number of therapeutic"
  },
  {
    "id": 299,
    "source": "guideline_c3debd",
    "text": "that Thus, there is insufficient information regarding their comparative clinicians offer either psychotherapy or second-generation antidepres- effectiveness to a greater number of therapeutic approaches. sants and use a shared decision-making approach to consider options. Comparative effectiveness studies indicated similar effects across differ- Addressing diverse child adolescent populations. Interestingly, ent models of psychotherapy. Thus, the panel does not make a recom- IPT-A has an evidence base focused on a more racially diverse mendation for a specific therapy for initial treatment among the following (African American and Latino) sample of youth than CBT (Zhou et models, presented in alphabetical order: behavioral therapy, cognitive al., 2015). However, studies of each of these"
  },
  {
    "id": 300,
    "source": "guideline_c3debd",
    "text": "the following (African American and Latino) sample of youth than CBT (Zhou et models, presented in alphabetical order: behavioral therapy, cognitive al., 2015). However, studies of each of these therapies contain areas and cognitive-behavioral therapy, interpersonal psychotherapy, psycho- of insufficient data and information to allow the panel to judge them dynamic therapy, and supportive therapy. If considering combined treat- in more depth or to make more nuanced recommendations. ment, the panel recommends cognitive-behavioral therapy or Specifically, most of the studies on IPT-A did not include information interpersonal psychotherapy plus a second-generation antidepressant. on long-term outcomes of treated participants. Moreover, for many Note that there are some differences in how the"
  },
  {
    "id": 301,
    "source": "guideline_c3debd",
    "text": "information interpersonal psychotherapy plus a second-generation antidepressant. on long-term outcomes of treated participants. Moreover, for many Note that there are some differences in how the panel chose to structure of the studies of CBT reviewed by the panel, the CBT condition was recommendations for children adolescents versus those for adults compared with a waitlist condition rather than other active treat- because there was insufficient evidence for treatments other than CBT ments. Thus, the effect sizes of the outcomes in the CBT arm might and IPT-A in the adolescent literature, while evidence of no difference be overstated given evidence that waitlist control conditions show between multiple treatments in the adult literature. The panel chose to greater effect sizes in favor of"
  },
  {
    "id": 302,
    "source": "guideline_c3debd",
    "text": "evidence of no difference be overstated given evidence that waitlist control conditions show between multiple treatments in the adult literature. The panel chose to greater effect sizes in favor of the active treatment than no treatment emphasize comparative effectiveness data in the adult literature. or usual treatment comparisons (Steinert, Stadter, Stark,   Beyond these recommendations the panel conditionally sug- Leichsenring, 2017). Despite these concerns, IPT-A and CBT still gests several treatments based on particular nuanced situations present the best evidence that the field has to date on positive out- (i.e., for an individual with depression who is also experiencing rela- comes for the treatment of depression in youth. tionship distress; please refer to Table 3 for details"
  },
  {
    "id": 303,
    "source": "guideline_c3debd",
    "text": "to date on positive out- (i.e., for an individual with depression who is also experiencing rela- comes for the treatment of depression in youth. tionship distress; please refer to Table 3 for details based on specific situations) and notes several treatments for which there is insuf- Efficacy of child adolescent psychopharmacological interventions. ficient evidence to be able to make a recommendation. Regarding The panel also reviewed the evidence for psychopharmacologic inter- complementary and alternative treatments, the panel gave no higher ventions for depression in children and adolescents. In this regard, than a conditional recommendation for use. Specifically, the panel while the panel found a review that met AMSTAR criteria (Cipriani et suggested starting with exercise and St."
  },
  {
    "id": 304,
    "source": "guideline_c3debd",
    "text": "In this regard, than a conditional recommendation for use. Specifically, the panel while the panel found a review that met AMSTAR criteria (Cipriani et suggested starting with exercise and St. John s Wort and then sug- al., 2016), many other reviews did not. The review included studies of gested several alternatives if these were not available or acceptable. medications that are not currently widely used in the treatment of The panel also noted a variety of complementary and alternative youth depression due to safety concerns. So, while there is clear evi- treatments for which the evidence is insufficient to be able to make dence from multiple randomized controlled trials for the use of fluox- a recommendation. However, the panel urges caution when using etine (Prozac) in children and"
  },
  {
    "id": 305,
    "source": "guideline_c3debd",
    "text": "is insufficient to be able to make dence from multiple randomized controlled trials for the use of fluox- a recommendation. However, the panel urges caution when using etine (Prozac) in children and adolescents, there is limited evidence over-the-counter agents to prevent unintended drug-drug interac- meeting the IOM or AMSTAR criteria for other antidepressants, tions particularly given variable manufacturing practices. 38 APA   Guideline for the Treatment of Depression Partial- or non-responders to initial antidepressant treatment and Richardson, McCarty, Radovic,   Suleiman, 2017). However, the relapse prevention. The panel then considered partial or non-re- current review did not address this or other considerations of treat- sponders to initial antidepressant treatment and recommended"
  },
  {
    "id": 306,
    "source": "guideline_c3debd",
    "text": "the relapse prevention. The panel then considered partial or non-re- current review did not address this or other considerations of treat- sponders to initial antidepressant treatment and recommended that ment delivery. these individuals switch from antidepressant medication alone to The panel found insufficient evidence about the effec- cognitive therapy alone or switch from antidepressant medication tiveness of psychotherapies in specific target groups, such as alone to another antidepressant medication. The panel then made no students, and people with general medical conditions, such as higher than a conditional suggestion and noted several instances in diabetes, heart disease, and cancer. There was also very limit- which there was insufficient information to make a recommendation ed"
  },
  {
    "id": 307,
    "source": "guideline_c3debd",
    "text": "than a conditional suggestion and noted several instances in diabetes, heart disease, and cancer. There was also very limit- which there was insufficient information to make a recommendation ed data on which to determine whether treatment format (e.g., for nuanced situations with this population. Finally, the panel consid- individual, group, phone-based, computer delivered, bibliothera- ered relapse prevention and made a conditional suggestion that cli- py, etc.) influenced efficacy. What little evidence was available nicians offer psychotherapy rather than antidepressant medication regarding format was primarily for CBT and did not find differenc- or treatment as usual to prevent relapse. es. However, the limitations of the literature reflect the need for Overall, the effect sizes of"
  },
  {
    "id": 308,
    "source": "guideline_c3debd",
    "text": "format was primarily for CBT and did not find differenc- or treatment as usual to prevent relapse. es. However, the limitations of the literature reflect the need for Overall, the effect sizes of these therapies are comparable and more research comparing modalities. direct comparisons among therapies do not indicate major differ- Overall, treatments for depression have a modest impact on ences between the therapies. There were many instances in which alleviating symptoms of depression (with numbers-needed-to- the panel determined there was insufficient evidence to be able to treat of about six to eight [meaning about six to eight need to be determine whether there was a difference in effect between two treated for each one that is successfully treated]). This reflects potential treatment"
  },
  {
    "id": 309,
    "source": "guideline_c3debd",
    "text": "to eight [meaning about six to eight need to be determine whether there was a difference in effect between two treated for each one that is successfully treated]). This reflects potential treatment options. The panel encourages shared deci- both the high rate of spontaneous recovery, placebo effects of sion-making with the patient. treatment, and the modest effect of treatment (either psychother- apy or pharmacotherapy). It should also be noted that there is an Subgroup effects. Unfortunately, there are no clear indications important group of patients who do not recover, neither through regarding which patient with which characteristics will benefit from spontaneous recovery nor treatments. which treatment, although there has been some recent work devel- oping algorithms that are"
  },
  {
    "id": 310,
    "source": "guideline_c3debd",
    "text": "regarding which patient with which characteristics will benefit from spontaneous recovery nor treatments. which treatment, although there has been some recent work devel- oping algorithms that are promising (Cohen   DeRubeis, 2018; Enduring effects of treatment. Overall psychotherapies seem to DeRubeis et al., 2014). It is therefore up to the therapist to discuss have longer term effects that can be seen 6 to 12 months after treat- with each patient which treatment he or she prefers, with consider- ment ends, while the relapse rates after discontinuation of antide- ation of expected outcomes, side effects, possible negative effects, pressants are very high, and direct comparisons between costs, and time investment of patients. The majority of patients psychotherapies and antidepressants"
  },
  {
    "id": 311,
    "source": "guideline_c3debd",
    "text": "side effects, possible negative effects, pressants are very high, and direct comparisons between costs, and time investment of patients. The majority of patients psychotherapies and antidepressants suggest that the effects of prefer psychotherapy over pharmacotherapy (McHugh, Whitton, psychotherapies may be better in the longer term (Cuijpers et al., Peckham, Welge,   Otto, 2013), although an important minority 2013; Karyotaki, Smit, de Beurs, et al., 2016; Karyotaki, Smit, (about 25 ) prefer pharmacotherapy. Patient preferences for spe- Henningsen, et al., 2016). There is clear evidence that CBT has an cific psychotherapies were not available in the reviewed systematic enduring effect, and other types of psychotherapies may as well, that reviews meta-analyses. is not found for"
  },
  {
    "id": 312,
    "source": "guideline_c3debd",
    "text": "that CBT has an cific psychotherapies were not available in the reviewed systematic enduring effect, and other types of psychotherapies may as well, that reviews meta-analyses. is not found for antidepressant medications (Cuijpers, 2013). The In addition, combined treatments of psychotherapy and phar- enduring effect is large (odds ratio greater than two), and it is robust macotherapy are more effective than either of the treatments (six out of eight studies reviewed by Cuijpers with a seventh just alone in some subpopulations, but the costs, risk of side effects, under two) and it is at least as large in magnitude as keeping patients and demands on patients are greater. In addition, some research on continuation antidepressant medication. Behavioral activation suggests combined treatment"
  },
  {
    "id": 313,
    "source": "guideline_c3debd",
    "text": "as large in magnitude as keeping patients and demands on patients are greater. In addition, some research on continuation antidepressant medication. Behavioral activation suggests combined treatment may interfere with enduring effects also showed a similar effect in the one study in which it was tested for psychotherapy (Hollon et al., 2014). As such it is up to the pro- (Dobson et al., 2008) and long-term dynamic psychotherapy relative vider and patient to decide whether a combined treatment is pref- to treatment as usual (which could include antidepressant medica- erable. For patients with chronic and treatment-resistant depres- tion) may have a similar effect as well (Fonagy, 2015). Further, the sion, combined treatment is usually recommended (Cuijpers et al., possibility remains that"
  },
  {
    "id": 314,
    "source": "guideline_c3debd",
    "text": "chronic and treatment-resistant depres- tion) may have a similar effect as well (Fonagy, 2015). Further, the sion, combined treatment is usually recommended (Cuijpers et al., possibility remains that any psychosocial intervention that teaches 2010; Jobst et al., 2016). skills or changes underlying diatheses will have an enduring effect that would not be expected for antidepressant. The possibility of Delivery of treatments. Although the recommendations focus on enduring effects of different treatments is a topic that may be dis- types of interventions, the way in which treatments are delivered is cussed between clinicians and patients as part of shared deci- also important. However, the current review provided limited infor- sion-making about treatment. mation in this area. For example,"
  },
  {
    "id": 315,
    "source": "guideline_c3debd",
    "text": "is cussed between clinicians and patients as part of shared deci- also important. However, the current review provided limited infor- sion-making about treatment. mation in this area. For example, collaborative care approaches have been well established, and a considerable number of trials have shown that collaborative care is an evidence-based and well-estab- Older Adults lished system for delivering treatments of depression. The collabora- tive care model for depression involves depression care managers The panel s recommendations and suggestions for CBT, prob- with special training in evidence-based interventions and regular lem-solving therapy, and life-review therapy rather than no treatment mental health specialty consultation and can provide efficacious care or treatment as usual"
  },
  {
    "id": 316,
    "source": "guideline_c3debd",
    "text": "interventions and regular lem-solving therapy, and life-review therapy rather than no treatment mental health specialty consultation and can provide efficacious care or treatment as usual are largely consistent with other reviews of for primary care patients across the life span adolescents, young, older adult depression treatment research (Cuijpers, Karyotaki, Pot, middle-aged, and older adults (IMPACT; Un tzer et al., 2002; et al., 2014a; Wilkinson   Izmeth, 2012). These treatments included APA   Guideline for the Treatment of Depression 39 modifications that made them more appropriate for use with older not indicated for subsyndromal depressive symptom cases and adults, as noted in the APA (2014) Guidelines for Psychological Practice thus there is a particular need for psychological"
  },
  {
    "id": 317,
    "source": "guideline_c3debd",
    "text": "use with older not indicated for subsyndromal depressive symptom cases and adults, as noted in the APA (2014) Guidelines for Psychological Practice thus there is a particular need for psychological treatments and with Older Adults. When considering initial treatment of major CBT, problem-solving therapy, life-review and possibly other inter- depressive disorder in older adults, the panel recommends either ventions can be recommended. It is also worth noting that older group life-review treatment or group CBT (either alone or added to adults and younger adults appear to demonstrate similar improve- usual care) over no treatment or combined pharmacotherapy and ments in response to psychotherapy (Cuijpers et al, 2009). interpersonal psychotherapy over interpersonal psychotherapy alone. If"
  },
  {
    "id": 318,
    "source": "guideline_c3debd",
    "text": "usual care) over no treatment or combined pharmacotherapy and ments in response to psychotherapy (Cuijpers et al, 2009). interpersonal psychotherapy over interpersonal psychotherapy alone. If these options are not available or acceptable the panel then Older adults  treatment preference and treatment considerations. conditionally suggests particular treatments based on nuanced situ- Because older adults often express a preference for psychological ations and also notes situations in which the evidence is insufficient treatments and provision of such service in primary healthcare set- to be able to make a recommendation. tings, it is important that efforts to integrate the two continue. For subthreshold minor depression the panel conditionally However, specialists in delivering late-life"
  },
  {
    "id": 319,
    "source": "guideline_c3debd",
    "text": "to make a recommendation. tings, it is important that efforts to integrate the two continue. For subthreshold minor depression the panel conditionally However, specialists in delivering late-life depression treatment, suggests CBT, life-review treatment, and problem-solving ther- particularly in the fields of psychology, psychiatry, and social work, apy and notes situations in which there is not sufficient evidence are scarce and thus create a conundrum for delivering efficacious to make a recommendation. For situations in which there is major interventions identified by this panel. Integrated care is one such depressive disorder or minor depression and cognitive impairment, model that may address the underuse of depression treatment ser- the panel suggests problem-solving therapy but"
  },
  {
    "id": 320,
    "source": "guideline_c3debd",
    "text": "care is one such depressive disorder or minor depression and cognitive impairment, model that may address the underuse of depression treatment ser- the panel suggests problem-solving therapy but notes insufficient vices by older adults (Bruce et al., 2004; Un tzer et al., 2002). In evidence to make a recommendation about the combination of addition, given that older adults are more likely to have other health behavioral activation and treatment as usual. conditions, psychotherapy remains a preferred treatment as medica- For persistent depressive disorder, the panel conditionally sug- tions have potential for adverse interactions with other medications. gests problem-solving therapy (individual) or paroxetine though Integrated care can help address both mental and physical health notes"
  },
  {
    "id": 321,
    "source": "guideline_c3debd",
    "text": "have potential for adverse interactions with other medications. gests problem-solving therapy (individual) or paroxetine though Integrated care can help address both mental and physical health notes that some argue that paroxetine is contraindicated in older problems and ensure more seamless treatment (Reiter, Dobmeyer,   adults due to its anticholinergic side effects (see the American Hunter, 2018). Finally, regarding the medication recommendations it Geriatrics Society 2015 Beers Criteria) and many geriatric psychi- should be noted that while nortriptyline was used in the past due to atrists would prefer another SSRI (i.e., escitalopram or sertraline). its efficacy and safety, practices have changed significantly, and When an older adult presents with both major depressive disorder"
  },
  {
    "id": 322,
    "source": "guideline_c3debd",
    "text": "would prefer another SSRI (i.e., escitalopram or sertraline). its efficacy and safety, practices have changed significantly, and When an older adult presents with both major depressive disorder nortriptyline is now viewed as a second- or third-line pharmacother- and medical or other complications, the panel makes several condi- apy strategy for major depression. It is generally reserved for patients tional suggestions based on the particular nuanced situation. who have not done well with a selective serotonin reuptake inhibitor or a serotonin-norepinephrine reuptake inhibitor, which are generally Relapse prevention in older adults. Finally, for prevention of recur- considered to be safer for older adults than nortriptyline. Moreover, rence the panel recommends combination interpersonal"
  },
  {
    "id": 323,
    "source": "guideline_c3debd",
    "text": "Relapse prevention in older adults. Finally, for prevention of recur- considered to be safer for older adults than nortriptyline. Moreover, rence the panel recommends combination interpersonal psychother- some argue that paroxetine is contraindicated in older adults due to apy and pharmacotherapy or combination supportive care and its anticholinergic side effects (see American Geriatrics Society 2015 pharmacotherapy. If those options are not available, the panel con- Beers List) and many geriatric psychiatrists would prefer another ditionally suggests interpersonal psychotherapy for prevention of SSRI (i.e., escitalopram or sertraline). There is some efficacy data recurrence. The panel notes that the evidence is insufficient to be from systematic reviews meta-analyses showing efficacy of"
  },
  {
    "id": 324,
    "source": "guideline_c3debd",
    "text": "of SSRI (i.e., escitalopram or sertraline). There is some efficacy data recurrence. The panel notes that the evidence is insufficient to be from systematic reviews meta-analyses showing efficacy of sec- able to recommend between cognitive-behavioral therapy (group) ond-generation antidepressants over placebo (i.e., see Nelson, plus pharmacotherapy and pharmacotherapy alone for preventing Delucchi,   Schneider, 2008). The panel encourages shared deci- recurrence. sion-making between patients and clinicians (see the following for additional resources: Cipriani et al., 2009; Fournier et al., 2010;   Relation to other literature. In another effort, Scogin and colleagues Nelson, Delucchi,   Schneider, 2013). (2005), using Society of Clinical Psychology criteria (a less rigorous criteria than"
  },
  {
    "id": 325,
    "source": "guideline_c3debd",
    "text": "Relation to other literature. In another effort, Scogin and colleagues Nelson, Delucchi,   Schneider, 2013). (2005), using Society of Clinical Psychology criteria (a less rigorous criteria than that of the IOM for guideline development), also found CBT, problem-solving therapy, and life-review to be beneficial but in addition found behavior therapy, brief psychodynamic therapy, and cognitive bibliotherapy to be evidence-based therapies. Studies of these latter interventions did not meet criteria for inclusion in current systematic reviews due to lack of some methodological features to reduce bias and improve the quality (typical of studies of psycholog- ical treatments conducted prior to 2000). Similarly, interpersonal psychotherapy has been identified by some as an effective treatment"
  },
  {
    "id": 326,
    "source": "guideline_c3debd",
    "text": "bias and improve the quality (typical of studies of psycholog- ical treatments conducted prior to 2000). Similarly, interpersonal psychotherapy has been identified by some as an effective treatment for older adults (Hinrichsen, 2009). The panel s recommendations and suggestions that psycho- logical treatments be provided across the severity spectrum (i.e., major depressive disorder, subthreshold) is important because subsyndromal or minor depressive symptom presentations are fre- quently occurring among older adults. Pharmacotherapy is usually 40 APA   Guideline for the Treatment of Depression CONSIDERATIONS FOR TREATMENT IMPLEMENTATION Importance of Informed Consent The panel encourages all clinicians to provide informed consent to patients. According to the American Psychological"
  },
  {
    "id": 327,
    "source": "guideline_c3debd",
    "text": "CONSIDERATIONS FOR TREATMENT IMPLEMENTATION Importance of Informed Consent The panel encourages all clinicians to provide informed consent to patients. According to the American Psychological Association s Ethical Principles of Psychologists and Code of Conduct (2017a), psychologists should obtain an informed consent from the patient prior to imple- menting psychological services. An informed consent is where psychologists (or other psy- chotherapy clinician)  inform clients patients as early as is feasible in the therapeutic relationship about the nature and anticipated course of therapy, fees, involvement of third parties, and limits of confidentiality and provide sufficient opportunity for the client patient to ask questions and receive answers  (APA, 2017a, p. 14). The informed"
  },
  {
    "id": 328,
    "source": "guideline_c3debd",
    "text": "fees, involvement of third parties, and limits of confidentiality and provide sufficient opportunity for the client patient to ask questions and receive answers  (APA, 2017a, p. 14). The informed consent process is not only evident in psychotherapy but in other med- ical fields as well and it ensures that the patients  rights are respected throughout treat- ment. For example, the American Medical Association s Code of Ethics also mandates that physicians provide informed consent to patients (American Medical Association, 2016). After assessing for the patient s ability to make decisions this code notes that informed consent should include information about any known diagnosis; why particular interven- tions are recommended and what is involved in these interventions; and benefits, harms,"
  },
  {
    "id": 329,
    "source": "guideline_c3debd",
    "text": "code notes that informed consent should include information about any known diagnosis; why particular interven- tions are recommended and what is involved in these interventions; and benefits, harms, and burdens of possible interventions including those for choosing to receive no treatment (American Medical Association, 2016). The informed consent process allows the patient to make an informed decision of whether to initiate or continue treatment, and it also sat- isfies the General Principles of Beneficence and Nonmaleficence common across ethics codes in which clinicians  take care to do no harm  (American Psychological Association, 2017a, p. 3). When working with children and adolescents, the provider should convey this same information to the parent guardian who must provide consent"
  },
  {
    "id": 330,
    "source": "guideline_c3debd",
    "text": "harm  (American Psychological Association, 2017a, p. 3). When working with children and adolescents, the provider should convey this same information to the parent guardian who must provide consent for treatment along with conveying this information to adolescents who must assent to treatment. For children, it also would be helpful to convey some of the information regarding interventions to be provided and the rationale in an age-appropriate manner (American Academy of Child and Adolescent Psychiatry, 2017). Incorporation of research not included in the current guidelines. The panel recognizes that there is literature that is relevant to decision-making about treatments that has not been incorporated in this guideline. In considering implementation of an intervention that is not reviewed"
  },
  {
    "id": 331,
    "source": "guideline_c3debd",
    "text": "that there is literature that is relevant to decision-making about treatments that has not been incorporated in this guideline. In considering implementation of an intervention that is not reviewed in the guideline, the panel encourages readers to consider number and quality of studies available. Interventions with both well-controlled studies of efficacy and comparative effectiveness relative to other effective treatments should be prioritized. APA   Guideline for the Treatment of Depression 41 Improving Access While Supporting Patient providers to address the difficulties patients face. The panel iden- tified many such barriers to adequate treatment, some of which Culture, Values, and Preferences were observable in the research literature (when the literature adequately reported"
  },
  {
    "id": 332,
    "source": "guideline_c3debd",
    "text": "The panel iden- tified many such barriers to adequate treatment, some of which Culture, Values, and Preferences were observable in the research literature (when the literature adequately reported information on harms, burdens, and attrition), Panel (including community and clinician members) discussions and some of which were apparent in feedback from individuals with regarding patient preferences, culture, and values highlighted the chal- lived experience. These barriers generally fell into two categories: lenges patients face in finding adequate mental health treatment and structural barriers (i.e., all related financial costs, affordable trans- particularly access to evidence-based interventions. Consequently, portation, clinic hours and locations, and childcare) and attitudinal the"
  },
  {
    "id": 333,
    "source": "guideline_c3debd",
    "text": "(i.e., all related financial costs, affordable trans- particularly access to evidence-based interventions. Consequently, portation, clinic hours and locations, and childcare) and attitudinal the panel encourages clinicians to strive to address potential barriers barriers (i.e., experiences of racial, ethnic, and cultural bias) for the to treatment with the patient. Moreover, clinicians are encouraged to purpose of discussion (Sareen et al., 2007). The panel identified engage in shared decision-making with the patient to ensure that the practical examples, listed in the table below. patient s needs and wants are taken into consideration. In the search for treatment options, it is important for TABLE 6 Patients  Values and Preferences Types of Barriers Examples of Barriers to Continued Care"
  },
  {
    "id": 334,
    "source": "guideline_c3debd",
    "text": "and wants are taken into consideration. In the search for treatment options, it is important for TABLE 6 Patients  Values and Preferences Types of Barriers Examples of Barriers to Continued Care Structural Awareness of resources  I don t know what to do.  Financial needs  My insurance won t cover it, and it s too expensive to pay out of pocket.  Time needs  I can t make it to the session in between my jobs.  Transportation needs  The Metro doesn t run that far out of the city.  Treatment availability  I was told to look for interpersonal therapy, but the closest person is 2 hours away.   You can t be seen for 45 days if it s not an emergency.  Treatment compatibility  He s Christian, and I m an atheist.  Treatment harms  It gave me chronic headaches.  Attitudinal Perceived need  I ll"
  },
  {
    "id": 335,
    "source": "guideline_c3debd",
    "text": "You can t be seen for 45 days if it s not an emergency.  Treatment compatibility  He s Christian, and I m an atheist.  Treatment harms  It gave me chronic headaches.  Attitudinal Perceived need  I ll solve it myself.   I m not sick enough to need help.  Treatment alienation   dissatisfaction  That therapist was horrible. He just wanted to prescribe me medications.  Negative associations  What if I m hospitalized against my will?  Stigma  What if they find out and I m fired from my job?   I don t want people to think I m crazy!  42 APA   Guideline for the Treatment of Depression Through this framework, the panel asserted that clinicians therapeutic benefit for a patient if the provider elicits a negative seeking to optimize the patient s therapeutic journey are faced with association or if"
  },
  {
    "id": 336,
    "source": "guideline_c3debd",
    "text": "the panel asserted that clinicians therapeutic benefit for a patient if the provider elicits a negative seeking to optimize the patient s therapeutic journey are faced with association or if the patient cannot adhere to treatment due to a distinct challenge to meet the patient  where s he stands.  The financial or other barriers. In the current context where data do not clinician might best help the patient navigate around such barriers generally provide support for one treatment over another, support- while using empirically guided judgment by personalizing treat- ing patients in educational and decision-making capacities may ment approaches, prioritizing shared decision-making, communi- increase engagement and overall success of treatment. cating openly and directly (when appropriate),"
  },
  {
    "id": 337,
    "source": "guideline_c3debd",
    "text": "and decision-making capacities may ment approaches, prioritizing shared decision-making, communi- increase engagement and overall success of treatment. cating openly and directly (when appropriate), utilizing technolo- gies that improve accessibility (when viable), making a concerted effort to accept more insurance options or provide sliding-scale fee Adapting Treatment to Fit the Individual structures, and ultimately by creating a nurturing and strong thera- peutic alliance and treatment engagement. One hallmark of a scientifically sound outcome study is the ability to For the patient that successfully navigates the barriers and document that individuals providing a particular treatment, espe- begins treatment, many factors hold significant influence over the cially with psychotherapy,"
  },
  {
    "id": 338,
    "source": "guideline_c3debd",
    "text": "successfully navigates the barriers and document that individuals providing a particular treatment, espe- begins treatment, many factors hold significant influence over the cially with psychotherapy, competently adhered to a treatment pro- relevance and compatibility of the treatment with his or her needs, tocol. This refers to the notion of treatment fidelity or integrity. culture, values, and beliefs. These factors include demographic Including protocols to evaluate treatment fidelity within a given characteristics, SES, preferences, values, personality traits, con- clinical trial makes it easier to assess whether the treatment under versational styles, treatment history, trauma history, coping mech- evaluation was actually delivered in the manner intended and pre- anisms, support"
  },
  {
    "id": 339,
    "source": "guideline_c3debd",
    "text": "it easier to assess whether the treatment under versational styles, treatment history, trauma history, coping mech- evaluation was actually delivered in the manner intended and pre- anisms, support networks, life circumstances, and resource avail- scribed (Nezu   Nezu, 2008). However, within  real-world  con- ability (time, money, and energy), as well as the real and perceived texts, it is likely that various exigencies arise such that complete commonalities and differences between patient and provider. adherence to a treatment protocol becomes difficult. Once again, Ultimately, each of these factors along with the intended or treatment providers must rely on their sound clinical judgment to unintended effects of the intervention a clinician provides can play know when to  deviate  from"
  },
  {
    "id": 340,
    "source": "guideline_c3debd",
    "text": "factors along with the intended or treatment providers must rely on their sound clinical judgment to unintended effects of the intervention a clinician provides can play know when to  deviate  from the protocol or cease a given treatment a significant role, dramatically influencing the patient s progress. if it is not  working.  Depending on the individual, any one factor may  tip the scale,  helping or hurting a patient s resolve. In effect, any one of these Applicability of results and clinical significance. The present clini- factors can result in treatment adherence or nonadherence and cal practice guideline was developed to provide advice and guid- thus in the success or failure of the individual s recovery. When the ance to various stakeholders (e.g., practitioners, patients) based"
  },
  {
    "id": 341,
    "source": "guideline_c3debd",
    "text": "practice guideline was developed to provide advice and guid- thus in the success or failure of the individual s recovery. When the ance to various stakeholders (e.g., practitioners, patients) based on individual fails to recover, chronic illness, treatment recidivism, and valid scientific evidence obtained within recent years. Whereas burdening of the crisis intervention systems can result. scrutiny of the extant scientific literature to inform such guidelines When considering treatment compatibility, clinicians could is critical and considered to be the  gold standard  methodology, benefit their patients by recognizing these many complex fac- the applicability of even an exhaustive and comprehensive review tors, while using empirically guided judgment and remembering and its subsequent"
  },
  {
    "id": 342,
    "source": "guideline_c3debd",
    "text": "their patients by recognizing these many complex fac- the applicability of even an exhaustive and comprehensive review tors, while using empirically guided judgment and remembering and its subsequent conclusions is also dependent on various con- that seeking treatment is itself a large hurdle for the majority of textual factors as noted. As such, when reading the recommenda- individuals. The challenge to find adequate care, acceptance of tions, the reader should also consider the ability to generalize from diversity, cultural competence, then compounded by the difficulty aggregate data to the individual. and exhaustion of the cognitive, behavioral, and emotional work of therapy, strongly necessitates the need for a beneficial therapeutic Ability to generalize from aggregate data to the"
  },
  {
    "id": 343,
    "source": "guideline_c3debd",
    "text": "individual. and exhaustion of the cognitive, behavioral, and emotional work of therapy, strongly necessitates the need for a beneficial therapeutic Ability to generalize from aggregate data to the individual. All alliance and treatment engagement. research data that were included as evidence (or lack) of the efficacy Further, it also means that a disconnect between patient and of a given approach to treat depression is based on group data. In fact, provider (e.g., any discord between the patient s ideal clinician a hallmark of sound outcome research involves including a sufficient and the clinician received, or ideal services and the services ren- number of participants in the study such that meaningful statistical dered [i.e., lapses in communication, discrepancies in treatment analyses"
  },
  {
    "id": 344,
    "source": "guideline_c3debd",
    "text": "received, or ideal services and the services ren- number of participants in the study such that meaningful statistical dered [i.e., lapses in communication, discrepancies in treatment analyses can be conducted. This is referred to as power, or the ability goals, momentary discomfort or perceptions of  awkwardness  of a given study to validly detect a result that truly exists in nature. for the patient]) can disrupt the therapeutic alliance (i.e., alliance However, such results can only provide general types of information. rupture; Muran   Barber, 2010) and the individual s commitment The more that the sample population of a given investigation deviates to treatment. Stated simply, clinically evidenced best practices from various characteristics of a given patient, the more informed are"
  },
  {
    "id": 345,
    "source": "guideline_c3debd",
    "text": "that the sample population of a given investigation deviates to treatment. Stated simply, clinically evidenced best practices from various characteristics of a given patient, the more informed are not universally synonymous with the patient s personal idea clinical judgment is necessary to validly identify a particular treat- of treatment success, and as such, any minute incongruities can ment approach for that individual. For example, if a given set of be the final straw that results in treatment dropout. This dropout studies that support the efficacy of a given approach included pri- has the potential for life-long negative associations and treatment marily White males as subjects between the ages of 25 to 50 years, alienation. it becomes less scientifically rigorous to suggest that"
  },
  {
    "id": 346,
    "source": "guideline_c3debd",
    "text": "the potential for life-long negative associations and treatment marily White males as subjects between the ages of 25 to 50 years, alienation. it becomes less scientifically rigorous to suggest that this same The community members and clinicians on the panel empha- intervention would automatically be effective for others who are sized the importance of personalizing each individual s care in depressed but are outside of the pool of these specific subject demo- accordance with his or her specific needs, within the context of graphics. While some of the studies included in the reviews were empirically guided judgment. Even the most efficacious, best evi- relatively homogenous, patients in other studies had greater demo- dence-based treatments for particular diagnoses may have no graphic"
  },
  {
    "id": 347,
    "source": "guideline_c3debd",
    "text": "guided judgment. Even the most efficacious, best evi- relatively homogenous, patients in other studies had greater demo- dence-based treatments for particular diagnoses may have no graphic diversity and comorbidity. Unfortunately, subgroup analyses APA   Guideline for the Treatment of Depression 43 were not available during the current guideline development to draw depression should ask related questions to be assured that the treat- adequate conclusions regarding treatment efficacy for specific sub- ment they believe they will be receiving will be provided in a quality groups, so when implementing these guideline recommendations, fashion. This care would ideally be provided by a qualified mental clinicians will especially need to consider their individual patients  health specialist"
  },
  {
    "id": 348,
    "source": "guideline_c3debd",
    "text": "these guideline recommendations, fashion. This care would ideally be provided by a qualified mental clinicians will especially need to consider their individual patients  health specialist though the panel acknowledges that accessibility to backgrounds and needs. these specialists can be a barrier to treatment. Similarly, behavioral health professionals seeking to provide those treatments recom- mended in these guidelines need to receive adequate training and Considering Patients  Diverse Backgrounds, experience in the specific treatment approaches prior to offering such services. Identities, and Comorbidities Ability to generalize from a given setting provider perspective. One aspect of professional competence is cultural and diversity com- Just as prospective recipients of psychotherapy"
  },
  {
    "id": 349,
    "source": "guideline_c3debd",
    "text": "and Comorbidities Ability to generalize from a given setting provider perspective. One aspect of professional competence is cultural and diversity com- Just as prospective recipients of psychotherapy should consider the petence. The American Psychological Association s (2017b) above issues, so should treatment providers (including administra- Multicultural Guidelines: An Ecological Approach to Context, Identity, tors) consider similar issues. For example, the efficacy of a given and Intersectionality encourage the provision of multiculturally com- approach as found in a research study may only reflect its efficacy petent services. Broadly, this multicultural competence includes based on the specific treatment circumstances. For example, circum-  appreciation for, understanding of, and"
  },
  {
    "id": 350,
    "source": "guideline_c3debd",
    "text": "only reflect its efficacy petent services. Broadly, this multicultural competence includes based on the specific treatment circumstances. For example, circum-  appreciation for, understanding of, and willingness to learn about the stances might include a treatment being delivered in an outpatient multicultural backgrounds of individuals, families, couples, groups, rather than an inpatient setting or whether there were any additional research participants, organizations, and communities  (American resources made available to study participants that are unavailable Psychological Association, 2017b, pp. 7-8). Multicultural refers to a to patient s in the provider s treatment setting (e.g., monetary incen- range of factors including culture, immigration status, race, language, tive to"
  },
  {
    "id": 351,
    "source": "guideline_c3debd",
    "text": "2017b, pp. 7-8). Multicultural refers to a to patient s in the provider s treatment setting (e.g., monetary incen- range of factors including culture, immigration status, race, language, tive to minimize attrition, providing treatments for free). Such cir- ethnicity, race, gender identity, sexual orientation, ability status, reli- cumstances may limit the generalizability of treatment efficacy to gion, socioeconomic status, employment, education, spirituality, and real-world contexts. others (APA, 2002; as cited in APA, 2017). Clinicians are also encour- When providers are confronted with implementing treatment aged to refer to the APA s (2015) Guidelines for Psychological Practice in settings that may be atypical from the  standard  outpatient with Transgender and Gender Nonconforming"
  },
  {
    "id": 352,
    "source": "guideline_c3debd",
    "text": "treatment aged to refer to the APA s (2015) Guidelines for Psychological Practice in settings that may be atypical from the  standard  outpatient with Transgender and Gender Nonconforming People and APA s (2012) psychotherapy or pharmacotherapy structure often included in Guidelines for Psychological Practice with Lesbian, Gay, and Bisexual research studies, an option for individualizing the treatment might Clients, as this population experiences increased mental health con- include an emphasis on a collaborative model where patients cerns. Providers are encouraged to provide multiculturally competent become more active participants in the treatment process. For services in the context of the current depression guideline recom- example, certain general medical settings have adopted a"
  },
  {
    "id": 353,
    "source": "guideline_c3debd",
    "text": "competent become more active participants in the treatment process. For services in the context of the current depression guideline recom- example, certain general medical settings have adopted a collabo- mendations. rative care model whereby patients are provided an initial choice of psychotherapy or pharmacotherapy and depending on one s prog- Existence of a behavioral health or medical disorder comorbidity. ress, predetermined algorithms help to determine further treat- As noted earlier, depression is frequently found to be comorbid with ment choices (e.g., Un tzer et al., 2002; depression with comor- other mental health problems (e.g., anxiety, posttraumatic stress bid medical disease Katon et al., 2010). Such protocols require disorder), as well as in combination with various medical"
  },
  {
    "id": 354,
    "source": "guideline_c3debd",
    "text": "with comor- other mental health problems (e.g., anxiety, posttraumatic stress bid medical disease Katon et al., 2010). Such protocols require disorder), as well as in combination with various medical problems involvement of various health care specialists to work together to (e.g., heart disease, cancer, stroke). Comorbidity was not directly improve a patient s depression and overall heath quality of life and reviewed and is not reflected in the recommendations. However, require additional resources beyond typical outpatient services. given the ubiquity of comorbidity, all stakeholders need to take this Altogether, administrators and therapists need to consider the rel- limitation into consideration when reviewing the present guideline evance of the literature to their specific treatment"
  },
  {
    "id": 355,
    "source": "guideline_c3debd",
    "text": "take this Altogether, administrators and therapists need to consider the rel- limitation into consideration when reviewing the present guideline evance of the literature to their specific treatment setting context, recommendations. options for addressing such gaps in literature when making treat- ment choices, and the applicability of the collaborative care model for their specific treatment setting or context. Generalizability of Treatments to Different Settings and Providers Monitoring Engagement with Treatment Ability to generalize from a given setting patient perspective. An aspect of professional competence involves the ability to accurately In a related manner, in order to better assess whether a treatment generalize to a given setting and set of circumstances. Scientifically works"
  },
  {
    "id": 356,
    "source": "guideline_c3debd",
    "text": "competence involves the ability to accurately In a related manner, in order to better assess whether a treatment generalize to a given setting and set of circumstances. Scientifically works involves determining the recipient s (i.e., patient s) actual sound research studies generally require that providers are experi- comprehension or application of any suggestions or directions  pre- enced and trained in the given approach under evaluation. This may scribed  by the therapist. From a pharmacotherapy perspective, this differ from typical usual care depending on the setting or place that involves identifying whether the patient followed directions regard- a treatment is provided. Patients seeking a particular treatment may ing medication (e.g., taking the prescribed pills at the appropriate"
  },
  {
    "id": 357,
    "source": "guideline_c3debd",
    "text": "identifying whether the patient followed directions regard- a treatment is provided. Patients seeking a particular treatment may ing medication (e.g., taking the prescribed pills at the appropriate wish to ask questions, not only about a given treatment, but the time). In other words, if one is uncertain whether a person actually extent to which those providing the treatment have been well trained. ingested the medication, it becomes difficult to conclude whether Within this context, prospective patients seeking treatment for any improvement (or lack of) in symptoms occurred because of the 44 APA   Guideline for the Treatment of Depression medication. For directive psychotherapy approaches, this might involve evaluating whether the patient completed a homework assignment, practiced a"
  },
  {
    "id": 358,
    "source": "guideline_c3debd",
    "text": "44 APA   Guideline for the Treatment of Depression medication. For directive psychotherapy approaches, this might involve evaluating whether the patient completed a homework assignment, practiced a certain skill, or read a prescribed book. For nondirective approaches, this may be difficult as there may be no instructions or guidance given; however, certain subtle indicators of patient comprehension or application may include a patient s increased curiosity, awareness, or insight into his her experiences. The panel highlights these treatment integrity concerns to under- score their importance regarding the quality of a given research study (Sharpless   Barber, 2009) and implications for recommendations. Contributions from Shared and Specific Factors to Treatment Outcome Future research is"
  },
  {
    "id": 359,
    "source": "guideline_c3debd",
    "text": "regarding the quality of a given research study (Sharpless   Barber, 2009) and implications for recommendations. Contributions from Shared and Specific Factors to Treatment Outcome Future research is needed to address the lack of adequate research examining the effective components of psychotherapy, or studies examining psychotherapeutic process, in the available reviews. This, in part, reflects the IOM s emphasis on quality of research for deter- mination of efficacy of interventions, resulting in a focus on random- ized controlled trials. While there is significant discussion of the relative importance of shared versus model-specific aspects of psy- chotherapy, there is not adequate research examining this question that sufficiently reduces potential risks of bias and other issues in a"
  },
  {
    "id": 360,
    "source": "guideline_c3debd",
    "text": "importance of shared versus model-specific aspects of psy- chotherapy, there is not adequate research examining this question that sufficiently reduces potential risks of bias and other issues in a manner that could inform treatment recommendations. However, there is research suggesting that this may be a promising area for future studies. For example, a study by Cuijpers, Reynolds, et al. (2012b) examined the contributions of nonspecific, extra-therapeu- tic, and specific factors to patients  improvement. Results indicated that nonspecific factors accounted for 49.6  of the improvement, whereas extra-therapeutic factors accounted for 33.3  and specific factors accounted for 17.1  of the improvement (Cuijpers, Reynolds, et al., 2012b). This correlational study suggests an important role"
  },
  {
    "id": 361,
    "source": "guideline_c3debd",
    "text": "extra-therapeutic factors accounted for 33.3  and specific factors accounted for 17.1  of the improvement (Cuijpers, Reynolds, et al., 2012b). This correlational study suggests an important role for nonspecific factors in treatment. The panel strongly recommends that researchers (and funding institutions) support studies that can identify key components for successful treatment of depression across models of psychotherapy and test aspects of therapeutic process that contribute to treatment outcomes. APA   Guideline for the Treatment of Depression 45 ENHANCING THERAPEUTIC ALLIANCE AND OTHER PRINCIPLES PROCESSES OF CHANGE Ideally, depression treatment research needs to provide evidence of efficacy, and also specify the change processes that account for the treatment s effects. Change"
  },
  {
    "id": 362,
    "source": "guideline_c3debd",
    "text": "PRINCIPLES PROCESSES OF CHANGE Ideally, depression treatment research needs to provide evidence of efficacy, and also specify the change processes that account for the treatment s effects. Change processes can be defined in terms of: (1) change principles, which refer to conditions or characteristics (e.g., participant, relationship, and treatment components) that have been shown to predict treat- ment outcome (see APA Presidential Task Force on Evidence-Based Practice, 2006; Castonguay   Beutler, 2006; see also Goldfried, 1980); (2) change mechanisms, which refer to factors that lead to therapeutic change as demonstrated by mediational or related analyses (Kazdin, 2007; Laurenceau, Hayes,   Feldman, 2007; Lorenzo-Luaces, German,   DeRubeis, 2015); and (3) change events, which refer to"
  },
  {
    "id": 363,
    "source": "guideline_c3debd",
    "text": "change as demonstrated by mediational or related analyses (Kazdin, 2007; Laurenceau, Hayes,   Feldman, 2007; Lorenzo-Luaces, German,   DeRubeis, 2015); and (3) change events, which refer to in-session interactions between patients and therapists that are linked to overall treatment outcomes (Greenberg, 1986). It is important to note that this brief discussion of change processes is descriptive and is not based on a systematic review. Rather, the panel is highlighting a few examples of com- monly cited change processes because of the value gained by understanding some of the ways that recommended treatments exert their beneficial effects. The panel is not making any formal recommendations in this section, and this is not a comprehensive list of all the change processes in the treatment of"
  },
  {
    "id": 364,
    "source": "guideline_c3debd",
    "text": "treatments exert their beneficial effects. The panel is not making any formal recommendations in this section, and this is not a comprehensive list of all the change processes in the treatment of depression. 46 APA   Guideline for the Treatment of Depression Change Principles mindfulness, rumination, worry, compassion, or meta-awareness mediated effects of mindfulness-based cognitive therapy for depres- sion. In addition, S. Cohen, O Leary, Foran, and Kliem (2014) report- Castonguay and Beutler (2006) reviewed numerous change princi- ed that among women who received brief couple therapy for depres- ples that have been shown in empirical studies to play a role in the sion, changes in depressive symptoms were mediated by changes treatment of depression (see Beutler, Castonguay,   Follette,"
  },
  {
    "id": 365,
    "source": "guideline_c3debd",
    "text": "ples that have been shown in empirical studies to play a role in the sion, changes in depressive symptoms were mediated by changes treatment of depression (see Beutler, Castonguay,   Follette, 2006, in their own illness-related cognitions and behaviors, and in their for an integration of these findings). Examples include: perceptions of increased positivity and support from their husbands. There is also some evidence that skills learning and practice during Participant. Patient expectations; readiness to change; and attach- homework assignments contribute to better outcomes for cogni- ment, coping, and personality styles (Beutler et al., 2006; see also tive, behavioral, and cognitive-behavioral therapies for depression Bernecker, 2012). (Kazantzis, Whittington,   Dattilio, 2010; Terides"
  },
  {
    "id": 366,
    "source": "guideline_c3debd",
    "text": "coping, and personality styles (Beutler et al., 2006; see also tive, behavioral, and cognitive-behavioral therapies for depression Bernecker, 2012). (Kazantzis, Whittington,   Dattilio, 2010; Terides et al., 2017). Research on change mechanisms in psychodynamic psycho- Technical. Cognitive reappraisals, trying new behaviors, altering therapies (some focused on depression) has provided varying sup- behavioral reinforcements, improving interpersonal and social func- port for the following variables facilitating better outcomes: greater tioning, promoting emotion processing and regulation, and conduct- insight, change in defensive style (more mature), less relationship ing a structured therapy session (Follette   Greenberg, 2006; see rigidity and maladaptive representations, higher object"
  },
  {
    "id": 367,
    "source": "guideline_c3debd",
    "text": "conduct- insight, change in defensive style (more mature), less relationship ing a structured therapy session (Follette   Greenberg, 2006; see rigidity and maladaptive representations, higher object relations, also Auszra, Greenberg,   Hermann, 2013; Missirlian, Toukmanian, greater reflective functioning, and better therapeutic alliances Warwar,   Greenberg, 2005; Pos, Greenberg, Goldman,   Korman, (see Barber, Muran, McCarthy   Keefe, 2013, for a review; see 2003; Whelton, 2004). also Minges, Solomonov,   Barber, 2017; Zilcha-Mano, Chiu, et al., 2016a;   Zilcha-Mano, Muran, et al., 2016b). Research on change Relationship. Research on psychotherapy per se has underscored mechanisms in humanistic-experiential therapies has shown that the association between having a positive therapeutic"
  },
  {
    "id": 368,
    "source": "guideline_c3debd",
    "text": "Research on change Relationship. Research on psychotherapy per se has underscored mechanisms in humanistic-experiential therapies has shown that the association between having a positive therapeutic relationship or emotional processing facilitates better outcomes (Auszra et al., alliance, that is, the means by which a therapist and a patient hope 2013; Pos, Greenberg,   Warwar, 2009; Pos et al., 2003). Finally, to engage with each other, and positive change (Cuijpers, Driessen, changes produced by antidepressant treatments are extreme- et al., 2012a). Norcross (2011) presents a number of meta-analyses ly complex and our understanding of those changes is evolving that examined the effect of elements of the therapeutic relationship (Dell Osso, Palazzo, Oldani,   Altamura, 2011). on"
  },
  {
    "id": 369,
    "source": "guideline_c3debd",
    "text": "of meta-analyses ly complex and our understanding of those changes is evolving that examined the effect of elements of the therapeutic relationship (Dell Osso, Palazzo, Oldani,   Altamura, 2011). on treatment outcome. An interdisciplinary task force concluded that evidence supported a demonstrable effect of the alliance and empathy, the probable effect of consensus and positive regard, and the promis- ing effect of rupture repair and management of the therapist emo- Change Events tional reactions (Norcross   Wampold, 2011). The implication of such consensus is that in addition to a given treatment approach for With regard to research on in-session change events, there have depression, people seeking treatment need to also consider the rela- been several intensive (small-scale,"
  },
  {
    "id": 370,
    "source": "guideline_c3debd",
    "text": "given treatment approach for With regard to research on in-session change events, there have depression, people seeking treatment need to also consider the rela- been several intensive (small-scale, mixed-method) studies in which tionship one has with the potential provider as it has been shown to patient and therapist interactions have been reliably observed, and be correlated with treatment outcome. Similarly, providers should these interaction features are found to be related to treatment out- attempt to offer evidenced-based treatment within the context of a comes for depression (Greenberg, 1986; Greenberg   Newman, positive therapeutic alliance. 1996). Examples include resolving problematic reactions (i.e., the reexperiencing of a problematic situation to better symbolize it in"
  },
  {
    "id": 371,
    "source": "guideline_c3debd",
    "text": "1986; Greenberg   Newman, positive therapeutic alliance. 1996). Examples include resolving problematic reactions (i.e., the reexperiencing of a problematic situation to better symbolize it in awareness and understand its personal significance; Watson, 1996), unfinished business (i.e., exploring lingering negative feelings toward Change Mechanisms a significant other; (Greenberg   Malcolm, 2002), and alliance rup- tures (i.e., understanding and overcoming difficulties in the patient  Lemmens, M ller, Arntz, and Huibers (2016) conducted a system- therapist relationship; Safran   Muran, 1996). This is an area of atic review of 35 studies aimed at identifying mediators in various research that requires more investment as it can provide clinicians forms of psychotherapy for depression. They"
  },
  {
    "id": 372,
    "source": "guideline_c3debd",
    "text": "This is an area of atic review of 35 studies aimed at identifying mediators in various research that requires more investment as it can provide clinicians forms of psychotherapy for depression. They found that change in more detailed information on how to interact with their patients. dysfunctional attitudes, negative  automatic  thoughts, mindfulness Although a full review of the change processes (including prin- and worry skills, and rumination mediated change in outcomes (e.g., ciples, mechanisms, and events) that predict or mediate outcomes depression symptoms) in most studies, and they found mixed evi- for depression treatment is beyond the scope of this clinical prac- dence supporting mediational roles for attributional style, behavioral tice guideline, the panel encourages"
  },
  {
    "id": 373,
    "source": "guideline_c3debd",
    "text": "they found mixed evi- for depression treatment is beyond the scope of this clinical prac- dence supporting mediational roles for attributional style, behavioral tice guideline, the panel encourages providers to review this import- components, and therapeutic alliance. ant work because of the critical clues this research provides about A review by Lorenzo-Luaces et al. (2015) reported some evi- how to improve therapeutic outcomes, and how to understand why dence that cognitive change (including both ability to use skills to a treatment may not be working as anticipated. Analogously, the modify cognitions and changes in cognitions, such as automatic panel encourages researchers to prioritize this critical domain of thoughts and beliefs) mediates symptom change in cognitive ther- study so"
  },
  {
    "id": 374,
    "source": "guideline_c3debd",
    "text": "cognitions and changes in cognitions, such as automatic panel encourages researchers to prioritize this critical domain of thoughts and beliefs) mediates symptom change in cognitive ther- study so that the field will be able to make stronger statements apy and mindfulness-based cognitive therapy for depression, as about the mechanisms underlying efficacious treatments. predicted by the theoretical models underpinning those therapies. A review by van der Velden et al. (2015) reported that changes in APA   Guideline for the Treatment of Depression 47 HOW THE APA CLINICAL PRACTICE GUIDELINE COMPARES TO OTHER CLINICAL PRACTICE GUIDELINES FOR TREATMENT OF DEPRESSION Various other organizations and professional associations have also developed guidelines on treating depression, though the most"
  },
  {
    "id": 375,
    "source": "guideline_c3debd",
    "text": "TO OTHER CLINICAL PRACTICE GUIDELINES FOR TREATMENT OF DEPRESSION Various other organizations and professional associations have also developed guidelines on treating depression, though the most recent versions of several of these documents are now considered to be outdated. This section will highlight guidelines for depression treatment from the American Psychiatric Association (2010), the American Academy of Child and Adolescent Psychiatry (2007), Kaiser Permanente Care Management Institute (2012), the Veteran s Affairs Department of Defense (2016), and the National Institute for Health and Care Excellence (updated in 2015). The American Psychiatric Association s last guideline on depression (Gelenberg et al., 2010) focused on major depressive disorder in adults and was published in"
  },
  {
    "id": 376,
    "source": "guideline_c3debd",
    "text": "and Care Excellence (updated in 2015). The American Psychiatric Association s last guideline on depression (Gelenberg et al., 2010) focused on major depressive disorder in adults and was published in 2010, prior to the association s adoption of the former Institute of Medicine s (2011) standards for guide- line development. This guideline is now listed as outdated. However, its main recommen- dations include overall psychiatric management for the disorder (i.e., therapeutic alliance, assessment, safety evaluation, determining the setting for treatment, consideration of func- tioning and quality of life, coordination of care, monitoring treatment response, outcome measurement, working on treatment adherence, and psychoeducation). For patients with mild to moderate major depressive"
  },
  {
    "id": 377,
    "source": "guideline_c3debd",
    "text": "quality of life, coordination of care, monitoring treatment response, outcome measurement, working on treatment adherence, and psychoeducation). For patients with mild to moderate major depressive disorder, antidepressant medication or psychotherapy were recommended as initial treatments. For moderate to severe major depressive disorder, a combination of antidepressant medication and psychotherapy was recommended. For severe major depressive disorder that was not responding to medication or psychotherapy or for which there was also associated catatonic or psychotic features, electroconvulsive therapy was recommended. The recommendations also included monitoring during the continuation phase of treatment, a maintenance phase of treatment, and tapering of medi- cation during the"
  },
  {
    "id": 378,
    "source": "guideline_c3debd",
    "text": "therapy was recommended. The recommendations also included monitoring during the continuation phase of treatment, a maintenance phase of treatment, and tapering of medi- cation during the discontinuation phase. The guideline also included clinical factors to con- sider during treatment such as psychiatric factors, psychosocial and demographic factors, and other medical conditions that are co-occurring. Like the American Psychiatric Association s guideline, the present American Psychological Association s guideline also includes recommendations for psychotherapy and for antidepressant medication; however, it more commonly recommends combinations of psychotherapy and antidepressant medication versus antidepressant medication alone. The American Psychological Association s guideline does not"
  },
  {
    "id": 379,
    "source": "guideline_c3debd",
    "text": "however, it more commonly recommends combinations of psychotherapy and antidepressant medication versus antidepressant medication alone. The American Psychological Association s guideline does not detail recommendations for the various stages of treatment as does the American Psychiatric Association s guideline. 48 APA   Guideline for the Treatment of Depression The most recent practice parameter for the American Academy children and adolescents and desires more comparative effec- of Child and Adolescent Psychiatry for depressive disorders in chil- tiveness and combined treatment research. dren and adolescents (Birmaher et al., 2007) is listed as historical The guideline for treating depression in adults from the Kaiser and not considered to be current. Many recommendations were"
  },
  {
    "id": 380,
    "source": "guideline_c3debd",
    "text": "dren and adolescents (Birmaher et al., 2007) is listed as historical The guideline for treating depression in adults from the Kaiser and not considered to be current. Many recommendations were Permanente Care Management Institute (2012) recommends similar in style to the American Psychiatric Association s practice either antidepressant medication or psychotherapy (cognitive-be- guideline, focusing on general considerations such as confidentiali- havioral therapy, interpersonal psychotherapy, or problem-solv- ty, screening, evaluation, phases to include in treatment (i.e., acute ing therapy) as first line treatments for patients whose major and continuation, possibly maintenance), and prevention. It also depressive disorder is mild to moderate, with consideration given included some"
  },
  {
    "id": 381,
    "source": "guideline_c3debd",
    "text": "as first line treatments for patients whose major and continuation, possibly maintenance), and prevention. It also depressive disorder is mild to moderate, with consideration given included some specific treatment recommendations. For children to patient and clinician preferences, medication side effects, and with a brief or uncomplicated depression, it recommended case cost. A combination of antidepressant medication and psychother- management, support, and psychoeducation. For children with apy (cognitive-behavioral therapy, interpersonal psychotherapy, or more complicated depression or who do not respond to support- problem-solving therapy) is recommended for patients with chron- ive psychotherapy, further treatment with psychotherapy or anti- ic or severe major depressive disorder."
  },
  {
    "id": 382,
    "source": "guideline_c3debd",
    "text": "do not respond to support- problem-solving therapy) is recommended for patients with chron- ive psychotherapy, further treatment with psychotherapy or anti- ic or severe major depressive disorder. According to that guideline, depressant medication was recommended. Regarding moderate the following medication classes can be used as first line treat- depression, it recommended either interpersonal psychotherapy or ment: tricyclics, selective serotonin reuptake inhibitor (SSRI), sero- cognitive-behavioral psychotherapy. For severe depression, anti- tonin norepinephrine reuptake inhibitor (SNRI), norepinephrine depressant medication is also recommended alone until the child reuptake inhibitor (NRI), or dopamine agonist, based on patient can begin psychotherapy or in combination with"
  },
  {
    "id": 383,
    "source": "guideline_c3debd",
    "text": "(SNRI), norepinephrine depressant medication is also recommended alone until the child reuptake inhibitor (NRI), or dopamine agonist, based on patient can begin psychotherapy or in combination with psychotherapy and clinician preferences, medication side effects, and cost. The from the start. A combination of antidepressant medication and Kaiser guideline does not recommend for or against St. John s Wort psychotherapy was recommended for children that do not respond (hypericum) for mild to moderate major depressive disorder but to monotherapy of either medication or psychotherapy. recommends against St. John s Wort for severe major depressive The American Academy of Child and Adolescent Psychiatry s disorder. The Kaiser guideline recommends consulting with spe- guideline recommendation"
  },
  {
    "id": 384,
    "source": "guideline_c3debd",
    "text": "against St. John s Wort for severe major depressive The American Academy of Child and Adolescent Psychiatry s disorder. The Kaiser guideline recommends consulting with spe- guideline recommendation for interpersonal psychotherapy or cialized behavioral health providers for those patients with suicidal CBT is similar to the American Psychological Association guide- ideation, plans, intent, or previous suicide attempts. line s recommendation for interpersonal psychotherapy (adapted The Kaiser guideline goes on to discuss second line treatments for adolescents) or CBT treatment. The American Academy of for those patients who continue to have symptoms after first line Child and Adolescent Psychiatry guideline also cautiously recom- treatment. These second line treatment recommendations"
  },
  {
    "id": 385,
    "source": "guideline_c3debd",
    "text": "Academy of for those patients who continue to have symptoms after first line Child and Adolescent Psychiatry guideline also cautiously recom- treatment. These second line treatment recommendations include mends certain antidepressant medications (selective serotonin an examination of adherence to treatment, and options such as reuptake inhibitors) and suggests combination of treatment may combining treatments, increasing antidepressant dosage, and be warranted with more severe clinical presentations. The APA switching treatments. The Kaiser guideline recommends against guideline recommendations, however, do not address combi- augmenting with pindolol but does not recommend for or against nation treatment of psychotherapy and antidepressant medica- providing atypical antipsychotics or"
  },
  {
    "id": 386,
    "source": "guideline_c3debd",
    "text": "however, do not address combi- augmenting with pindolol but does not recommend for or against nation treatment of psychotherapy and antidepressant medica- providing atypical antipsychotics or inositol or folate as second line tion for children adolescents. However, it should be noted that treatments. the Treatment of Adolescent Depression (TADS) study is the APA s guideline also recommends that certain treatment largest study to date examining adolescents with persistent and approaches might be considered or applied first (i.e., psychothera- impairing major depression. This study compared CBT as a stand- py or pharmacotherapy for adults) and then suggests other options alone intervention to antidepressant medication (fluoxetine), the (i.e., complementary and alternative treatments for"
  },
  {
    "id": 387,
    "source": "guideline_c3debd",
    "text": "CBT as a stand- py or pharmacotherapy for adults) and then suggests other options alone intervention to antidepressant medication (fluoxetine), the (i.e., complementary and alternative treatments for adults) if the combination of CBT and medication, and a placebo sugar pill first options are not available or acceptable. Both the APA and across 13 sites and included over 400 adolescents (March et al., Kaiser guidelines recommend consideration of patient culture, val- 2004). The study concluded that combination treatment of flu- ues and preferences, and medication side effects. The APA guide- oxetine and CBT resulted in significantly better outcomes than line was frequently unable to recommend a specific antidepressant CBT or fluoxetine alone (March et al., 2004). A more recent evi-"
  },
  {
    "id": 388,
    "source": "guideline_c3debd",
    "text": "oxetine and CBT resulted in significantly better outcomes than line was frequently unable to recommend a specific antidepressant CBT or fluoxetine alone (March et al., 2004). A more recent evi- medication over another treatment due to insufficient evidence, dence-based update examined psychosocial interventions for the though did recommend a combination of antidepressant medica- treatment of child and adolescent depression (Weersing, Jeffreys, tion and psychotherapy versus antidepressant medication alone in Do, Schwartz,   Bolano, 2016). This study concluded that both some cases. CBT and interpersonal psychotherapy are well-established inter- The focus of the Veteran s Affairs Department of Defense ventions (though they have limited evidence for racially diverse (2016) guideline is on"
  },
  {
    "id": 389,
    "source": "guideline_c3debd",
    "text": "psychotherapy are well-established inter- The focus of the Veteran s Affairs Department of Defense ventions (though they have limited evidence for racially diverse (2016) guideline is on adults with major depressive disorder being youth), with evidence of efficacy in multiple trials by independent treated in the Veteran s Affairs Department of Defense setting. investigative teams. However, the conclusion is tempered by Recommendations from this guideline include the domains of iden- the smaller number of studies for interpersonal psychotherapy tification, assessment and triage, treatment setting, and manage- adapted for adolescents (IPT-A) and the concern that the effects ment. The management recommendations for adults are the clos- of CBT may be diminished when applied to populations"
  },
  {
    "id": 390,
    "source": "guideline_c3debd",
    "text": "and manage- adapted for adolescents (IPT-A) and the concern that the effects ment. The management recommendations for adults are the clos- of CBT may be diminished when applied to populations with more est in content scope to APA s guideline. First line psychotherapy comorbidity and diversity of ethnicity and socioeconomic sta- treatments recommended by the guideline for mild to moderate tus, and when compared to active treatments (Weersing et al., major depressive disorder include: acceptance and commitment 2016). While informative, the panel did not find these studies to therapy, behavioral therapy behavioral activation, cognitive-be- yet warrant recommendations regarding combined treatment for havioral therapy, interpersonal psychotherapy, mindfulness-based APA   Guideline for the"
  },
  {
    "id": 391,
    "source": "guideline_c3debd",
    "text": "therapy behavioral activation, cognitive-be- yet warrant recommendations regarding combined treatment for havioral therapy, interpersonal psychotherapy, mindfulness-based APA   Guideline for the Treatment of Depression 49 cognitive therapy, and problem-solving therapy. First line pharma- across settings (e.g., treat on outpatient basis, assessment of cotherapy treatments recommended by the guideline for mild to social network and bullying, treatment alliance), and stepped care moderate major depressive disorder include selective serotonin depending on the focus of treatment. For mild depression and per- reuptake inhibitor (except fluvoxamine) (SSRI), serotonin norepi- sistent depressive disorder, the guideline recommends watchful nephrine reuptake inhibitor (SNRI), mirtazapine, and"
  },
  {
    "id": 392,
    "source": "guideline_c3debd",
    "text": "and per- reuptake inhibitor (except fluvoxamine) (SSRI), serotonin norepi- sistent depressive disorder, the guideline recommends watchful nephrine reuptake inhibitor (SNRI), mirtazapine, and bupropion. waiting for up to 4 weeks, nondirective supportive therapy, group The Veteran s Affairs Department of Defense guideline did not cognitive-behavioral therapy, or guided self-help. The NICE guide- find sufficient evidence to be able to recommend one particular line recommends against using antidepressant medication as an psychotherapy or pharmacotherapy versus another. The guideline initial treatment for mild depression in children and adolescents. further recommends that if a patient has not demonstrated suffi- For moderate to severe depression, the guideline recommends cient response after"
  },
  {
    "id": 393,
    "source": "guideline_c3debd",
    "text": "for mild depression in children and adolescents. further recommends that if a patient has not demonstrated suffi- For moderate to severe depression, the guideline recommends cient response after 4 to 6 weeks of trying a pharmacotherapy, the brief psychological therapy (individual CBT, interpersonal psycho- patient should switch to another medication or to psychotherapy therapy, family therapy, or psychodynamic psychotherapy) with or or augment with another medication or psychotherapy. It recom- without fluoxetine. mends that patient preference should be used to determine psy- For depression that is recurrent, unresponsive to treatment, or chotherapy format (individual or group). Computer-based cogni- psychotic, the NICE guideline recommends intensive psychological tive-behavioral therapy"
  },
  {
    "id": 394,
    "source": "guideline_c3debd",
    "text": "is recurrent, unresponsive to treatment, or chotherapy format (individual or group). Computer-based cogni- psychotic, the NICE guideline recommends intensive psychological tive-behavioral therapy can be offered as a first-line treatment or therapy of an alternative therapy than what was already tried (indi- as an augmentation to treatment based on patient preferences for vidual CBT, interpersonal psychotherapy, or shorter term family patients with mild to moderate major depressive disorder. Further therapy, lasting at least three months) or systemic family therapy for those with mild to moderate major depressive disorder who or 30 weekly sessions of individual child psychotherapy. This treat- decline or are unable to access first line recommended psychother- ment may be done with or"
  },
  {
    "id": 395,
    "source": "guideline_c3debd",
    "text": "moderate major depressive disorder who or 30 weekly sessions of individual child psychotherapy. This treat- decline or are unable to access first line recommended psychother- ment may be done with or without fluoxetine. If the child is unre- apies or pharmacotherapies, the guideline suggests offering short- sponsive to fluoxetine, then sertraline or citalopram may be used. term psychodynamic psychotherapy or nondirective supportive The NICE guideline recommends against using paroxetine, venla- psychotherapy. In treating severe or chronic or recurrent complex faxine, tricyclic antidepressants, or St. John s Wort. For psychotic major depressive disorder the guideline recommends a combi- depression, the guideline recommends that consideration be given nation of pharmacotherapy and"
  },
  {
    "id": 396,
    "source": "guideline_c3debd",
    "text": "or St. John s Wort. For psychotic major depressive disorder the guideline recommends a combi- depression, the guideline recommends that consideration be given nation of pharmacotherapy and psychotherapy. The Veteran s to augmenting treatment with an antipsychotic. The guideline goes Affairs Department of Defense guideline also goes on to provide on to discuss inpatient care, electroconvulsive therapy, discharge recommendations for monitoring, continuation and maintenance, planning, recurrent depression and prevention of relapse, and the and additional treatment considerations (i.e., for specific popu- transition of the child to adult services, areas not covered for chil- lations, for severe or chronic or recurrent complex major depres- dren and adolescents in the APA guideline. The NICE"
  },
  {
    "id": 397,
    "source": "guideline_c3debd",
    "text": "popu- transition of the child to adult services, areas not covered for chil- lations, for severe or chronic or recurrent complex major depres- dren and adolescents in the APA guideline. The NICE guideline also sive disorder, and complementary and alternative treatments and contains recommendations for future research based on the pan- self-help). el s review of the research evidence. Although the APA guideline used the same review that served Similar to APA s guideline, the NICE guideline looks at both as the evidence base for the Veteran s Affairs Department of children and adolescents. Portions of the NICE guideline focus Defense guideline as one source of information for its guide- on contextual factors, similar to the focus of APA s professional lines, the reader will note some"
  },
  {
    "id": 398,
    "source": "guideline_c3debd",
    "text": "Portions of the NICE guideline focus Defense guideline as one source of information for its guide- on contextual factors, similar to the focus of APA s professional lines, the reader will note some differences. For example, in some practice guidelines. While the NICE guideline recommends var- instances the Veteran s Affairs Department of Defense guideline ious psychotherapies depending on where the patient s diagno- recommends a particular intervention for which the APA guideline sis and response fits in the stepped care model, the APA guide- does not due to insufficient evidence or other factors. It should be line recommends CBT or interpersonal psychotherapy and notes noted that the APA guideline deemed evidence to be insufficient insufficient evidence to recommend particular treatments"
  },
  {
    "id": 399,
    "source": "guideline_c3debd",
    "text": "It should be line recommends CBT or interpersonal psychotherapy and notes noted that the APA guideline deemed evidence to be insufficient insufficient evidence to recommend particular treatments over for drafting a recommendation if all the outcomes for that particu- others. The NICE guideline focuses its medication recommenda- lar intervention were classified as having very low insufficient evi- tion for moderate or severe depression on fluoxetine, with a few dence and only drafted recommendations for those interventions other antidepressants recommended as alternatives if the patient included in the review in which at least one outcome was of low is not responsive to medication. The APA guideline likewise recom- or higher quality evidence. Moreover, following best practices, the mends"
  },
  {
    "id": 400,
    "source": "guideline_c3debd",
    "text": "in the review in which at least one outcome was of low is not responsive to medication. The APA guideline likewise recom- or higher quality evidence. Moreover, following best practices, the mends fluoxetine as a first line medication, given the lower risk for APA panel only used data from a systematic review included in the suicidal ideation and behavior, compared with other medications Veteran s Affairs Department of Defense review if it was consid- for adolescent patients with major depressive disorder. The APA ered current from the past 5 years (dating no farther back than guideline then notes that if fluoxetine is not a treatment option or 2012). Thus, the reader will note some differences in conclusions is not acceptable, the panel recommends shared decision-making drawn from the"
  },
  {
    "id": 401,
    "source": "guideline_c3debd",
    "text": "notes that if fluoxetine is not a treatment option or 2012). Thus, the reader will note some differences in conclusions is not acceptable, the panel recommends shared decision-making drawn from the same data review between the guidelines. regarding medication options with a child psychiatrist in addition to The guideline from the National Institute for Health and Care the clinician, patient, and their parents guardians or family mem- Excellence (NICE) focuses on children and adolescents ages 5 18 bers actively involved in their care. years old. It was published in 2005, and currently another update is in progress with information on antidepressant medication and psychotherapies. This guideline recommends providing good psy- choeducation, support and informed consent, consideration of lan-"
  },
  {
    "id": 402,
    "source": "guideline_c3debd",
    "text": "is in progress with information on antidepressant medication and psychotherapies. This guideline recommends providing good psy- choeducation, support and informed consent, consideration of lan- guage and culture, assessment and care coordination, organizing and planning of service, considering various factors in treatment 50 APA   Guideline for the Treatment of Depression CHALLENGES IN DEVELOPING THE GUIDELINE AND RECOMMENDATIONS FOR FUTURE EFFORTS In developing this guideline, the panel consistently identified and documented challenges and limitations for the purposes of improving future efforts at both research and guideline devel- opment and implementation. The challenges fell broadly into three domains: 1. The limitations of the guideline s scope based on the PICOTS (Population,"
  },
  {
    "id": 403,
    "source": "guideline_c3debd",
    "text": "efforts at both research and guideline devel- opment and implementation. The challenges fell broadly into three domains: 1. The limitations of the guideline s scope based on the PICOTS (Population, Interventions, Comparators, Outcomes, Timing, and Settings) chosen. 2. Constraints and applicability of the IOM guideline development standards to mental health and particularly depression. 3. General and cohort-specific limitations of the current research literature. Considerations Regarding Guideline Scope The current guideline focused on the PICOTS (Population, Interventions, Comparators, Outcomes, Timing, Settings) described in the introduction. The panel wanted to be as broadly inclusive as possible, but nonetheless had to limit the areas of focus to rigorously evaluate a segment of"
  },
  {
    "id": 404,
    "source": "guideline_c3debd",
    "text": "Outcomes, Timing, Settings) described in the introduction. The panel wanted to be as broadly inclusive as possible, but nonetheless had to limit the areas of focus to rigorously evaluate a segment of literature in a realistic time frame. The panel therefore did not systematically review the literature relevant to a number of important populations (e.g., populations with bipolar disorder, psychotic depression, or other medical disorders) and settings (e.g., collab- orative care, inpatient treatment). An additional area not captured by the panel was stepped care. Some clinicians, for example, may follow a stepped care approach to treatment based on the patient s history of number of prior episodes of depression. Some of these components not reviewed by the panel were captured partially"
  },
  {
    "id": 405,
    "source": "guideline_c3debd",
    "text": "may follow a stepped care approach to treatment based on the patient s history of number of prior episodes of depression. Some of these components not reviewed by the panel were captured partially within the available reviews, but the pre- sentation of the data prevented systematic recommendations. These decisions reflected the panel s desire to address questions of care relevant to the largest segment of individuals with depression and focus on topics of broadest interest to the membership of APA and related disciplines. The panel expects future efforts will expand on this and other guidelines to address important areas such as populations with comorbid medical disorders, populations with comorbid substance use disorders, collaborative care models, treatment specifically in primary care"
  },
  {
    "id": 406,
    "source": "guideline_c3debd",
    "text": "to address important areas such as populations with comorbid medical disorders, populations with comorbid substance use disorders, collaborative care models, treatment specifically in primary care settings, alternative treatment modalities, and models using longer term or maintenance approaches to treatment. For example, there is emerging research regarding promising Internet-based interventions in general and particularly for children and adoles- cents (Reyes-Portillo et al., 2014). There is need for a more detailed examination of comple- mentary and alternative interventions for depression than what was included in the current guideline, as well as examination of the role of peer providers (individuals with lived experi- ence of depression) in treatment. APA   Guideline for the"
  },
  {
    "id": 407,
    "source": "guideline_c3debd",
    "text": "than what was included in the current guideline, as well as examination of the role of peer providers (individuals with lived experi- ence of depression) in treatment. APA   Guideline for the Treatment of Depression 51 As noted previously, the guideline initially was going to only conducting systematic reviews of clinical effectiveness research, address treatment for adolescents. However, the available reviews and the second to develop standards for developing clinical prac- often included both children and adolescents together. The panel tice guidelines. incorporated children into the guideline, but because the original The first committee report describes the specific means by search focused solely on adolescents, the sampling of the child lit- which systematic reviews and meta-analyses"
  },
  {
    "id": 408,
    "source": "guideline_c3debd",
    "text": "but because the original The first committee report describes the specific means by search focused solely on adolescents, the sampling of the child lit- which systematic reviews and meta-analyses are to be conducted. erature is likely incomplete. In addition, while the literatures were Elsewhere in the current document, it is noted that in order to fol- often combined, there are important developmental and theoret- low IOM standards, it was important to generally include reviews ical reasons to consider children and adolescents separately. The that involved more than one individual to screen and select studies panel ultimately decided to separate recommendations for chil- to include in the review, as well as to extract quantitative data from dren versus adolescents but was constrained in"
  },
  {
    "id": 409,
    "source": "guideline_c3debd",
    "text": "and select studies panel ultimately decided to separate recommendations for chil- to include in the review, as well as to extract quantitative data from dren versus adolescents but was constrained in its ability to make each study. In addition, although not a hard and fast standard, the specific recommendations for children due to the limited literature IOM notes that systematic reviews become outdated at 5.5 years. focusing exclusively on children included in the reviews. Future Following such guidance restricted our ability to incorporate those efforts would benefit from a separate systematic review dedicated reviews that did not meet such standards, regardless of the quality to childhood depression. of the review in all other aspects. However, when such restrictions Another domain not"
  },
  {
    "id": 410,
    "source": "guideline_c3debd",
    "text": "review dedicated reviews that did not meet such standards, regardless of the quality to childhood depression. of the review in all other aspects. However, when such restrictions Another domain not included but that is an important priority led to a major lack of information on which to base recommenda- is universal prevention. The panel focused on treatment of depres- tions (see Method section as well as section below on constraints sive disorders, determining this would be the domain of most inter- using the IOM standards), we did include meta-analyses that did est to the consumers of this report. However, the panel also rec- not meet such standards but that did meet quality criteria per ognizes that preventive interventions are an important aspect of AMSTAR review. care, particularly"
  },
  {
    "id": 411,
    "source": "guideline_c3debd",
    "text": "report. However, the panel also rec- not meet such standards but that did meet quality criteria per ognizes that preventive interventions are an important aspect of AMSTAR review. care, particularly for health care systems, and recommends that Attempting to follow the standards and guidance set forth future guidelines address prevention approaches (e.g., Horowitz   by the IOM can be limiting if systematic reviews are not available Garber, 2006; Garber et al., 2009; Horowitz, Garber, Ciesla, Young, (see section below for additional detail), despite the existence of   Mufson, 2007). multiple individual studies. As such, developing clinical practice As noted in the introduction, a number of areas were not guidelines that are  trustworthy  can be difficult. On one hand, it addressed in the"
  },
  {
    "id": 412,
    "source": "guideline_c3debd",
    "text": "individual studies. As such, developing clinical practice As noted in the introduction, a number of areas were not guidelines that are  trustworthy  can be difficult. On one hand, it addressed in the PICOTS for the guideline, including screening for becomes crucial to follow scientifically sound protocols, such as the depression, assessment of associated or comorbid conditions (e.g., IOM guidance. On the other hand, doing so can limit the ability to suicidality, medical problems), monitoring response to treatment develop clinical practice guidelines in such a manner that includes and follow-up after treatment, locus of care, primary prevention of all potentially relevant data. For example, several meta-analyses depression, dose (differential beyond current recommended), tim- that are"
  },
  {
    "id": 413,
    "source": "guideline_c3debd",
    "text": "after treatment, locus of care, primary prevention of all potentially relevant data. For example, several meta-analyses depression, dose (differential beyond current recommended), tim- that are viewed by many as supportive of the efficacy of various ing or duration of treatments for depression, costs of treatments, psychotherapies for depression are actually considered outdated specific populations (e.g., caregivers), and mechanisms of change. or do not meet the rigorous IOM standards. As such, although These areas are important domains of investigation and comment. information about the potential viability and efficacy of such ther- The panel has supplemented the guideline mechanisms in some apies are at times in the  collective conscious  of the health pro- sections with information"
  },
  {
    "id": 414,
    "source": "guideline_c3debd",
    "text": "viability and efficacy of such ther- The panel has supplemented the guideline mechanisms in some apies are at times in the  collective conscious  of the health pro- sections with information related to some of these domains when fessions at large, it may not be included in current clinical practice appropriate, but the panel is supportive of future efforts to incor- guidelines. The lack of studies to help answer questions regard- porate these domains formally into guidelines, where there is liter- ing comparative effectiveness and the efficacy and relevance of ature available. various treatments for ethnic minority populations is particularly challenging. The situation is even more complex as single studies need to be evaluated for quality (as with a meta-analysis or similar Implications"
  },
  {
    "id": 415,
    "source": "guideline_c3debd",
    "text": "for ethnic minority populations is particularly challenging. The situation is even more complex as single studies need to be evaluated for quality (as with a meta-analysis or similar Implications of Alignment with the Institute of endeavor) and typically do not have sufficient strength of evidence alone to draw robust conclusions. Medicine Standards This state of affairs leads to a scientific and profession- al dilemma should the panel have used IOM guidance? In the It is noted throughout this document that the current clinical practice absence of any other  gold standard,  the answer is  yes  given guideline development panel adopted the Institute of Medicine s that the ultimate goal is to produce a scientifically sound clinical (2011a) standards for guideline development. What are these"
  },
  {
    "id": 416,
    "source": "guideline_c3debd",
    "text": "given guideline development panel adopted the Institute of Medicine s that the ultimate goal is to produce a scientifically sound clinical (2011a) standards for guideline development. What are these stan- practice guideline. Alternatively, future efforts to create differing dards? To begin with, the definition of a clinical practice guideline clinical practice guideline development guidance, whether they according to the IOM (2011a) involves  . . . statements that include are slight variations of the current IOM standards or something recommendations intended to optimize patient care that are created by other agencies or professional groups, may yield more informed by a systematic review of evidence and an assessment of viable approaches. The development of the original CONSORT the"
  },
  {
    "id": 417,
    "source": "guideline_c3debd",
    "text": "are created by other agencies or professional groups, may yield more informed by a systematic review of evidence and an assessment of viable approaches. The development of the original CONSORT the benefits and harms of alternative care options  (p. 4). (Consolidated Standards of Reporting Trials) statement guidelines Historically, these standards are the product of a collabora- provided standards for reporting clinical trials in order to foster tion between the IOM and the Agency for Health Care Research transparency and scholarship. Because the original CONSORT was and Quality in 2008. The impetus for this partnership was initial- developed for the general medical field, various extensions have ly called for by Congress and the then-Secretary of Health and been developed to better suit"
  },
  {
    "id": 418,
    "source": "guideline_c3debd",
    "text": "impetus for this partnership was initial- developed for the general medical field, various extensions have ly called for by Congress and the then-Secretary of Health and been developed to better suit differing populations, methodolog- Human Services as a means of empowering committees to con- ical approaches, and content. Relevant to this clinical practice duct two major studies one devoted to identifying standards for 52 APA   Guideline for the Treatment of Depression guideline, a formal extension of the CONSORT guidelines is cur- comparison conditions in the general adult population. Studies of rently being developed by an international consensus group to be play therapy varied greatly in definition of intervention (the one relevant and appropriate for clinical trials specific to social"
  },
  {
    "id": 419,
    "source": "guideline_c3debd",
    "text": "of rently being developed by an international consensus group to be play therapy varied greatly in definition of intervention (the one relevant and appropriate for clinical trials specific to social and study of acceptable quality focused on war-abducted youth, raising psychological interventions, including psychotherapy trials (hence questions of generalizability). Medication as a comparator across the title Consolidated Standards of Reporting Trials for Social the age populations varied greatly in terms of quality of treatment and Psychological Intervention Trials; Montgomery et al., 2013). In and conformity to standards of practice, with the physician mem- this vein, it is possible that the current IOM guidance may be the bers of the panel noting that in some cases the standard doses"
  },
  {
    "id": 420,
    "source": "guideline_c3debd",
    "text": "In and conformity to standards of practice, with the physician mem- this vein, it is possible that the current IOM guidance may be the bers of the panel noting that in some cases the standard doses were starting point but not the final best approach for developing clini- below recommended doses, or the medication was not used in cur- cal practice guidelines that involve predominantly psychotherapy rent practice (e.g., nefazodone). These limitations restricted the research. The nature of both funding sources (e.g., requirements nature of the recommendations the panel could make. to receive grants) and aspects of research design (e.g., inability to Panel members did discuss whether there were ways to effec- blind participants to the treatment they receive) may require differ- tively include"
  },
  {
    "id": 421,
    "source": "guideline_c3debd",
    "text": "and aspects of research design (e.g., inability to Panel members did discuss whether there were ways to effec- blind participants to the treatment they receive) may require differ- tively include research that did not depend on randomized con- ent criteria for evaluating the quality of research. This is, however, trolled designs as generally those studies do not meet the quality perhaps also an empirical question. In the meantime, to pursue a inclusion criteria for systematic review. In domains where there are scientifically sound path, adopting the IOM guidance is considered limited randomized controlled trials available, it may be reasonable to be the best current approach. However, it is also important to to develop preliminary recommendations based on well-designed acknowledge"
  },
  {
    "id": 422,
    "source": "guideline_c3debd",
    "text": "controlled trials available, it may be reasonable to be the best current approach. However, it is also important to to develop preliminary recommendations based on well-designed acknowledge limitations. The full reports for each of these devel- correlational studies, particularly if there is longitudinal data avail- opment standards are available online (IOM, 2011a; IOM, 2011b). able. The panel does recommend review of guideline development The panel was committed to ensuring the scientific rigor of the processes to ensure emerging best practices are captured in APA s development process by following the IOM standards for guideline processes and determine if specific modification may be indicated development while simultaneously generating a guideline that was for guidelines related to"
  },
  {
    "id": 423,
    "source": "guideline_c3debd",
    "text": "following the IOM standards for guideline processes and determine if specific modification may be indicated development while simultaneously generating a guideline that was for guidelines related to mental and behavioral health. For example, based on an adequate inclusion of the research literature. When maintaining a double-blind condition in a psychotherapy study is reviewing the original umbrella review of treatments conducted not possible (the provider and participant know the intervention by an evidence-based practice center for the panel, it became being provided), and this leads to such studies being judged as clear that a large number of systematic reviews and meta-analy- lower quality. ses were not included in that umbrella review due to not meeting the IOM standards, yet"
  },
  {
    "id": 424,
    "source": "guideline_c3debd",
    "text": "to such studies being judged as clear that a large number of systematic reviews and meta-analy- lower quality. ses were not included in that umbrella review due to not meeting the IOM standards, yet frequently these were the only reviews covering a key domain. The panel determined it could not create Limitations of Existing Treatment Research an adequately meaningful guideline without broadening the inclu- Literature sion parameters and determined to consider reviews that did not utilize a dual review process for selecting articles for inclusion. All In creating this guideline, the panel had an opportunity to identify a other requirements were maintained, such as excluding reviews number of domains in which there are extensive needs for future including trials that were not appropriately"
  },
  {
    "id": 425,
    "source": "guideline_c3debd",
    "text": "an opportunity to identify a other requirements were maintained, such as excluding reviews number of domains in which there are extensive needs for future including trials that were not appropriately controlled. While sin- research. gle review increases the risk of bias in article selection (Edwards et al., 2002), the panel in reviewing the literature determined that Extensive evidence for a variety of treatments. Depression is one the guideline would not adequately cover the PICOTS (Population, of the disorders most widely studied in psychotherapy research, with Interventions, Comparators, Outcomes, Timing, Settings) without over 400 randomized clinical trials for depression across the last 3 some expansion of the available literature, and this modification decades (Cuijpers, van"
  },
  {
    "id": 426,
    "source": "guideline_c3debd",
    "text": "Outcomes, Timing, Settings) without over 400 randomized clinical trials for depression across the last 3 some expansion of the available literature, and this modification decades (Cuijpers, van Straten, Warmerdam,   Andersson, 2008). was the most scientifically defensible of all options. All identified However, while a large number of studies focused on the efficacy of reviews not conducted or evaluated by an evidence-based practice one approach, cognitive-behavioral therapy (CBT), fewer studies center were evaluated by a scientist external to the guideline devel- have examined other widely utilized treatments including psychody- opment process using the AMSTAR criteria before including the namic therapy, interpersonal psychotherapy, behavioral activation, reviews in the evidence base."
  },
  {
    "id": 427,
    "source": "guideline_c3debd",
    "text": "utilized treatments including psychody- opment process using the AMSTAR criteria before including the namic therapy, interpersonal psychotherapy, behavioral activation, reviews in the evidence base. problem-solving therapy, and emotion-focused therapy, among Even with this expansion, there were some domains that were others. Most of these treatments have demonstrated preliminary inadequately addressed. For example, there was only one study of efficacy necessitating the need for further study. In addition, while psychodynamic therapy identified in the child and adolescent lit- the largest body of literature is for CBT, the definition of CBT is not erature reviews (Trowell et al., 2007), despite it being a common the same across all CBT studies. This heterogeneity limits the ability"
  },
  {
    "id": 428,
    "source": "guideline_c3debd",
    "text": "body of literature is for CBT, the definition of CBT is not erature reviews (Trowell et al., 2007), despite it being a common the same across all CBT studies. This heterogeneity limits the ability modality in the community (i.e., the IMPACT study in the United to make conclusions about the CBT model. It is imperative that the Kingdom; see Midgley   Kennedy, 2011). In another example, stud- field generate more evidence to support different psychotherapies ies of newer therapies such as schema-focused therapy, emotion-fo- (with preliminary efficacy as this is crucial for the advancement of cused therapy, and acceptance and commitment therapy, although the scientific field, diversification of education, and training opportu- used in the community for treating depression, were not reviewed."
  },
  {
    "id": 429,
    "source": "guideline_c3debd",
    "text": "therapy, and acceptance and commitment therapy, although the scientific field, diversification of education, and training opportu- used in the community for treating depression, were not reviewed. nities for and adherence to scientific calls for personalized approaches These newer therapies were not covered in existing meta-analyses to treatment). There is also interest and awareness of growing areas that were of high enough quality per AMSTAR standards and thus in complementary and alternative medicine such as those included were not considered for a recommendation by the panel. Use of in this review and others that were not included (such as emotional smartphone-based treatment was not reviewed due to inadequate support animals). APA   Guideline for the Treatment of Depression 53"
  },
  {
    "id": 430,
    "source": "guideline_c3debd",
    "text": "in this review and others that were not included (such as emotional smartphone-based treatment was not reviewed due to inadequate support animals). APA   Guideline for the Treatment of Depression 53 Secondary outcomes. Symptomatic change (or reductions in the populations (e.g., often the youth of color included in studies are dis- severity and duration of symptoms) has been widely considered the proportionately from communities experiencing individual-level and gold standard for improvement in treatments of depression. neighborhood-level socioeconomic disadvantage). Within these However, it is important to consider patients  improvement beyond studies, it is imperative that researchers identify culturally relevant symptom change. Very few studies have focused on investigating means of"
  },
  {
    "id": 431,
    "source": "guideline_c3debd",
    "text": "is important to consider patients  improvement beyond studies, it is imperative that researchers identify culturally relevant symptom change. Very few studies have focused on investigating means of assessing depression in racially diverse populations. Doing treatment gains in a wide range of functional domains of patient-cen- so would more accurately identify individuals in need of treatment tered outcomes, such as quality of life, employment status, integra- and utilize measures that are sensitive to the symptom changes of tion in the community, social engagement, satisfaction in these populations throughout the course of treatment. Also, further interpersonal relationships, etc. research is needed to examine culturally relevant outcomes of stan- dardized interventions as well as"
  },
  {
    "id": 432,
    "source": "guideline_c3debd",
    "text": "populations throughout the course of treatment. Also, further interpersonal relationships, etc. research is needed to examine culturally relevant outcomes of stan- dardized interventions as well as interventions targeted specifically Long-term outcomes of psychotherapy. There is still lack of suffi- to the needs of these diverse groups, such as school-based mental cient evidence on the enduring long-term effects of treatments for health services for minority youth (Atkins, Frazier, Adil,   Talbott, depression. While some evidence suggests that effects of some 2003; Bear, Finer, Guo,   Lau, 2014; Langley, Nadeem, Kataoka, psychotherapies persist longer than the effects of medication (e.g., Stein,   Jaycox, 2010). Given preliminary evidence suggesting that Hollon   Ponniah, 2010; Cuijpers"
  },
  {
    "id": 433,
    "source": "guideline_c3debd",
    "text": "Langley, Nadeem, Kataoka, psychotherapies persist longer than the effects of medication (e.g., Stein,   Jaycox, 2010). Given preliminary evidence suggesting that Hollon   Ponniah, 2010; Cuijpers et al., 2013; Fonagy et al., 2015), ethnicity moderates treatment effects (e.g., Barber et al., 2012), there is still a need for data from long-term follow-ups with multiple researchers should focus on studying process and outcomes of psy- time points. In that respect, understanding long-term change trajec- chotherapies among racially, ethnically, and gender diverse popu- tories could also help researchers develop interventions that are lations (Perry, Chaplo,   Baucom, 2017). Of note, there are special focused on relapse prevention. issues to consider when conducting research with diverse groups"
  },
  {
    "id": 434,
    "source": "guideline_c3debd",
    "text": "develop interventions that are lations (Perry, Chaplo,   Baucom, 2017). Of note, there are special focused on relapse prevention. issues to consider when conducting research with diverse groups (APA, 2017b; Council of National Psychological Associations for Treatment for patients with comorbid medical conditions. While the Advancement of Ethnic Minority Interests, 2007). These issues there is a large body of literature demonstrating the relation between include training in multicultural competency to properly conduct various medical conditions (e.g., obesity, cardiovascular disease, research with such individuals, using culturally relevant and appro- chronic pain, cancer) and depression, few randomized controlled priate assessment tools for a given group or subgroup, and including trials"
  },
  {
    "id": 435,
    "source": "guideline_c3debd",
    "text": "with such individuals, using culturally relevant and appro- chronic pain, cancer) and depression, few randomized controlled priate assessment tools for a given group or subgroup, and including trials have been conducted targeting depression among these popu- individuals of a particular minority population of research focus with- lations. One of the reasons is that randomized controlled trials have in a larger stakeholder framework. had strict exclusion criteria, leaving outpatients suffering from comorbid conditions. Randomized controlled trials with strict exclu- Cohort specific limitations: Child and adolescent. Broadly, additional sion criteria have led to a better understanding of efficacy of treat- studies of psychotherapy interventions in general for diverse children ments for this"
  },
  {
    "id": 436,
    "source": "guideline_c3debd",
    "text": "Child and adolescent. Broadly, additional sion criteria have led to a better understanding of efficacy of treat- studies of psychotherapy interventions in general for diverse children ments for this clearly defined and fairly homogenous population. with depression that include long-term follow-up are needed. While However, less is known about patient populations who do not fit this the field recognizes the benefits of interpersonal psychotherapy category. Therefore, future research should examine some of the (adapted for adolescents) and CBT for youth, the literature is cur- more commonly co-occurring physical ailments of depression like rently insufficient for definitively stating which therapies are most stroke, diabetes, and cancer, as well as subsyndromal depression and efficacious"
  },
  {
    "id": 437,
    "source": "guideline_c3debd",
    "text": "physical ailments of depression like rently insufficient for definitively stating which therapies are most stroke, diabetes, and cancer, as well as subsyndromal depression and efficacious for specific populations (e.g., preadolescents, young substance use disorders. children, and children of color). Also, more studies with children and with adolescents comparing active interventions are needed. Treatment for racially, ethnically, and gender diverse populations. In addition, the meta-analyses and reviews included a number Despite the increasing awareness of the importance of accessibility of indicated prevention focused studies in the analyses assessing of mental health care for racially, ethnically, and gender diverse per- the evidence base for depression interventions. These study par-"
  },
  {
    "id": 438,
    "source": "guideline_c3debd",
    "text": "indicated prevention focused studies in the analyses assessing of mental health care for racially, ethnically, and gender diverse per- the evidence base for depression interventions. These study par- sons and the emphasis on multiculturalism, the panel was unable to ticipants endorsed depression symptoms albeit subsyndromal but address depression within groups of people of color and other diverse elevated enough that they were considered depressed. However, groups across age cohorts. For example, there is a growing yet lim- the target outcome for indicated prevention studies is preven- ited body of knowledge regarding conceptualizations of the etiology tion of increasing symptom severity and acquisition of a depres- of depression in people of color (Sontag-Padilla et al., 2016; Stein et"
  },
  {
    "id": 439,
    "source": "guideline_c3debd",
    "text": "body of knowledge regarding conceptualizations of the etiology tion of increasing symptom severity and acquisition of a depres- of depression in people of color (Sontag-Padilla et al., 2016; Stein et sion diagnosis rather than recovery or remission from diagnosed al., 2010), the diagnosis of depression in adults and youth of color depression. Combining prevention and intervention studies within (Breland-Noble, Al-Mateen,   Singh, 2016; Breland-Noble, meta-analyses may have obscured differences in outcomes of sim- Sotomayor,   Burriss, 2015), and most effective delivery methods of ilar treatments with different targets, reducing the confidence in treatment for these populations (Camacho et al., 2015). Unfortunately, strength of effectiveness for a given treatment approach. there is a"
  },
  {
    "id": 440,
    "source": "guideline_c3debd",
    "text": "with different targets, reducing the confidence in treatment for these populations (Camacho et al., 2015). Unfortunately, strength of effectiveness for a given treatment approach. there is a dearth of evidence regarding treatment engagement and outcomes for most racial ethnic groups in the U.S. (including adults Limitations in older adults. Three of the most salient limitations of and youth), thereby restricting the panel s ability to account for treat- the intervention literature to date in late-life depression treatment ment response variability in relation to racial and ethnic group diver- and prevention concern (1) the underrepresentation of racial and sity within the current guideline. ethnic minority participants, (2) the relative dearth of participants Future research must expand"
  },
  {
    "id": 441,
    "source": "guideline_c3debd",
    "text": "and prevention concern (1) the underrepresentation of racial and sity within the current guideline. ethnic minority participants, (2) the relative dearth of participants Future research must expand its inclusion of underserved and among the  oldest old  strata of society (i.e., those older than 75 or underrepresented populations in depression treatment research. 80), and (3) the paucity of information on treatment response mod- There is particular need for more comprehensive sampling of these ifiers. There is increasing interest in testing measures of medical 54 APA   Guideline for the Treatment of Depression morbidity and of cognitive impairment as moderators of treatment therapy) are offered, has demonstrated moderately higher levels of response, with early promising leads in these"
  },
  {
    "id": 442,
    "source": "guideline_c3debd",
    "text": "of Depression morbidity and of cognitive impairment as moderators of treatment therapy) are offered, has demonstrated moderately higher levels of response, with early promising leads in these domains. Moreover, treatment response and remission versus care as usual (Bruce et al., comparative effectiveness research is needed to address the treat- 2004; Un tzer et al., 2002). It has further demonstrated reduction ment of depression in patients for whom treatments fail in later life. in long-term rates of mortality from co-occurring medical conditions Despite establishing that some psychotherapies are ben- (Gallo et al., 2013). Thus, both the short- and long-term risks and eficial to older adults, the research literature is at best limited. benefits of antidepressant pharmacotherapy in older"
  },
  {
    "id": 443,
    "source": "guideline_c3debd",
    "text": "are ben- (Gallo et al., 2013). Thus, both the short- and long-term risks and eficial to older adults, the research literature is at best limited. benefits of antidepressant pharmacotherapy in older adults, togeth- Moderators of effect, such as health and cognitive status, are poor- er with patient preferences, need to be carefully weighed in shared ly understood. The majority of older adults included in treatment decision-making with patients and families. studies are younger older adults, and little is known about the ben- efits of treatment for those in the eighth and ninth decades of life. Finally, as is common across all age cohorts, the diversity of patient Need for a Clearer Taxonomy of samples is minimal. Psychotherapies Last, family caregiver burden in the context of late-life"
  },
  {
    "id": 444,
    "source": "guideline_c3debd",
    "text": "Finally, as is common across all age cohorts, the diversity of patient Need for a Clearer Taxonomy of samples is minimal. Psychotherapies Last, family caregiver burden in the context of late-life depres- sion is a significant public health issue. This underscores the impor- The great deal of variability in what is grouped in a review as a par- tance of engaging family members in the process of care, both as ticular form of psychotherapy (e.g., cognitive therapy, psychody- sources of reliable information about how a loved one with depres- namic therapy, etc.) also interferes with establishing clear treatment sion is doing, and also to foster engagement in and adherence to guidelines. The panel, in some cases, had difficulty determining what treatment for a sufficient period of time to"
  },
  {
    "id": 445,
    "source": "guideline_c3debd",
    "text": "clear treatment sion is doing, and also to foster engagement in and adherence to guidelines. The panel, in some cases, had difficulty determining what treatment for a sufficient period of time to realize and to sustain was included in categories in reviews and how the determinations meaningful benefit. Family caregivers are frequently demoralized by were made and, at times, questioned whether treatments should be their loved one s depression and welcome the opportunity to learn grouped together. For example, group and individual psychodynamic more about the illness and its treatment and resources for self-care. psychotherapy were grouped together in a meta-analysis (Driessen et al., 2015) with an outcome suggesting less efficacy than other Older adult patients for whom treatment fails."
  },
  {
    "id": 446,
    "source": "guideline_c3debd",
    "text": "for self-care. psychotherapy were grouped together in a meta-analysis (Driessen et al., 2015) with an outcome suggesting less efficacy than other Older adult patients for whom treatment fails. Similar to the general treatment approaches. However, when only individual treatments adult population, there is also a great need for comparative effective- were analyzed, there was no difference between psychodynamic and ness research because, as suggested by the Nelson et al. (2008) other treatment approaches (Driessen et al., 2015) which is consis- meta-analysis, existing treatments may benefit no more than half of tent with Barber et al. (2012). Similarly, a well-defined model of older adults with major depression. Further, as noted above, there is psychotherapy, emotion-focused therapy, was"
  },
  {
    "id": 447,
    "source": "guideline_c3debd",
    "text": "more than half of tent with Barber et al. (2012). Similarly, a well-defined model of older adults with major depression. Further, as noted above, there is psychotherapy, emotion-focused therapy, was grouped in reviews limited information about moderators of treatment response (which under  non-specific and supportive models  (Cuijpers, Driessen, et treatment for which patient). Some practitioners advocate switching al., 2012a). Experts indicate that this is a mis-categorization, but the class of antidepressant, while others argue for the use of augmenta- categorization resulted in masking potential evidence regarding effi- tion strategies. The data do not provide conclusive evidence for either cacy of this intervention. switching or augmentation strategies. Other times, the same or"
  },
  {
    "id": 448,
    "source": "guideline_c3debd",
    "text": "potential evidence regarding effi- tion strategies. The data do not provide conclusive evidence for either cacy of this intervention. switching or augmentation strategies. Other times, the same or similar labels were used to describe Judging from the statistic numbers-needed-to-treat report- approaches that are actually quite different from each other. For ed in randomized, placebo-controlled trials, antidepressant phar- instance, although conceptually similar, psychoanalysis, psycho- macotherapy appears to be more effective in long-term or main- analytic psychotherapy, brief psychodynamic psychotherapy, and tenance treatment (over 2 3 years), with respect to preventing interpersonal psychotherapy are also different regarding emphasis, recurrence of major depressive episodes, than in"
  },
  {
    "id": 449,
    "source": "guideline_c3debd",
    "text": "psychotherapy, and tenance treatment (over 2 3 years), with respect to preventing interpersonal psychotherapy are also different regarding emphasis, recurrence of major depressive episodes, than in short-term use focus, strategies, length of treatment, and hypothesized mecha- (up to 12 weeks) with respect to rates of response or remission. A nisms of action. Although this labeling issue exists and was rec- meta-analysis by Kok and colleagues (Kok, Heeren,   Nolen, 2011; ognized by the panel, the panel strove to use labels similar to the Kok, Nolen,   Heeren, 2012) estimated a number needed to treat investigators in order to maintain consistency with the language of 3.4. The clinical relevance of this observation is considerable, used by investigators as well as to maintain a sufficient"
  },
  {
    "id": 450,
    "source": "guideline_c3debd",
    "text": "to treat investigators in order to maintain consistency with the language of 3.4. The clinical relevance of this observation is considerable, used by investigators as well as to maintain a sufficient sampling given the risk for a chronic, relapsing course in late-life depres- of studies under each treatment approach. However, it is possible sion (Kok   Reynolds, 2017). There is yet, however, no strong evi- that the outcomes of meta-analyses and reviews might be differ- dence-based consensus about which patients need maintenance ent based on alternate groupings of interventions (i.e., cognitive pharmacotherapy, apart from those with three or more episodes of therapy alone or combined with cognitive-behavioral therapy or major depression. behavioral therapy for analyses) potentially"
  },
  {
    "id": 451,
    "source": "guideline_c3debd",
    "text": "pharmacotherapy, apart from those with three or more episodes of therapy alone or combined with cognitive-behavioral therapy or major depression. behavioral therapy for analyses) potentially resulting in differ- The modest efficacy of antidepressant pharmacotherapy needs ent evaluations of effectiveness. Given this possibility, there is a to be weighed against side-effect burden and adverse effects, espe- need for formal efforts at developing a more universal taxonomy cially in frail older adults with medical poly-morbidity. Potential of psychotherapies that can better categorize shared and unique safety concerns in older adults treated with antidepressants include features of interventions incorporated in specific treatments. The drug drug interactions, hyponatremia, falls and fractures,"
  },
  {
    "id": 452,
    "source": "guideline_c3debd",
    "text": "safety concerns in older adults treated with antidepressants include features of interventions incorporated in specific treatments. The drug drug interactions, hyponatremia, falls and fractures, gastroin- panel strongly recommends that researchers carefully operation- testinal bleeding, cardiovascular effects, and bone metabolism oste- alize and specifically define the treatment approach that they are oporosis. At the same time, however, evidence-based management investigating and label accordingly. The problem is compounded of late-life depression in primary care patients (where most patients by the fact that it is often hard to know how the actual treatments are treated), in which both pharmacotherapy and learning-based were delivered, how adherent the therapists were, and how much"
  },
  {
    "id": 453,
    "source": "guideline_c3debd",
    "text": "by the fact that it is often hard to know how the actual treatments are treated), in which both pharmacotherapy and learning-based were delivered, how adherent the therapists were, and how much psychotherapies (interpersonal psychotherapy and problem-solving  borrowing  from other treatment modalities was done. APA   Guideline for the Treatment of Depression 55 Need for Rigorous Comparisons of Treatments supports articles including links to archives and appendices to facil- itate transparency and replicability, especially when journals allow and Treatment Modality very limited number of words. This can be particularly helpful with publication of treatment manuals associated with specific interven- Despite the increasing number of studies and meta-analyses com- tions. The panel also"
  },
  {
    "id": 454,
    "source": "guideline_c3debd",
    "text": "words. This can be particularly helpful with publication of treatment manuals associated with specific interven- Despite the increasing number of studies and meta-analyses com- tions. The panel also supports incorporating a section on harms and paring different treatments, the differences, process, and outcome burdens in reports on psychotherapy trials, consistent with the stan- data on different treatments remains elusive (Cuijpers, 2015; Cuijpers dard practice in pharmacotherapy research. Throughout the process et al., 2008), and more rigorous treatment comparisons of psycho- of completing this guideline, the inability to assess harms and bur- logical interventions are needed. One of the most challenging and dens of specific interventions was a major obstacle to having confi- yet"
  },
  {
    "id": 455,
    "source": "guideline_c3debd",
    "text": "this guideline, the inability to assess harms and bur- logical interventions are needed. One of the most challenging and dens of specific interventions was a major obstacle to having confi- yet pressing needs is developing methods to evaluate the contribu- dence in recommendations for psychotherapies. In terms of outcomes, tion of specific aspects of psychotherapy models compared with the the panel notes the need for longer term outcomes and supports shared or nonspecific aspects. In particular, designs that use a gen- researchers using the 5R model (response, remission, recovery, eral form of psychotherapy that represents the shared components relapse and recurrence; Frank et al., 1991) for defining symptom out- of effective models as a control condition would contribute to comes. End of"
  },
  {
    "id": 456,
    "source": "guideline_c3debd",
    "text": "psychotherapy that represents the shared components relapse and recurrence; Frank et al., 1991) for defining symptom out- of effective models as a control condition would contribute to comes. End of treatment response and remission (e.g., brief period of improving the ability to separate out the unique contributions of symptom improvement) are typically reported (Frank et al., 1991). specific models. Fewer studies have compared the efficacy of individ- However, recovery (e.g., depressive episode has been in remission for ual modalities of treatment versus group modalities. One of the an extended period of time), relapse (e.g., re-emergence of depres- biggest research gaps in terms of treatment implications is the eval- sive episode during a prior period of remission) and recurrence (e.g.,"
  },
  {
    "id": 457,
    "source": "guideline_c3debd",
    "text": "period of time), relapse (e.g., re-emergence of depres- biggest research gaps in terms of treatment implications is the eval- sive episode during a prior period of remission) and recurrence (e.g., uation of either the efficacy of treatments delivered in a group format re-emergence of symptoms during a prior period of recovery) are or comparisons of a treatment delivered in an individual format to also meaningful outcomes for evaluating treatments but are much treatment in a group format. Given how frequently group is the less commonly reported. Yet the outcomes of recovery, relapse, and modality of treatment in certain settings (i.e., Veteran s Administration recurrence are critical for understanding the endurance of treatment and psychiatric hospitals), better data on its comparability"
  },
  {
    "id": 458,
    "source": "guideline_c3debd",
    "text": "of treatment in certain settings (i.e., Veteran s Administration recurrence are critical for understanding the endurance of treatment and psychiatric hospitals), better data on its comparability to tradi- effects (Frank et al., 1991). The panel also supports expanded incor- tional individual therapy is imperative. poration of clinical significance (i.e., evaluating whether change of Another important domain is assessing new models of deliv- treatment leads to clinically meaningful difference such as changing ering previously supported approaches. This includes delivery in from meeting diagnostic criteria to no longer meeting criteria) for new environments (e.g., primary care, in home) and through the evaluating outcomes in addition to the traditional use of statistical use of new"
  },
  {
    "id": 459,
    "source": "guideline_c3debd",
    "text": "diagnostic criteria to no longer meeting criteria) for new environments (e.g., primary care, in home) and through the evaluating outcomes in addition to the traditional use of statistical use of new technologies (e.g., phone, video-conferencing, Internet, significance. smartphone apps). The panel found that some reviews lumped dif- ferent settings or technologies together, limiting the panel s ability to make comparisons. Testing Moderators and Mediators of Treatment Outcome Improving Methodology and Reporting in Some psychotherapy research demonstrated that, after treatment Treatment Studies completion, more than half of patients remained depressed (Thase et al., 1997), and of those who improved by the end of treatment, Along these lines, it is critical that randomized controlled trials"
  },
  {
    "id": 460,
    "source": "guideline_c3debd",
    "text": "completion, more than half of patients remained depressed (Thase et al., 1997), and of those who improved by the end of treatment, Along these lines, it is critical that randomized controlled trials test- about 40  experienced a relapse in depressive symptoms (Steinert, ing theoretically sound interventions be designed using the principles Hofmann, Kruse,   Leichsenring, 2014). Little is known about the of available study design guidelines (e.g., Consolidated Standards of reasons behind patient deterioration or lack of improvement, and Reporting Trials, Journal Article Reporting Standards Altman et al., less still about how to help patients achieve and maintain treatment 2001; Appelbaum et al., 2018; Levitt et al., 2018). The design features gains. The panel believes that researchers"
  },
  {
    "id": 461,
    "source": "guideline_c3debd",
    "text": "Altman et al., less still about how to help patients achieve and maintain treatment 2001; Appelbaum et al., 2018; Levitt et al., 2018). The design features gains. The panel believes that researchers should focus their efforts that the panel encourages researchers to adopt include: adequate on outcomes as well as on the identification of moderators of treat- control conditions (waitlist controls can artificially inflate effect sizes; ment outcomes to identify characteristics that predict treatment Furukawa et al., 2014); clear definitions of both active and control failure success. More specifically, if a given treatment protocol has conditions; extended long-term follow-up; comparisons between been found to be efficacious, for example, in comparison to no treat- treatment modalities"
  },
  {
    "id": 462,
    "source": "guideline_c3debd",
    "text": "if a given treatment protocol has conditions; extended long-term follow-up; comparisons between been found to be efficacious, for example, in comparison to no treat- treatment modalities (e.g., group vs. individual); direct comparisons ment, a large portion of the sample may still have not responded fully of dosage differences (e.g., number, length, or frequency of sessions) (or at all). Testing the moderator variables associated with who does for psychotherapies; definition and assessment of training in the and does not respond to a treatment is a next step in improving the intervention; and assessment of competence in and fidelity to the ability to develop and improve treatments, although doing so will intervention. The panel was concerned that many studies included in require much"
  },
  {
    "id": 463,
    "source": "guideline_c3debd",
    "text": "and assessment of competence in and fidelity to the ability to develop and improve treatments, although doing so will intervention. The panel was concerned that many studies included in require much larger sample sizes in order to have sufficient power to reviews provided an insufficient summary description of important test those hypotheses. Moderator variables can include a wide range components of their study design. Specifically, a number of studies of patient characteristics (e.g., sex, age, symptom severity, comor- did not provide information on the training and competence of the bidity, religion, physical health status), treatment-related factors providers, which again limits the ability to determine strength of (e.g., therapist competency, setting, treatment dose), and per-"
  },
  {
    "id": 464,
    "source": "guideline_c3debd",
    "text": "bidity, religion, physical health status), treatment-related factors providers, which again limits the ability to determine strength of (e.g., therapist competency, setting, treatment dose), and per- recommendations, as it is not known whether the treatment was son-centered outcomes (e.g., treatment preferences, treatment cost adequately delivered when under evaluation. In addition, the panel and accessibility). Also, it will be important for the field to consider 56 APA   Guideline for the Treatment of Depression developing innovative ways to match patients with treatments. Last, studies should examine the efficacy of a step-wise approach like switching patients from medication to types of psychotherapies (or vice versa) in cases of treatment failure (see Rush et al., 2006, for"
  },
  {
    "id": 465,
    "source": "guideline_c3debd",
    "text": "should examine the efficacy of a step-wise approach like switching patients from medication to types of psychotherapies (or vice versa) in cases of treatment failure (see Rush et al., 2006, for preliminary evidence). Ultimately, the goal of such research is to better understand how to make the treatment more effective for all persons or to better understand for which individuals the treatment is not recommended. Funding Needs Given the complexity and large amount of resources required to conduct scientifically valid randomized clinical trials (Barber, 2009; Nezu   Nezu, 2008), it is understandable that available high-quality research is limited. Funding is highly competitive and thus available to a relatively small number of investigators. To address the many questions raised in this"
  },
  {
    "id": 466,
    "source": "guideline_c3debd",
    "text": "that available high-quality research is limited. Funding is highly competitive and thus available to a relatively small number of investigators. To address the many questions raised in this document, it will require more investment in complex and expensive research across many investigative teams. In particular, key questions of moderators and mediators of treatment response require much larger sample sizes than are typical of current psychotherapy research studies. APA   Guideline for the Treatment of Depression 57 CONCLUSION Overall these limitations require caution and conservative recommendations given the gaps in the depression intervention literature. Thus, while the panel makes recommendations based on following the IOM (2011a) criteria for rigorous guideline development, the panel"
  },
  {
    "id": 467,
    "source": "guideline_c3debd",
    "text": "given the gaps in the depression intervention literature. Thus, while the panel makes recommendations based on following the IOM (2011a) criteria for rigorous guideline development, the panel is aware of the limits of its assessment and scope of its recommendations. The field is strongly urged to address significant issues related to study design and standardization of methodol- ogy (e.g., consistent inclusion of racially diverse populations, and consistency in defining treatments and measurement of outcomes). Further the field is encouraged to generate additional research and reviews on humanistic therapies, emotion-focused therapy, and dif- ferent treatment modalities. Altogether, the current guideline makes an important contribu- tion to the field and complements existing knowledge by"
  },
  {
    "id": 468,
    "source": "guideline_c3debd",
    "text": "therapies, emotion-focused therapy, and dif- ferent treatment modalities. Altogether, the current guideline makes an important contribu- tion to the field and complements existing knowledge by addressing treatment of depression from childhood through older adulthood, including an examination of psychotherapeutic interventions. Moreover, this guideline was developed following the IOM (2011a) standards for trustworthy guideline development. Finally, this guideline is an outgrowth of APA s evi- dence-based practice policy and is predicated on the three domains noted in earlier work by both the IOM and APA (American Psychological Association Presidential Task Force on Evidence-Based Practice, 2006) integrating the best available research; practitioner exper- tise; and patient culture, values"
  },
  {
    "id": 469,
    "source": "guideline_c3debd",
    "text": "and APA (American Psychological Association Presidential Task Force on Evidence-Based Practice, 2006) integrating the best available research; practitioner exper- tise; and patient culture, values and preferences. 58 APA   Guideline for the Treatment of Depression Conflicts of Interest industry. However, these experts may possess unique insight into appropriate health care needs and recommendations. There is growing recognition that financial relations to the Prior to final appointment to the panel, candidates completed a pharmaceutical industry threaten the integrity of research and of conflict of interest (COI) form that was then reviewed by the advi- clinical practice guidelines. However, the issue is still contentious, sory steering committee or APA staff to ensure there were no iden-"
  },
  {
    "id": 470,
    "source": "guideline_c3debd",
    "text": "of interest (COI) form that was then reviewed by the advi- clinical practice guidelines. However, the issue is still contentious, sory steering committee or APA staff to ensure there were no iden- and exclusion of all potential guideline development panel mem- tified conflicts that would prohibit participation, with the bers with such conflicts may itself be seen as biased against phar- understanding that some  adversarial conflict  representing differ- macological treatments or particular medical specialties. Similarly, ent points of views was to be expected and encouraged in this pro- experts with respect to psychotherapy tend to have intellectual cess. While intellectual affiliations were expected, no panel members passions for specific types of psychosocial interventions that also had"
  },
  {
    "id": 471,
    "source": "guideline_c3debd",
    "text": "with respect to psychotherapy tend to have intellectual cess. While intellectual affiliations were expected, no panel members passions for specific types of psychosocial interventions that also had been singularly identified with particular approaches to inter- constitute potential conflicts. Yet, such individuals may be dif- vention nor had significant known financial conflicts. Once the panel ficult to replace because of their unique insights, as well as their was formed, all panel members completed an educational module status in the eyes of key stakeholders (IOM, 2011b). Hence, rath- on conflicts of interest that underscored the importance of identify- er than exclude topic experts and risk minimizing expertise, APA ing and managing any potential conflicts, both financial and"
  },
  {
    "id": 472,
    "source": "guideline_c3debd",
    "text": "on conflicts of interest that underscored the importance of identify- er than exclude topic experts and risk minimizing expertise, APA ing and managing any potential conflicts, both financial and intellec- follows the principle of adversarial collaboration in which compet- tual. The APA conflicts of interest policy and disclosure form are ing interests are balanced on panels and committees, rather than included in the appendix. avoided. This approach is also used by other leading developer All panel members and staff affiliated with development of of clinical practice guidelines, such as the American College of the depression clinical practice guideline updated their conflicts of Cardiology Foundation American Heart Association Task Force on interest form on an annual basis and were asked"
  },
  {
    "id": 473,
    "source": "guideline_c3debd",
    "text": "College of the depression clinical practice guideline updated their conflicts of Cardiology Foundation American Heart Association Task Force on interest form on an annual basis and were asked to provide more Practice Guidelines (American College of Cardiology Foundation   timely updates if changes in their disclosures were perceived to American Heart Association, 2010; IOM, 2011b). be relevant to the development of the guideline. All were asked to disclose all potential conflicts of interest with the understanding Conflict of interest forms for all authors are available by request for that these would be reviewed and evaluated, and a decision would public review. be made regarding how to manage identified conflicts. Conflicts of interest included not only possibilities for financial or"
  },
  {
    "id": 474,
    "source": "guideline_c3debd",
    "text": "these would be reviewed and evaluated, and a decision would public review. be made regarding how to manage identified conflicts. Conflicts of interest included not only possibilities for financial or professional gain, but also strong intellectual viewpoints that might then limit Author Disclosures someone from objectively reviewing the evidence. Emphasis was placed on disclosing all potential conflicts and allowing the staff The Clinical Practice Guideline Development Panel reported the fol- and chair (or other appropriate entity in the case of the chair) to lowing disclosures during the development and approval of this review the disclosures and determine whether or not such infor- guideline. The following points, drawn from panelists  disclosures, mation could reasonably be construed"
  },
  {
    "id": 475,
    "source": "guideline_c3debd",
    "text": "and approval of this review the disclosures and determine whether or not such infor- guideline. The following points, drawn from panelists  disclosures, mation could reasonably be construed as to be a source of possi- were among the information noted in assessing and managing poten- ble influence on the guideline development process. Furthermore, tial financial and intellectual conflicts of interest. on first joining the initiative and at the initial face-to-face meeting, panel members were asked to verbalize their conflicts, so all pres- John R. McQuaid, PhD (Chair), is a clinical psychologist, Associate ent would be familiar with the diversity of perspectives and range Chief of Staff for Mental Health and Vice Chair at San Francisco s of possible influences. This practice continued at"
  },
  {
    "id": 476,
    "source": "guideline_c3debd",
    "text": "Associate ent would be familiar with the diversity of perspectives and range Chief of Staff for Mental Health and Vice Chair at San Francisco s of possible influences. This practice continued at subsequent face- Department of Veteran s Affairs, as well as a professor of clinical to-face meetings. psychology in the Department of Psychiatry at the University of All authors were required to disclose their intellectual inter- California, San Francisco. He is also a coauthor of a self-help book, ests, financial and professional interests, interests related to APA, Peaceful Mind: Using Mindfulness and Cognitive Behavioral Psychology and other relevant interests. They were also required to disclose to Overcome Depression (2004). interests of family members, defined as  a spouse, domestic part-"
  },
  {
    "id": 477,
    "source": "guideline_c3debd",
    "text": "and Cognitive Behavioral Psychology and other relevant interests. They were also required to disclose to Overcome Depression (2004). interests of family members, defined as  a spouse, domestic part- ner, parent, child, or other relative with whom [they] have a com- Elizabeth H. Lin, MD, MPH (Vice-Chair), is a clinical professor in the parably close tie.  Authors were asked to disclose the following Department of Psychiatry and Behavioral Sciences at the University of potential conflicts of interest: scientific educational professional Washington School of Medicine, an adjunct scientific investigator at communications, communications to a general audience, roles Kaiser Permanente Washington Health Research Institute, and a family at APA or other organizations, relevant honoraria,"
  },
  {
    "id": 478,
    "source": "guideline_c3debd",
    "text": "investigator at communications, communications to a general audience, roles Kaiser Permanente Washington Health Research Institute, and a family at APA or other organizations, relevant honoraria, endorsements, medicine physician at Washington Permanente Medical Group. She has research funding or royalties, payment for services or training, and received research funding from National Institutes of Health and devel- serving as expert witnesses. None of the reported potential con- oped evidence-based models for integrating mental health into primary flicts of interest precluded a nominated candidate from serving on care. Dr. Lin codeveloped Collaborative Care for Depression and the guideline development panel. Excluding all guideline develop- TEAMcare (integrates depression care with"
  },
  {
    "id": 479,
    "source": "guideline_c3debd",
    "text": "candidate from serving on care. Dr. Lin codeveloped Collaborative Care for Depression and the guideline development panel. Excluding all guideline develop- TEAMcare (integrates depression care with systematic chronic medical ment panel candidates with any potential conflicts of interest risks care for multimorbidity patients). She has led professional training to excluding the level and type of expertise needed to fully evaluate disseminate and implement the integrated care models in Community treatment benefits and risks. The most knowledgeable individuals Health Plan of Washington and Providence Health   Services. Dr. Lin can be conflicted because of expertise in their areas of interest, and has also led workshops to bring mindfulness and compassion to clinical they may possess both"
  },
  {
    "id": 480,
    "source": "guideline_c3debd",
    "text": "Health   Services. Dr. Lin can be conflicted because of expertise in their areas of interest, and has also led workshops to bring mindfulness and compassion to clinical they may possess both financial and intellectual conflicts of inter- practice for continuing medical education programs of Kaiser est from participating in research and serving as consultants to Permanente Medical Groups and Foundation of Medical Excellence. APA   Guideline for the Treatment of Depression 59 Jacques P. Barber, PhD, is a clinical psychologist and a professor and Laura H. Mufson, PhD, is a clinical psychologist, professor of medical dean of the Gordon F. Derner School of Psychology at Adelphi psychology, associate director, Division of Child and Adolescent University. He is also a professor emeritus of"
  },
  {
    "id": 481,
    "source": "guideline_c3debd",
    "text": "professor of medical dean of the Gordon F. Derner School of Psychology at Adelphi psychology, associate director, Division of Child and Adolescent University. He is also a professor emeritus of psychology in the Psychiatry in the Department of Psychiatry at Columbia University Department of Psychiatry at the University of Pennsylvania s College of Physicians and Surgeons Columbia University Medical Perelman School of Medicine. Dr. Barber receives royalties from Center, as well as a research scientist and director of the Department of Guilford Press and Cambridge University Press on texts in dynamic Clinical Psychology at New York State Psychiatric Institute. Dr. Mufson therapy and provides workshops at several conferences including the receives royalties from Guilford Publications for the"
  },
  {
    "id": 482,
    "source": "guideline_c3debd",
    "text": "Clinical Psychology at New York State Psychiatric Institute. Dr. Mufson therapy and provides workshops at several conferences including the receives royalties from Guilford Publications for the book titled American Psychological Association and the American Psychiatric Interpersonal Psychotherapy for Depressed Adolescents, Second Edition Association related to the content of his books. He previously (2004), by Mufson, Dorta, Moreau, and Weissman. She also receives received research funding from the National Institute of Mental royalties from Oxford University Press for the books titled Preventing Health, National Institute on Drug Addiction, United States Israel Adolescent Depression: Interpersonal Psychotherapy Adolescent Skills Binational Fund and the Swedish Government. He also"
  },
  {
    "id": 483,
    "source": "guideline_c3debd",
    "text": "Preventing Health, National Institute on Drug Addiction, United States Israel Adolescent Depression: Interpersonal Psychotherapy Adolescent Skills Binational Fund and the Swedish Government. He also received com- Training (2016) by Young, Mufson, and Schueler, and Family-based plementary supplies from Pfizer, Inc. for one of his clinical trials. Interpersonal Psychotherapy for Depressed Preadolescents (2018) by Dietz, Weinberg, and Mufson. In addition, she receives funding from the Alfiee M. Breland-Noble, PhD, MHSc is director of the African National Institute for Mental Health to conduct studies of efficacy and American Knowledge Optimized for Mindfully-Healthy Adolescents effectiveness of interpersonal psychotherapy for depressed adolescents (AAKOMA) and associate professor of"
  },
  {
    "id": 484,
    "source": "guideline_c3debd",
    "text": "studies of efficacy and American Knowledge Optimized for Mindfully-Healthy Adolescents effectiveness of interpersonal psychotherapy for depressed adolescents (AAKOMA) and associate professor of psychiatry at the Georgetown and provides training for clinicians in interpersonal psychotherapy. University Medical Center. She currently receives federal support for biomedical research from the National Institute for Mental Health Arthur M. Nezu, PhD, DHL, ABPP, was trained as a clinical psycholo- and the National Institute on Child and Maternal Health of the gist and is currently Distinguished University Professor of Psychology, National Institutes of Health. Dr. Breland-Noble receives regular Professor of Medicine, and Professor of Public Health at Drexel requests to present her current"
  },
  {
    "id": 485,
    "source": "guideline_c3debd",
    "text": "University Professor of Psychology, National Institutes of Health. Dr. Breland-Noble receives regular Professor of Medicine, and Professor of Public Health at Drexel requests to present her current research findings regarding depres- University. He was previously editor of the Journal of Consulting and sion in racially diverse children and youth from public and private Clinical Psychology, current associate editor of the American academic institutions in the United States. In the past year, she has Psychologist, and incoming editor-in-chief of Clinical Psychology: provided treatment to a diverse group of children and adults in clini- Science and Practice. He was a member of the APA task force that cal settings. recently revised the Journal Article Reporting Standards for quanti- tative"
  },
  {
    "id": 486,
    "source": "guideline_c3debd",
    "text": "group of children and adults in clini- Science and Practice. He was a member of the APA task force that cal settings. recently revised the Journal Article Reporting Standards for quanti- tative research and the codeveloper of problem-solving therapy Pim Cuijpers, PhD, is a clinical psychologist and the director of the (PST). He receives royalties as a coauthor for books on PST, such as Department of Clinical, Neuro and Developmental Psychology at the Problem-Solving Therapy: A Treatment Manual (2013; Springer) and Vrije Universiteit Amsterdam. has been funded for his research and program development activities by the National Cancer Institute, the National Institute of Mental Leslie Samuel Greenberg, PhD, is a distinguished research professor Health, the Department of Veterans Affairs,"
  },
  {
    "id": 487,
    "source": "guideline_c3debd",
    "text": "activities by the National Cancer Institute, the National Institute of Mental Leslie Samuel Greenberg, PhD, is a distinguished research professor Health, the Department of Veterans Affairs, the Department of in the Department of Psychology at York University and the director Defense, the U.S. Air Force, and the Pew Charities Trusts. of the York Psychotherapy Research Clinic. Charles F. Reynolds, III, MD, is a psychiatrist and an Endowed Vanessa Y. Jones is a certified surgical technologist and has worked Professor in geriatric psychiatry at the University of Pittsburgh School in this capacity in both general and specialty surgery with a range of of Medicine University of Pittsburgh Medical Center (UPMC) and a healthcare providers since 2001. Her personal experience of depres- professor of"
  },
  {
    "id": 488,
    "source": "guideline_c3debd",
    "text": "in both general and specialty surgery with a range of of Medicine University of Pittsburgh Medical Center (UPMC) and a healthcare providers since 2001. Her personal experience of depres- professor of behavioral and community health science at the sion led her to develop a depression and bipolar support alliance University of Pittsburgh s Graduate School of Public Health. He also group in Howard County, MD in 2006. Ms. Jones continues to run serves as the director of the Aging Institute of UPMC Senior Services. this advocacy group as a point of contact for new participants and Dr. Reynolds receives funding from the National Institute of Mental plans and facilitates group support meetings. Health (NIMH) to perform psychosocial and pharmacological inter- vention research in older adults at"
  },
  {
    "id": 489,
    "source": "guideline_c3debd",
    "text": "funding from the National Institute of Mental plans and facilitates group support meetings. Health (NIMH) to perform psychosocial and pharmacological inter- vention research in older adults at risk for or already living with mood Michael  Misha  Kessler, BA, is a published and award-winning advo- disorders. He currently receives pharmaceutical supplies for his cate and public speaker, social entrepreneur, and software developer. NIMH research from Bristol Myers Squibb, Wyeth, and Eli Lilly. The His personal experiences with mental health challenges as a young three pharmaceutical companies do not play a role in his research. adult became the foundation of his career, motivating him to find creative solutions to pressing issues in the mental health space, unit- Forrest Scogin, Jr., PhD, is"
  },
  {
    "id": 490,
    "source": "guideline_c3debd",
    "text": "not play a role in his research. adult became the foundation of his career, motivating him to find creative solutions to pressing issues in the mental health space, unit- Forrest Scogin, Jr., PhD, is a clinical psychologist and a professor in ing principles of consumer autonomy and user-oriented design. Mr. the Department of Psychology at the University of Alabama. He Kessler founded Remedient, a digital marketing and design firm for formerly directed a Graduate Psychology Education grant from the mental health professionals, which aims to create greater digital Health Resources and Service Administration s Bureau of Health accessibility for consumers; Seven Summits for Suicide Prevention, a Professions that developed interdisciplinary training and proactive biennial mountain climbing"
  },
  {
    "id": 491,
    "source": "guideline_c3debd",
    "text": "Administration s Bureau of Health accessibility for consumers; Seven Summits for Suicide Prevention, a Professions that developed interdisciplinary training and proactive biennial mountain climbing charity and fundraiser, which donates models for the provision of psychological services to underserved 100  of proceeds to small budget suicide prevention nonprofits; and populations in primary care clinics. Crisis International, a global resource directory and knowledge base for suicide intervention and postvention needs. Conflict of interest forms for all authors are available by request for public review. 60 APA   Guideline for the Treatment of Depression Developer Pediatrics, Epidemiology, and Clinical and Translational Science, Epidemiology at the University of Pittsburgh School of"
  },
  {
    "id": 492,
    "source": "guideline_c3debd",
    "text": "public review. 60 APA   Guideline for the Treatment of Depression Developer Pediatrics, Epidemiology, and Clinical and Translational Science, Epidemiology at the University of Pittsburgh School of Medicine, for their expert consultation. We are grateful to RTI-UNC scientists for American Psychological Association Depression Guideline their systematic review work and methodological guidance. Development Panel. The Depression Guideline Development Panel is a multidisciplinary Panel of experts. Funding Source Sponsor This guideline was developed with financial support from the American Psychological Association. The Depression Guideline Development Panel (GDP) functioned as an independent Panel of the association. Final recommendations were reviewed by the APA Council of Representatives for"
  },
  {
    "id": 493,
    "source": "guideline_c3debd",
    "text": "Association. The Depression Guideline Development Panel (GDP) functioned as an independent Panel of the association. Final recommendations were reviewed by the APA Council of Representatives for approval (yes or no) as APA policy. However, the Council had no influence on the content of the recommendations. Acknowledgments We thank former panel member Mr. Iden Campbell McCollum for his valuable contributions to information on patient culture, values, and preferences and Dr. Rhonda Robinson Beale for her contributions to the panel s understanding of real-life application of guidelines and implications within health care systems. We are appreciative of the Advisory Steering Committee s support and guidance in this endeavor. We are grateful to former APA Executive Director of Practice, Dr."
  },
  {
    "id": 494,
    "source": "guideline_c3debd",
    "text": "within health care systems. We are appreciative of the Advisory Steering Committee s support and guidance in this endeavor. We are grateful to former APA Executive Director of Practice, Dr. Katherine Nordal, for her support and championing of this initiative as well as APA s Board of Professional Affairs, Board of Scientific Affairs, Council of Representatives, and Board of Directors. We appreciate the work of Dr. Eirini Karyotaki in evaluating the method- ological quality of multiple systematic reviews used by the panel. We appreciate the work of APA staff Mr. Jacob Marzalik and Dr. C. Vaile Wright and former APA staff Ms. Shannon Beattie supporting the work of this panel. We also thank Dr. Neal Ryan, the Joaquim Puig- Antich Professor of Child Psychiatry, and Dr. David Brent, the"
  },
  {
    "id": 495,
    "source": "guideline_c3debd",
    "text": "Vaile Wright and former APA staff Ms. Shannon Beattie supporting the work of this panel. We also thank Dr. Neal Ryan, the Joaquim Puig- Antich Professor of Child Psychiatry, and Dr. David Brent, the Endowed Chair in Suicide Studies and Professor of Psychiatry, APA   Guideline for the Treatment of Depression 61 REFERENCES Ajilchi, B., Ahadi, H., Najati, V.,   Delavar, A. (2013). The effectiveness American Geriatrics Society 2015 Beers Criteria Update Expert Panel. of intensive short term dynamic psychotherapy in decrease of (2015). American geriatrics society 2015 updated beers criteria for depression level. European Journal of Experimental Biology, 3(2), potentially inappropriate medication use in older adults. Journal of the 342 346. American Geriatrics Society, 63, 2227 2246. doi:"
  },
  {
    "id": 496,
    "source": "guideline_c3debd",
    "text": "depression level. European Journal of Experimental Biology, 3(2), potentially inappropriate medication use in older adults. Journal of the 342 346. American Geriatrics Society, 63, 2227 2246. doi: 10.1111 jgs.13702 Albert, P. R. (2015). Why is depression more prevalent in women? American Medical Association. (2016). Informed consent. Retrieved from Journal of Psychiatry   Neuroscience: JPN, 40(4), 219 221.   org 10.1503 jpn.150205 American Psychiatric Association. (2013). Diagnostic and statistical manual Alegr a, M., Canino, G., R os, R., Vera, M., Calder n, J., Rusch, D.,   Ortega, of mental disorders (5th ed.). Washington, DC: Author. A. N. (2002). Mental health care for Latinos: Inequalities in use of American Psychiatric Association. (2016). Code of medical ethics opinion speciality"
  },
  {
    "id": 497,
    "source": "guideline_c3debd",
    "text": "disorders (5th ed.). Washington, DC: Author. A. N. (2002). Mental health care for Latinos: Inequalities in use of American Psychiatric Association. (2016). Code of medical ethics opinion speciality mental health services among Latinos, African Americans, 2.1.1. Retrieved from  and non-Latino Whites. Psychiatric Services, 53(12), 1547 1555. informed-consent Alegr a, M., Chatterji, P., Wells, K., Cao, Z., Chen, C.-n., Takeuchi, D., . . . American Psychological Association, Presidential Task Force on Meng, X.-L. (2008). Disparity in depression treatment among racial Evidence-Based Practice. (2006). Evidence-based practice in and ethnic minority populations in the United States. Psychiatric psychology. American Psychologist, 61(4), 271 285. doi: 10.1037 0003- Services, 59(11), 1264 1272."
  },
  {
    "id": 498,
    "source": "guideline_c3debd",
    "text": "(2006). Evidence-based practice in and ethnic minority populations in the United States. Psychiatric psychology. American Psychologist, 61(4), 271 285. doi: 10.1037 0003- Services, 59(11), 1264 1272. doi:10.1176 appi.ps.59.11.1264 066X.61.4.271 Alegr a, M., Mulvaney-Day, N., Woo, M., Torres, M., Gao, S.,   Oddo, V. American Psychological Association. (2012). Guidelines for psychological (2007). Correlates of past-year mental health service use among practice with lesbian, gay, and bisexual clients. American Psychologist, Latinos: Results from the National Latino and Asian American Study. 67(1), 10 42.  American Journal of Public Health, 97(1), 76 83. American Psychological Association. (2014). Guidelines for psychological Alegr a, M., Vallas, M.,   Pumariega, A. J. (2010). Racial and"
  },
  {
    "id": 499,
    "source": "guideline_c3debd",
    "text": "67(1), 10 42.  American Journal of Public Health, 97(1), 76 83. American Psychological Association. (2014). Guidelines for psychological Alegr a, M., Vallas, M.,   Pumariega, A. J. (2010). Racial and ethnic practice with older adults. American Psychologist, 69(1), 34 65. http:   disparities in pediatric mental health. Child and Adolescent Psychiatric psycnet.apa.org fulltext 2014-01475-001.html Clinics, 19(4), 759 774. doi:10.1016 j.chc.2010.07.001 American Psychological Association. (2015a). Professional practice Alexopoulos, G. S., Raue, P.,   Are n, P. (2003). Problem-solving therapy guidelines: Guidance for developers and users. American Psychologist, versus supportive therapy in geriatric major depression with executive 70(9), 823 831.  dysfunction. American Journal of Geriatric"
  },
  {
    "id": 500,
    "source": "guideline_c3debd",
    "text": "Guidance for developers and users. American Psychologist, versus supportive therapy in geriatric major depression with executive 70(9), 823 831.  dysfunction. American Journal of Geriatric Psychiatry, 11(1), 46 52. American Psychological Association. (2015b). Guidelines for Allart-van Dam, E., Hosman, C. M. H., Hoogduin, C. A. L.,   Schaap, C. psychological practice with transgender and gender nonconforming P. D. R. (2003). The coping with depression course: Short-term people. American Psychologist, 70(9), 832 864.  outcomes and mediating effects of a randomized controlled trial in the org doi 10.1037 a0039906 treatment of subclinical depression. Behavior Therapy, 34, 381 396. American Psychological Association. (2017a). Ethical principles of Al-Mateen, C. S.,   Rogers, K. M. (2018)."
  },
  {
    "id": 501,
    "source": "guideline_c3debd",
    "text": "doi 10.1037 a0039906 treatment of subclinical depression. Behavior Therapy, 34, 381 396. American Psychological Association. (2017a). Ethical principles of Al-Mateen, C. S.,   Rogers, K. M. (2018). Suicide among African- psychologists and code of conduct. Washington, DC: Author. American and other African-Origin youth. In A.J. Pumariega   N. Sharma (Eds.), Suicide among diverse youth (pp. 31 49). Cham, American Psychological Association. (2017b). Multicultural guidelines: An Switzerland: Springer. ecological approach to context, identity, and intersectionality. Retrieved from:  Altman, D. G., Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., ... Lang, T. (2001). The revised CONSORT statement for reporting Aneshensel, C. S.,   Sucoff, C. A. (1996). The neighborhood context"
  },
  {
    "id": 502,
    "source": "guideline_c3debd",
    "text": "Schulz, K. F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., ... Lang, T. (2001). The revised CONSORT statement for reporting Aneshensel, C. S.,   Sucoff, C. A. (1996). The neighborhood context of randomized trials: Explanation and elaboration. Annals Of Internal adolescent mental health. Journal of Health and Social Behavior, 37(4), Medicine, 134(8), 663 694. 293 310. American Academy of Child and Adolescent Psychiatry. (2013). Facts Appelbaum, M., Cooper, H., Kline, R. B., Mayo-Wilson, E., Nezu, A. M.,   for families: The depressed child Vol. 4 [Fact sheet]. Retrieved from Rao, S. M. (2018). Journal article reporting standards for quantitative  research in psychology: The APA Publications and Communications families 04 the depressed child.pdf Board task force report. American"
  },
  {
    "id": 503,
    "source": "guideline_c3debd",
    "text": "M. (2018). Journal article reporting standards for quantitative  research in psychology: The APA Publications and Communications families 04 the depressed child.pdf Board task force report. American Psychologist, 73(1), 3 25. http:   psycnet.apa.org doi 10.1037 amp0000191 American Academy of Child and Adolescent Psychiatry. (2017). Facts for families: Know your rights: Consent and confidentiality No. 103 [Fact Appleton, K. M., Rogers, P. J.,   Ness, A. R. (2010). Updated sheet]. Retrieved from  systematic review and meta-analysis of the effects of n-3 long- youth facts for families fff-guide Know-Your-Rights-Consent-and- chain polyunsaturated fatty acids on depressed mood. American Confidentiality-103.aspx Journal of Clinical Nursing, 91(3), 757 770.  ajcn.2009.28313 American College of"
  },
  {
    "id": 504,
    "source": "guideline_c3debd",
    "text": "Know-Your-Rights-Consent-and- chain polyunsaturated fatty acids on depressed mood. American Confidentiality-103.aspx Journal of Clinical Nursing, 91(3), 757 770.  ajcn.2009.28313 American College of Cardiology Foundation   American Heart Association. (2010). Methodology manual and policies from the Are n, P. A., Raue, P., Mackin, R. S., Kanellopoulos, D., McCulloch, C.,   ACCF AHA task force on practice guidelines. Retrieved from https:   Alexopoulos, G.S. (2010). Problem-solving therapy and supportive professional.heart.org idc groups ahamah-public  wcm  sop  therapy in older adults with major depression and executive documents downloadable ucm 319826.pdf dysfunction. American Journal of Psychiatry, 167(11), 1391 1398. Armbruster, P.,   Kazdin, A. E. (1994). Attrition in child"
  },
  {
    "id": 505,
    "source": "guideline_c3debd",
    "text": "with major depression and executive documents downloadable ucm 319826.pdf dysfunction. American Journal of Psychiatry, 167(11), 1391 1398. Armbruster, P.,   Kazdin, A. E. (1994). Attrition in child psychotherapy. Advances in Clinical Child Psychology 16, 81 108. 62 APA   Guideline for the Treatment of Depression Arnberg, F. K., Linton, S. J., Hultcrantz, M., Heintz, E.,   Jonsson, U. Bastos, A. G., Guimar es, L. S. P.,   Trentini, C. M. (2013). Neurocognitive (2014). Internet-delivered psychological treatments for mood and changes in depressed patients in psychodynamic psychotherapy, anxiety disorders: A systematic review of their efficacy, safety, and therapy with fluoxetine and combination therapy. Journal of Affective cost-effectiveness. PLoS ONE, 9(5), e98118. doi: 10.1371 journal."
  },
  {
    "id": 506,
    "source": "guideline_c3debd",
    "text": "disorders: A systematic review of their efficacy, safety, and therapy with fluoxetine and combination therapy. Journal of Affective cost-effectiveness. PLoS ONE, 9(5), e98118. doi: 10.1371 journal. Disorders, 151, 1066 1075. pone.0098118 Bear, L., Finer, R., Guo, S.,   Lau, A. S. (2014). Building the gateway to Atkins, M. S., Frazier, S. L., Adil, J. A.,   Talbott, E. (2003). School based success: An appraisal of progress in reaching underserved families mental health services in urban communities. In M. D. Weist, S. and reducing racial disparities in school-based mental health. W. Evans,   N. A. Lever (Eds.), Handbook of school mental health: Psychological Services, 11(4), 388 397.  Advancing practice and research (pp. 165 178). New York, NY: Springer. a0037969388 Auszra, L., Greenberg,"
  },
  {
    "id": 507,
    "source": "guideline_c3debd",
    "text": "A. Lever (Eds.), Handbook of school mental health: Psychological Services, 11(4), 388 397.  Advancing practice and research (pp. 165 178). New York, NY: Springer. a0037969388 Auszra, L., Greenberg, L. S.,   Herrmann, I. (2013). Client emotional Becker, S. P., Langberg, J. M.,   Evans, S. W. (2015). Sleep problems productivity Optimal client in-session emotional processing in predict comorbid externalizing behaviors and depression in young experiential therapy. Psychotherapy Research, 23(6), 732 746. http:   adolescents with attention-deficit hyperactivity disorder. European dx.doi.org 10.1080 10503307.2013.816882 Child and Adolescent Psychiatry, 24(8), 897 907. doi:10.1007 s00787- 014-0636-6 Avenevoli, S., Swendsen, J., He, J. P., Burstein, M.,   Merikangas, K. R. (2015). Major depression"
  },
  {
    "id": 508,
    "source": "guideline_c3debd",
    "text": "10503307.2013.816882 Child and Adolescent Psychiatry, 24(8), 897 907. doi:10.1007 s00787- 014-0636-6 Avenevoli, S., Swendsen, J., He, J. P., Burstein, M.,   Merikangas, K. R. (2015). Major depression in the National Comorbidity Survey  Behnke, K., Jensen, G. S., Graubaum, H.-J.,   Gruenwald, J. (2002). Adolescent supplement: Prevalence, correlates, and treatment. Journal Hypericum perforatum versus fluoxetine in the treatment of mild to of the American Academy of Child and Adolescent Psychiatry, 54(1), moderate depression. Advances in Therapy, 19(1), 43 52. 37 44. doi:10.1016 j.jaac.2014.10.010 Bell, A. C.,   D Zurilla, T. J. (2009). Problem-solving therapy for Ayen, I.,   Hautzinger, M. (2004). Kognitive verhaltenstherapie bei depression: A meta-analysis. Clinical Psychology Review, 29,"
  },
  {
    "id": 509,
    "source": "guideline_c3debd",
    "text": "Bell, A. C.,   D Zurilla, T. J. (2009). Problem-solving therapy for Ayen, I.,   Hautzinger, M. (2004). Kognitive verhaltenstherapie bei depression: A meta-analysis. Clinical Psychology Review, 29, 348-353. depressionen im klimakterium: Eine kontrollierte, randomisierte  inteventionsstudie [Cognitive behavioral therapy in menopausal Bernecker, S. I. (2012). How and for whom does interpersonal depression: A controlled, randomized intervention study]. Zeitschrift psychotherapy for depression work? Psychotherapy Bulletin, 47(2), f r Klinische Psychologie und Psychotherapie, 33(4), 290 299. doi: 13 17. 10.1026 1616-3443.33.4.290 Beutel, M. E., Wei flog, G., Leuteritz, K., Wiltink, J., Haselbacher, Backenstrass, M., Joest, K., Frank, A., Hingmann, S., Mundt, C.,   A., Ruckes, C., . . . Br hler,"
  },
  {
    "id": 510,
    "source": "guideline_c3debd",
    "text": "17. 10.1026 1616-3443.33.4.290 Beutel, M. E., Wei flog, G., Leuteritz, K., Wiltink, J., Haselbacher, Backenstrass, M., Joest, K., Frank, A., Hingmann, S., Mundt, C.,   A., Ruckes, C., . . . Br hler, E. (2014). Efficacy of short-term Kronm ller, K.-T. (2006). Preferences for treatment in primary care: psychodynamic psychotherapy (STPP) with depressed breast cancer A comparison of nondepressive, subsyndromal and major depressive patients: Results of a randomized controlled multicenter trial. Annals patients. General Hospital Psychiatry, 28(2), 178 180.  of Oncology, 25, 378 384. org 10.1016 j.genhosppsych.2005.10.001 Beutler, L. E., Castonguay, L. G.,   Follette, W. C. (2006). Therapeutic Baldessarini, R. J., Lau, W. K., Sim, J., Sum, M. Y.,   Sim, K. (2015). factors in dysphoric disorders."
  },
  {
    "id": 511,
    "source": "guideline_c3debd",
    "text": "Beutler, L. E., Castonguay, L. G.,   Follette, W. C. (2006). Therapeutic Baldessarini, R. J., Lau, W. K., Sim, J., Sum, M. Y.,   Sim, K. (2015). factors in dysphoric disorders. Journal of Clinical Psychology, 62(6), Duration of intitial treatment antidepressant treatment and 639 647.  subsequent relapse of major depression. Journal of Clinical Psychopharmacology, 35(1), 75 76. Biescheuvel-Leliefeld, K. E. M., Kok, G. D., Bockting, C. L. H., Cuijpers, P., Hollon, S. D., van Marwijk, H. W. J.,   Smit, F. (2015). Effectiveness Barbato, A.,   D Avanzo, B. (2008). Efficacy of couple therapy as a of psychological interventions in preventing recurrence of depressive treatment for depression: A meta-analysis. Psychiatric Quarterly, 79(2), disorder: Meta-analysis and meta-regression. Journal of"
  },
  {
    "id": 512,
    "source": "guideline_c3debd",
    "text": "of psychological interventions in preventing recurrence of depressive treatment for depression: A meta-analysis. Psychiatric Quarterly, 79(2), disorder: Meta-analysis and meta-regression. Journal of Affective 121 132. doi: 10.1007 s11126-008-9068-0 Disorders, 174, 400 410.  Barber, J. P. (2009). Towards a working through of some core conflicts Birmaher, B., Brent, D., Bernet, W., Bukstein, O., Walter, H., Benson, R. in psychotherapy research. Psychotherapy Research, 19(1), 1 12. doi: S., . . . Medicus, J. (2007). Practice parameter for the assessment 10.1080 10503300802609680. and treatment of children and adolescents with depressive disorders. Barber, J. P., Barrett, M. S., Gallop, R., Rynn, M. A.,   Rickels, K. (2012). Journal of the American Academy of Child   Adolescent Psychiatry,"
  },
  {
    "id": 513,
    "source": "guideline_c3debd",
    "text": "of children and adolescents with depressive disorders. Barber, J. P., Barrett, M. S., Gallop, R., Rynn, M. A.,   Rickels, K. (2012). Journal of the American Academy of Child   Adolescent Psychiatry, 46(11), Short-term dynamic psychotherapy versus pharmacotherapy for 1503 1526.  major depressive disorder: A randomized, placebo-controlled trial. Birmaher, B.,   Rozel, J. S. (2003). The school age child. In I. M. Goodyer Journal of Clinical Psychiatry, 73(1), 66 73. doi: 10.4088 JCP.11m06831 (Ed.), Unipolar depression: A lifespan perspective. Cambridge, England: Barber, J. P., Muran, J. C., McCarthy, K. S.,   Keefe, R. J. (2013). Research Oxford University Press. on psychodynamic therapies. In M. J. Lambert (Ed.), Bergin and Birmaher, B., Ryan, N. D., Williamson, D. E., Brent, D. A.,"
  },
  {
    "id": 514,
    "source": "guideline_c3debd",
    "text": "McCarthy, K. S.,   Keefe, R. J. (2013). Research Oxford University Press. on psychodynamic therapies. In M. J. Lambert (Ed.), Bergin and Birmaher, B., Ryan, N. D., Williamson, D. E., Brent, D. A., Kaufman, J., Dahl, Garfield s handbook of psychotherapy and behavior change (6th ed., pp. R. E., . . . Nelson, B. (1996). Childhood and adolescent depression: 443 494). New York, NY: Wiley. A review of the past 10 years. Part I. Journal of the American Barkham, M., Shapiro, D. A., Hardy, G. E.,   Rees, A. (1999). Academy of Child and Adolescent Psychiatry, 35(11), 1427 1439. doi: Psychotherapy in two-plus-one sessions: Outcomes of a randomized 10.1097 00004583-199611000-00011 controlled trial of cognitive-behavioral and psychodynamic- Bjerkenstedt, L., Edman, G. V., Alken, R. G.,   Mannel, M."
  },
  {
    "id": 515,
    "source": "guideline_c3debd",
    "text": "two-plus-one sessions: Outcomes of a randomized 10.1097 00004583-199611000-00011 controlled trial of cognitive-behavioral and psychodynamic- Bjerkenstedt, L., Edman, G. V., Alken, R. G.,   Mannel, M. (2005). interpersonal therapy for subsyndromal depression. Journal of Hypericum extract LI 160 and fluoxetine in mild to moderate Consulting and Clinical Psychology, 67(2), 201 211. depression: A randomized, placebo-controlled multi-center study in Barrett, J. E., Williams, J. W., Oxman, T. E., Frank, E., Katon, W., Sullivan, outpatients. European Archives of Psychiatry   Clinical Neuroscience, 225, M., . . . Sengupta, A. S. (2001). Treatment of dysthymia and minor 40 47. doi: 10.1007 s00406-004-0532-z depression in primary care: A randomized trial in patients aged 18 to Blackstock, J. S.,"
  },
  {
    "id": 516,
    "source": "guideline_c3debd",
    "text": "225, M., . . . Sengupta, A. S. (2001). Treatment of dysthymia and minor 40 47. doi: 10.1007 s00406-004-0532-z depression in primary care: A randomized trial in patients aged 18 to Blackstock, J. S., Chae, K. B., Mauk, G. W.,   McDonald, A. (2018). 59 years. The Journal of Family Practice, 50(5), 405 412. Achieving access to mental health care for school-aged children in rural communities: A literature review. Rural Educator, 39(1), 12 25. APA   Guideline for the Treatment of Depression 63 Blazer, D. G. (2003). Depression in late life: Review and commentary. The Bright, J. I., Baker, K. D.,   Neimeyer, R. A. (1999). Professional and Journal of Gerontology, 58(3), 249 265. paraprofessional group treatments for depression: A comparison of cognitive-behavioral and mutual support"
  },
  {
    "id": 517,
    "source": "guideline_c3debd",
    "text": "K. D.,   Neimeyer, R. A. (1999). Professional and Journal of Gerontology, 58(3), 249 265. paraprofessional group treatments for depression: A comparison of cognitive-behavioral and mutual support interventions. Journal of Blom, M. B. J., Jonker, K., Dusseldorp, E., Spinhoven, P., Hoencamp, E., Consulting and Clinical Psychology, 67(4), 491 501. Haffmans, J.,   van Dyck, R. (2007). Combination treatment for acute depression is superior only when psychotherapy is added to Bruce, M. L., Ten Have, T. R., Reynolds, C. F., III, Katz, I. I., Schulberg, H. medication. Psychotherapy and Psychosomatics, 76, 289 297. doi: C., Mulsant, B. H., . . . Alexopoulos, G. S. (2004). Reducing suicidal 10.1159 000104705 ideation and depressive symptoms in depressed older primary care patients: A randomized"
  },
  {
    "id": 518,
    "source": "guideline_c3debd",
    "text": "76, 289 297. doi: C., Mulsant, B. H., . . . Alexopoulos, G. S. (2004). Reducing suicidal 10.1159 000104705 ideation and depressive symptoms in depressed older primary care patients: A randomized controlled trial. JAMA, 291(9), 1081 1091. doi: Blumenthal, J. A., Babyak, M. A., Moore, K. A., Craighead, E., Herman, 10.1001 jama.291.9.1081 S., Khatri, P., . . . Krishnan, R. (1999). Effects of exercise training on older adults with major depression. Archives of Internal Medicine, 159, Butters, M. A., Whyte, E. M., Nebes, R. D., Begley, A. E., Dew, M. A., 2349 2356. Mulsant, B. H., . . . Becker, J. T. (2004). The nature and determinants of neuropsychological functioning in late-life depression. Archives of Boyd, C. M., Singh, S., Varadhan, R., Weiss, C. O., Sharma, R., Bass, E. B., General"
  },
  {
    "id": 519,
    "source": "guideline_c3debd",
    "text": "J. T. (2004). The nature and determinants of neuropsychological functioning in late-life depression. Archives of Boyd, C. M., Singh, S., Varadhan, R., Weiss, C. O., Sharma, R., Bass, E. B., General Psychiatry, 61(5), 587 595. doi: 10.1001 archpsyc.61.6.587   Puhan, M. A. (2012). Methods for benefit and harm assessment in systematic reviews: Methods research report. (Prepared by the Johns Caldwell, C., Assari, S.,   Breland-Noble, A. M. (2016). The epidemiology Hopkins University Evidence-based Practice Center under contract of mental disorders in African American children and adolescents. In No. 290-2007-10061-I). AHRQ Publication No. 12(13)-EHC150-EF. A. M. Breland-Noble, C. S. Al-Mateen,   N. N. Singh (Eds.), Handbook Rockville, MD: Agency for Healthcare Research and Quality. of mental"
  },
  {
    "id": 520,
    "source": "guideline_c3debd",
    "text": "No. 290-2007-10061-I). AHRQ Publication No. 12(13)-EHC150-EF. A. M. Breland-Noble, C. S. Al-Mateen,   N. N. Singh (Eds.), Handbook Rockville, MD: Agency for Healthcare Research and Quality. of mental health in African American youth (pp. 3 20). New York, NY: Springer. Bradley, K. L., McGrath, P. J., Brannen, C. L.,   Bagnell, A. L. (2010). Adolescents  attitudes and opinion about depression treatment. Camacho, A., Gonzalez, P., Castaneda, S. F., Simmons, A., Buelna, C., Community Mental Health Journal, 46(3), 242 251. doi: 10.1007  Lemus, H.,   Talavera, G. A. (2015). Improvement in depressive s10597-009-9224-5 symptoms among Hispanic Latinos receiving a culturally tailored IMPACT and problem-solving intervention in a community health Breland-Noble, A. M. (2004). Mental healthcare"
  },
  {
    "id": 521,
    "source": "guideline_c3debd",
    "text": "s10597-009-9224-5 symptoms among Hispanic Latinos receiving a culturally tailored IMPACT and problem-solving intervention in a community health Breland-Noble, A. M. (2004). Mental healthcare disparities affect center. Community Mental Health Journal, 51(4), 385 392. doi:10.1007  treatment of Black adolescents. Psychiatric Annals, 34(7), 535 538. s10597-014-9750-7 Breland-Noble, A. M.,   AAKOMA Project Adult Advisory Board. Carney, R. M.,   Freedland, K. E. (2008). Depression in patients with (2012). Community and treatment engagement for depressed coronary heart disease. The American Journal of Medicine, 121(2), S20  African American youth: The AAKOMA FLOA pilot. Journal of Clinical S27.  Psychology in Medical Settings, 19(1), 41 48. doi: 10.1007 s10880-011- 9281-0 Carrington, C. H."
  },
  {
    "id": 522,
    "source": "guideline_c3debd",
    "text": "of Medicine, 121(2), S20  African American youth: The AAKOMA FLOA pilot. Journal of Clinical S27.  Psychology in Medical Settings, 19(1), 41 48. doi: 10.1007 s10880-011- 9281-0 Carrington, C. H. (1979). A comparison of cognitive and analytically oriented brief treatment approaches to depression in black women (Doctoral Breland-Noble, A. M., Al-Mateen, C. S.,   Singh, N. N. (Eds.). (2016). dissertation). Retrieved from ProQuest Dissertations and Theses Handbook of mental health in African American youth. New York, NY: database. (UMI No. 7926513) Springer. Carson, N., Le Cook, B.,   Alegr a, M. (2010). Social determinants of Breland-Noble, A. M., Bell, C. C., Burriss, A.,   AAKOMA Project Adult mental health treatment among Haitian, African American, and White Advisory Board. (2011).  Mama"
  },
  {
    "id": 523,
    "source": "guideline_c3debd",
    "text": "(2010). Social determinants of Breland-Noble, A. M., Bell, C. C., Burriss, A.,   AAKOMA Project Adult mental health treatment among Haitian, African American, and White Advisory Board. (2011).  Mama just won t accept this : Adult youth in community health centers. Journal of Health Care for the Poor perspectives on engaging depressed African American teens in and Underserved, 21(2), 32 48. doi:10.1353 hpu.0.0297 clinical research and treatment. Journal of Clinical Psychology in Medical Settings, 18(3), 225 234. doi:10.1007 s10880-011-9235-6 Castonguay, L.G.,   Beutler, L. E. (Eds.). (2006). Principles of therapeutic change that work. New York, NY: Oxford University Press. Breland-Noble, A. M., Burriss, A., Poole, H. K.,   AAKOMA Project Adult Advisory Board. (2010). Engaging depressed"
  },
  {
    "id": 524,
    "source": "guideline_c3debd",
    "text": "Principles of therapeutic change that work. New York, NY: Oxford University Press. Breland-Noble, A. M., Burriss, A., Poole, H. K.,   AAKOMA Project Adult Advisory Board. (2010). Engaging depressed African-American Cauce, A. M., Domenech-Rodriguez, M., Paradise, M., Cochran, B. N., adolescents in treatment: Lessons from The AAKOMA Project. Shea, J. M., Srebnik, D.,   Baydar, N. (2002). Cultural and contextual Journal of Clinical Psychology: In Session, 66(8), 868 879. doi: 10.1002  influences in mental health help seeking: A focus on ethnic minority jclp.20708 youth. Journal of Consulting and Clinical Psychology, 70(1), 44 55. doi:10.1037 0022-006X.70.1.44 Breland-Noble, A. M., Sotomayor, J.,   Burriss, F. A. (2015). Assessing mood disorders and suicidality in African Americans. In L. T."
  },
  {
    "id": 525,
    "source": "guideline_c3debd",
    "text": "Clinical Psychology, 70(1), 44 55. doi:10.1037 0022-006X.70.1.44 Breland-Noble, A. M., Sotomayor, J.,   Burriss, F. A. (2015). Assessing mood disorders and suicidality in African Americans. In L. T. Benuto Centers for Disease Control and Prevention (CDC). (2012). Web-based   B. D. Leany (Eds.), Guide to psychological assessment with African injury statistics query and reporting system (WISQARS ). Retrieved from Americans (pp. 87 104): New York, NY: Springer.  Brenner, R., Azbel, V., Madhusoodanan, S.,   Pawlowska, M. (2000). Centers for Disease Control and Prevention (CDC). (2017). Suicide among Comparison of an extract of hypericum (LI 160) and sertraline in youth. Retrieved from  the treatment of depression: A double-blind, randomized pilot study. toolstemplates entertainmented tips"
  },
  {
    "id": 526,
    "source": "guideline_c3debd",
    "text": "among Comparison of an extract of hypericum (LI 160) and sertraline in youth. Retrieved from  the treatment of depression: A double-blind, randomized pilot study. toolstemplates entertainmented tips SuicideYouth.html Clinical Therapeutics, 22(4), 411 419. Chan, Y. Y., Lo, W. Y., Yang, S. N., Chen, Y. H.,   Lin, J. G. (2015). The Brent, D. A. (1993). Depression and suicide in children and adolescents. benefit of combined acupuncture and antidepressant medication Pediatrics in Review, 14(10), 380 388. for depression: A systematic review and meta-analysis. Journal of Affective Disorders, 176, 106 117.  Brent, D. A., Perper, J. A., Goldstein, C. E., Kolko, D. J., Allan, M. J., Allman, jad.2015.01.048 C. J.,   Zelenak, J. P. (1988). Risk factors for adolescent suicide: A comparison of"
  },
  {
    "id": 527,
    "source": "guideline_c3debd",
    "text": "176, 106 117.  Brent, D. A., Perper, J. A., Goldstein, C. E., Kolko, D. J., Allan, M. J., Allman, jad.2015.01.048 C. J.,   Zelenak, J. P. (1988). Risk factors for adolescent suicide: A comparison of adolescent suicide victims with suicidal inpatients. Chen, C., Lin, W., Wang, S., Wang, C., Li, G., Qu, S., . . . Xiao, W. (2014). Archives of General Psychiatry, 45(6), 581 588. Acupuncture electroacupunture enhances anti-depressant effect of Seroxat: The Symptom Checklist-90 scores. Neural Regeneration Research, 9(2), 213 222. doi: 10.4103 1673-5374.125353 64 APA   Guideline for the Treatment of Depression Chen, C.-H., Tseng, Y.-F., Chou, F.-H.,   Wang, S.-Y. (2000). Effects Costello, E. J., Mustillo, S., Erkanli, A., Keeler, G.,   Angold, A. (2003). of support group intervention in"
  },
  {
    "id": 528,
    "source": "guideline_c3debd",
    "text": "of Depression Chen, C.-H., Tseng, Y.-F., Chou, F.-H.,   Wang, S.-Y. (2000). Effects Costello, E. J., Mustillo, S., Erkanli, A., Keeler, G.,   Angold, A. (2003). of support group intervention in postnatally distressed women: Prevalence and development of psychiatric disorders in childhood A controlled study in Taiwan. Journal of Psychosomatic Research, and adolescence. Archives of General Psychiatry, 60(8), 837 844. doi: 49(6), 395 399.  10.1001 archpsyc.60.8.837 3999(00)00180-X Costello, J. C., Foley, D. L.,   Angold, A. (2006). 10-year research Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., update review: The epidemiology of child and adolescent psychiatric Churchill, R., . . . Barbui, C. (2009). Comparative efficacy and disorders: II. Developmental"
  },
  {
    "id": 529,
    "source": "guideline_c3debd",
    "text": "G., Geddes, J. R., Higgins, J. P., update review: The epidemiology of child and adolescent psychiatric Churchill, R., . . . Barbui, C. (2009). Comparative efficacy and disorders: II. Developmental epidemiology. Journal of the American acceptability of 12 new-generation antidepressants: A multiple- Academy of Child and Adolescent Psychiatry, 45(1), 8 25.  treatments meta-analysis. The Lancet, 373(9665), 746 758. doi: org 10.1097 01.chi.0000184929.41423.c0 10.1016 S0140-6736(09)60046-5 Council of National Psychological Associations for the Advancement Cipriani, A., Zhou, X., Del Giovane, C., Hetrick, S. E., Qin, B., Whittington, of Ethnic Minority Interests. (2000). Guidelines for research in ethnic C., . . . Xie, P. (2016). Comparative efficacy and tolerability of minority communities."
  },
  {
    "id": 530,
    "source": "guideline_c3debd",
    "text": "Hetrick, S. E., Qin, B., Whittington, of Ethnic Minority Interests. (2000). Guidelines for research in ethnic C., . . . Xie, P. (2016). Comparative efficacy and tolerability of minority communities. Retrieved from  antidepressants for major depressive disorder in children and resources cnpaaemi-guidelines.pdf adolescents: A network meta-analysis. The Lancet, 388(10047), Cuijpers, P. (2013). Effective therapies or effective mechanisms in 881 890. treatment guidelines for depression? Depression and Anxiety, 30, Cohen, S., O Leary, K. D.,   Foran, H. (2010). A randomized clinical trial 1055 1057. doi: 10.1002 da.22205 of a brief, problem-focused couple therapy for depression. Behavior Cuijpers, P. (2015). Psychotherapies for adult depression: Recent Therapy, 41(4), 433 446. doi: 10.1016"
  },
  {
    "id": 531,
    "source": "guideline_c3debd",
    "text": "1057. doi: 10.1002 da.22205 of a brief, problem-focused couple therapy for depression. Behavior Cuijpers, P. (2015). Psychotherapies for adult depression: Recent Therapy, 41(4), 433 446. doi: 10.1016 j.beth.2009.11.004 developments. Current Opinion Psychiatry, 28, 1 6. doi: 10.1097  Cohen, S., O Leary, K. D., Foran, H. M.,   Kliem, S. (2014). Mechanisms of YCO.0000000000000121 change in brief couple therapy for depression. Behavior Therapy, 45(3), Cuijpers, P., Donker, T., Weissman, M. M., Ravits, P.,   Cristea, I. A. 402 417. (2016). Interpersonal psychotherapy for mental health problems: A Cohen, Z. D.,   DeRubeis, R. J. (2018). Treatment selection in depression. comprehensive meta-analysis. American Journal of Psychiatry, 173(7), Annual Review of Clinical Psychology, 14, 209 236.  680"
  },
  {
    "id": 532,
    "source": "guideline_c3debd",
    "text": "Cohen, Z. D.,   DeRubeis, R. J. (2018). Treatment selection in depression. comprehensive meta-analysis. American Journal of Psychiatry, 173(7), Annual Review of Clinical Psychology, 14, 209 236.  680 687. org 10.1146 annurev-clinpsy-050817-084746 Cuijpers, P., Driessen, E., Hollon, S. D., van Oppen, P., Barth, J.,   Connell, C. M., Shaw, B. A., Holmes, S. B.,   Foster, N. L. (2001). Andersson, G. (2012a). The efficacy of non-directive supportive Caregivers  attitudes toward their famly members  participation therapy for adult depression: A meta-analysis. Clinical Psychology in Alzheimer s disease research: Implications for recruitment and Review, 32(4), 280 291. retention. Alzheimer Disease   Associated Disorders, 15(3), 137 145. Cuijpers, P., Hollon, S. D., van Straten, A., Bockting, C.,"
  },
  {
    "id": 533,
    "source": "guideline_c3debd",
    "text": "research: Implications for recruitment and Review, 32(4), 280 291. retention. Alzheimer Disease   Associated Disorders, 15(3), 137 145. Cuijpers, P., Hollon, S. D., van Straten, A., Bockting, C., Berking, M.,   Conner, K. O., Copeland, V. C., Grote, N. K., Koeske, G., Rosen, D., Andersson, G. (2013). Does cognitive behaviour therapy have an Reynolds, C. F., III,   Brown, C. (2010). Mental health treatment enduring effect that is superior to keeping patients on continuation seeking among older adults with depression: The impact of stigma pharmacotherapy? A meta-analysis. BMJ Open, 3(e002542). doi: and race. The American Journal of Geriatric Psychiatry, 18(6), 531 543. 10.1136 bmjopen-2012-002542 Conway, K. P., Swendsen, J., Husky, M. M., He, J.-P.,   Merikangas, K. Cuijpers, P., Karyotaki,"
  },
  {
    "id": 534,
    "source": "guideline_c3debd",
    "text": "and race. The American Journal of Geriatric Psychiatry, 18(6), 531 543. 10.1136 bmjopen-2012-002542 Conway, K. P., Swendsen, J., Husky, M. M., He, J.-P.,   Merikangas, K. Cuijpers, P., Karyotaki, E., Pot, A. M., Park, M.,   Reynolds, C. F., R. (2016). Association of lifetime mental disorders and subsequent III. (2014a). Managing depression in older age: Psychological alcohol and illicit drug use: Results from the National Comorbidity interventions. Maturitas, 79(2), 160 169. Survey Adolescent Supplement. Journal of the American Academy Cuijpers, P., Karyotaki, E., Weitz, E., Andersson, G., Hollon, S. D.,   of Child and Adolescent Psychiatry, 55(4), 280 288. doi: van Straten, A. (2014d). The effects of psychotherapies for major org 10.1016 j.jaac.2016.01.006 depression in adults on"
  },
  {
    "id": 535,
    "source": "guideline_c3debd",
    "text": "G., Hollon, S. D.,   of Child and Adolescent Psychiatry, 55(4), 280 288. doi: van Straten, A. (2014d). The effects of psychotherapies for major org 10.1016 j.jaac.2016.01.006 depression in adults on remission, recovery and improvement: A Cooney, G. M., Dwan, K., Greig, C. A., Lawlor, D. A., Rimer, J., Waugh, meta-analysis. Journal of Affective Disorders, 159, 118 126. F. R., . . . Mead, G. E. (2013). Exercise for depression (review). Cuijpers, P., Koole, S. L., van Dijke, A., Roca, M., Li, J.,   Reynolds, C. F., Cochrane Database of Systematic Reviews, 9(CD004366). doi: III. (2014b). Psychotherapy for subclinical depression: Meta-analysis. 10.1002 14651858.CD004366.pub6 British Journal of Psychiatry, 205(4), 268 274. Cooper, P. J., Murray, L., Wilson, A.,   Romaniuk, H. (2003). Controlled"
  },
  {
    "id": 536,
    "source": "guideline_c3debd",
    "text": "for subclinical depression: Meta-analysis. 10.1002 14651858.CD004366.pub6 British Journal of Psychiatry, 205(4), 268 274. Cooper, P. J., Murray, L., Wilson, A.,   Romaniuk, H. (2003). Controlled Cuijpers P., Reynolds C. F., III, Donker T., Li, J., Andersson, G.,   Beekman, trial of the short- and long-term effect of psychological treatment of A. (2012b). Personalized treatment of adult depression: Medication, post-partum depresion: I. Impact on maternal mood. British Journal of psychotherapy, or both? Depression and Anxiety, 29, 855 864. Psychiatry, 182, 412 419. Cuijpers, P., van Straten, A., Schuurmans, J., van Oppen, P., Hollon, S.,   Corbie-Smith, G., Thomas, S. B., Williams, M. V.,   Moody-Ayers, Andersson, G. (2010). Psychotherapy for chronic major depression S. (1999). Attitudes"
  },
  {
    "id": 537,
    "source": "guideline_c3debd",
    "text": "A., Schuurmans, J., van Oppen, P., Hollon, S.,   Corbie-Smith, G., Thomas, S. B., Williams, M. V.,   Moody-Ayers, Andersson, G. (2010). Psychotherapy for chronic major depression S. (1999). Attitudes and beliefs of African Americans toward and dysthmia: A meta-analysis. Clinical Psychology Review, 30, 51 62. participation in medical research. Journal of General Internal Medicine, 14(9), 537 546.  Cuijpers, P., van Straten, A., Warmerdam, L.,   Andersson, G. (2008). Psychological treatment of depression: A meta-analytic database of Costello, D. M., Swendsen, J., Rose, J. S.,   Dierker, L. C. (2008). Risk and randomized studies. BMC Psychiatry, 8(36), 1 6. doi: 10.1186 1471- protective factors associated with trajectories of depressed mood 244X-8-36 from adolescence to early adulthood."
  },
  {
    "id": 538,
    "source": "guideline_c3debd",
    "text": "C. (2008). Risk and randomized studies. BMC Psychiatry, 8(36), 1 6. doi: 10.1186 1471- protective factors associated with trajectories of depressed mood 244X-8-36 from adolescence to early adulthood. Journal of Consulting and Clinical Psychology, 76(2), 173 183. doi:10.1037 0022-006X.76.2.173 Cuijpers, P., Vogelzangs, N., Twisk, J., Kleiboer, A., Li, J.,   Penninx, B. W. (2014c). Comprehensive meta-analysis of excess mortality in Costello, E. J., Erkanli, A.,   Angold, A. (2006). Is there an epidemic depression in the general community versus patients with specific of child or adolescent depression? Journal of Child Psychology and illnesses. The American Journal of Psychiatry, 171(4), 453 462. Psychiatry, 47(12), 1263 1271. doi: 10.1111 j.1469-7610.2006.01682.x APA   Guideline for the"
  },
  {
    "id": 539,
    "source": "guideline_c3debd",
    "text": "Journal of Child Psychology and illnesses. The American Journal of Psychiatry, 171(4), 453 462. Psychiatry, 47(12), 1263 1271. doi: 10.1111 j.1469-7610.2006.01682.x APA   Guideline for the Treatment of Depression 65 Cummings, J. R.,   Druss, B. G. (2011). Racial ethnic differences in mental Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, health service use among adolescents with major depression. Journal R. J., Addis, M. E., . . . Jacobson, N. S. (2006). Randomized trial of the American Academy of Child and Adolescent Psychiatry, 50(2), of behavioral activation, cognitive therapy, and antidepressant 160 170. doi: 10.1016 j.jaac.2010.11.004 medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology, 74(4), 658"
  },
  {
    "id": 540,
    "source": "guideline_c3debd",
    "text": "therapy, and antidepressant 160 170. doi: 10.1016 j.jaac.2010.11.004 medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology, 74(4), 658 670. doi: Curry, J. F. (2014). Future directions in research on psychotherapy for 10.1037 0022-006X.74.4.658 adolescent depression. Journal of Clinical Child   Adolescent Psychology, 43(3), 510 526. Diniz, B. S., Butters, M. A., Albert, S. M., Dew, M. A.,   Reynolds, C. F., III. (2013). Late-life depression and risk of vascular dementia Curry, J. F.,   Hersch, J. (2016). Depressive disorders and substance use and Alzheimer s disease: Systematic review and meta-analysis of disorders. Washington, DC: American Psychiatric Publishing. community-based cohort studies. British Journal of Psychiatry,"
  },
  {
    "id": 541,
    "source": "guideline_c3debd",
    "text": "use and Alzheimer s disease: Systematic review and meta-analysis of disorders. Washington, DC: American Psychiatric Publishing. community-based cohort studies. British Journal of Psychiatry, 202(5), David, D., Szentagotai, A., Lupu, V.,   Cosman, D. (2008). Rational 329 335. doi: 10.1192 bjp.bp.112.118307 emotive behavior therapy, cognitive therapy, and medication in the Djernes, J. K. (2006). Prevalence and predictors of depression in treatment of major depressive disorder: A randomized clinical trial, populations of elderly: A review. Acta Psychiatrica Scandinavica, 113(5), posttreatment outcomes, and six-month follow-up. Journal of Clinical 372 387. Psychology, 64(6), 728 746. doi: 10.1002 jclp.20487 Dobscha, S. K., Corson, K.,   Gerrity, M. S. (2007). Depression treatment David, E. J."
  },
  {
    "id": 542,
    "source": "guideline_c3debd",
    "text": "and six-month follow-up. Journal of Clinical 372 387. Psychology, 64(6), 728 746. doi: 10.1002 jclp.20487 Dobscha, S. K., Corson, K.,   Gerrity, M. S. (2007). Depression treatment David, E. J. R. (2010). Cultural mistrust and mental health help-seeking preferences of VA primary care patients. Psychosomatics, 48(6), attitudes among Filipino Americans. Asian American Journal of 482 488. Psychology, 1(1), 57 66. doi: 10.1037 a0018814 Dobson, K. S., Hollon, S. D., Dimidjian, S., Schmaling, K. B., Kohlenberg, David-Ferdon, C.,   Kaslow, N. J. (2008). Evidence-based psychosocial R. J., Gallop, R. J., . . . Jacobson, N. S. (2008). Randomized trial treatments for child and adolescent depression. Journal of of behavioral activation, cognitive therapy, and antidepressant Clinical Child and"
  },
  {
    "id": 543,
    "source": "guideline_c3debd",
    "text": "R. J., . . . Jacobson, N. S. (2008). Randomized trial treatments for child and adolescent depression. Journal of of behavioral activation, cognitive therapy, and antidepressant Clinical Child and Adolescent Psychology, 37(1), 62 104. doi: medication in the prevention of relapse and recurrence in major 10.1080 15374410701817865 depression. Journal of Consulting Clinical Psychology, 76(3), 468 477. Davidson, J. R. T., Gadde, K. M., Fairbank, J. A., Ramakrishan, K. R., Doi, Y., Roberts, R. E., Takeuchi, K.,   Suzuki, S. (2001). Multiethnic Califf, R. M., Binanay, C., . . . Weisler, R. H., on behalf of Hypericum comparison of adolescent major depression based on the DSM-IV Depression Trial Study Group (2002). Effect of hypericum perforatum criteria in a U.S.-Japan study. Journal of the"
  },
  {
    "id": 544,
    "source": "guideline_c3debd",
    "text": "on behalf of Hypericum comparison of adolescent major depression based on the DSM-IV Depression Trial Study Group (2002). Effect of hypericum perforatum criteria in a U.S.-Japan study. Journal of the American Academy of Child (st john s wort) in major depressive disorder: A randomized controlled and Adolescent Psychiatry, 40(11), 1308 1315. trial. JAMA, 287(14), 1807 1814. Driessen, E., Cuijpers, P., de Maat, S. M., Abbass, A. A., de Jonghe, F.,   Dekker, J. J. M., Koelen, J. A., Van, H. L., Schoevers, R. A., Peen, J., Dekker, J. M. (2010). The efficacy of short-term psychodynamic Hendriksen, M., . . . De Jonghe, F. (2008). Speed of action: The psychotherapy for depression: A meta-analysis. Clinical Psychology relative efficacy of short psychodynamic supportive psychotherapy Review, 30,"
  },
  {
    "id": 545,
    "source": "guideline_c3debd",
    "text": "M., . . . De Jonghe, F. (2008). Speed of action: The psychotherapy for depression: A meta-analysis. Clinical Psychology relative efficacy of short psychodynamic supportive psychotherapy Review, 30, 25 36. doi: 10.1016 j.cpr.2009.08.010 and pharmacotherapy in the first 8 weeks of a treatment algorithm for depression. Journal of Affective Disorders, 109, 183 188. doi: 10.1016 j. Driessen, E., Hegelmaier, L. M., Abbass, A. A., Barber, J. P., Dekker, J. jad.2007.10.015 J., Van, H. L., . . . Cuijpers, P. (2015). The efficacy of short-term psychodynamic psychotherapy for depression: A meta-analysis Dell Osso, B., Palazzo, M. C., Oldani, L.,   Altamura, A. C. (2011). The update. Clinical Psychology Review, 42, 1 15.  noradrenergic action in antidepressant treatments: Pharmacological"
  },
  {
    "id": 546,
    "source": "guideline_c3debd",
    "text": "Dell Osso, B., Palazzo, M. C., Oldani, L.,   Altamura, A. C. (2011). The update. Clinical Psychology Review, 42, 1 15.  noradrenergic action in antidepressant treatments: Pharmacological cpr.2015.07.004 and clinical aspects. CNS Neuroscience and Therapeutics, 17, 723 732. doi: 10.1111 j.1755-5949.2010.00217.x Driessen, E., Van, H. L., Don, F. J., Peen, J., Kool, S., Westra, D., . . . Dekker, J. J. M. (2013). The efficacy of cognitive-behavioral therapy Department of Veterans Affairs, Department of Defense. (2016). VA DoD and psychodynaic therapy in the outpatient treatment of major clinical practice guideline for the management of major depressive disorder. depression: A randomized clinical trial. American Journal of Psychiatry, Retrieved from  170(9), 1041 1050. mdd"
  },
  {
    "id": 547,
    "source": "guideline_c3debd",
    "text": "of major clinical practice guideline for the management of major depressive disorder. depression: A randomized clinical trial. American Journal of Psychiatry, Retrieved from  170(9), 1041 1050. mdd VADoDMDDCPGFINAL82916.pdf ECRI Institute. (2015). Management of major depressive disorder: Evidence DeRubeis, R. J., Cohen, Z. D., Forand, N. R., Fournier, J. C., Gelfand, L. A., synthesis report clinical practice guildeline. Falls Church, VA: The Lewin   Lorenzo-Luaces, L. (2014). The Personalized Advantage Index: Group. Translating research on prediction into individualized treatment recommendations. A demonstration. PLOS One, 9(1), e83875. Edwards, P., Clarke, M., DiGuiseppi, C., Pratap, S., Roberts, I.,   Wentz, R. doi:10.1371 journal.pone.0083875 (2002). Identification of randomized"
  },
  {
    "id": 548,
    "source": "guideline_c3debd",
    "text": "A demonstration. PLOS One, 9(1), e83875. Edwards, P., Clarke, M., DiGuiseppi, C., Pratap, S., Roberts, I.,   Wentz, R. doi:10.1371 journal.pone.0083875 (2002). Identification of randomized controlled trials in systematic reviews: Accuracy and reliability of screening records. Statistics of DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, Medicine, 21(11), 1635 1640. P. R., Salomon, R. M., . . . Gallop, R. (2005). Cognitive therapy vs medications in the treatment of moderate to severe depression. Ekers, D., Webster, L., Van Straten, A., Cuijpers, P., Richards, D.,   Gilbody, Archives in General Psychiatry, 62, 409 416. S. (2014). Behavioural activation for depression: An update of meta- analysis of effectiveness and sub group analysis. PLoS ONE, 9(6), Dietz, L. J.,"
  },
  {
    "id": 549,
    "source": "guideline_c3debd",
    "text": "Archives in General Psychiatry, 62, 409 416. S. (2014). Behavioural activation for depression: An update of meta- analysis of effectiveness and sub group analysis. PLoS ONE, 9(6), Dietz, L. J., Weinberg, R. J., Brent, D. A.,   Mufson, L. (2015). Family-based e100100. doi: 10.1371 journal.pone.0100100 interpersonal psychotherapy (FB-IPT) for depressed preadolescents: Examining efficacy and potential treatment mechanisms. Journal of the Elderon, L.,   Whooley, M. A. (2013). Depression and cardiovascular American Academy of Child   Adolescent Psychiatry, 54(3), 191 199. disease. Progress in Cardiovascular Diseases, 55(6), 511 523. Evans, R. L.,   Connis, R. T. (1995). Comparison of brief group therapies for depressed cancer patients receiving radiation treatment. Public Health Reports,"
  },
  {
    "id": 550,
    "source": "guideline_c3debd",
    "text": "Cardiovascular Diseases, 55(6), 511 523. Evans, R. L.,   Connis, R. T. (1995). Comparison of brief group therapies for depressed cancer patients receiving radiation treatment. Public Health Reports, 110(3), 306 311. 66 APA   Guideline for the Treatment of Depression Fan, L., Wen-bin, F., Xu, N., Liu, J., Ou, A.,   Wang, Y. (2010). Meta- Fuchs, C. Z.,   Rehm, L. P. (1977). A self-control behavior therapy analysis of 20 clinical, randomized, controlled trials of acupuncture program for depression. Journal of Consulting and Clinical Psychology, for depression. Neural Regeneration Research 5(24), 1862 1869. doi: 45(2), 206 215. 10.3969 j.issn.1673-5374.2010.24.004 Furukawa, T. A., Horikoshi, M., Kawakami, N., Kadota, M., Sasaki, M., Fava, M., Alpert, J., Nierenberg, A. A., Mischoulon, D.,"
  },
  {
    "id": 551,
    "source": "guideline_c3debd",
    "text": "1862 1869. doi: 45(2), 206 215. 10.3969 j.issn.1673-5374.2010.24.004 Furukawa, T. A., Horikoshi, M., Kawakami, N., Kadota, M., Sasaki, M., Fava, M., Alpert, J., Nierenberg, A. A., Mischoulon, D., Otto, M. W., Sekiya, Y., . . . Grothaus, L. C., on behalf of the GENKI Project (2012). Zajecka, J., . . . Rosenbaum. J. F. (2005). A double-blind, randomized Telephone cognitive-behavioral therapy for subthreshold depression trial of st john s wort, fluoxetine, and placebo in major depressive presenteeism in workplace: A randomized controlled trial. PLoS ONE, disorder. Journal of Clinical Psychopharmacology, 25(5), 441 447. doi: 7(4), e355330. doi: 10.1371 journal.pone.0035330 10.1097 01.jcp.0000178416.60426.29 Furukawa, T. A., Noma, H., Caldwell, D. M., Honyashiki, M., Shinohara, Fernandez y"
  },
  {
    "id": 552,
    "source": "guideline_c3debd",
    "text": "25(5), 441 447. doi: 7(4), e355330. doi: 10.1371 journal.pone.0035330 10.1097 01.jcp.0000178416.60426.29 Furukawa, T. A., Noma, H., Caldwell, D. M., Honyashiki, M., Shinohara, Fernandez y Garcia, E., Franks, P., Jerant, A., Bell, R. A.,   Kravitz, R. L. K., Imai, H., . . . Churchill, R. (2014). Waiting list may be a nocebo (2011). Depression treatment preferences of Hispanic individuals: condition in psychotherapy trials: A contribution from network meta- Exploring the influence of ethnicity, language, and explanatory models. analysis. Acta Psychiatrica Scandinavica, 130(3), 181 192.  Journal of the American Board of Family Medicine, 24(1), 39 50. doi: org 10.1111 acps.12275 10.3122 jabfm.2011.01.100118 Gallagher, D. E.,   Thompson, L. W. (1982). Treatment of major Fewell, Z., Smith, G."
  },
  {
    "id": 553,
    "source": "guideline_c3debd",
    "text": "of the American Board of Family Medicine, 24(1), 39 50. doi: org 10.1111 acps.12275 10.3122 jabfm.2011.01.100118 Gallagher, D. E.,   Thompson, L. W. (1982). Treatment of major Fewell, Z., Smith, G. D.,   Sterne, J. A. (2007). The impact of residual depressive disorder in older adult outpatients with brief and unmeasured confounding in epidemiologic studies: A stimulation psychotherapies. Psychotherapy: Theory, Research and Practice, 19(4), study. American Journal of Epidemiology, 166(6), 646 655. 482 490. Fiske, A., Wetherell, J. L.,   Gatz, M. (2010). Depression in older adults. Gallagher-Thompson, D.,   Steffen, A. M. (1994). Comparative effects Annual Review of Clinical Psychology, 5, 363 389. doi: 10.1146 annurev. of cognitive-behavioral and brief psychodynamic psychotherapies"
  },
  {
    "id": 554,
    "source": "guideline_c3debd",
    "text": "D.,   Steffen, A. M. (1994). Comparative effects Annual Review of Clinical Psychology, 5, 363 389. doi: 10.1146 annurev. of cognitive-behavioral and brief psychodynamic psychotherapies clinpsy.032408.153621 for depressed family caregivers. Journal of Consulting and Clinical Psychology, 62(3), 543 549. doi: 10.1037 0022-006X.62.3.543 Follette, W. C.,   Greenberg, L. S. (2006). Chapter 4: Technique factors in treating dysphoric disorders. In L. G. Castonguay   L. E. Beutler (Eds.), Gallo, J. J., Morales, K. H., Bogner, H. R., Raue, P. J., Zee, J., Bruce, M. L., Principles of therapeutic change that work (pp. 83 110). New York, NY:   Reynolds, C. F., III. (2013). Long term effect of depression care Oxford University Press. management on mortality in older adults: Follow-up of cluster"
  },
  {
    "id": 555,
    "source": "guideline_c3debd",
    "text": "change that work (pp. 83 110). New York, NY:   Reynolds, C. F., III. (2013). Long term effect of depression care Oxford University Press. management on mortality in older adults: Follow-up of cluster randomized clinical trial in primary care. BMJ, 346(f2570). doi: Fonagy, P. (2015). The effectiveness of psychodynamic psychotherapies: 10.1136 bmj.f2570 An update. World Psychiatry, 14(2), 137 150. Garber, J., Clarke, G. N., Weersing, V. R., Beardslee, W. R., Brent, D. A., Fonagy, P., Cottrell, D., Phillips, J., Bevington, D., Glaser, D.,   Allison, E. Gladstone, T. R. G., . . . Iyengar, S. (2009). Prevention of depression (2015). What works for whom? A critical review of treatments for children in at-risk adolescents: A randomized controlled trial. JAMA, 301(21), and adolescents (2nd ed.)."
  },
  {
    "id": 556,
    "source": "guideline_c3debd",
    "text": "Prevention of depression (2015). What works for whom? A critical review of treatments for children in at-risk adolescents: A randomized controlled trial. JAMA, 301(21), and adolescents (2nd ed.). New York, NY: Guilford Press. 2215 2224. doi: 10.1001 jama.2009.788 Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. Garber, J.,   Weersing, V. R. (2010). Comorbidity of anxiety and D., Shelton, R. C.,   Fawcett, J. (2010). Antidepressant drug effects depression in youth: Implications for treatment and prevention. Clinical and depression severity: A patient-level meta-analysis. JAMA, 303(1), psychology, 17(4), 293 306. doi:10.1111 j.1468-2850.2010.01221.x 47 53. doi: 10.1001 jama.2009.1943 Garland, A. F., Lau, A. S., Yeh, M., McCabe, K. M., Hough, R. L.,   Frank, E.,"
  },
  {
    "id": 557,
    "source": "guideline_c3debd",
    "text": "JAMA, 303(1), psychology, 17(4), 293 306. doi:10.1111 j.1468-2850.2010.01221.x 47 53. doi: 10.1001 jama.2009.1943 Garland, A. F., Lau, A. S., Yeh, M., McCabe, K. M., Hough, R. L.,   Frank, E., Cassano, G. B., Rucci, P., Thompson, W. K., Kraemer, H. C., Landsverk, J. A. (2005). Racial and ethnic differences in utilization of Fagioloini, A., . . . Forgione, R. N. (2011). Predictors and moderators mental health services among high-risk youths. The American Journal of time to remission of major depression with interpersonal of Psychiatry, 162(7), 1336 1343. psychotherapy and ssri pharmacotherapy. Psychological Medicine, 41(1), 151 162. doi: 10.1017 S0033291710000553 Garrison, C. Z., Addy, C. L., Jackson, K. L., McKeown, R. E.,   Waller, J. L. (1992). Major depressive disorder and dysthymia in"
  },
  {
    "id": 558,
    "source": "guideline_c3debd",
    "text": "Psychological Medicine, 41(1), 151 162. doi: 10.1017 S0033291710000553 Garrison, C. Z., Addy, C. L., Jackson, K. L., McKeown, R. E.,   Waller, J. L. (1992). Major depressive disorder and dysthymia in young Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. adolescents. American Journal of Epidemiology, 135(7), 792 802. W., . . . Weissman, M. M. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Gartlehner, G., Gaynes, B. N., Amick, H. R., Asher, G., Morgan, L. C., Remission, recovery, relapse, and recurrence. Archives of General Coker-Schwimmer, E., Lohr, K. N. (2015). Nonpharmacological versus Psychiatry, 48(9), 851 855.  pharmacological treatments for adult patients with major depressive"
  },
  {
    "id": 559,
    "source": "guideline_c3debd",
    "text": "and recurrence. Archives of General Coker-Schwimmer, E., Lohr, K. N. (2015). Nonpharmacological versus Psychiatry, 48(9), 851 855.  pharmacological treatments for adult patients with major depressive archpsyc.1991.01810330075011 disorder (RTI International-University of North Carolina Evidence- based Practice Center Contract No. 290-2012-00008-I). Retrieved Freedenthal, S. (2007). Racial disparities in mental health service use by from Agency for Healthcare Research and Quality website: https:   adolescents who thought about or attempted suicide. Suicide and Life- www.ncbi.nlm.nih.gov pubmed 26764438 Threatening Behavior, 37(1), 22 34. Gastpar, M., Singer, A.,   Zeller, K. (2005). Efficacy and tolerability of Freedland, K. E., Skala, J. A., Carney, R. M., Rubin, E. H., Lustman, P. J.,"
  },
  {
    "id": 560,
    "source": "guideline_c3debd",
    "text": "26764438 Threatening Behavior, 37(1), 22 34. Gastpar, M., Singer, A.,   Zeller, K. (2005). Efficacy and tolerability of Freedland, K. E., Skala, J. A., Carney, R. M., Rubin, E. H., Lustman, P. J., hypericum extract STW3 in long-term treatment with a once-daily D vila-Rom n, V. G., . . . Hogue, C. W., Jr. (2009). Treatment of dosage in comparsion with sertraline. Pharmacopsychiatry, 38(2), depression after coronary artery bypass surgery. Archives of General 78 86. doi: 10.1005 s-2005-837807 Psychiatry, 66(4), 387 396. Gastpar, M., Singer, A.,   Zeller, K. (2006). Comparative efficacy Frieden, T. R., Jaffe, H. W., Cono, J., Richards, C. L.,   Iademarco, M. F. and safety of a once-daily dosage of hypericum extract STW3- (2016). Sexual identity, sex of sexual contacts, and health-related VI"
  },
  {
    "id": 561,
    "source": "guideline_c3debd",
    "text": "T. R., Jaffe, H. W., Cono, J., Richards, C. L.,   Iademarco, M. F. and safety of a once-daily dosage of hypericum extract STW3- (2016). Sexual identity, sex of sexual contacts, and health-related VI and citalopram in patients with moderate depression: A behaviors among students in grades 9-12 United States and selected double-blind, randomised, multicentre, placebo-controlled study. sites, 2015. Morbidity and Mortality Weekly Report, 65(9).  Pharmacopsychiatry, 39(2), 66 75. doi: 10.1055 s-2006-931544 cdc.gov mmwr volumes 65 ss ss6509a1.htm?s cid ss6509a1 w APA   Guideline for the Treatment of Depression 67 Gaudiano, B. A., Hughes, J. A.,   Miller, I. W. (2013). Patients  treatment Gowda, U., Mutowo, M. P., Smith, B. J., Wluka, A. E.,   Renzaho, A. M. expectancies in clinical trials of"
  },
  {
    "id": 562,
    "source": "guideline_c3debd",
    "text": "of Depression 67 Gaudiano, B. A., Hughes, J. A.,   Miller, I. W. (2013). Patients  treatment Gowda, U., Mutowo, M. P., Smith, B. J., Wluka, A. E.,   Renzaho, A. M. expectancies in clinical trials of antidepressants versus psychotherapy N. (2015). Vitamin D supplementation to reduce depression in for depression: A study using hypothetical vignettes. Comprehensive adults: Meta-analysis of randomized controlled trials. Nutrition, 31(3), Psychiatry, 54(1), 28 33. doi: 10.1016 j.comppsych.2012.06.003 421 429.  Gelenberg, A. J., Freeman, M. P., Markowitz, J. C. Rosenbaum, J. F., Gudi o, O. G., Lau, A. S., Yeh, M., McCabe, K. M.,   Hough, R. L. (2009). Thase, M. E., Trivedi, M. H.,   Van Rhoads, R. S. (2010). Practice Understanding racial ethnic disparities in youth mental health guideline for"
  },
  {
    "id": 563,
    "source": "guideline_c3debd",
    "text": "A. S., Yeh, M., McCabe, K. M.,   Hough, R. L. (2009). Thase, M. E., Trivedi, M. H.,   Van Rhoads, R. S. (2010). Practice Understanding racial ethnic disparities in youth mental health guideline for the treatment of patients with major depressive disorder services: Do disparities vary by problem type? Journal of Emotional and (3rd ed.). [Adobe Digital Editions version]. Retrieved from https:   Behavioral Disorders, 17(1), 3 16. doi:10.1177 1063426608317710 psychiatryonline.org pb assets raw sitewide practice guidelines  Guyatt, G., Akl, E. A., Hirsh, J., Kearon, C., Crowther, M., Gutterman, D., . . . guidelines mdd.pdf Sch nemann, H. (2010). The vexing problem of guidelines and conflict Gertsik, L., Poland, R. E., Bresee, C.,   Rapaport, M. H. (2012). Omega-3 of interest: A potential"
  },
  {
    "id": 564,
    "source": "guideline_c3debd",
    "text": "D., . . . guidelines mdd.pdf Sch nemann, H. (2010). The vexing problem of guidelines and conflict Gertsik, L., Poland, R. E., Bresee, C.,   Rapaport, M. H. (2012). Omega-3 of interest: A potential solution. Annals of Internal Medicine, 152(11), fatty acide augmentation of citalopram treatment for patients with 738 741. major depressive disorder. Journal of Clinical Psychopharmacology, 32(1), Guyatt, G. H., Oxman, A. D., Sultan, S., Brozek, J., Glasziou, P., Alonso- 61 64. doi: 10.1097 JCP.0b013e31823f3b5f Coello, P., . . . Sch nemann, H. (2013). GRADE guidelines: 11. Making Gibbons, M. B. C., Thompson, S. M., Scott, K., Schauble, L. A., Mooney, T., an overall rating of confidence in effect estimates for a single Thompson, D., . . . Crits-Christoph, P. (2012). Supportive-expressive"
  },
  {
    "id": 565,
    "source": "guideline_c3debd",
    "text": "B. C., Thompson, S. M., Scott, K., Schauble, L. A., Mooney, T., an overall rating of confidence in effect estimates for a single Thompson, D., . . . Crits-Christoph, P. (2012). Supportive-expressive outcomes and for all outcomes. Journal of Clinical Epidemiology, 66, dynamic psychotherapy in the community mental health system: A 151 157. pilot effectiveness trial for the treatment of depression. Psychotherapy, Guyatt, G. H., Oxman, A. D., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, 49(3), 303 316. doi: 10.1037 a0027694 P., . . . Sch nemann, H. J. (2011). GRADE guidelines: 4. Rating the Givens, J. L., Houston, T. K., Van Voorhees, B. W., Ford, D. E.,   quality of evidence study limitations (risk of bias). Journal of Clinical Cooper, L. A. (2007). Ethnicity and preferences for depression"
  },
  {
    "id": 566,
    "source": "guideline_c3debd",
    "text": "J. L., Houston, T. K., Van Voorhees, B. W., Ford, D. E.,   quality of evidence study limitations (risk of bias). Journal of Clinical Cooper, L. A. (2007). Ethnicity and preferences for depression Epidemiology, 64(4), 407 415. doi: 10.1016 j.jclinepi.2010.07.017 treatment. General Hospital Psychiatry, 29(3), 182 191. doi: 10.1016 j. Haigh, E. A. P., Bogucki, O. E., Sigmon, S. T.,   Blazer, D. G. (2016). genhosppsych.2006.11.002 Depression among older adults: A 20-year update on five common Glied, S.,   Pine, D. S. (2002). Consequences and correlates of adolescent myths and misconceptions. American Journal of Geriatric Psychiatry, depression. Archives of Pediatric Adolescent Medicine,156(10), 1009  26(1), 107 122.  1014. doi: 10.1001 archpedi.156.10.1009 Hanson, A. E.,   Scogin, F. (2008)."
  },
  {
    "id": 567,
    "source": "guideline_c3debd",
    "text": "Journal of Geriatric Psychiatry, depression. Archives of Pediatric Adolescent Medicine,156(10), 1009  26(1), 107 122.  1014. doi: 10.1001 archpedi.156.10.1009 Hanson, A. E.,   Scogin, F. (2008). Older adults  acceptance of Glue, P., Donovan, M. R., Kolluri, S.,   Emir, B. (2010). Meta-analysis psychological, pharmacological, and combination treatments for of relapse prevention antidepressant trials in depressive disorders. geriatric depression. The Journals of Gerontology: Series B: Psychological Australian   New Zealand Journal of Psychiatry, 44(8), 697 705. http:   Sciences and Social Sciences, 63(4), P245 P248.  dx.doi.org 10.3109 00048671003705441 org doi 10.1093 geronb 63.4.P245 Gluud, L. L. (2006). Bias in clinical intervention research. American Journal Haringsma, R., Engels, G."
  },
  {
    "id": 568,
    "source": "guideline_c3debd",
    "text": "63(4), P245 P248.  dx.doi.org 10.3109 00048671003705441 org doi 10.1093 geronb 63.4.P245 Gluud, L. L. (2006). Bias in clinical intervention research. American Journal Haringsma, R., Engels, G. I., Cuijpers, P.,   Spinhoven, P. (2006). of Epidemiology, 163(6), 493 501.  Effectiveness of the coping with depression (CWD) course for older adults provided by the community-based mental health care system Goldfried, M. R. (1980). Toward the delineation of therapeutic change in the Netherlands: A randomized controlled field trial. International principles. American Psychologist, 35(11), 991 999.  Psychogeriatrics, 18(2), 307 325. doi: 10.1017 S104161020500253X org doi 10.1037 0003-066X.35.11.991 Harrer, G., Schmidt, U., Kuhn, U.,   Biller, A. (1999). Comparison of Goodman, J. H. (2009). Women s"
  },
  {
    "id": 569,
    "source": "guideline_c3debd",
    "text": "18(2), 307 325. doi: 10.1017 S104161020500253X org doi 10.1037 0003-066X.35.11.991 Harrer, G., Schmidt, U., Kuhn, U.,   Biller, A. (1999). Comparison of Goodman, J. H. (2009). Women s attitudes, preferences, and perceived equivalence between the st. john s wort extract lohyp-57 and barriers to treatment for perinatal depression. Birth, 36(1), 60 69. fluoxetine. Arzneimittel-Forschung, 49(4), 289 296. Green, S., Higgins, J. P. T., Alderson, P., Clarke, M., Mulrow, C. D.,   Hasin, D. S., Goodwin, R. D., Stinson, F. S.,   Grant, B. F. (2005). Oxman, A. D. (2008). Chapter 1: Introduction. In J. P. T. Higgins Epidemiology of major depressive disorder: Results from the   S. Green (Eds.), Cochrane handbook for systematic reviews of national epidemiologic survey on alcoholism and related"
  },
  {
    "id": 570,
    "source": "guideline_c3debd",
    "text": "In J. P. T. Higgins Epidemiology of major depressive disorder: Results from the   S. Green (Eds.), Cochrane handbook for systematic reviews of national epidemiologic survey on alcoholism and related conditions. interventions (pp. 3 9). Chichester, England: Wiley.  Archives of General Psychiatry, 62(10), 1097 1106. doi: 10.1001  org 10.1002 9780470712184.ch1 archpsyc.62.10.1097 Greenberg, L.S. (1986). Change process research. Journal of Consulting Hatcher-Kay, C.,   King, C. (2003). Depression and suicide. Pediatrics in   Clinical Psychology, 54(1), 4 9.  Review, 24(11), 363 371. doi 10.1037 0022-006X.54.1.4 Hautzinger, M.,   Welz, S. (2004). Kognitive verhaltenstherapie bei Greenberg, L. S.,   Malcolm, W. (2002). Resolving unfinished business: depressionen im alter: Ergebnisse einer"
  },
  {
    "id": 571,
    "source": "guideline_c3debd",
    "text": "0022-006X.54.1.4 Hautzinger, M.,   Welz, S. (2004). Kognitive verhaltenstherapie bei Greenberg, L. S.,   Malcolm, W. (2002). Resolving unfinished business: depressionen im alter: Ergebnisse einer kontrollierten vergleichsstudie Relating process to outcome. Journal of Consulting and Clinical unter ambulanten bedingungen an depressionnen mittleren Psychology, 70(2), 406 416.  schweregrads [Cognitive behavioral therapy for depression in old age: 006X.70.2.406 results of a controlled comparative study under ambulant conditions Greenberg, L. S.,   Newman, F. L. (1996). An approach to psychotherapy at low severity of depression]. Zeitschrift f r Gerontologie und Geriatrie, change process research: Introduction to the special section. Journal 37, 427 435. of Consulting   Clinical Psychology,"
  },
  {
    "id": 572,
    "source": "guideline_c3debd",
    "text": "at low severity of depression]. Zeitschrift f r Gerontologie und Geriatrie, change process research: Introduction to the special section. Journal 37, 427 435. of Consulting   Clinical Psychology, 64(3), 435 438.  Hautzinger, M.,   Welz, S. (2007). Kurz- und l ngerfristige wirksamkeit org doi 10.1037 0022-006X.64.3.435 psychologischer interventionen bei depressionen im alter [Short- Gong, H., Ni, C., Shen, X., Wu, T.,   Jiang, C. (2015). Yoga for prenatal term and longer-term effectiveness of psychological interventions depression: A systematic review and meta-analysis. BMC Psychiatry, in depression in old age]. Zeitschrift f r Klinische Psychologie und 15(14). doi: 10.1186 s12888-015-0393-1 Psychotherapie, 37(1), 52 60. doi: 10.1026 1616-3443.37.1.52 68 APA   Guideline for the Treatment"
  },
  {
    "id": 573,
    "source": "guideline_c3debd",
    "text": "in old age]. Zeitschrift f r Klinische Psychologie und 15(14). doi: 10.1186 s12888-015-0393-1 Psychotherapie, 37(1), 52 60. doi: 10.1026 1616-3443.37.1.52 68 APA   Guideline for the Treatment of Depression Hegerl, U., Hautzinger, M., Mergl, R., Kohnen, R., Sch tze, M., Insel, T. R. (2009). Translating scientific opportunity into public Scheunemann, W., . . . Henkel, V. (2010). Effects of pharmacotherapy health impact: A strategic plan for research on mental illness. and psychotherapy in depressed primary-care patients: A randomized, Archives of General Psychiatry, 66(2), 128 133. doi: 10.1001  controlled trial including a patients  choice arm. International archgenpsychiatry.2008.540 Journal of Neuropsychopharmacology, 13, 31 44. doi: 10.1017  Institute of Medicine (2011a). Clinical"
  },
  {
    "id": 574,
    "source": "guideline_c3debd",
    "text": "controlled trial including a patients  choice arm. International archgenpsychiatry.2008.540 Journal of Neuropsychopharmacology, 13, 31 44. doi: 10.1017  Institute of Medicine (2011a). Clinical practice guidelines we can trust. S1461145709000224 Washington, DC: National Academies Press. Herne, M. A., Bartholomew, M. L.,   Weahkee, R. L. (2014). Suicide Institute of Medicine. (2011b). Finding what works in health care: Standard mortality among American Indians and Alaska Natives, 1999-2009 for systematic reviews. Washington, DC: National Academies Press. [Supplemental material]. American Journal of Public Health, 104(S3), S336 S342. Jackson, J. S., Abelson, J. M., Berglund, P. A., Mezuk, B., Torres, M.,   Zhang, R. (2011). The intersection of race, ethnicity, immigration, and Hetrick, S."
  },
  {
    "id": 575,
    "source": "guideline_c3debd",
    "text": "of Public Health, 104(S3), S336 S342. Jackson, J. S., Abelson, J. M., Berglund, P. A., Mezuk, B., Torres, M.,   Zhang, R. (2011). The intersection of race, ethnicity, immigration, and Hetrick, S. E., Cox, G. R., Witt, K. G., Bir, J. J.,   Merry, S. N. (2016). cultural influences on the nature and distribution of mental disorders: Cognitive behavioural therapy (CBT), third-wave CBT and An examination of major depression. In D. A. Regier, W. E. Narrow, E. interpersonal therapy (IPT) based interventions for preventing A. Kuhl,   D. J. Kupfer (Eds.), The conceptual evolution of DSM-5 (pp. depression in children and adolescents. Cochrane Database of 267 285). Arlington, VA: American Psychiatric Publishing. Systematic Reviews, 8(CD003380). doi: 10.1002 14651858. CD003380.pub4 Jacobs, R. H.,"
  },
  {
    "id": 576,
    "source": "guideline_c3debd",
    "text": "in children and adolescents. Cochrane Database of 267 285). Arlington, VA: American Psychiatric Publishing. Systematic Reviews, 8(CD003380). doi: 10.1002 14651858. CD003380.pub4 Jacobs, R. H., Klein, J. B., Reinecke, M. A., Silva, S. G., Tonev, S., Breland- Noble, A., . . . March, J. S. (2008). Ethnic differences in attributions Hinrichsen, G. A. (2009). Interpersonal psychotherapy: A treatment for and treatment expectancies for adolescent depression. International late-life depression. Psychiatric Annals, 39(9), 838 843. Journal of Cognitive Therapy, 1(2), 163 178.  Hoffman, B. M., Blumenthal, J. A., Babyak, M. A., Smith, P. J., Rogers, ijct.2008.1.2.163 S. D., Doraiswamy, P. M.,   Sherwood, A. (2008). Exercise fails to Jakobsen, J. C., Hansen, J. L., Simonsen, E.,   Gluud, C. (2012)."
  },
  {
    "id": 577,
    "source": "guideline_c3debd",
    "text": "J. A., Babyak, M. A., Smith, P. J., Rogers, ijct.2008.1.2.163 S. D., Doraiswamy, P. M.,   Sherwood, A. (2008). Exercise fails to Jakobsen, J. C., Hansen, J. L., Simonsen, E.,   Gluud, C. (2012). The effect improve neurocognition in depressed middle-aged and older adults. of adding psychodynamic therapy to antidepressants in patients with Medicine   Science in Sports   Exercise, 40(7), 1344 1352. doi: 10.1249  major depressive disorder: A systematic review of randomized clinical MSS.0b013e31816b877c trials with meta-analyses and trial sequential analyses. Journal of Holden, J. M., Sagovsky, R.,   Cox, J. L. (1989). Counselling in a general Affective Disorders, 137, 4 14. doi: 10.1016 j.jad.2011.03.035 practice setting: Controlled study of health visitor intervention Jans, L. A. W., Giltay,"
  },
  {
    "id": 578,
    "source": "guideline_c3debd",
    "text": "Cox, J. L. (1989). Counselling in a general Affective Disorders, 137, 4 14. doi: 10.1016 j.jad.2011.03.035 practice setting: Controlled study of health visitor intervention Jans, L. A. W., Giltay, E. J.,   Willem Van der Does, W. (2010). The in treatment of postnatal depression. British Medical Journal, 298, efficacy of n-3 fatty acids DHA and EPA (fish oil) for perinatal 223 226. depression. British Journal of Nutrition, 104(11), 1577 1585. doi: 10.1017  Hollon, S. D., DeRubeis, R. J., Fawcett, J., Amsterdam, J. D., Shelton, S0007114510004125 R. C., Zajecka, J., . . . Gallop, R. (2014). Effect of cognitive therapy Jaycox, L. H., Asarnow, J. R., Sherbourne, C. D., Rea, M. M., LaBorde, A. P., with antidepressant medications vs antidepressants alone on   Wells, K. B. (2006). Adolescent"
  },
  {
    "id": 579,
    "source": "guideline_c3debd",
    "text": "Effect of cognitive therapy Jaycox, L. H., Asarnow, J. R., Sherbourne, C. D., Rea, M. M., LaBorde, A. P., with antidepressant medications vs antidepressants alone on   Wells, K. B. (2006). Adolescent primary care patients  preferences the rate of recovery in major depressive disorder: A randomized for depression treatment. Administration and Policy in Mental Health clinical trial. JAMA Psychiatry, 71(10), 1157 1164. doi: 10.1001  and Mental Health Services Research, 33(2), 198 207. doi: 10.1007  jamapsychiatry.2014.1054 s10488-006-0033-7 Hollon, S. D.,   Ponniah, K. (2010). A review of empirically supported Jaycox, L. H., Stein, B. D., Paddock, S., Miles, J. N. V., Chandra, A., psychological therapies for mood disorders in adults. Depression Meredith, L. S., . . . Burnam, M. A. (2009)."
  },
  {
    "id": 580,
    "source": "guideline_c3debd",
    "text": "supported Jaycox, L. H., Stein, B. D., Paddock, S., Miles, J. N. V., Chandra, A., psychological therapies for mood disorders in adults. Depression Meredith, L. S., . . . Burnam, M. A. (2009). Impact of teen depression and Anxiety, 27(10), 891 932.  on academic, social, and physical functioning. Pediatrics, 124(4), e596  da.20741 e605. doi:10.1542 peds.2008-3348 Horowitz, J. L.,   Garber, J. (2006). The prevention of depressive Jazayeri, S., Tehrani-Doost, M., Keshavarz, S. A., Hosseini, M., Djazayery, symptoms in children and adolescents: A meta-analytic review. A., Amini, H., . . . Peet, M. (2008). Comparison of therapeutic effects Journal of Consulting and Clinical Psychology, 74(3), 401 415. doi: of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately 10.1037"
  },
  {
    "id": 581,
    "source": "guideline_c3debd",
    "text": ". Peet, M. (2008). Comparison of therapeutic effects Journal of Consulting and Clinical Psychology, 74(3), 401 415. doi: of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately 10.1037 0022-006X.74.3.401 and in combination, in major depressive disorder. Australian and New Horowitz, J. L., Garber, J., Ciesla, J. A., Young, J. F.,   Mufson, L. (2007). Zealand Journal of Psychiatry, 42, 192 198. Prevention of depressive symptoms in adolescents: A randomized Jobst, A., Brakemeier, E., Buchheim, A., Caspar, F., Cuijpers, P., Ebmeier, K. trial of cognitive-behaivoral and interpersonal prevention programs. P., . . . Padberg, J. (2016). European Psychiatric Association guidance Journal of Consulting and Clinical Psychology, 75(5), 693 706. doi: on psychotherapy in chronic"
  },
  {
    "id": 582,
    "source": "guideline_c3debd",
    "text": "prevention programs. P., . . . Padberg, J. (2016). European Psychiatric Association guidance Journal of Consulting and Clinical Psychology, 75(5), 693 706. doi: on psychotherapy in chronic depression across Europe. European 10.1037 0022-006X.75.5.693 Psychiatry, 33, 18 36.  Houle, J., Villaggi, B., Beaulieu, M. D., Lesperance, F., Rondeau, G.,   Johansson, R., Ekbladh, S., Hebert, A., Lindstr m, M., M ller, S., Petitt, E., Lambert, J. (2013). Treatment preferences in patients with first . . . Andersson, G. (2012). Psychodynamic guided self-help for adult episode depression. Journal of Affective Disorders, 147(1-3), 94 100. depression through the internet: A randomised controlled trial. PLoS  ONE, 7(5), e38021. doi: 10.1371 journal.pone.0038021 Huey, S. J., Jr.,   Polo, A. J. (2010)."
  },
  {
    "id": 583,
    "source": "guideline_c3debd",
    "text": "Disorders, 147(1-3), 94 100. depression through the internet: A randomised controlled trial. PLoS  ONE, 7(5), e38021. doi: 10.1371 journal.pone.0038021 Huey, S. J., Jr.,   Polo, A. J. (2010). Assessing the effects of evidence- Johansson, R., Nyblom, A., Carlbring, P., Cuijpers, P.,   Andersson, G. based psychotherapies with ethnic minority youths. In J. R. Weisz (2013). Choosing between internet-based psychodynamic versus   A. E. Kazdin (Eds.), Evidence-based psychotherapies for children and cognitive behavioral therapy for depression: A pilot preference study. adolescents (pp. 451 465). New York, NY: Guilford Press. BMC Psychiatry, 13(268).  244X 13 268 APA   Guideline for the Treatment of Depression 69 Kaiser Permanente Care Management Institute. (2012). Diagnosis Kelly, J. A., Murphy,"
  },
  {
    "id": 584,
    "source": "guideline_c3debd",
    "text": "York, NY: Guilford Press. BMC Psychiatry, 13(268).  244X 13 268 APA   Guideline for the Treatment of Depression 69 Kaiser Permanente Care Management Institute. (2012). Diagnosis Kelly, J. A., Murphy, D. A., Bahr, G. R., Kalichman, S. C., Morgan, M. G., and treatment of depression in adults: 2012 clinical practice Stevenson, Y., . . . Bernstein, B. M. (1993). Outcome of cognitive- guideline. Retrieved from  behavioral and support group brief therapies for depressed, HIV- summary 39432 diagnosis-and-treatment-of-depression-in-adults- infected person. American Journal of Psychiatry, 150(11), 1679 1686. 2012-clinical-practice-guideline Kendall, P. C., Gosch, E., Furr, J. M.,   Sood, E. (2008). Flexibility within Kahn, J. S., Kehle, T. J., Jenson, W. R.,   Clark, E. (1990). Comparison of"
  },
  {
    "id": 585,
    "source": "guideline_c3debd",
    "text": "1679 1686. 2012-clinical-practice-guideline Kendall, P. C., Gosch, E., Furr, J. M.,   Sood, E. (2008). Flexibility within Kahn, J. S., Kehle, T. J., Jenson, W. R.,   Clark, E. (1990). Comparison of fidelity. Journal of the American Academy of Child   Adolescent cognitive-behavioral, relaxation, and self-modeling interventions for Psychiatry, 47(9), 987 993. depression among middle-school students. School Psychology Review, Kendrick, L., Anderson, N. L. R.,   Moore, B. (2007). Perceptions 19(2), 196 211. of depression among young African American men. Family and Kaneriya, S. H., Robbins-Welty, G. A., Smagula, S. F., Karp, J. F., Butters, Community Health, 30(1), 63 73. M. A., Lenze, E. J., . . . Reynolds, C. F., III. (2016). Predictors and Kessler, R. C., Berglund, P., Demler, O., Jin, R.,"
  },
  {
    "id": 586,
    "source": "guideline_c3debd",
    "text": "G. A., Smagula, S. F., Karp, J. F., Butters, Community Health, 30(1), 63 73. M. A., Lenze, E. J., . . . Reynolds, C. F., III. (2016). Predictors and Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. moderators of remission with aripiprazole augmentation in treatment- R., . . . . Wang, P. S. (2003). The epidemiology of major depressive resistant late-life depression: An analysis of the IRL-GRey randomized disorder: Results from the National Comorbidity Survey Replication clinical trial. JAMA Psychiatry, 73(4), 329 336. doi: 10.1001  (NCS-R). JAMA, 289(23), 3095 3105. jamapsychiatry.2015.3447 Kessler, R. C., McGonagle, K. A., Swartz, M., Blazer, D. G.,   Nelson, C. Kann, L., Kinchen, S., Shanklin, S. L., Flint, K. H., Kawkins, J., Harris, W. A., B. (1993). Sex"
  },
  {
    "id": 587,
    "source": "guideline_c3debd",
    "text": "jamapsychiatry.2015.3447 Kessler, R. C., McGonagle, K. A., Swartz, M., Blazer, D. G.,   Nelson, C. Kann, L., Kinchen, S., Shanklin, S. L., Flint, K. H., Kawkins, J., Harris, W. A., B. (1993). Sex and depression in the National Comorbidity Survey I: . . . Zaza, S. (2014). Youth risk behavior surveillance United States, Lifetime prevalence, chronicity and recurrence. Journal of Affective 2013. Morbidity and Mortality Weekly Report: Surveillance Summaries, Disorders, 29, 85 96. 63(4), 1 168. King, M., Sibbald, B., Ward, E., Bower, P., Lloyd, M., Gabbay, M.,   Byford, Karyotaki, E., Smit, Y., de Beurs, D., Henningsen, K., Robays, J., Huibers, S. (2000). Randomised controlled trial of non-directive counselling, M., Weitz, E., . . . Cuijpers, P. (2016). The long-term efficacy of acute-"
  },
  {
    "id": 588,
    "source": "guideline_c3debd",
    "text": "Y., de Beurs, D., Henningsen, K., Robays, J., Huibers, S. (2000). Randomised controlled trial of non-directive counselling, M., Weitz, E., . . . Cuijpers, P. (2016). The long-term efficacy of acute- cognitive-behaviour therapy and usual general practitioner care in the phase psychotherapy for depression: A meta-analysis of randomized management of depression as well as mixed anxiety and depression in trials. Depression and Anxiety, 33, 370 383. primary care. Health Technology Assessment, 4(19), 1 83. Karyotaki, E., Smit, Y., Henningsen, K. H., Huibers, M. J. H., Robays, J., de Kinney, J.,   Dittmar, K. (1995). Homebuilders: Helping families help Beurs, D.,   Cuijpers, P. (2016). Combining pharmacotherapy and themselves. In M. Schwartz   P. AuClaire (Eds.), Home-based services"
  },
  {
    "id": 589,
    "source": "guideline_c3debd",
    "text": "J.,   Dittmar, K. (1995). Homebuilders: Helping families help Beurs, D.,   Cuijpers, P. (2016). Combining pharmacotherapy and themselves. In M. Schwartz   P. AuClaire (Eds.), Home-based services psychotherapy or monotherapy for major depression? A meta- for troubled children (pp. 29 54). Lincoln, NE: University of Nebraska analysis on the long-term effects. Journal of Affective Disorders, 194, Press. 144 152. Kiosses, D. N., Are n, P. A., Teri, L.,   Alexopoulos, G. S. (2010). Kasper, S., Volz, H. P., M ller, H. J., Dienel, A.,   Kieser, M. (2008). Home-delivered problem adaptation therapy (PATH) for depressed, Continuation and long-term maintenance treatment with hypericum cognitively impaired, disabled elders: A preliminary study. American extract WS  5570 after recovery from an acute"
  },
  {
    "id": 590,
    "source": "guideline_c3debd",
    "text": "for depressed, Continuation and long-term maintenance treatment with hypericum cognitively impaired, disabled elders: A preliminary study. American extract WS  5570 after recovery from an acute episode of moderate Journal of Geriatric Psychiatry, 18(11), 988 998. depression A double-blind, randomized, placebo controlled long- term trial. European Neuropsychopharmacology, 18(11), 803 813. https:   Klainin-Yobas, P., Oo, W. N., Yew, P. Y. S.,   Lau, Y. (2015). Effects of doi.org 10.1016 j.euroneuro.2008.06.006 relaxastion interventions on depression and anxiety among older adults: a systematic review. Aging   Mental Health, 19(12), 1043 1055. Kataoka, S. H., Zhang, L.,   Wells, K. B. (2002). Unmet need for mental doi: 10.1080 13607863.2014.997191 health care among U.S. children: Variation"
  },
  {
    "id": 591,
    "source": "guideline_c3debd",
    "text": "review. Aging   Mental Health, 19(12), 1043 1055. Kataoka, S. H., Zhang, L.,   Wells, K. B. (2002). Unmet need for mental doi: 10.1080 13607863.2014.997191 health care among U.S. children: Variation by ethnicity and insurance status. The American Journal of Psychiatry, 159(9), 1548 1555. Kocsis, J. H., Gelenberg, A. J., Rothbaum, B. O., Klein, D. N., Trivedi, M. H., doi:10.1176 appi.ajp.159.9.1548 Manber, R., . . . Thase, M. E. (2009). Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for Katon, W. J. (2003). Clinical and health services relationships between augmentation of antidepressant nonresponse in chronic depression: major depression, depressive symptoms, and general medical illness. The REVAMP trial. Archives of General Psychiatry, 66(11),"
  },
  {
    "id": 592,
    "source": "guideline_c3debd",
    "text": "between augmentation of antidepressant nonresponse in chronic depression: major depression, depressive symptoms, and general medical illness. The REVAMP trial. Archives of General Psychiatry, 66(11), 1178 1188. doi: Biological Psychiatry, 54(3), 216 226.  10.1001 archgenpsychiatry.2009.144 3223(03)00273-7 Kok, R. M., Heeren, T. J., Nolen, W. A. (2011). Continuing treatment of Katon, W. J., Lin, E. H. B., Williams, L. H., Ciechanowski, P., Heckbert, depression in the elderly: A systematic review and meta-analysis S. R., Ludman, E., . . . VonKorff, M. (2010). Comorbid depression is of double-blind, randomized controlled trials with antidepressants. associated with an increased risk of dementia diagnosis in patients American Journal of Geriatric Psychiatry, 19(3), 249 255. with diabetes: A"
  },
  {
    "id": 593,
    "source": "guideline_c3debd",
    "text": "randomized controlled trials with antidepressants. associated with an increased risk of dementia diagnosis in patients American Journal of Geriatric Psychiatry, 19(3), 249 255. with diabetes: A prospective cohort study. Journal of General Internal Medicine, 25(5), 423 429.  Kok, R. M., Nolen, W. A.,   Heeren, T. J. (2012). Efficacy of treatment s11606-009-1248-6 in older depressed patients: A systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. Kazantzis, N., Whittington, C.,   Dattilio, F. (2010). Meta-analysis of Journal of Affective Disorders, 141(2-3), 103 115. homework effects in cognitive and behavioral therapy: A replication and extension. Clinical Psychology: Science and Practice, 17(2), 144 156. Kok, R. M.,   Reynolds, C. F., III."
  },
  {
    "id": 594,
    "source": "guideline_c3debd",
    "text": "141(2-3), 103 115. homework effects in cognitive and behavioral therapy: A replication and extension. Clinical Psychology: Science and Practice, 17(2), 144 156. Kok, R. M.,   Reynolds, C. F., III. (2017). Management of depression doi: 10.1111 j.1468-2850.2010.01204.x in older adults: A review. JAMA: Journal of the American Medical Association, 317(20), 2114 2122.  Kazdin, A. E. (2007). Mediators and mechanisms of change in jama.2017.5706 psychotherapy research. Annual Review of Clinical Psychology, 3, 1 27.  Konnert, C., Dobson, K.,   Stelmach, L. (2009). The prevention of depression in nursing home residents: A randomized clinical trial of cognitive-behavioral therapy. Aging   Mental Health, 13(2), 288 299.  70 APA   Guideline for the Treatment of Depression Kovacs, M., Feinberg, T. L.,"
  },
  {
    "id": 595,
    "source": "guideline_c3debd",
    "text": "home residents: A randomized clinical trial of cognitive-behavioral therapy. Aging   Mental Health, 13(2), 288 299.  70 APA   Guideline for the Treatment of Depression Kovacs, M., Feinberg, T. L., Crouse-Novak, M. A., Paulauskas, S. L.,   Lebowitz, B. D., Pearson, J. L., Schneider, L. S., Reynolds, C. F., III, Finkelstein, R. (1984). Depressive disorders in childhood. I. A Alexopoulos, G. S., Bruce, M. L., . . . Parmelee, P. (1997). Diagnosis longitudinal prospective study of characteristics and recovery. and treatment of depression in late life: Consensus statement update. Archives of General Psychiatry, 41(3), 229 237. JAMA: Journal of the American Medical Association, 278(14), 1186 1190.  Kovacs, M., Feinberg, T. L., Crouse-Novak, M., Paulauskas, S. L., Pollock, M.,   Finkelstein, R."
  },
  {
    "id": 596,
    "source": "guideline_c3debd",
    "text": "Psychiatry, 41(3), 229 237. JAMA: Journal of the American Medical Association, 278(14), 1186 1190.  Kovacs, M., Feinberg, T. L., Crouse-Novak, M., Paulauskas, S. L., Pollock, M.,   Finkelstein, R. (1984). Depressive disorders in childhood. II. A Lemma, A.,   Fonagy, P. (2013). Feasibility study of a psychodynamic longitudinal study of the risk for a subsequent major depression. online group intervention for depression and anxiety. Psychoanalytic Archives of General Psychiatry, 41(7), 643 649. Psychology, 30(3), 367 380. doi: 10.1037 a0033239 Kovacs, M., Gatsonis, C., Paulauskas, S. L.,   Richards, C. (1989). Lemmens, L. H. J. M., M ller, V. N. L. S., Arntz, A.,   Huibers, M. J. H. Depressive disorders in childhood. IV. A longitudinal study of (2016). Mechanisms of change in psychotherapy"
  },
  {
    "id": 597,
    "source": "guideline_c3debd",
    "text": "C. (1989). Lemmens, L. H. J. M., M ller, V. N. L. S., Arntz, A.,   Huibers, M. J. H. Depressive disorders in childhood. IV. A longitudinal study of (2016). Mechanisms of change in psychotherapy for depression: An comorbidity with and risk for anxiety disorders. Archives of General empirical update and evaluation of research aimed at identifying Psychiatry, 46(9), 776 782. psychological mediators. Clinical Psychology Review, 50, 95 107. http:   psycnet.apa.org doi 10.1016 j.cpr.2016.09.004 Kovacs, M., Paulauskas, S., Gatsonis, C.,   Richards, C. (1988). Depressive disorders in childhood. III. A longitudinal study of comorbidity with Lenox-Smith, A. J.,   Jiang, Q. (2008). Venlafaxine extended release and risk for conduct disorders. Journal of Affective Disorders, 15(3), versus citalopram"
  },
  {
    "id": 598,
    "source": "guideline_c3debd",
    "text": "A longitudinal study of comorbidity with Lenox-Smith, A. J.,   Jiang, Q. (2008). Venlafaxine extended release and risk for conduct disorders. Journal of Affective Disorders, 15(3), versus citalopram in patients with depression unresponsive 205 217. to a selective serotonin reuptake inhibitor. International Clinical Psychopharmacology, 23(3), 113 119. doi: 10.1097  Kramer, T.,   Garralda, M. E. (1998). Psychiatric disorders in adolescents YIC.0b013e3282f424c2 in primary care. The British Journal of Psychiatry, 173(6), 508 513.  Lenze, E. J., Mulsant, B. H., Blumberger, D. M., Karp, J. F., Newcomer, J. W., Anderson, S. J., . . . Reynolds, C. F., III (2015). Efficacy, safety, and Lam, R. W., Parikh, S. V., Ramasubbu, R., Michalak, E. E., Tam, E. M., Axler, tolerability of augmentation"
  },
  {
    "id": 599,
    "source": "guideline_c3debd",
    "text": "Newcomer, J. W., Anderson, S. J., . . . Reynolds, C. F., III (2015). Efficacy, safety, and Lam, R. W., Parikh, S. V., Ramasubbu, R., Michalak, E. E., Tam, E. M., Axler, tolerability of augmentation pharmacotherapy with aripiprazole for A., . . . Manjunath, C. V. (2013). Effects of combined pharmacotherapy treatment-resistant depression in late life: A randomised, double- and psychotherapy for improving work functioning in major blind, placebo-controlled trial. The Lancet, 386(10011), 2404 2412. depressive disorder. The British Journal of Psychiatry, 203(5), 358 365.   Levitt, H. M., Bamberg, M., Creswell, J. W., Frost, D. M., Josselson, R.,   Landenberger, N. A. D. (2001). Self-concept and attributional style in the Su rez-Orozco, C. (2018). Journal article reporting standards for"
  },
  {
    "id": 600,
    "source": "guideline_c3debd",
    "text": "M., Creswell, J. W., Frost, D. M., Josselson, R.,   Landenberger, N. A. D. (2001). Self-concept and attributional style in the Su rez-Orozco, C. (2018). Journal article reporting standards for treatment of depression. Dissertation Abstracts International: Section B. qualitative primary, qualitative meta-analytic, and mixed methods Sciences and Engineering, 63(1-B), 533. research in psychology: The APA Publications and Communications Langley, A. K., Nadeem, E., Kataoka, S. H., Stein, B. D.,   Jaycox, L. K. Board task force report. American Psychologist, 73(1), 26 46. http:   (2010). Evidence-based mental health programs in schools: Barriers dx.doi.org 10.1037 amp0000151 and facilitators of successful implementation. School Mental Health, Lewinsohn, P. M., Hops, H., Roberts, R. E., Seeley,"
  },
  {
    "id": 601,
    "source": "guideline_c3debd",
    "text": "mental health programs in schools: Barriers dx.doi.org 10.1037 amp0000151 and facilitators of successful implementation. School Mental Health, Lewinsohn, P. M., Hops, H., Roberts, R. E., Seeley, J. R.,   Andrews, J. A. 2(3), 105 113. doi: 10.1007 s12310-010-9038-1 (1993). Adolescent psychopathology: I. Prevalence and incidence of LaPointe, K. A.,   Rimm, D. C. (1980). Cognitive, assertive, and insight- depression and other DSM-III-R disorders in high school students. oriented group therapies in the treatment of reactive depression in Journal of Abnormal Psychology, 102(1), 133 144. doi: 10.1037 0021- women. Psychotherapy: Theory, Research and Practice, 17(3), 312 321. 843X.102.1.133 Lara, M. A., Navarro, C.,   Navarrete, L. (2010). Outcome results of Lewinsohn, P. M., Roberts, R. E.,"
  },
  {
    "id": 602,
    "source": "guideline_c3debd",
    "text": "0021- women. Psychotherapy: Theory, Research and Practice, 17(3), 312 321. 843X.102.1.133 Lara, M. A., Navarro, C.,   Navarrete, L. (2010). Outcome results of Lewinsohn, P. M., Roberts, R. E., Seeley, J. R., Rohde, P., Gotlib, I. H.,   a psycho-educational intervention in pregnancy to prevent PPD: Hops, H. (1994). Adolescent psychopathology: II. Psychosocial risk A randomized control trial. Journal of Affective Disorders, 122(1-2), factors for depression. Journal of Abnormal Psychology,103(2), 302 315. 109 117. doi: 10.1016 j.jad.2009.06.024 doi: 10.1037 0021-843X.103.2.302 Laurenceau, J. P., Hayes, A. M.,   Feldman, G. C. (2007). Some Lewinsohn, P. M., Rohde, P., Klein, D. N.,   Seeley, J. R. (1999). methodological and statistical issues in the study of change processes Natural course of"
  },
  {
    "id": 603,
    "source": "guideline_c3debd",
    "text": "Hayes, A. M.,   Feldman, G. C. (2007). Some Lewinsohn, P. M., Rohde, P., Klein, D. N.,   Seeley, J. R. (1999). methodological and statistical issues in the study of change processes Natural course of adolescent major depressive disorder: I. in psychotherapy. Clinical Psychology Review, 27(6), 682 695. http:   Continuity into young adulthood. Journal of the American Academy psycnet.apa.org doi 10.1016 j.cpr.2007.01.007 of Child and Adolescent Psychiatry,38(1), 56 63.  org 10.1097 00004583-199901000-00020 Lavretsky, H., Alstein, L. L., Olmstead, R. E., Ercoli, L. M., Riparetti-Brown, M., Cyr, N. S.,   Irwin, M. R. (2011). Complementary use of tai chi Lewinsohn, P. M., Rohde, P., Seeley, J. R., Klein, D. N.,   Gotlib, I. H. chih augments escitalopram treatment of geriatric depression: A"
  },
  {
    "id": 604,
    "source": "guideline_c3debd",
    "text": "N. S.,   Irwin, M. R. (2011). Complementary use of tai chi Lewinsohn, P. M., Rohde, P., Seeley, J. R., Klein, D. N.,   Gotlib, I. H. chih augments escitalopram treatment of geriatric depression: A (2000). Natural course of adolescent major depressive disorder in a randomized controlled trial. The American Journal of Geriatric Psychiatry, community sample: Predictors of recurrence in young adults. American 19(10), 839 850.  Journal of Psychiatry, 157(10), 1584 1591. Le, H.-N., Perry, D. F.,   Stuart, E. (2011). Randomized controlled trial Liberman, R. P.,   Eckman, T. (1981). Behavior therapy vs insight-oriented of a preventative intervention for perinatal depression in high-risk therapy for repeated suicide attempters. Archives of General Psychiatry, infants. Journal of Consulting and"
  },
  {
    "id": 605,
    "source": "guideline_c3debd",
    "text": "vs insight-oriented of a preventative intervention for perinatal depression in high-risk therapy for repeated suicide attempters. Archives of General Psychiatry, infants. Journal of Consulting and Clinical Psychology, 79(2), 135 141. doi: 38(11), 1126 1130. 10.1037 a0022492 Lieverse, R., Van Someren, E. J. W., Nielen, M. M. A., Uitdehaag, B. M. J., Leaf, P. J., Alegr a, M., Cohen, P., Goodman, S. H., Horwitz, S. M., Hoven, Smit, J. H.,   Hoogendijk, W. J. G. (2011). Bright light treatment in C. W., . . . Regier, D. A. (1996). Mental health service use in the elderly patients with nonseasonal major depressive disorder. Archives community and schools: Results from the four-community MECA of General Psychiatry, 68(1), 61 70. Study. Journal of the American Academy of Child and Adolescent"
  },
  {
    "id": 606,
    "source": "guideline_c3debd",
    "text": "major depressive disorder. Archives community and schools: Results from the four-community MECA of General Psychiatry, 68(1), 61 70. Study. Journal of the American Academy of Child and Adolescent Psychiatry, 35(7), 889 897.  199607000-00014 APA   Guideline for the Treatment of Depression 71 Lin, E. H. B., Heckbert, S. R., Rutter, C. M., Katon, W. J., Ciechanowski, P., March, J., Silva, S., Petrycki, S., Curry, J., Wells, K., Fairbank, J., . . . Ludman, E. V., . . . Von Korff, M. (2009). Depression and increased Treatment for Adolescents With Depression Study (TADS) mortality in diabetes: Unexpected causes of death. The Annals of Team. (2004). Fluoxetine, cognitive behavioral therapy, and Family Medicine, 7(5), 414 421. doi: 10.1370 afm.998. PMC2746517 their combination for adolescents"
  },
  {
    "id": 607,
    "source": "guideline_c3debd",
    "text": "causes of death. The Annals of Team. (2004). Fluoxetine, cognitive behavioral therapy, and Family Medicine, 7(5), 414 421. doi: 10.1370 afm.998. PMC2746517 their combination for adolescents with depression: Treatment for adolescents with depression study (TADS) randomized controlled Lin, E. H. B., Katon, W., Von Korff, M., Tang, L. Q., Williams, J. W., Kroenke, trial. JAMA, 292(7), 807 820.  K., . . . Un tzer, J., for the IMPACT Investigators. (2003). Effect of improving depression care on pain and functional outcomes among Marcus, M., Yasamy, T., van Ommeren, M., Chisholm, D., Saxena, S., older adults with arthritis: A randomized controlled trial. JAMA,   World Health Organization, Department of Mental Health and 290(18), 2428 2434. doi: 10.1001 jama.290.18.2428 Substance Abuse. (2012)."
  },
  {
    "id": 608,
    "source": "guideline_c3debd",
    "text": "adults with arthritis: A randomized controlled trial. JAMA,   World Health Organization, Department of Mental Health and 290(18), 2428 2434. doi: 10.1001 jama.290.18.2428 Substance Abuse. (2012). Depression: A global public health concern [Fact sheet]. Retrieved from  Linde, K., Berner, M. M.,   Kriston, L. (2008). St. john s wort for major management depression who paper depression wfmh 2012. depression (review). Cochrane Database of Systematic Reviews, pdf?ua 1 4(CD000448). doi: 10.1002 14651858.CD000448.pub3. Matthew, P.,   Brodersen, D. M. (2018). Income inequality and Lindsey, M. A., Brandt, N. E., Becker, K. D., Lee, B. R., Barth, R. P., Daleiden, health outcomes in the United States: An empirical analysis. The E. L.,   Chorpita, B. F. (2014). Identifying the common elements of"
  },
  {
    "id": 609,
    "source": "guideline_c3debd",
    "text": "Brandt, N. E., Becker, K. D., Lee, B. R., Barth, R. P., Daleiden, health outcomes in the United States: An empirical analysis. The E. L.,   Chorpita, B. F. (2014). Identifying the common elements of Social Science Journal, 55(4), 432 442.  treatment engagement interventions in children s mental health soscij.2018.05.001 services. Clinical Child and Family Psychology Review, 17(3), 283 298. doi: 10.1007 s10567-013-0163-x McCabe, K. M. (2002). Factors that predict premature termination among Mexican-American children in outpatient psychotherapy. Liu, E. T. H., Chen, W. L., Li, Y. H., Wang, C. H., Mok, T. J.,   Huang, H. Journal of Child and Family Studies, 11(3), 347 359. S. (2009). Exploring the efficacy of cognitive bibliotherapy and a potential mechanism of change in the treatment of"
  },
  {
    "id": 610,
    "source": "guideline_c3debd",
    "text": "H., Mok, T. J.,   Huang, H. Journal of Child and Family Studies, 11(3), 347 359. S. (2009). Exploring the efficacy of cognitive bibliotherapy and a potential mechanism of change in the treatment of depressive McHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A.,   Otto, M. symptoms among the Chinese: A randomized controlled trial. W. (2013). Patient preference for psychological vs. pharmacological Cognitive Therapy and Research, 33, 449 461. doi: 10.1007 s10608- treatment of psychiatric disorders: A meta-analytic review. The 008-9228-4 Journal of Clinical Psychiatry, 74(6), 595 602.  doi 10.4088 JCP.12r07757 Liu, N. H., Daumit, G. L., Dua, T., Aquila, R., Charlson, F., Cuijpers, P., . . . Saxena, S. (2017). Excess mortality in persons with severe mental McKay, M. M.,   Bannon, W."
  },
  {
    "id": 611,
    "source": "guideline_c3debd",
    "text": "doi 10.4088 JCP.12r07757 Liu, N. H., Daumit, G. L., Dua, T., Aquila, R., Charlson, F., Cuijpers, P., . . . Saxena, S. (2017). Excess mortality in persons with severe mental McKay, M. M.,   Bannon, W. M., Jr. (2004). Engaging families in child disorders: A multilevel intervention framework and priorities for mental health services. Child   Adolescent Psychiatric Clinics of North clinical practice, policy and research agendas. World Psychiatry, 16(1), America, 13, 905 921. doi: 10.1016 j.chc.2004.04.001 30 40. doi: 10.1002 wps.20384 McLean, P. D.,   Hakstian, A. R. (1979). Clinical depression: Comparative Liu, X., Vitetta, L., Kostner, K., Crompton, D., Williams, G., Brown, W. efficacy of outpatient treatments. Journal of Consulting and Clinical J., . . . Whiteford, H. (2015). The effects"
  },
  {
    "id": 612,
    "source": "guideline_c3debd",
    "text": "Comparative Liu, X., Vitetta, L., Kostner, K., Crompton, D., Williams, G., Brown, W. efficacy of outpatient treatments. Journal of Consulting and Clinical J., . . . Whiteford, H. (2015). The effects of tai chi in centrally obese Psychology, 47(5), 818 836. adults with depression symptoms. Evidence-Based Complementary McLoughlin, A. B., Gould, M. S.,   Malone, K. M. (2015). Global trends in and Alternative Medicine, 2015(879712), 1 8.  teenage suicide: 2003-2014. QJM: An International Journal of Medicine, org 10.1155 2015 879712 108(10), 765 780.  Lorenzo-Luaces, L., German, R. E.,   DeRubeis, R. J. (2015). It s McMiller, W. P.,   Weisz, J. R. (1996). Help-seeking preceding mental complicated: The relation between cognitive change procedures, health clinic intake among African-American,"
  },
  {
    "id": 613,
    "source": "guideline_c3debd",
    "text": "R. J. (2015). It s McMiller, W. P.,   Weisz, J. R. (1996). Help-seeking preceding mental complicated: The relation between cognitive change procedures, health clinic intake among African-American, Latino, and Caucasian cognitive change, and symptom change in cognitive therapy for youth. Journal of the American Academy of Child   Adolescent Psychiatry, depression. Clinical Psychology Review, 41, 3 15.  35(8), 1086 1094.  doi 10.1016 j.cpr.2014.12.003 00020 L we, B., Schulz, U., Gr fe, K.,   Wilke, S. (2006). Medical patients  Meeks, T. W., Vahia, I. V., Lavretsky, H., Kulkarni, G.,   Jeste, D. V. (2011). attitudes toward emotional problems and their treatment: What do A tune in  a minor  can  b major : A review of epidemiology, illness they really want? Journal of General Internal"
  },
  {
    "id": 614,
    "source": "guideline_c3debd",
    "text": "D. V. (2011). attitudes toward emotional problems and their treatment: What do A tune in  a minor  can  b major : A review of epidemiology, illness they really want? Journal of General Internal Medicine, 21(1), 39 45. course, and public health implications of subthreshold depression in  older adults. Journal of Affective Disorders, 129(1-3), 126 142. https:   Ly, K. H., Truschel, A., Jarl, L., Magnusson, S., Windahl, T., Johansson, R., doi.org 10.1016 j.jad.2010.09.015 . . . Andersson, G. (2014). Behavioural activation versus mindfulness- Mellers, B., Hertwig, R.,   Kahneman, D. (2001). Do frequency based guided self-help treatment administered through a smartphone representations eliminate conjunction effects? An exercise in application: A randomised controlled trial. BMJ Open,"
  },
  {
    "id": 615,
    "source": "guideline_c3debd",
    "text": "Do frequency based guided self-help treatment administered through a smartphone representations eliminate conjunction effects? An exercise in application: A randomised controlled trial. BMJ Open, 4(e003440), adversarial collaboration. Psychological Science, 12(4), 269 275. http:   1 13. doi: 10.1136 bmjopen-2013-003440 www.jstor.org stable 40063630?origin JSTOR-pdf Lynch, D. J., Tamburrino, M. B.,   Nagel, R. (1997). Telephone counseling Menchetti, M., Rucci, P., Bortolotti, B., Bombi, A., Scocco, P., Chmura, H., for patients with minor depression: Preliminary findings in a family   Berardi, D. (2014). Moderators of remission with interpersonal practice setting. The Journal of Family Practice, 44(3), 294 298. counselling or drug treatment in primary care patients with Maina, G., Forner,"
  },
  {
    "id": 616,
    "source": "guideline_c3debd",
    "text": "D. (2014). Moderators of remission with interpersonal practice setting. The Journal of Family Practice, 44(3), 294 298. counselling or drug treatment in primary care patients with Maina, G., Forner, F.,   Bogetto, F. (2005). Randomized controlled depression: Randomised controlled trial. The British Journal of trial comparing brief dynamic and supportive therapy with waiting Psychiatry, 204(2), 144 150. doi: 10.1192 bjp.bp.112.122663 list condition in minor depressive disorders. Psychotherapy and Merikangas, A. K., Mendola, P., Pastor, P. N., Reuben, C. A.,   Cleary, S. Psychosomatics, 74, 43 50. doi: 10.1159 000082026 D. (2012). The association between major depressive disorder and obesity in US adolescents: Results from the 2001-2004 National Health and Nutrition Examination Survey."
  },
  {
    "id": 617,
    "source": "guideline_c3debd",
    "text": "43 50. doi: 10.1159 000082026 D. (2012). The association between major depressive disorder and obesity in US adolescents: Results from the 2001-2004 National Health and Nutrition Examination Survey. Journal of Behavioral Medicine, 35(2), 149 154. doi:10.1007 s10865-011-9340-x 72 APA   Guideline for the Treatment of Depression Merikangas, K. R., He, J., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, Mossey, J. M., Knott, K. A., Higgins, M.,   Talerico, K. (1996). L., . . . Swendsen, J. (2010). Lifetime prevalence of mental disorders Effectiveness of a psychosocial intervention, interpersonal counseling, in US adolescents: Results from the National Comorbidity Study  for subdysthymic depression in medically ill elderly. Journal of Adolescent Supplement (NCS-A). Journal of the American"
  },
  {
    "id": 618,
    "source": "guideline_c3debd",
    "text": "counseling, in US adolescents: Results from the National Comorbidity Study  for subdysthymic depression in medically ill elderly. Journal of Adolescent Supplement (NCS-A). Journal of the American Academy Gerontology: Medical Sciences, 51A(4), M172 M178. of Child and Adolescent Psychiatry, 49(10), 980 989.  Mozaffari-Khosravi, H., Nabizade, L., Yassini-Ardakani, S. M., org 10.1016 j.jaac.2010.05.017 Hadinedoushan, H.,   Barzegar, K. (2013). The effect of 2 Midgley, N.,   Kennedy, E. (2011). Psychodynamic psychotherpy for different single injections of high dose vitamin D on improving the children and adolescents: A critical review of the evidence base. depression in depresed patients with vitamin D deficiency. Journal Journal of Child Psychotherapy, 37(3), 232 260.  of Clinical"
  },
  {
    "id": 619,
    "source": "guideline_c3debd",
    "text": "the children and adolescents: A critical review of the evidence base. depression in depresed patients with vitamin D deficiency. Journal Journal of Child Psychotherapy, 37(3), 232 260.  of Clinical Psychopharmacology, 33(3), 378 385. doi: 10.1097  80 0075417X.2011.614738 JCP.0b013e31828f619a Milgrom, J., Gemmil, A. W., Ericksen, J., Burrows, G., Buist, A.,   Reece, J. Mufson, L., Dorta, K. P., Wickramaratne, P., Nomura, Y., Olfson, M.,   (2015). Treatment of postnatal depression with cognitive behavioural Weissman, M. M. (2004). A randomized effectiveness trial of therapy, sertraline and combination therapy: A randomised controlled interpersonal psychotherapy for depressed adolescents. Archives of trial. Australian   New Zealand Journal of Psychiatry, 49(3), 236 245. General Psychiatry,"
  },
  {
    "id": 620,
    "source": "guideline_c3debd",
    "text": "therapy: A randomised controlled interpersonal psychotherapy for depressed adolescents. Archives of trial. Australian   New Zealand Journal of Psychiatry, 49(3), 236 245. General Psychiatry, 61(6), 577 584. doi: 10.1001 archpsyc.61.6.577 doi: 10.1177 0004867414565474 Mufson, L., Weissman, M. M., Moreau, D.,   Garfinkel, R. (1999). Efficacy Milgrom, J., Negri, L. M., Gemmill, A. W., McNeil, M.,   Martin, P. R. of interpersonal psychotherapy for depressed adolescents. Archives (2005). A randomized controlled trial of psychological interventions of General Psychiatry, 56(6), 573 579. doi: 10-1001 pubs.Arch Gen for postnatal depression. British Journal of Clinical Psychology, 44, Psychiatry-ISSN-0003-990x-56-6-yoa8163 529 542. doi: 10.1348 014466505X34200 Mun z, R. F., Le, H.-N., Oppen, C."
  },
  {
    "id": 621,
    "source": "guideline_c3debd",
    "text": "pubs.Arch Gen for postnatal depression. British Journal of Clinical Psychology, 44, Psychiatry-ISSN-0003-990x-56-6-yoa8163 529 542. doi: 10.1348 014466505X34200 Mun z, R. F., Le, H.-N., Oppen, C. G., Diaz, M. A., Urizar, G. G., Jr., Soto, Minges, M. V., Solomonov, N.,   Barber, J. P. (2017). What makes J., . . . Lieberman, A. F. (2007). Prevention of postpartum depression psychodynamic psychotherapy work? A review of five perspectives. in low-income women: Development of the mam s y beb s mothers Psychoanalytic Inquiry, 37(3), 191 201. and babies course. Cognitive and Behavioral Practice, 14, 70 83. Mischoulon, D., Price, L. H., Carpenter, L. L., Tyrka, A. R., Papakostas, G. Muran, J. C.,   Barber, J. P. (Eds.). (2010). The therapeutic alliance: An I., Baer, L., . . . Fava, M. (2014). A"
  },
  {
    "id": 622,
    "source": "guideline_c3debd",
    "text": "70 83. Mischoulon, D., Price, L. H., Carpenter, L. L., Tyrka, A. R., Papakostas, G. Muran, J. C.,   Barber, J. P. (Eds.). (2010). The therapeutic alliance: An I., Baer, L., . . . Fava, M. (2014). A double-blind, randomized, placebo- evidence-based guide to practice. New York, NY: Guilford Press. controlled clinical trial of s-adenosyl-l-methionine (SAMe) versus Murray, C. B. (1998). Racism and mental health. Encyclopedia of mental escitalopram in major depressive disorder. The Journal of Clinical health, 3, 345 357. Psychiatry, 75(4), 370 376. doi: 10.4088 JCP.13m08591 Mynors-Wallis, L. M., Gath, D., Day, A.,   Baker, F. (2000). Randomised Missirlian, T. M., Toukmanian, S. G., Warwar, S. H.,   Greenberg, L. S. controlled trial of problem solving treatment, antidepressant (2005). Emotional"
  },
  {
    "id": 623,
    "source": "guideline_c3debd",
    "text": "D., Day, A.,   Baker, F. (2000). Randomised Missirlian, T. M., Toukmanian, S. G., Warwar, S. H.,   Greenberg, L. S. controlled trial of problem solving treatment, antidepressant (2005). Emotional arousal, client perceptual processing, and the medication, and combined treatment for major depression in primary working alliance in experiential psychotherapy for depression. Journal care. British Medical Journal, 320, 26 30. of Consulting and Clinical Psychology, 73(5), 861 871.  org 10.1037 0022-006X.73.5.861 National Institute for Health and Care Excellence. (2005). Depression in children and young people: Identification and management. Retrieved Mojtabai, R., Olfson, M.,   Han, B. (2016). National trends in the from  prevalence and treatment of depression in adolescents and young adults."
  },
  {
    "id": 624,
    "source": "guideline_c3debd",
    "text": "young people: Identification and management. Retrieved Mojtabai, R., Olfson, M.,   Han, B. (2016). National trends in the from  prevalence and treatment of depression in adolescents and young adults. Pediatrics, 138(6), e20161878. doi: 10.1542 peds.2016 1878 National Institute for Health and Care Excellence. (2009). Depression in adults: recognition and management. Retrived from  Montgomery, P., Mayo-Wilson, E., Hopewell, S., Macdonald, G., Moher, org.uk guidance cg90 D.,   Grant, S. (2013). Developing a reporting guideline for social and psychological intervention trials. American Journal of Public National Institute for Health and Care Excellence. (2012). The guidelines Health, 103(10), 1741 1746.  manual. Retrieved from  AJPH.2013.301447 resources"
  },
  {
    "id": 625,
    "source": "guideline_c3debd",
    "text": "trials. American Journal of Public National Institute for Health and Care Excellence. (2012). The guidelines Health, 103(10), 1741 1746.  manual. Retrieved from  AJPH.2013.301447 resources the-guidelines-manual-pdf-2007970804933 Moon, S. S.,   Rao, U. (2010). Youth-family, youth-school relationship, National Institute for Health and Care Excellence. (2014). Developing and depression. Child and Adolescent Social Work Journal, 27(2), 115 131. NICE guidelines: The manual. Retrieved from  doi:10.1007 s10560-010-0194-9 Media Default About what-we-do our-programmes developing- NICE-guidelines-the-manual.pdf Moradveisi, L., Huibers, M. J. H., Renner, F., Arasteh, M.,   Arntz, A. (2013). Behavioural activation v. antidepressant medication for National Institute of Mental Health (NIMH). (2015)."
  },
  {
    "id": 626,
    "source": "guideline_c3debd",
    "text": "Moradveisi, L., Huibers, M. J. H., Renner, F., Arasteh, M.,   Arntz, A. (2013). Behavioural activation v. antidepressant medication for National Institute of Mental Health (NIMH). (2015). Depression: What you treating depression in Iran: Randomised trial. The British Journal of need to know (NIH Publication No. 15-3561). Retrieved from https:   Psychiatry, 202(3), 204 211. doi: 10.1192 bjp.bp.112.113696 www.nimh.nih.gov health publications depression-what-you-need- to-know depression-what-you-need-to-know-pdf 151827.pdf Moreno, R. A., Teng, C. T., de Almeida, K. M.,   Junior, H. T. (2005). Hypericum perforatum versus fluoxetine in the treatmen of mild to Naylor, E. V., Antonuccio, D. O., Litt, M., Johnson, G. E., Spogen, D. R., moderate depression: A randomized double-blind trial in a"
  },
  {
    "id": 627,
    "source": "guideline_c3debd",
    "text": "Hypericum perforatum versus fluoxetine in the treatmen of mild to Naylor, E. V., Antonuccio, D. O., Litt, M., Johnson, G. E., Spogen, D. R., moderate depression: A randomized double-blind trial in a Brazilian Williams, R., . . . Higgins, D. L., (2010). Bibliotherapy as a treatment sample. Review of Brazilian Psychiatry, 28(1), 29 32. for depression in primary care. Journal of Clinical Psychology in Medical Settings, 17(3), 258 271. doi: 10.1007 s10880-010-9207-2 Morris, N. E. (1975). A group self-instruction method for the treatment of depressed outpatients (Doctoral dissertation, University of Toronto, Nelson J. C., Delucchi, K.,   Schneider L. S. (2008). Efficacy of second- Toronto, Ontario, Canada). Retrieved from  generation antidepressants in late-life depression: A meta-analysis of"
  },
  {
    "id": 628,
    "source": "guideline_c3debd",
    "text": "of Toronto, Nelson J. C., Delucchi, K.,   Schneider L. S. (2008). Efficacy of second- Toronto, Ontario, Canada). Retrieved from  generation antidepressants in late-life depression: A meta-analysis of utoronto.ca details?2179690 uuid f4e44c86-a83f-4909-b5ae- the evidence. American Journal of Geriatric Psychiatry, 16(7), 558 567. 0fee07b23da6  APA   Guideline for the Treatment of Depression 73 Nelson, J. C., Delucchi, K. L.,   Schneider, L. S. (2013). Moderators of Owens, D. K., Lohr, K. N., Atkins, D., Treadwell, J. R., Reston, J. T., Bass, E. outcome in late-life depression: A patient-level meta-analysis. The B., . . . Helfand, M. (2010). AHRQ series paper 5: Grading the strength American Journal of Psychiatry, 170(6), 651 659. doi: 10.1176 appi. of a body of evidence when comparing"
  },
  {
    "id": 629,
    "source": "guideline_c3debd",
    "text": "meta-analysis. The B., . . . Helfand, M. (2010). AHRQ series paper 5: Grading the strength American Journal of Psychiatry, 170(6), 651 659. doi: 10.1176 appi. of a body of evidence when comparing medical interventions agency ajp.2012.12070927 for healthcare research and quality and the effective health-care program. Journal of Clinical Epidemiology, 63(5), 513 523. doi: 10.1016 j. Neugebauer, R., Klin, J., Markowitz, J. C., Bleiberg, K. L., Baxi, L., Rosing, jclinepi.2009.03.009 M. A., . . . Keith, J. (2006). Pilot randomized controlled trial of interpersonal counseling for subsyndromal depression following Pakseresht, S., Boutsani, H., Azemi, M. E., Nilsaz, J., Babapour, R.,   miscarriage. Journal of Clinical Psychiatry, 67(8), 1299 1304. Haghdust, M. R. (2012). Evaluation of"
  },
  {
    "id": 630,
    "source": "guideline_c3debd",
    "text": "depression following Pakseresht, S., Boutsani, H., Azemi, M. E., Nilsaz, J., Babapour, R.,   miscarriage. Journal of Clinical Psychiatry, 67(8), 1299 1304. Haghdust, M. R. (2012). Evaluation of pharmaceutical products of st. john s wort efficacy added on tricyclic antidepressants in treating Nezu, A. M.,   Nezu, C. M. (Eds.). (2008). Evidence-based outcome major depressive disorder: A double blind randomized control trial. research: A practical guide to conducting randomized clinical trials for Jundishapur Journal of Natural Pharmaceutical Products, 7(3), 106 110. psychosocial interventions. New York, NY: Oxford University Press. Papakostas, G. I., Crawford, C. M., Scalia, M. J.,   Fava, M. (2007). Timing Ng, C.-H.,   Schweitzer, I. (2002). An overview of the management of of clinical"
  },
  {
    "id": 631,
    "source": "guideline_c3debd",
    "text": "New York, NY: Oxford University Press. Papakostas, G. I., Crawford, C. M., Scalia, M. J.,   Fava, M. (2007). Timing Ng, C.-H.,   Schweitzer, I. (2002). An overview of the management of of clinical improvement and symptom resolution in the treatment of treatment resistant depression in late life. Psychogeriatrics, 2, 156 164. major depressive disorder: A replication of findings with the use of a Nieuwsma, J. A., Trivedi, R. B., McDuffie, J., Kronish, I., Benjamin, D., double-blind, placebo-controlled trial of hypericum perforatum versus   Williams, J. W. (2012). Brief psychotherapy for depression: A fluoxetine. Neuropsychobiology, 56, 132 137. doi: 10.1159 000115779 systematic review and meta-analysis. The International Journal of Pastore, D. R., Juszczak, L., Fisher, M. M.,   Friedman, S."
  },
  {
    "id": 632,
    "source": "guideline_c3debd",
    "text": "A fluoxetine. Neuropsychobiology, 56, 132 137. doi: 10.1159 000115779 systematic review and meta-analysis. The International Journal of Pastore, D. R., Juszczak, L., Fisher, M. M.,   Friedman, S. B. (1998). School- Psychiatry in Medicine, 43(2), 129 151. based health center utilization: A survey of users and nonusers. Nock, M. K., Hwang, I., Sampson, N. A.,   Kessler, R.C. (2010). Mental Archives of Pediatric Adolescent Medicine, 152(8), 763 767. doi:10.1001  disorders, comorbidity and suicidal behavior: Results from the archpedi.152.8.763 national comorbidity survey replication. Molecular Psychiatry, 15(8), Patel, V., Weiss, H. A., Chowdhary, N., Naik, S., Pednekar, S., Chatterjee, 868 876. doi: 10.1038 mp.2009.29 S., . . . Kirkwood, B. R. (2010). Effectiveness of an intervention led by"
  },
  {
    "id": 633,
    "source": "guideline_c3debd",
    "text": "15(8), Patel, V., Weiss, H. A., Chowdhary, N., Naik, S., Pednekar, S., Chatterjee, 868 876. doi: 10.1038 mp.2009.29 S., . . . Kirkwood, B. R. (2010). Effectiveness of an intervention led by Nolen-Hoeksema, S. (2001). Gender differences in depression. lay health counsellors for depressive and anxiety disorders in primary Current Directions in Psychological Science, 10(5), 173 176. care in Goa, India (MANAS): A cluster randomised controlled trial. Retrieved from  The Lancet, 376(9758), 2086 2095.  handle 2027.42 71710 1467-8721.00142.pdf?sequence 1 6736(10)61508-5 Nolen-Hoeksema, S.,   Girgus, J. S. (1994). The emergence of gender Perry, N. S., Chaplo, S. D.,   Baucom, K. J. W. (2017). The impact differences in depression during adolescence. Psychological Bulletin, of cumulative minority"
  },
  {
    "id": 634,
    "source": "guideline_c3debd",
    "text": "J. S. (1994). The emergence of gender Perry, N. S., Chaplo, S. D.,   Baucom, K. J. W. (2017). The impact differences in depression during adolescence. Psychological Bulletin, of cumulative minority stress on cognitive behavioral therapy 115(3), 424 443.  treatment with gender minority individuals: Case study and clinical recommendations. Cognitive and Behavioral Practice, 24(4), 472 483. Norcross, J. C. (Ed.). (2011). Psychotherapy relationships that work:  Evidence-based responsiveness (2nd ed.). New York, NY: Oxford University Press. Piet, J.,   Hougaard, E. (2011). The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive Norcross, J. C.,   Wampold, B. E. (2011). Evidence-based therapy disorder: A systematic review and meta-analysis."
  },
  {
    "id": 635,
    "source": "guideline_c3debd",
    "text": "cognitive therapy for prevention of relapse in recurrent major depressive Norcross, J. C.,   Wampold, B. E. (2011). Evidence-based therapy disorder: A systematic review and meta-analysis. Clinical Psychology relationships: Research conclusions, and clinical practices. Review, 31(6), 1032 1040. doi: 10.1016 j.cpr.2011.05.002 Psychotherapy, 48(1), 98 102. Pinquart M., Duberstein P. R.,   Lyness J. M. (2006). Treatments Ofonedu, M. E., Percy, W. H., Harris-Britt, A.,   Belcher, H. M. E. (2013). for later-life depressive conditions: A meta-analytic comparison Depression in inner city African American youth: A phenomenological of pharmacotherapy and psychotherapy. American Journal of study. Journal of Child and Family Studies, 22(1), 96 106. doi:10.1007  Psychotherapy, 163(9), 1493 1501."
  },
  {
    "id": 636,
    "source": "guideline_c3debd",
    "text": "American youth: A phenomenological of pharmacotherapy and psychotherapy. American Journal of study. Journal of Child and Family Studies, 22(1), 96 106. doi:10.1007  Psychotherapy, 163(9), 1493 1501. s10826-012-9583-3 Pos, A. E., Greenberg, L. S., Goldman, R. N.,   Korman, L. M. (2003). Ojeda, V. D.,   Bergstresser, S. M. (2008). Gender, race-ethnicity, and Emotional processing during experiential treatment of depression. psychosocial barriers to mental health care: An examination of Journal of Consulting and Clinical Psychology, 71(6), 1007 1016. http:   perceptions and attitudes among adults reporting unmet need. Journal dx.doi.org 10.1037 0022-006X.71.6.1007 of Health and Social Behavior, 49(3), 317 334.  2F002214650804900306 Pos, A. E., Greenberg, L. S.,   Warwar, S. H. (2009). Testing"
  },
  {
    "id": 637,
    "source": "guideline_c3debd",
    "text": "reporting unmet need. Journal dx.doi.org 10.1037 0022-006X.71.6.1007 of Health and Social Behavior, 49(3), 317 334.  2F002214650804900306 Pos, A. E., Greenberg, L. S.,   Warwar, S. H. (2009). Testing a model of change in the experiential treatment of depression. Journal of Okumura, Y.,   Ichikura, K. (2014). Efficacy and acceptability of group Consulting and Clinical Psychology, 77(6), 1055 1066.  cognitive behavioral therapy for depression: A systematic review and org 10.1037 a0017059 meta-analysis. Journal of Affective Disorders, 164, 155 164.  org 10.1016 j.jad.2014.04.023 Pot, A. M., Bohlmeijer, E. T., Onrust, S., Melenhorst, A.-S., Veerbeek, M.,   De Vries, W. (2010). The impact of life review on depression in older Olfson, M., Gameroff, M. J., Marcus, S. C.,   Waslick, B. D. (2003)."
  },
  {
    "id": 638,
    "source": "guideline_c3debd",
    "text": "E. T., Onrust, S., Melenhorst, A.-S., Veerbeek, M.,   De Vries, W. (2010). The impact of life review on depression in older Olfson, M., Gameroff, M. J., Marcus, S. C.,   Waslick, B. D. (2003). adults: A randomized controlled trial. International Psychogeriatrics, Outpatient treatment of child and adolescent depression in the United 22(4), 572 581. doi: 10.1017 S104161020999175X States. Archives of General Psychiatry, 60(12), 1236 1242.  org 10.1001 archpsyc.60.12.1236 Qu, S.-S., Huang, Y., Zhang, Z.-J., Chen, J.-Q., Lin, R.-Y., Wang, C.-Q., . . . Zhang, Y.-C. (2013). A 6-week randomized controlled trial with 4-week follow-up of acupuncture combined with paroxetine in patients with major depressive disorder. Journal of Psychiatric Research, 47(6), 726 732.  74 APA   Guideline for the"
  },
  {
    "id": 639,
    "source": "guideline_c3debd",
    "text": "controlled trial with 4-week follow-up of acupuncture combined with paroxetine in patients with major depressive disorder. Journal of Psychiatric Research, 47(6), 726 732.  74 APA   Guideline for the Treatment of Depression Rabkin, J. G. (2008). HIV and depression: 2008 review and update. Rohde, P., Lewinsohn, P. M., Klein, D. N., Seeley, J. R.,   Gau, J. M. Current HIV AIDS Reports, 5, 163 171. (2013). Key characteristics of major depressive disorder occurring in childhood, adolescence, emerging adulthood, and adulthood. Clinical Rahman, A., Patel, V., Maselko, J.,   Kirkwood, B. (2008). The neglected Psychological Science, 1(1), 41 53. doi: 10.1177 2167702612457599  m  in MCH programmes Why mental health of mothers is important for child nutrition. Tropical Medicine   International"
  },
  {
    "id": 640,
    "source": "guideline_c3debd",
    "text": "The neglected Psychological Science, 1(1), 41 53. doi: 10.1177 2167702612457599  m  in MCH programmes Why mental health of mothers is important for child nutrition. Tropical Medicine   International Health, 13(4), Rosenfeld, R.,   Shiffman, R. N. (2009). Clinical practice guideline 579 583. doi: 10.1111 j.1365-3156.2008.02036.x development manual: A quality-driven approach for translating evidence into action. Otolaryngology Head   Neck Surgery, 140(6, Raue, P. J., Schulberg, H. C., Heo, M., Klimstra, S.,   Bruce, M. L. (2009). Suppl 1), 1 43. Patients  depression treatment preferences and initiation, adherence, and outcome: A randomized primary care study. Psychiatric Services, Rosso, G., Martini, B.,   Maina, G. (2013). Brief dynamic therapy and 60(3), 337 343.  depression severity: A"
  },
  {
    "id": 641,
    "source": "guideline_c3debd",
    "text": "adherence, and outcome: A randomized primary care study. Psychiatric Services, Rosso, G., Martini, B.,   Maina, G. (2013). Brief dynamic therapy and 60(3), 337 343.  depression severity: A single-blind randomized study. Journal of Affective Disorders, 147(1-3), 101 106.  Reeves, B. C., Deeks, J. J., Higgins, J. P. T.,   Wells, G. A., on behalf of the jad.2012.10.017 Cochrane Non-Randomised Studies Methods Group. (2011). Chapter 13: Including non-randomized studies. In J. P. T. Higgins   S. Green Rossell , J.,   Bernal, G. (1999). The efficacy of cognitive-behavioral and (Eds.), Cochrane handbook for systematic reviews of interventions version interpersonal treatments for depresion in Puerto Rican adolescents. 5.1.0. Retrieved from www.handbook.cochrane.org Journal of Consulting and"
  },
  {
    "id": 642,
    "source": "guideline_c3debd",
    "text": "handbook for systematic reviews of interventions version interpersonal treatments for depresion in Puerto Rican adolescents. 5.1.0. Retrieved from www.handbook.cochrane.org Journal of Consulting and Clinical Psychology, 67(5), 734 745. Reiter, J. T., Dobmeyer, A. C.,   Hunter, C. L. (2018). The Primary Care Rossell , J., Bernal, G.,   Rivera-Medina, C. (2012). Individual and group Behavioral Health (PCBH) Model: An overview and operations CBT and IPT for Puerto Rican adolescents with depressive symptoms. definition. Journal Clinical Psychology in Medical Settings, 25(2), Cultural Diversity   Ethnic Minority Psychology, 14(3), 234 245. doi: 109 126.  10.1037 1099-9809.14.3.234. Renner, F., Cuijpers, P.,   Huibers, M. J. H. (2014). The effect of Rothman, K. J., Greenland, S.,   Lash, T. L."
  },
  {
    "id": 643,
    "source": "guideline_c3debd",
    "text": "Ethnic Minority Psychology, 14(3), 234 245. doi: 109 126.  10.1037 1099-9809.14.3.234. Renner, F., Cuijpers, P.,   Huibers, M. J. H. (2014). The effect of Rothman, K. J., Greenland, S.,   Lash, T. L. (2008). Modern epidemiology psychotherapy for depression on improvements in social functioning: (3rd ed.). Philadelphia, PA: Wolters Kluwer Health Lippincott a meta-analysis. Psychological Medicine, 44(14), 2913 2926. doi: Williams   Wilkins. 10.1017 S0033291713003152 Rucci, P., Frank, E., Scocco, P., Calugi, S., Miniati, M., Fagiolini, A.,   Reyes-Portillo, J. A., Mufson, L., Greenhill, L. L., Gould, M. S., Fisher, P. W., Cassano, G. B., (2011). Treatment-emergent suicidal ideation during 4 Tarlow, N.,   Rynn, M. A. (2014). Web-based interventions for youth months of acute management of"
  },
  {
    "id": 644,
    "source": "guideline_c3debd",
    "text": "Gould, M. S., Fisher, P. W., Cassano, G. B., (2011). Treatment-emergent suicidal ideation during 4 Tarlow, N.,   Rynn, M. A. (2014). Web-based interventions for youth months of acute management of unipolar major depression with ssri internalizing problems: A systematic review. Journal of the American pharmacotherapy or interpersonal psychotherapy in a randomized Academy of Child   Adolescent Psychiatry, 53(12), 1254 1270. http:   clinical trial. Depression   Anxiety, 28(4), 303 309. doi: 10.1002  psycnet.apa.org doi 10.1016 j.jaac.2014.09.005 da.20758 Reynolds, C. F., III, Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, Miller, M. D., . . . Kupfer, D. J. (2006). Maintenance treatment of major A. A., Thase,"
  },
  {
    "id": 645,
    "source": "guideline_c3debd",
    "text": "B. G., Mulsant, B. H., Frank, E., Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, Miller, M. D., . . . Kupfer, D. J. (2006). Maintenance treatment of major A. A., Thase, M. E., . . . Fava, M., for the STAR D Study Team. (2006). depression in old age. The New England Journal of Medicine, 354(11), Bupropion-sr, sertraline, or venlafaxine-xr after failure of ssris for 1130 1138. depression. The New England Journal of Medicine, 354(12), 1231 1242. Reynolds, C. F., III, Frank, E., Perel, J. M., Imber, S. D., Cornes, C., Miller, Rushton, J. L., Clark, S. J.,   Freed, G. L. (2000). Pediatrician and family M. D., . . . Kupfer, D. J. (1999). Nortriptyline and interpersonal physician prescription of selective serotonin reuptake inhibitors. psychotherapy as maintenance"
  },
  {
    "id": 646,
    "source": "guideline_c3debd",
    "text": "L. (2000). Pediatrician and family M. D., . . . Kupfer, D. J. (1999). Nortriptyline and interpersonal physician prescription of selective serotonin reuptake inhibitors. psychotherapy as maintenance therapies for recurrent major Pediatrics 105(6), e82. doi: 10.1542 peds.105.6.e82 depression: A randomized controlled trial in patients older than 59 Rushton, J. L., Forcier, M.,   Schectman, R. M. (2002). Epidemiology years. JAMA, 281(1), 39 45. doi: 10.1001 jama.281.1.39 of depressive symptoms in the National Longitudinal Study of Reynolds, C. F., III, Thomas, S. B., Morse, J. Q., Anderson, S. J., Albert, S., Adolescent Health. Journal of the American Academy of Child and Dew, M. A., . . . Quinn, S. C. (2014). Early intervention to preempt Adolescent Psychiatry, 41(2), 199 205. doi:10.1097"
  },
  {
    "id": 647,
    "source": "guideline_c3debd",
    "text": "J., Albert, S., Adolescent Health. Journal of the American Academy of Child and Dew, M. A., . . . Quinn, S. C. (2014). Early intervention to preempt Adolescent Psychiatry, 41(2), 199 205. doi:10.1097 00004583- major depression among older black and white adults. Psychiatric 200202000-00014 Services, 65(6), 765 773. Safran, J. D.,   Muran, J. C. (1996). The resolution of ruptures in the Richards, C. S.,   O Hara, M. W. (2014). Introduction. In C. S. Richards therapeutic alliance. Journal of Consulting and Clinical Psychology, 64(3),   M. W. O Hara (Eds.), The Oxford handbook of depression and 447 458.  comorbidity (pp. 1 10). New York, NY: Oxford University Press. Salminen, J. K., Karlsson, H., Hietala, J., Kajander, J., Aalto, S., Markkula, Richards, D.,   Richardson, T. (2012)."
  },
  {
    "id": 648,
    "source": "guideline_c3debd",
    "text": "and 447 458.  comorbidity (pp. 1 10). New York, NY: Oxford University Press. Salminen, J. K., Karlsson, H., Hietala, J., Kajander, J., Aalto, S., Markkula, Richards, D.,   Richardson, T. (2012). Computer-based psychological J., . . . Toikka, T. (2008). Short-term psychodynamic psychotherapy treatments for depression: A systematic review and meta- and fluoxetine in major depressive disorder: A randomized analysis. Clinical Psychology Review, 32(4), 329 342. doi: 10.1016 j. comparative study. Psychotherapy   Psychosomatics, 77, 351 357. doi: cpr.2012.02.004 10.1159 000151388 Richardson, L. P., McCarty, C. A., Radovic, A.,   Suleiman, A. B. (2017). Saluja, G., Iachan, R., Scheidt, P. C., Overpeck, M. D., Sun, W.,   Giedd, J. Research in the integration of behavioral health for adolescents"
  },
  {
    "id": 649,
    "source": "guideline_c3debd",
    "text": "McCarty, C. A., Radovic, A.,   Suleiman, A. B. (2017). Saluja, G., Iachan, R., Scheidt, P. C., Overpeck, M. D., Sun, W.,   Giedd, J. Research in the integration of behavioral health for adolescents and N. (2004). Prevalence of and risk factors for depressive symptoms young adults in primary care settings: A systematic review. Journal of among young adolescents. Archives of Pediatrics   Adolescent Medicine, Adolescent Health, 60(3), 261 269. doi:10.1016 j.jadohealth.2016.11.013 158(8), 760 765. doi:10.1001 archpedi.158.8.760 Riolo, S. A., Nguyen, T. A., Greden, J. F., King, C. A. (2005). Prevalence of depression by race ethnicity: Findings from the National Health and Nutrtion Examination Survey III. American Journal of Public Health, 95(6), 998 1000. APA   Guideline for the Treatment of"
  },
  {
    "id": 650,
    "source": "guideline_c3debd",
    "text": "of depression by race ethnicity: Findings from the National Health and Nutrtion Examination Survey III. American Journal of Public Health, 95(6), 998 1000. APA   Guideline for the Treatment of Depression 75 Samson, D.,   Schoelles, K. M. (2012). Chapter 2: Developing the topic Shain, B.,   the Committee on Adolescence. (2016). Suicide and suicide and structuring systematic reviews of medical tests: Utility of PICOTS, attempts in adolescents. Pediatrics, 138(1), e20161420. doi: 10.1542  analytic frameworks, decision trees, and other frameworks. In S. peds.2016-1420 M. Chang, D. B. Matchar, G. W. Smetana,   C. A. Umscheid (Eds.) Shanahan, L., Copeland, W. E., Costello, E. J.,   Angold, A. (2011). Child-, Methods guide for medical test reviews [E-reader version]. Rockville, adolescent- and"
  },
  {
    "id": 651,
    "source": "guideline_c3debd",
    "text": "W. Smetana,   C. A. Umscheid (Eds.) Shanahan, L., Copeland, W. E., Costello, E. J.,   Angold, A. (2011). Child-, Methods guide for medical test reviews [E-reader version]. Rockville, adolescent- and young adult-onset depressions: Differential risk MD: Agency for Healthcare Research and Quality. Retrieved from: factors in development? Psychological Medicine, 41(11), 2265 2274.  doi: 10.1017 s0033291711000675 Sareen, J., Jagdeo, A., Cox, B. J., Clara, I., ten Have, M., Belik, S., . . . Stein, Shapiro, D. A., Barkham, M., Rees, A., Hardy, G. E., Reynold, S.,   Startup, M. B. (2007). Perceived barriers to mental health service utilization M. (1994). Effects of treatment duration and severity of depression in the United States, Ontario, and the Netherlands. Psychiatric Services, on the"
  },
  {
    "id": 652,
    "source": "guideline_c3debd",
    "text": "barriers to mental health service utilization M. (1994). Effects of treatment duration and severity of depression in the United States, Ontario, and the Netherlands. Psychiatric Services, on the effectiveness of cognitive-behavioral and psychodynamic- 58(3), 357 364. interpersonal psychotherapy. Journal of Consulting and Clinical Schl gelhofer, M., Willinger, U., Wiesegger, G., Eder, H., Priesch, M., Psychology, 62(3), 522 534. Itzlinger, U., . . . Aschauer, H. (2014). Clinical study results from a Sharpless, B. A.,   Barber, J. P. (2009). A conceptual and empirical randomized controlled trial of cognitive behavioural guided self-help review of the meaning, measurement, development, and teaching of in patients with partially remitted depressive disorder. Psychology intervention"
  },
  {
    "id": 653,
    "source": "guideline_c3debd",
    "text": "trial of cognitive behavioural guided self-help review of the meaning, measurement, development, and teaching of in patients with partially remitted depressive disorder. Psychology intervention competence. Clinical Psychology Review, 29(1), 47 56. doi: and Psychotherapy: Theory, Research and Practice, 87(2), 178 190. doi: doi:10.1016 j.cpr.2008.09.008 10.1111 papt.12008 Shaw, B. F. (1977). Comparison of cognitive therapy and behavior therapy Schnittker, J., Freese, J.,   Powell, B. (2000). Nature, nurture, neither, nor: in the treatment of depression. Journal of Consulting and Clinical Black-White differences in beliefs about the causes and appropriate Psychology, 45(4), 543 551. treatment of mental illness. Social Forces, 78(3), 1101 1132.  org 10.1093 sf 78.3.1101 Shea, B. J., Grimshaw,"
  },
  {
    "id": 654,
    "source": "guideline_c3debd",
    "text": "differences in beliefs about the causes and appropriate Psychology, 45(4), 543 551. treatment of mental illness. Social Forces, 78(3), 1101 1132.  org 10.1093 sf 78.3.1101 Shea, B. J., Grimshaw, J. M., Wells, G. A., Boers, M., Andersson, N., Hamel, C.,   Bouter, L. M. (2007). Development of AMSTAR: A measurement Schrader, E. (2000). Equivalence of St John s wort extract (Ze 117) tool to assess the methodological quality of systematic reviews. BMC and fluoxetine: a randomized, controlled study in mild-moderate Medical Research Methodology, 7(10). doi: 10.1186 1471-2288-7-10 depression. International Clinical Psychopharmacology, 15(2), 61 68.  Shean, G. (2016). Psychotherapy outcome research: Issues and questions. Psychodynamic Psychiatry, 44(1), 1 24. Schulberg H. C., Katon, W., Simon G."
  },
  {
    "id": 655,
    "source": "guideline_c3debd",
    "text": "Clinical Psychopharmacology, 15(2), 61 68.  Shean, G. (2016). Psychotherapy outcome research: Issues and questions. Psychodynamic Psychiatry, 44(1), 1 24. Schulberg H. C., Katon, W., Simon G. E.,   Rush A. J. (1998). Treating major depression in primary care practice: An update of the agency Shiffman, R. N. (2009). Chapter 11: Clinical practice guidelines: for health care policy and research practice guidelines. Archives of Supporting decisions, optimizing care. In C. U. Lehmann, G. R. Kim,   General Psychiatry, 55(12), 1121 1127. doi:10.1001 archpsyc.55.12.1121 K. B. Johnson (Eds.), Pediatric informatics: Computer applications in child health (pp. 149 159). New York, NY: Springer. Sch nemann, H., Hill, S., Guyatt, G., Akl, E. A.,   Ahmed, F. (2011). The GRADE approach and Bradford Hill s"
  },
  {
    "id": 656,
    "source": "guideline_c3debd",
    "text": "informatics: Computer applications in child health (pp. 149 159). New York, NY: Springer. Sch nemann, H., Hill, S., Guyatt, G., Akl, E. A.,   Ahmed, F. (2011). The GRADE approach and Bradford Hill s criteria for causation. Journal of Shinohara, K., Honyashiki, M., Imai, H, Hunot, V., Caldwell, D. M., Davies, Epidemiology   Community Health, 65(5), 392 395. P., . . . Churchill, R. (2013). Behavioural therapies versus other psychological therapies for depression (review). Cochrane Database Sch nemann, H. J., Osborne, M., Moss, J., Manthous, C., Wagner, G., of Systematic Reviews, 10(CD008696), 1 103. doi: 10.1002 14651858. Sicilian, L., . . . Jaeschke, R. (2009). An official American Thoracic CD008696.pub2 Society policy statement: Managing conflict of interest in professional societies."
  },
  {
    "id": 657,
    "source": "guideline_c3debd",
    "text": "1 103. doi: 10.1002 14651858. Sicilian, L., . . . Jaeschke, R. (2009). An official American Thoracic CD008696.pub2 Society policy statement: Managing conflict of interest in professional societies. American Journal of Respiratory Critical Care Medicine, 180(6), Simon, G. E., Katon, W. J., Lin, E. H. B., Ludman, E., VonKorff, M., 564 580. Ciechanowski, P.,   Young, B. A. (2005). Diabetes complications and depression as predictors of health service costs. General Scogin, F. R., Moss, K., Harris, G. M.,   Presnell, A. H. (2014). Treatment Hospital Psychiatry, 27(5), 344 351.  of depressive symptoms in diverse, rural, and vulnerable older adults. genhosppsych.2005.04.008 International Journal of Geriatric Psychiatry, 29(3), 310 316. http:   dx.doi.org 10.1002 gps.4009 Simson, U., Nawarotzky,"
  },
  {
    "id": 658,
    "source": "guideline_c3debd",
    "text": "in diverse, rural, and vulnerable older adults. genhosppsych.2005.04.008 International Journal of Geriatric Psychiatry, 29(3), 310 316. http:   dx.doi.org 10.1002 gps.4009 Simson, U., Nawarotzky, U., Friese, G., Porck, W., Schottenfeld-Naor, S., Hahn, S., . . . Kruse, J. (2008). Psychotherapy intervention Scogin, F., Welsh, D., Hanson, A., Stump, J.,   Coates, A. (2005). to reduce depressive symptoms in patients with diabetic foot Evidence-based psychotherapies for depression in older adults. syndrome. Diabetic Medicine, 25(2), 206 212. doi: 10.1111 j.1464- Clinical Psychology: Science and Practice, 12(3), 222 237.  5491.2007.02370.x org 10.1093 clipsy bpi033 Sirey, J. A., Hannon, C. P., D Angelo, D.,   Knies, K. (2012). A community Scott, A. I. F.,   Freeman, C. P. L. (1992). Edinburgh"
  },
  {
    "id": 659,
    "source": "guideline_c3debd",
    "text": "12(3), 222 237.  5491.2007.02370.x org 10.1093 clipsy bpi033 Sirey, J. A., Hannon, C. P., D Angelo, D.,   Knies, K. (2012). A community Scott, A. I. F.,   Freeman, C. P. L. (1992). Edinburgh primary care treatment intervention advancing active treatment in the elderly depression study: Treatment outcome, patient satisfaction, and cost (ACTIVATE): A pilot study. Journal of Gerontological Social Work, 55(5), after 16 weeks. British Medical Journal, 304, 883 887. 382 391. doi: 10.1080 01634372.2011.644029 Scott, L. D. J.,   Davis, L. E. (2006). Young, Black, and male in foster care: Slade, E. P. (2003). The relationship between school characteristics and Relationship of negative social contextual experiences to factors the availability of mental health and related health services in middle"
  },
  {
    "id": 660,
    "source": "guideline_c3debd",
    "text": "(2003). The relationship between school characteristics and Relationship of negative social contextual experiences to factors the availability of mental health and related health services in middle relevant to mental health service delivery. Journal of Adolescence, and high schools in the United States. The Journal of Behavioral Health 29(5), 721 736. Services   Research, 30(4), 382 392.  Segal, Z. V., Kennedy, S., Gemar, M., Hood, K., Pedersen, R.,   Buis, BF02287426 T. (2006). Cognitive reactivity to sad mood provocation and the Snell-Johns, J., Mendez, J. L.,   Smith, B. H. (2004). Evidence-based prediction of depressive relapse. Archives of General Psychiatry, 63(7), solutions for overcoming access barriers, decreasing attrition, and 749 755. doi: 10.1001 archpsyc.63.7.749 promoting"
  },
  {
    "id": 661,
    "source": "guideline_c3debd",
    "text": "prediction of depressive relapse. Archives of General Psychiatry, 63(7), solutions for overcoming access barriers, decreasing attrition, and 749 755. doi: 10.1001 archpsyc.63.7.749 promoting change with underserved families. Journal of Family Psychology, 18(1), 19 35. doi: 10.1037 0893-3200.18.1.19 76 APA   Guideline for the Treatment of Depression Snowden, L. R., Masland, M. C., Fawley, K.,   Wallace, N. (2009). Ethnic Strauss, C., Cavanagh, K., Oliver, A.,   Pettman, D. (2014). Mindfulness- differences in children s entry into public mental health care via based interventions for people diagnosed with a current episode of emergency mental health services. Journal of Child and Family Studies, an anxiety or depressive disorder: A meta-analysis of randomised 18(5), 512 519. doi: 10.1007"
  },
  {
    "id": 662,
    "source": "guideline_c3debd",
    "text": "with a current episode of emergency mental health services. Journal of Child and Family Studies, an anxiety or depressive disorder: A meta-analysis of randomised 18(5), 512 519. doi: 10.1007 s10826-008-9253-7 controlled trials. PLoS ONE, 9(4), e96110. doi: 10.1371 journal. pone.0096110 Snowden, L. R.,   Thomas, K. (2000). Medicaid and African American outpatient mental health treatment. Mental Health Services Research, Substance Abuse and Mental Health Service Administration (SAMHSA), 2(2), 115 120. Center for Behavioral Health Statistics and Quality. (2015). Behavioral health trends in the United States: Results from the 2014 national survey Snowden, L. R.,   Yamada, A.-M. (2005). Cultural differences in access on drug use and health (HHS Publication No. SMA 15-4927, NSDUH to care."
  },
  {
    "id": 663,
    "source": "guideline_c3debd",
    "text": "the United States: Results from the 2014 national survey Snowden, L. R.,   Yamada, A.-M. (2005). Cultural differences in access on drug use and health (HHS Publication No. SMA 15-4927, NSDUH to care. Annual Review of Clinical Psychology, 1, 143 166.  Series H-50). Retrieved from  org 10.1146 annurev.clinpsy.1.102803.143846 default files NSDUH-FRR1-2014 NSDUH-FRR1-2014.pdf So, M., Yamaguchi, S., Hashimoto, S., Mitsuhiro, S., Furukawa, T. A., Suicide Prevention Resource Center. (2013). Suicide among racial ethnic   McCrone, P. (2013). Is computer-based CBT really helfpful for populations in the U.S.: Hispanics [Fact sheet]. Retrieved from https:   adult depression? A meta-analytic re-evaluation of CCBT for adult www.sprc.org sites default files migrate library Hispanics 20 depression in"
  },
  {
    "id": 664,
    "source": "guideline_c3debd",
    "text": "the U.S.: Hispanics [Fact sheet]. Retrieved from https:   adult depression? A meta-analytic re-evaluation of CCBT for adult www.sprc.org sites default files migrate library Hispanics 20 depression in terms of clinical implementation and methodological Sheet 20Aug 2028 202013 20Final.pdf validity. BMC Psychiatry, 13(113), 1 14.  com 1471-244X 13 113 Sun, H., Zhao, H., Ma, C., Bao, F., Zhang, J., Wang, D.-H., . . . He, W. (2013). Effects of electroacupuncture on depression and the production of Sontag-Padilla, L., Woodbridge, M. W., Mendelsohn, J., D Amico, E. J., glial cell line-derived neurotrophic factor compared with fluoxitine: Osilla, K. C., Jaycox, L. H., . . . Stein, B. D. (2016). Factors affecting A randomized controlled pilot study. The Journal of Alternative and mental health"
  },
  {
    "id": 665,
    "source": "guideline_c3debd",
    "text": "factor compared with fluoxitine: Osilla, K. C., Jaycox, L. H., . . . Stein, B. D. (2016). Factors affecting A randomized controlled pilot study. The Journal of Alternative and mental health service utilization among California public college and Complementary Medicine, 19(9), 733 739. doi: 10.1089 acm.2011.0637 university students. Psychiatric Services, 67(8), 890 897. doi: 10.1176  appi.ps.201500307 Szegedi, A., Kohnen, R., Dienel, A.,   Kieser, M. (2005). Acute treatment of moderate to severe depression with hypericum extract WS 5570 S zeri-Varma, G. (2012). Depression in the elderly: Clinical features and (St John s wort): Randomised controlled double blind non-inferiority risk factors. Aging and Disease, 3(6), 465 471. trial versus paroxetine. British Medical Journal, 330, 503 506."
  },
  {
    "id": 666,
    "source": "guideline_c3debd",
    "text": "features and (St John s wort): Randomised controlled double blind non-inferiority risk factors. Aging and Disease, 3(6), 465 471. trial versus paroxetine. British Medical Journal, 330, 503 506. doi: Spek, V., Nyklicek, I, Smits, N., Cuijpers, P., Riper, H., Keyzer, J.,   10.1136 bmj.38356.655266.82 Pop, V. (2007). Internet-based cognitive behavioural therapy for Szigethy, E., Bujoreanu, S. I., Youk, A. O., Weisz, J., Benhayon, D., subthreshold depression in people over 50 years old: A randomized Fairclough, D., . . . DeMaso, D. R. (2014). Randomized efficacy trial controlled clinical trial. Psychological Medicine, 1797 1806. doi: 10.1017  of two psychotherapies for depression in youth with inflammatory S0033291707000542 bowel disease. Journal of the American Academy of Child and"
  },
  {
    "id": 667,
    "source": "guideline_c3debd",
    "text": "trial. Psychological Medicine, 1797 1806. doi: 10.1017  of two psychotherapies for depression in youth with inflammatory S0033291707000542 bowel disease. Journal of the American Academy of Child and Adolescent Stark, K. D., Streuand, W., Krumholz, L. S.,   Patel, P. (2010). Cognitive- Psychiatry, 53(7), 726 735. doi: 10.1016 j.jaac.2014.04.014 behavioral therapy for depression: The ACTION program for girls. Teh, C. F., Sorbero, M. J., Mihalyo, M. J., Kogan, J. N., Schuster, J., Reynolds, In J. R. Weisz   A. E. Kazdin (Eds.), Evidence-based psychotherapies C. F., III,   Stein, B. D. (2010). Predictors of adequate depression for children and adolsecents (2nd ed., pp. 93 109). New York, NY: treatment among medicaid-enrolled adults. Health Services Research, Guilford Press 45(1), 302 315."
  },
  {
    "id": 668,
    "source": "guideline_c3debd",
    "text": "Predictors of adequate depression for children and adolsecents (2nd ed., pp. 93 109). New York, NY: treatment among medicaid-enrolled adults. Health Services Research, Guilford Press 45(1), 302 315.  Stein, G. L., Curry, J. F., Hersh, J., Breland-Noble, A., March, J., Silva, S. G., . Terides, M. D., Dear, B. F., Fogliati, V. J., Gandy, M., Karin, E., Jones, M. P.,   . . Jacobs, R. (2010). Ethnic differences among adolescents beginning Titov, N. (2018). Increased skills usage statistically mediates symptom treatment for depression. Cultural Diversity and Ethnic Minority reduction in self-guided internet-delivered cognitive-behavioural Psychology, 16(2), 152 158.  therapy for depression and anxiety: A randomised controlled trial. a0018666 Cognitive Behaviour Therapy, 47(1), 43 61. Steinert,"
  },
  {
    "id": 669,
    "source": "guideline_c3debd",
    "text": "internet-delivered cognitive-behavioural Psychology, 16(2), 152 158.  therapy for depression and anxiety: A randomised controlled trial. a0018666 Cognitive Behaviour Therapy, 47(1), 43 61. Steinert, C., Hofmann, M., Kruse, J.,   Leichsenring, F. (2014). Relapse Thapar, A., Collishaw, S., Pine, D. S.,   Thapar, A. K. (2012). Depression in rates after psychotherapy for depression stable long-term effects? A adolescence. The Lancet, 379(9820), 1056 1067. doi:10.1016 S0140- meta-analysis. Journal of Affective Disorders, 168(15), 107 118. https:   6736(11)60871-4 doi.org 10.1016 j.jad.2014.06.043 Thase, M. E., Friedman, E. S., Biggs, M. M., Wisniewski, S. R., Trivedi, Steinert, C., Stadter, K., Stark, R.,   Leichsenring, F. (2017). The effects M. H., Luther, J. F., . . . Rush, A. J. (2007)."
  },
  {
    "id": 670,
    "source": "guideline_c3debd",
    "text": "Thase, M. E., Friedman, E. S., Biggs, M. M., Wisniewski, S. R., Trivedi, Steinert, C., Stadter, K., Stark, R.,   Leichsenring, F. (2017). The effects M. H., Luther, J. F., . . . Rush, A. J. (2007). Cognitive therapy versus of waiting for treatment: A meta-analysis of waitlist control groups medication in augmentation and switch strategies as second-step in randomized controlled trials for social anxiety disorder. Clinical treatments: A STAR D report. American Journal of Psychiatry, 164(5), Psychology   Psychotherapy, 24(3), 649 660.  739 752. cpp.2032 Thase, M. E., Greenhouse, J. B., Frank, E. Reynolds, C. F., III, Pilkonis, P. A., Stevenson, M. D., Scope, A., Sutcliffe, P. A., Booth, A., Slade, P., Parry, G., Hurley, K., . . . Kupfer, D. J. (1997). Treatment of major depression with . ."
  },
  {
    "id": 671,
    "source": "guideline_c3debd",
    "text": "Reynolds, C. F., III, Pilkonis, P. A., Stevenson, M. D., Scope, A., Sutcliffe, P. A., Booth, A., Slade, P., Parry, G., Hurley, K., . . . Kupfer, D. J. (1997). Treatment of major depression with . . . Group Cognitive Behavioural Therapy for Postnatal Depression psychotherapy or psychotherapy-pharmacotherapy combinations. Advisory Group. (2010). Group cognitive behavioural therapy for Archives of General Psychiatry, 54, 1009 1015. postnatal depresion: A systematic review of clinical effectiveness, cost-effectiveness, and value of information analyses. Health Thompson, L. W., Gallagher, D.,   Breckenridge, J. S. (1987). Comparative Technology Assessment, 14(44). doi: 10.3310 hta14440 effectiveness of psychotherapies for depressed elders. Journal of Consulting and Clinical Psychology, 55(3),"
  },
  {
    "id": 672,
    "source": "guideline_c3debd",
    "text": "J. S. (1987). Comparative Technology Assessment, 14(44). doi: 10.3310 hta14440 effectiveness of psychotherapies for depressed elders. Journal of Consulting and Clinical Psychology, 55(3), 385 390. APA   Guideline for the Treatment of Depression 77 Thyme, K. E., Sundin, E. C., Stahlberg, G., Lindstrom, B., Eklof, H.,   Wiberg, van t Veer-Tazelaar, P. J., van Marwijk, H. W. J., van Oppen, P., van Hout, B. (2007). The outcome of short-term psychodynamic art therapy H. P. J., van der Horst, H., Cuijpers, P., . . . Beekman, A. T. F. (2009). compared to short-term psychodynamic verbal therapy for depressed Stepped-care prevention of anxiety and depression in late life: A women. Psychodynamic Psychotherapy, 21(3), 250 264. randomized controlled trial. Archives of General Psychiatry, 66(3), 297"
  },
  {
    "id": 673,
    "source": "guideline_c3debd",
    "text": "depressed Stepped-care prevention of anxiety and depression in late life: A women. Psychodynamic Psychotherapy, 21(3), 250 264. randomized controlled trial. Archives of General Psychiatry, 66(3), 297 304. Tompson, M. C., Boger, K. D.,   Asarnow, J. R. (2012). Enhancing the developmental appropriateness of treatment for depression van Voorhees, B. W., Paunesku, D., Gollan, J., Kuwabara, S., Reinecke, M., in youth: Integrating the family in treatment. Child   Adolescent   Basu, A. (2008). Predicting future risk of depressive episode in Psychiatric Clinics of North America, 21(2), 345 384. doi: 10.1016 j. adolescents: The Chicago Adolescent Depression Risk Assessment chc.2012.01.003 (CADRA). The Annals of Family Medicine, 6(6), 503 511. doi:10.1370  afm.887 Treweek, S., Oxman, A. D.,"
  },
  {
    "id": 674,
    "source": "guideline_c3debd",
    "text": "doi: 10.1016 j. adolescents: The Chicago Adolescent Depression Risk Assessment chc.2012.01.003 (CADRA). The Annals of Family Medicine, 6(6), 503 511. doi:10.1370  afm.887 Treweek, S., Oxman, A. D., Alderson, P., Bossuyt, P. M., Brandt, L., Bro ek, J., . . . Alonso-Coello, P. (2013). Developing and evaluating V zquez, F. L., Torres, A., Blanco, V., D az, O., Otero, P.,   Hermida, E. communication strategies to support informed decisions and practice (2012). Comparison of relaxation training with a cognitive-behavioural based on evidence (DECIDE): Protocol and preliminary results. intervention for indicated prevention of depression in university Implementation Science, 8(6), 1 12. students: A randomized controlled trial. Journal of Psychiatric Research, 46(11), 1456 1463.  Trivedi, M. H.,"
  },
  {
    "id": 675,
    "source": "guideline_c3debd",
    "text": "for indicated prevention of depression in university Implementation Science, 8(6), 1 12. students: A randomized controlled trial. Journal of Psychiatric Research, 46(11), 1456 1463.  Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., . . . Rush, A. J., for the STAR D Study Team. (2006). Verduyn, C., Barrowclough, C., Roberts, J., Tarrier, N.,   Harrington, Medication augmetation after the failure of SSRIs for depression. The R. (2003). Maternal depression and child behaviour problems: New England Journal of Medicine, 354(12), 1243 1252. Randomised placebo-controlled trial of a cognitive-behavioural group intervention. British Journal of Psychiatry, 183(4), 342 348.  Trowell J., Joffe, I., Campbell, J., Clemente, C., Almgyist, F., Soininen, M., . . org"
  },
  {
    "id": 676,
    "source": "guideline_c3debd",
    "text": "trial of a cognitive-behavioural group intervention. British Journal of Psychiatry, 183(4), 342 348.  Trowell J., Joffe, I., Campbell, J., Clemente, C., Almgyist, F., Soininen, M., . . org 10.1192 bjp.183.4.342 . Tsiantis, J. (2007). Childhood depression: A place for psychotherapy. An outcome study comparing individual psychodynamic Viswanathan, M., Ansari, M. T., Berkman, N. D., Chang, S., Hartling, L., psychotherapy and family therapy. European   Child Adolescent McPheeters, L. M., . . . Treadwell, J. R. (2012). Assessing the risk Psychiatry, 16(3), 157 167. of bias of individual studies in systematic reviews of health care interventions. Agency for Healthcare Research and Quality: Methods Un tzer, J., Katon, W., Callahan, C. M., Williams, J. W., Hunkeler, E., Guide for Comparative"
  },
  {
    "id": 677,
    "source": "guideline_c3debd",
    "text": "in systematic reviews of health care interventions. Agency for Healthcare Research and Quality: Methods Un tzer, J., Katon, W., Callahan, C. M., Williams, J. W., Hunkeler, E., Guide for Comparative Effectiveness Reviews. Rockville, MD. Retrieved Harpole, L., . . . IMPACT Investigators. (2002). Collaborative care from:  management of late-life depression in the primary care setting: A pdf PubMedHealth PMH0077771.pdf randomized controlled trial. JAMA, 288(22), 2836 2845. doi: 10.1001  jama.288.22.2836 von Wolff, A., H zel, L. P., Westphal, A., H rter, M.,   Kriston, L. (2012). Combination of pharmacotherapy and psychotherpay in the treatment Un tzer, J., Katon, W., Callahan, C. M., Williams, J. J., Hunkeler, E., of chronic depression: A systematic review and meta-analysis. Harpole, L., . ."
  },
  {
    "id": 678,
    "source": "guideline_c3debd",
    "text": "and psychotherpay in the treatment Un tzer, J., Katon, W., Callahan, C. M., Williams, J. J., Hunkeler, E., of chronic depression: A systematic review and meta-analysis. Harpole, L., . . . Oishi, S. (2003). Depression treatment in a sample BMC Psychiatry, 12(61), 1 10.  of 1,801 depressed older adults in primary care. Journal of The 244X 12 61 American Geriatrics Society, 51(4), 505 514. doi:10.1046 j.1532- 5415.2003.51159.x Vos, T., Barber, R. M., Bell, B., Bertozzl-Villa, A., Blrukov, S., Bolliger, I., . . . Murray, C. J. L. (2015). Global, regional, and national U.S. Burden of Disease Collaborators. (2013). The state of U.S. health, incidence, prevalence, and years lived with disability for 301 acute 1990-2010: Burden of diseases, injuries, and risk factors. JAMA, and chronic diseases"
  },
  {
    "id": 679,
    "source": "guideline_c3debd",
    "text": "(2013). The state of U.S. health, incidence, prevalence, and years lived with disability for 301 acute 1990-2010: Burden of diseases, injuries, and risk factors. JAMA, and chronic diseases and injuries in 188 countries, 1990-2013: A 310(6), 591 608. doi: 10.1001 jama.2013.13805 systematic analysis for the global burden of disease study 2013. The U.S. Department of Health and Human Services, Centers for Disease Lancet, 386(9995), 743 800. doi:  Control and Prevention, National Center for Health Statistics. (2012). 6736(15)60692-4 Health, United States, 2011: With special feature on socioeconomic status Vostanis, P., Feehan, C.,   Grattan, E. (1998). Two-year outcome of and health (Catalog No. 76-641496). Retrieved from  children treated for depression. European Child   Adolescent"
  },
  {
    "id": 680,
    "source": "guideline_c3debd",
    "text": "status Vostanis, P., Feehan, C.,   Grattan, E. (1998). Two-year outcome of and health (Catalog No. 76-641496). Retrieved from  children treated for depression. European Child   Adolescent Psychiatry, gov nchs data hus hus11.pdf 7(1), 12 18. van der Velden, A. M., Kuyken, W., Wattar, U., Crane, C., Pallesen, K. J., Vostanis, P., Feehan, C., Grattan, E.,   Bickerton, W. L. (1996a). A Dahlgaard, J., . . . Piet, J. (2015). A systematic review of mechanisms randomised controlled out-patient trial of cognitive-behavioural of change in mindfulness-based cognitive therapy in the treatment treatment for children and adolescents with depression: 9-month of recurrent major depressive disorder. Clinical Psychology Review, 37, follow-up. Journal of Affective Disorders, 40(1-2), 105 116. doi: 26 39."
  },
  {
    "id": 681,
    "source": "guideline_c3debd",
    "text": "for children and adolescents with depression: 9-month of recurrent major depressive disorder. Clinical Psychology Review, 37, follow-up. Journal of Affective Disorders, 40(1-2), 105 116. doi: 26 39.  10.1016 0165-0327(96)00054-7 van Gurp, G., Meterissian, G. B., Haiek, L. N., McCusker, J.,   Bellavance, Vostanis, P., Feehan, C., Grattan, E.,   Bickerton, W. L. (1996b). Treatment F. (2002). St john s wort or sertraline? Randomized controlled trial in for children and adolescents with depression: Lessons from a primary care. Canadian Family Physician, 48(5), 905 912. controlled trial. Clinical Child Psychology and Psychiatry, 1(2), 199 212. van Hees, M. L. J. M., Rotter, T., Ellermann,   Evers, S. M. A. A. (2013). Wade, T. J, Cairney, J.,   Pevalin, D. J. (2002). Emergence of gender The"
  },
  {
    "id": 682,
    "source": "guideline_c3debd",
    "text": "Child Psychology and Psychiatry, 1(2), 199 212. van Hees, M. L. J. M., Rotter, T., Ellermann,   Evers, S. M. A. A. (2013). Wade, T. J, Cairney, J.,   Pevalin, D. J. (2002). Emergence of gender The effectiveness of individual interpersonal psychotherapy as differences in depression during adolescence: National panel results a treatment for major depressive disorder in adult outpatients: from three countries. Journal of the American Academy of Child and A systematic review. BMC Psychiatry, 13(22), 1 10.  Adolescent Psychiatry, 41(2), 190 198. biomedcentral.com 1471-244X 13 22 78 APA   Guideline for the Treatment of Depression Wassertheil-Smoller, S., Arredondo, E. M., Cai, J., Castaneda, S. F., Wiles, N., Thomas, L., Abel, A., Barnes, M., Carroll, F., Ridgway, N., . . . Choca, J. P., Gallo,"
  },
  {
    "id": 683,
    "source": "guideline_c3debd",
    "text": "for the Treatment of Depression Wassertheil-Smoller, S., Arredondo, E. M., Cai, J., Castaneda, S. F., Wiles, N., Thomas, L., Abel, A., Barnes, M., Carroll, F., Ridgway, N., . . . Choca, J. P., Gallo, L. C., . . . Penedo, F. J. (2014). Depression, anxiety, Lewis, G. (2014). Clinical effectiveness and cost-effectiveness of antidepressant use, and cardiovascular disease among Hispanic cognitive behavioural therapy as an adjunct pharmacotherapy men and women of different national backgrounds: Results from for treatment-resistant depression in primary care: The CoBaLT the hispanic community health study study of latinos. Annals randomised controlled trial. Health Technology Assessment, 18(31), of Epidemiology, 24(11), 822 830.  1 167. doi: 10.3310 hta18310 annepidem.2014.09.003 Wilkinson, P.,"
  },
  {
    "id": 684,
    "source": "guideline_c3debd",
    "text": "study study of latinos. Annals randomised controlled trial. Health Technology Assessment, 18(31), of Epidemiology, 24(11), 822 830.  1 167. doi: 10.3310 hta18310 annepidem.2014.09.003 Wilkinson, P.,   Izmeth, Z. (2012). Continuation and maintenance Webb, C. A., DeRubeis, R. J.,   Barber, J. P. (2010). Therapist adherence  treatments for depression in older people. The Cochrane Database of competence and treatment outcome: A meta-analytic review. Journal Systematic Reviews, 14(11), 1 47.  of Consulting and Clinical Psychology, 78(2), 200 211.  CD006727.pub2 org 10.1037 2Fa0018912 Williams, D. R., Gonzalez, H. M., Neighbors, H., Nesse, R., Abelson, J. M., Weersing, V. R., Jeffreys, M., Do, M. C. T., Schwartz, K. T. G.,   Bolano, C. Sweetman, J.,   Jackson, J. S. (2007). Prevalence and"
  },
  {
    "id": 685,
    "source": "guideline_c3debd",
    "text": "D. R., Gonzalez, H. M., Neighbors, H., Nesse, R., Abelson, J. M., Weersing, V. R., Jeffreys, M., Do, M. C. T., Schwartz, K. T. G.,   Bolano, C. Sweetman, J.,   Jackson, J. S. (2007). Prevalence and distribution (2016). Evidence base update of psychosocial treatments for child and of major depressive disorder in African Americans, Caribbean adolescent depression. Journal of Clinical Child   Adolescent Psychology, blacks, and non-Hispanic whites: Results from the national survey 46(1), 11 43.  of American life. Archives of General Psychiatry, 64(3), 305 315. doi: 10.1001 archpsyc.64.3.305 Weinberger, A. H., Gbedemah, M., Martinez, A. M., Nash, D., Galea, S.,   Goodwin, R. D. (2017). Trends in depression prevalence in the Williams, J. W., Barrett, J., Oxman T., Frank, E., Katon, W.,"
  },
  {
    "id": 686,
    "source": "guideline_c3debd",
    "text": "Weinberger, A. H., Gbedemah, M., Martinez, A. M., Nash, D., Galea, S.,   Goodwin, R. D. (2017). Trends in depression prevalence in the Williams, J. W., Barrett, J., Oxman T., Frank, E., Katon, W., Sullivan, M., . . . USA from 2005 to 2015: Widening disparities in vulnerable groups. Sengupta, A. (2000). Treatment of dysthymia and minor depression Psychological Medicine, 48, 1308 1315.  in primary care: A randomized controlled trial in older adults. JAMA, S0033291717002781 284(12), 1519 1526. Weisz, J. R., McCarty, C. A.,   Valeri, S. M. (2006). Effects of Wirz-Justice, A., Bader, A., Frisch, U., Stieglitz, R. D., Alder, J., Bitzer, J., psychotherapy for depression in children and adolescents: A meta- . . . Richer-R ssler, A. (2011). A randomized, double-blind, placebo- analysis."
  },
  {
    "id": 687,
    "source": "guideline_c3debd",
    "text": "Frisch, U., Stieglitz, R. D., Alder, J., Bitzer, J., psychotherapy for depression in children and adolescents: A meta- . . . Richer-R ssler, A. (2011). A randomized, double-blind, placebo- analysis. Psychological Bulletin, 132(1), 132 149. doi: 10.1037 0033- controlled study of light therapy for antepartum depression. Journal of 2909.132.1.132 Clinical Psychiatry, 72(7), 986 993. Weisz, J. R., Thurber, C. A., Sweeney, L., Proffitt, V. D.,   LeGagnoux, G. L. Wittink, M. N., Cary, M., TenHave, T., Baron, J.,   Gallo, J. J. (2010). (1997). Brief treatment of mild-to-moderate child depression using Towards patient-centered care for depression: Conjoint methods to primary and secondary control enhancement training. Journal of tailor treatment based on preferences. Patient, 3(3), 145 157. doi:"
  },
  {
    "id": 688,
    "source": "guideline_c3debd",
    "text": "Towards patient-centered care for depression: Conjoint methods to primary and secondary control enhancement training. Journal of tailor treatment based on preferences. Patient, 3(3), 145 157. doi: Consulting Clinical Psychology, 65(4), 703 707. 10.2165 11530660 Weisz, J. R.,   Weiss, B. (1989). Assessing the effects of clinic-based Wollersheim, J. P.,   Wilson, G. L. (1991). Group treatment of unipolar psychotherapy with children and adolescents. The Journal of Consulting depression: A comparison of coping, supporting, bibliotherapy, and and Clinical Psychology, 57(6), 741 746. delayed treatment groups. Professional Psychology: Research and Practice, 22(6), 496 502. Wesselhoeft, R., S rensen, M. J., Heiervang, E. R.,   Bilenberg, N. (2013). Subthreshold depression in children and"
  },
  {
    "id": 689,
    "source": "guideline_c3debd",
    "text": "treatment groups. Professional Psychology: Research and Practice, 22(6), 496 502. Wesselhoeft, R., S rensen, M. J., Heiervang, E. R.,   Bilenberg, N. (2013). Subthreshold depression in children and adolescents a systematic World Health Organization. (2008). The global burden of disease: 2004 review. Journal of Affective Disorders, 151(1), 7 22. doi:10. 1016 j. update. Retrieved from  jad.2013.06.010 disease GBD report 2004update full.pdf?ua 1 Whelton, W. J. (2004). Emotional processes in psychotherapy: Evidence Wu, P., Katic, B. J., Liu, X. H., Fan, B.,   Fuller, C. J. (2010). Mental health across therapeutic modalities. Clinical Psychology   Psychotherapy, 11(1), service use among suicidal adolescents: Findings from a U.S. national 58 71.  community survey. Psychiatric Services, 61(1),"
  },
  {
    "id": 690,
    "source": "guideline_c3debd",
    "text": "across therapeutic modalities. Clinical Psychology   Psychotherapy, 11(1), service use among suicidal adolescents: Findings from a U.S. national 58 71.  community survey. Psychiatric Services, 61(1), 17 24. Wickberg, B.,   Hwang, C. P. (1996). Counselling of postnatal depression: Wu, P., Hoven, C. W., Cohen, P., Liu, X., Moore, R. E., Tiet, Q., . . . Bird, H. A controlled study on a population-based Swedish sample. Journal R. (2001). Factors associated with use of mental health services for of Affective Disorders, 39(3), 209 216.  depression by children and adolescents. Psychiatric Services, 52(2), 0327(96)00034-1 189 195.  Wickramaratne, P. J., Greenwald, S.,   Weissman, M. M. (2000). Wulson, L. R.,   Singal, B. M. (2003). Do depressive symptoms increase Psychiatric disorders in the"
  },
  {
    "id": 691,
    "source": "guideline_c3debd",
    "text": "52(2), 0327(96)00034-1 189 195.  Wickramaratne, P. J., Greenwald, S.,   Weissman, M. M. (2000). Wulson, L. R.,   Singal, B. M. (2003). Do depressive symptoms increase Psychiatric disorders in the relatives of probands with prepubertal- the risk for the onset of coronary disease? A systematic quantitative onset or adolescent-onset major depression. Journal of the American review. Psychosomatic Medicine, 65(2), 201 210. doi: 10.1097 01  Academy of Child and Adolescent Psychiatry, 39(11), 1396 1405. doi: PSY.0000058371.50240.E3 10.1097 00004583-200011000-00014 Yang, L. H.,   WonPat-Borja, A. J. (2007). Psychopathology among Asian Wiersma, J. E., Van Schaik, D. J. F., Hoogendorn, A. W., Dekker, J. J., Van, Americans. In F. T. L. Leong, A. Ebreo, L. Kinoshita, A. G. Inman,   L. H. L.,"
  },
  {
    "id": 692,
    "source": "guideline_c3debd",
    "text": "A. J. (2007). Psychopathology among Asian Wiersma, J. E., Van Schaik, D. J. F., Hoogendorn, A. W., Dekker, J. J., Van, Americans. In F. T. L. Leong, A. Ebreo, L. Kinoshita, A. G. Inman,   L. H. L., Schoevers, R. A., . . . Van Oppen, P. (2014). The effectiveness H. Yang (Eds.), Handbook of Asian American psychology (2nd ed.) (pp. of the cognitive behavioral analysis system of psychotherapy for 379 405). Thousand Oaks, CA: Sage. chronic depression: A randomized controlled trial. Psychotherapy and Yeung, A., Lepoutre, V., Wayne, P., Yeh, G., Slipp, L. E., Fava, M., . . . Psychosomatics, 83, 263 269. doi: 10.1159 000360795 Fricchione, G. L. (2012). Tai chi treatment for depression in Chinese Willemse, G. R. W. M., Smit, F., Cuijpers, P.,   Tiemens, B. G. (2004). Americans. American Journal of"
  },
  {
    "id": 693,
    "source": "guideline_c3debd",
    "text": "doi: 10.1159 000360795 Fricchione, G. L. (2012). Tai chi treatment for depression in Chinese Willemse, G. R. W. M., Smit, F., Cuijpers, P.,   Tiemens, B. G. (2004). Americans. American Journal of Physical Medicine   Rehabilitation, Minimal-contact psychotherapy for sub-threshold depression in 91(10), 863 870. doi: 10.1097 PHM.0b013e31826eaaae primary care. British Journal of Psychiatry, 185, 416 421. APA   Guideline for the Treatment of Depression 79 Young, J. F., Benas, J. S., Schueler, C. M., Gallop, R., Gillham, J. E.,   Mufson, L. (2016). A randomized depression prevention trial comparing interpersonal psychotherapy Adolescent skills training to group counseling in schools. Prevention Science, 17(3), 314 324. Zandberg, L. J., Rosenfield, D., Alpert, E., McLean, C. P.,   Foa, E. B."
  },
  {
    "id": 694,
    "source": "guideline_c3debd",
    "text": "interpersonal psychotherapy Adolescent skills training to group counseling in schools. Prevention Science, 17(3), 314 324. Zandberg, L. J., Rosenfield, D., Alpert, E., McLean, C. P.,   Foa, E. B. (2016) Predictors of dropout in concurrent treatment of posttraumatic stress disorder and alcohol dependence: Rate of improvement matters. Behaviour Research and Therapy, 80, 1 9. doi: 10.1016 j. brat.2016.02.005 Zhang, J., Chen, J., Chen, J., Li, X., Lai, X., Zhang, S.,   Wang, S. (2014). Early filiform needle acupuncture for poststroke depression: A meta- analysis of 17 randomized controlled clinical trials. Neural Regeneration Research, 9(7), 773 784. doi: 10.4103 1673-5374.131590 Zhang, W.-J., Yang, X.-B.,   Zhong, B.-L. (2009). Combination of acupuncture and fluoxetine for depression: A"
  },
  {
    "id": 695,
    "source": "guideline_c3debd",
    "text": "trials. Neural Regeneration Research, 9(7), 773 784. doi: 10.4103 1673-5374.131590 Zhang, W.-J., Yang, X.-B.,   Zhong, B.-L. (2009). Combination of acupuncture and fluoxetine for depression: A randomized, double-blind, sham-controlled trial. The Journal of Alternative and Complementary Medicine, 15(8), 837 844. doi: 10.1089 acm.2008.0607 Zhang, Z.-J., Chen, H.-Y., Yip, K-.C, Ng, R.,   Wong, V. T. (2010). The effectiveness and safety of acupuncture therapy in depressive disorders: Systematic review and meta-analysis. Journal of Affective Disorders, 124(1-2), 9 21.  Zhou, X., Hetrick, S. E., Cuijpers, P., Qin, B., Barth, J., Whittington, C. J., . . . Xie, P. (2015) Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and"
  },
  {
    "id": 696,
    "source": "guideline_c3debd",
    "text": "P., Qin, B., Barth, J., Whittington, C. J., . . . Xie, P. (2015) Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis. World Psychiatry, 14(2), 207 222. Zilcha-Mano, S., Chui, H., Dolev, T., McCarthy, K. S., Dinger, U.,   Barber, J. P. (2016a). Changes in causal attributions and relationship representations: Are they specific or common mechanisms in the treatment of depression? Journal of Affective Disorders, 193(15), 73 80.  Zilcha-Mano, S., Muran, J. C., Hungr, C., Eubanks, C. F., Safran, J. D.,   Winston, A. (2016b). The relationship between alliance and outcome: Analysis of a two-person perspective on alliance and session outcome. Journal of Consulting and Clinical Psychology, 84(6), 484"
  },
  {
    "id": 697,
    "source": "guideline_c3debd",
    "text": "Winston, A. (2016b). The relationship between alliance and outcome: Analysis of a two-person perspective on alliance and session outcome. Journal of Consulting and Clinical Psychology, 84(6), 484 496. 80 APA   Guideline for the Treatment of Depression APA   Guideline for the Treatment of Depression 81 82 APA   Guideline for the Treatment of Depression"
  }
]